Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123718-138132387	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0"	"Cell type enriched"	"Detected in single"	9	"Cholangiocytes: 2.5"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 2.5;stomach cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA008017	Enhanced				"Intracellular and membrane"	NA	NA					"HPA008017: AB_1078073"	"unprognostic (1.21e-1)"	"unprognostic (2.52e-1)"			"unprognostic (2.14e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.48e-3)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	25.9	0.1	0.1	0.1	1.5	0.4	0.3	0.1	0.1	0.1	0.2	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	25.0	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.6	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.6	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AADACL4		ENSG00000204518	"Arylacetamide deacetylase like 4"	Q5VUY2	1	12644547-12667086	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.8;epididymis: 3.5;vagina: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 2.1;REH: 1.0"					"Not detected"	"Not detected"									NA	NA									"unprognostic (3.20e-1)"								"unprognostic (1.89e-2)"						2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8			0.0	0.4	3.5	0.0	0.7	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.7	0.0		0.1	0.2	0.0	0.0	0.7		1.1	0.0		0.0	1.4	0.2	0.0	0.0	0.5	0.0	0.6	0.4	1.4			0.0		0.0	0.4	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 57.0;Hepatocytes: 97.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.2	1.5	0.0	0.0	13.1	25.1	0.0	5.1	14.3	2.9	5.1	0.0	5.1	0.0	0.8	6.4	15.6	0.1	0.0	5.9	5.8	0.0	0.0	0.0	0.3	0.1	25.7	0.0	0.0	29.6	1.6	10.5	29.6	24.8	13.1	0.0	0.0	2.3	17.0	2.8	0.0	0.0	0.0	0.4	20.1	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.7	0.4	0.4	0.0	32.8	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3	0.0	3.0	4.7	1.0	1.3	1.1	57.0	28.1	4.0	1.2	0.0	0.0	0.1	5.0	6.8	1.8	20.2	0.0	0.0	3.0	0.6	2.1	2.2	1.1	97.0	9.3	27.0	0.0	20.3	11.9	0.0	0.3	0.8	5.0	0.0	0.0	19.7	14.9	0.0	0.7	18.3	21.8	0.0	2.3	1.7	2.3	1.4	0.3	0.0	0.0	4.9
ABR	MDB	ENSG00000159842	"Active BCR-related"	Q12979	17	1003518-1229021	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.6"	"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 8.9"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.8;hTERT-RPE1: 20.2;LHCN-M2: 12.6;RPMI-8226: 10.8;TIME: 20.9;U-251 MG: 21.0;U-698: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053618, HPA054824"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA053618: AB_2682208, HPA054824: AB_2682616"	"unprognostic (1.69e-1)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.20e-3)"	"unprognostic (4.43e-3)"	"prognostic favorable (2.21e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.74e-2)"	12.9	5.8	31.8	18.0	28.7	6.0	5.8	7.0	43.6	6.6	19.9	12.0	2.3	9.4	7.9	4.0	11.0	6.1	6.7	26.6	24.0	16.9	6.8	4.0	9.3	6.9	14.1	27.0	3.9	5.0	8.3	6.0	7.2	11.3	4.6	21.6	19.4	23.7	3.4	2.9	5.9	11.9	25.1	8.1	8.1	13.6	3.8	11.3	2.9	7.0	2.3	18.0	7.2	7.4	0.3	0.7	8.9	0.8	0.0	0.8	0.0	0.5	0.6	0.2	0.0	0.9	0.1	0.5	0.1	0.1	0.0	0.0	0.4	0.0	18.8	0.3	0.1	0.8	0.0	2.0	0.0	0.4	5.8	10.2	0.0	0.2	0.0	0.4	2.3	6.7	0.2	0.0	0.1	6.7	20.2	0.0	0.0	0.0	0.0	12.6	0.7	0.0	2.5	0.1	0.4	0.1	0.1	0.0	10.8	0.1	0.2	0.2	0.3	0.0	0.0	1.0	0.0	5.9	2.9	20.9	0.1	0.2	2.1	21.0	0.0	0.2	15.4	1.0	4.1	0.4	8.9	0.3	1.0	0.2	0.8	0.4	0.1	0.3	0.0	0.7	0.3	0.0	0.3	0.9	0.0	0.4	0.0	0.8	0.0	31.8	28.7	7.0	43.6	24.0	16.9	14.1	27.0	11.3	11.3	29.8	21.1	7.8	15.2	15.1	60.3	21.8	25.5	10.7	17.0	1.8	2.0	1.9	0.0	15.6	33.8	21.5	39.3	0.0	5.5	2.5	13.4	17.6	18.5	0.8	27.7	11.1	14.5	18.4	24.0	112.5	12.7	28.3	18.6	18.0	35.9	29.4	29.8	25.9	8.9	5.8	18.0	38.8	21.7	1.9	7.5	14.8	1.8	13.8	49.9	22.6
AC004754.1		ENSG00000269881			16	249547-269943	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"intestine: 15.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.4;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5;hTERT-RPE1: 2.9"									"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-2)"	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.3	0.6	0.6	0.2			15.3	0.3	0.3	0.1	0.2	0.0	0.9	0.4	1.4	0.3	0.1	0.0	0.0	0.7		0.1	1.7	0.0	0.2	0.0		0.2	0.0		0.0	0.3	1.0	0.1	7.4	0.2	0.7	0.0	0.1	0.9			0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.4	1.8	2.4	2.4	0.5	0.0	1.2	0.0	0.1	0.3	0.1	0.0	5.1	1.1	0.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	1.0	0.0	0.2	1.0	2.9	0.7	0.1	0.0	0.3	0.0	2.1	0.0	0.2	1.2	0.6	0.0	1.3	0.0	0.0	0.9	0.0	0.3	1.0	0.0	0.0	0.4	0.2	1.0	0.6	0.0	0.4	0.0	1.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.8	0.0	0.5	1.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
AC008878.1		ENSG00000267952			19	7507052-7519622	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"retina: 19.5;skeletal muscle: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AF22: 9.8;ASC diff: 11.1;fHDF/TERT166: 11.9;hTERT-RPE1: 14.2;SuSa: 11.1"															NA	NA															"unprognostic (4.56e-1)"							"unprognostic (8.56e-2)"	2.1	2.0	3.1	1.2	6.3	1.6	3.5	4.9	6.8	0.4	1.9	0.9	1.2	0.4	2.6	0.4	2.5	2.2	2.0	1.5	2.2	1.8	5.4	1.5	1.9	0.6	3.9	1.0	1.7	0.4	0.4	0.6	0.9	3.3	0.8	1.7	19.5	0.7	0.6	21.3	0.9	1.7	0.7	7.1	2.4	1.2	1.0	2.5	0.0	2.0	0.0	0.4	0.9	2.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	9.8	1.1	11.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.6	0.0	1.0	2.3	6.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	14.2	4.0	0.0	0.0	0.0	2.7	0.6	0.1	0.0	0.2	2.7	0.0	2.4	3.5	1.7	3.6	0.0	0.0	3.0	1.1	1.0	0.0	11.1	0.5	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.1	6.3	4.9	5.2	2.2	1.8	3.9	1.0	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC011462.1		ENSG00000255730			19	41350853-41425001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"blood: 24.8"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 2: 1.7;Ciliated cells: 1.4;granulocytes: 2.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"basal ganglia: 19.9"	"Cell type enhanced"	"Detected in many"		"classical monocyte: 24.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.3;SK-MEL-30: 8.3;THP-1: 14.7"					"Low region specificity"	"Detected in all"			HPA036640	Approved					NA	NA					"HPA036640: AB_10671964"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"		"unprognostic (2.65e-1)"		"unprognostic (3.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.18e-8)"	"unprognostic (8.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.97e-2)"	5.0	5.8	1.7	6.2	19.9	10.5	3.6	1.5	8.0	6.6	3.5	0.8	0.6	1.3	5.4	2.1	3.9	5.3	0.7	3.1	1.5	2.6	4.7	3.3	5.9	3.8	2.4	2.9	3.1	3.5	3.3	3.1	2.5	3.1	5.5	0.7	2.3	1.7	1.9	9.0	9.2	1.9	5.4	2.3	4.5	2.5	7.3	2.6	0.0	2.9	1.7	3.2	10.5	7.5	1.0	11.8	8.2	24.8	1.4	5.6	15.7	3.0	0.0	5.9	2.5	1.6	0.2	1.7	1.7	1.4	0.8	0.0	0.0	3.9	0.0	3.2	2.1	1.9	0.1	0.0	0.9	1.2	1.6	1.6	3.9	0.1	1.1	4.8	0.7	0.4	3.8	3.6	1.5	7.6	9.3	2.8	0.0	0.9	5.6	0.0	0.0	4.2	5.1	0.8	0.0	0.0	1.7	0.0	0.3	0.5	0.0	0.0	3.7	0.8	0.0	8.3	2.8	1.1	14.7	0.5	0.0	2.8	0.4	0.0	4.7	0.0	0.1	1.8	3.8	0.1	6.2	24.8	1.5	3.9	9.2	4.3	0.6	3.7	2.9	11.8	1.0	5.6	3.1	8.2	1.4	7.2	8.1	4.0	15.7	1.7	19.9	1.5	5.0	1.5	2.6	2.4	2.9	3.1	2.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC012309.1		ENSG00000267360			19	37093019-37210512	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 2.6;thyroid gland: 2.7"	"Cell type enhanced"	"Detected in single"	32	"Club cells: 1.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"T-reg: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.2;hTERT-RPE1: 2.2;LHCN-M2: 1.9;MOLT-4: 1.6;SCLC-21H: 2.5"															NA	NA						"unprognostic (2.21e-2)"	"unprognostic (1.81e-1)"		"unprognostic (7.33e-2)"	"unprognostic (1.96e-1)"			"unprognostic (2.68e-1)"		"unprognostic (2.08e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.09e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.36e-1)"	1.1	0.0	0.6	0.0	1.0	0.2	0.2	0.6	2.6	0.9	0.6			0.0	0.5	0.0	0.0	0.4	1.5	1.1	0.6	0.3	0.1	0.0	0.1	1.7	0.7		0.1	0.0	0.0	0.1	0.2		0.1	0.0		0.0	0.0	0.5	1.2	0.1	0.0	0.4	0.4	0.3	1.3			2.7		0.0	0.2	0.3	0.8	0.2	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.0	0.0	1.9	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0											0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC068580.4		ENSG00000250644			11	1734821-1763954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"adrenal gland: 84.9"	"Group enriched"	"Detected in some"	17	"Alveolar cells type 2: 1.7;Ciliated cells: 4.0;granulocytes: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.8;hTERT-RPE1: 46.3;SH-SY5Y: 14.5;U-87 MG: 17.5"									HPA003001	Uncertain					NA	NA					"HPA003001: AB_1078404"	"unprognostic (5.71e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-6)"	"unprognostic (1.77e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.35e-2)"	"unprognostic (5.79e-5)"	"unprognostic (7.47e-2)"	33.3	84.9	5.0	5.4	5.1	15.6	13.8	12.2	25.7	7.5	8.3	7.6	7.9	5.1	7.0	9.9	6.9	5.3	17.6	18.3	5.6	8.8	32.5	35.5	22.2	17.0	9.7	4.3	7.8	12.5	3.7	4.0	11.1	8.0	6.1	4.4	50.8	20.6	22.6	14.3	10.5	19.1	3.8	7.6	16.7	7.4	7.0	5.2	3.3	6.8	8.9	7.7	13.7	8.3	0.5	3.8	7.6	6.9	8.1	2.0	4.7	0.3	2.5	0.1	0.5	0.9	0.5	0.6	0.7	1.0	0.2	0.3	0.6	63.8	0.1	0.9	3.0	2.0	4.5	0.0	0.0	0.0	0.2	0.9	0.4	0.4	0.2	1.1	0.6	1.4	2.3	0.7	0.3	0.3	46.3	0.1	0.2	0.0	1.0	5.2	6.2	0.0	0.7	0.2	2.4	0.2	0.1	0.9	0.4	2.5	2.8	0.2	14.5	0.2	4.8	9.0	0.1	11.3	0.2	1.5	3.2	0.4	0.7	1.0	2.8	6.3	0.1	17.5	0.5	2.7	1.5	6.9	2.1	1.9	3.2	1.4	0.5	1.0	1.1	2.1	0.2	1.5	2.0	7.6	8.1	4.3	3.8	1.1	4.7	5.0	5.1	12.2	10.5	5.6	8.8	9.7	4.3	8.0	5.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AC073610.3		ENSG00000272822			12	48903503-48957365	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;hTERT-RPE1: 8.0"									HPA068942			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA068942: AB_2732124"	"unprognostic (7.48e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.66e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.01e-12)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.06e-2)"	6.8	3.4	10.5	2.2	20.7	3.6	4.6	7.7	27.5	6.4	4.9	6.3	2.6	2.2	9.7	7.3	5.1	4.7	7.6	7.2	8.8	7.2	5.0	4.1	5.5	5.5	5.7	13.7	6.1	7.4	2.2	5.3	3.3	10.6	5.4	4.6	3.5	4.8	4.5	3.4	4.4	4.2	10.6	4.6	4.7	4.0	8.4	4.3	3.3	5.0	2.3	4.4	4.9	3.9	0.8	1.8	1.1	1.1	1.3	3.2	2.0	1.0	0.4	3.8	2.9	4.1	1.6	0.0	1.6	7.9	2.3	1.0	0.0	1.1	1.1	2.4	1.4	2.5	0.4	1.4	0.0	2.1	5.1	0.6	1.1	0.6	0.0	2.8	0.0	1.1	0.4	2.0	0.6	1.3	8.0	1.0	1.9	0.1	1.4	1.3	0.4	0.2	0.6	0.0	2.1	1.1	2.2	0.6	0.2	0.2	0.3	1.9	0.5	0.9	0.7	0.8	0.7	0.2	0.5	4.3	0.7	0.5	0.2	0.5	2.0	0.3	0.7	1.8	1.1	0.4	0.9	1.1	0.3	2.7	0.4	3.2	0.6	0.9	1.8	0.9	0.8	2.3	2.6	1.1	1.3	0.4	1.8	0.5	2.0	10.5	20.7	7.7	27.5	8.8	7.2	5.7	13.7	10.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
AC093668.1		ENSG00000270249			7	102541501-102592444	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"parathyroid gland: 6.9"	"Cell type enriched"	"Detected in single"	12	"Club cells: 1.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0"									HPA046970			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA046970: AB_2679882"																		0.4	0.7	0.6	0.8	0.6	0.7	0.4	3.1	1.1	1.0	1.0			2.5	0.9	2.5	0.4	0.6	0.0	0.3	0.6	0.5	1.4	0.1	0.7	0.5	0.3		0.7	1.2	6.9	2.9	0.4		0.5	0.6		1.1	0.2	5.4	1.7	1.4	0.0	0.3	1.3	1.1	0.2			0.3		0.1	0.4	0.7	4.0	3.5	1.3	1.0	0.7	5.3	1.2	0.1	0.0	1.0	0.2	0.2	3.7	0.5	1.1	0.7	0.6	0.0	0.0	2.1	2.3	0.7	1.6	0.4	0.8	0.0	0.0	0.0	0.7	0.0	1.3	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.2	0.0	4.0	0.0	0.4	2.6	1.3	0.5	2.3	1.0	1.4	0.0	0.5	0.3	0.8	1.5	1.2	0.0	0.0	0.2	1.7	0.5	0.0	0.0	0.0	0.1	0.3	0.0	1.8	1.5	0.4	0.4	1.0	0.0	0.0	0.7	0.4	2.9	0.9	4.1	4.0	3.8	2.9	1.7	3.1	5.3	3.0	1.3	0.7	1.0	3.5	5.1	1.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACSS3	FLJ21963	ENSG00000111058	"Acyl-CoA synthetase short chain family member 3"	Q9H6R3	12	80936414-81261205	"Enzymes, Predicted membrane proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 42.8;Hepatocytes: 47.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 8.3;neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 9.4;ASC TERT1: 10.7;Hep G2: 26.5;hTERT-RPE1: 9.1;RH-30: 12.3;SK-BR-3: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039353, HPA047956, HPA061517"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039353: AB_2676460, HPA047956: AB_2680223, HPA061517: AB_2684549"	"unprognostic (8.59e-2)"	"unprognostic (9.29e-4)"	"unprognostic (1.47e-1)"	"unprognostic (9.37e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (6.16e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-4)"	19.6	18.3	7.4	1.9	8.3	1.0	8.1	2.7	7.7	13.2	2.6	5.5	10.8	1.2	18.2	14.4	2.0	8.3	8.1	10.9	6.4	3.9	24.4	37.1	8.8	1.7	7.4	6.5	16.7	2.6	21.3	11.0	4.1	6.5	7.1	1.6	10.3	20.4	11.4	9.8	2.1	1.9	6.6	5.5	2.8	1.9	4.0	4.1	0.0	9.2	2.9	1.6	3.5	6.3	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.1	2.2	0.0	9.4	10.7	0.0	1.5	7.0	1.1	1.2	0.3	0.0	0.1	0.0	3.1	3.3	0.1	0.0	0.0	0.7	0.0	1.7	0.0	0.1	26.5	3.2	0.3	0.0	7.2	0.0	0.3	0.0	9.1	0.2	0.0	0.0	0.0	5.0	0.6	0.0	0.1	3.2	0.0	0.0	0.0	12.3	1.7	0.0	0.0	2.1	0.0	0.0	11.6	0.0	4.8	5.2	0.3	0.0	1.9	1.8	0.2	0.7	0.1	0.1	0.0	2.3	0.0	2.1	8.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	7.4	8.3	2.7	7.7	6.4	3.9	7.4	6.5	6.5	4.1	20.8	42.8	0.0	7.0	0.8	31.6	19.3	15.3	6.7	5.7	12.2	3.9	1.3	5.0	4.0	33.3	1.0	0.0	0.0	2.6	0.6	4.3	4.4	0.0	47.4	0.6	27.0	0.0	3.1	2.4	6.4	22.2	0.4	0.0	0.0	0.0	19.7	0.2	0.0	22.3	26.7	4.5	6.5	5.7	4.2	0.5	0.1	0.5	0.0	0.0	2.0
ACTA2	ACTSA	ENSG00000107796	"Actin, alpha 2, smooth muscle, aorta"	P62736	10	88935074-88991339	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Peritubular cells: 4973.4;Sertoli cells: 2981.6;Smooth muscle cells: 1930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 54.8;fHDF/TERT166: 84.7;HHSteC: 87.2;HSkMC: 47.9;hTERT-RPE1: 101.9;SuSa: 42.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 143.1"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"		NA	NA			"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	48.1	9.5	1.6	76.4	5.2	0.0	40.0	1.2	7.5	264.5	121.9	5.4	120.3	9.4	332.1	158.2	209.0	151.1	204.3	51.7	1.7	1.8	38.1	12.8	36.5	19.1	3.6	6.4	136.5	3.9	1.9	2.8	52.8	11.8	188.5	35.9	55.2	31.8	251.1	19.9	16.3	32.1	378.4	3.3	44.0	82.3	84.9	1.5	2.2	17.8	24.9	12.8	354.7	71.3	3.3	5.5	10.5	6.7	1.8	29.5	5.0	0.5	2.5	6.7	13.8	27.5	54.8	1.2	14.6	18.3	1.6	6.2	0.0	1.1	0.9	1.5	84.7	1.1	0.1	0.2	3.3	1.5	7.8	1.5	0.0	0.7	15.5	87.2	0.1	0.4	47.9	6.1	10.0	3.9	101.9	1.5	0.4	0.0	0.9	17.2	1.4	0.1	3.6	0.3	0.0	0.1	0.1	0.0	0.5	3.6	0.6	0.0	1.0	1.3	1.0	0.1	42.3	4.3	0.1	3.7	3.2	0.5	4.1	1.2	2.8	0.2	0.0	4.0	1.3	3.4	10.5	6.5	8.7	9.6	4.4	7.6	3.3	7.9	10.8	5.5	1.0	0.9	6.1	5.7	1.8	6.7	0.2	29.5	5.0	1.6	5.2	1.2	7.5	1.7	1.8	3.6	6.4	11.8	1.5	8.9	6.7	0.0	22.3	38.4	1.3	21.9	2.5	9.4	2.3	0.0	5.9	15.0	1.7	1.3	7.5	27.9	2.1	0.0	0.8	12.2	105.9	12.2	5.7	3.4	33.5	0.0	0.0	763.0	3.5	21.9	130.9	9.2	52.3	2.8	1.9	12.7	2.3	3.5	4973.4	7.9	1.1	2981.6	1930.6	2.3	13.3	35.4	19.8	15.8	6.6	8.5
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin, beta like 2"	Q562R1	5	57480016-57482809	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4"	"Cell type enhanced"	"Detected in some"	15	"Ductal cells: 1.3;Early spermatids: 2.3;Pancreatic endocrine cells: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;hTERT-RPE1: 3.4;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain					NA	NA		2600000000			"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.8	0.0	0.0	1.2	0.1	0.1	3.4	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.8	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	6.8	0.6	0.0	0.6	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.3	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM23	MDC3	ENSG00000114948	"ADAM metallopeptidase domain 23"	O75077	2	206443539-206621130	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.5;heart muscle: 19.3;parathyroid gland: 67.6"	"Cell type enhanced"	"Detected in many"	18	"Bipolar cells: 28.0;Cardiomyocytes: 52.9;Late spermatids: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 5.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;RH-30: 21.9;RPMI-8226: 57.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033276	Approved				"Intracellular and membrane"	NA	NA		24000			"CAB033276: AB_2305247"	"unprognostic (7.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.03e-3)"	2.0	4.7	8.5	2.5	30.5	2.3	1.7	14.2	27.4	3.4	2.4	3.4	0.3	2.0	2.5	3.8	3.8	1.2	4.0	19.3	8.7	11.4	1.5	1.4	2.0	2.3	9.8	13.5	2.4	5.7	67.6	4.8	1.0	22.4	1.8	2.6	2.4	1.5	2.8	8.1	1.6	2.4	4.2	3.9	1.4	2.0	6.5	4.0	0.8	1.3	1.6	2.7	3.2	2.4	0.4	0.0	0.0	0.0	0.0	5.7	0.4	0.0	0.3	7.6	0.0	4.1	6.1	0.3	0.8	0.9	1.1	0.2	8.9	0.1	1.0	0.0	1.2	13.6	11.4	4.9	0.2	0.1	4.3	4.2	0.0	0.6	0.1	4.0	0.0	0.5	2.2	0.0	0.0	0.0	18.8	13.3	0.4	0.0	0.0	2.8	0.1	0.1	0.0	15.0	0.1	1.5	0.0	21.9	57.1	0.0	5.5	6.0	2.4	0.0	0.0	4.2	3.9	0.0	0.0	11.5	3.8	3.6	2.0	1.7	15.5	0.0	0.0	7.3	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.5	30.5	14.2	25.6	8.7	11.4	9.8	13.5	22.4	4.0	0.0	0.0	0.0	0.7	0.3	28.0	52.9	0.0	1.4	0.0	1.8	2.0	0.0	0.0	0.0	9.9	2.1	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	3.2	1.7	0.0	0.0	20.6	0.6	0.0	3.3	0.0	0.0	3.5	0.1	0.0	2.8	0.0	6.0	0.0	0.4	4.5	3.6	0.4	0.1	0.0	0.0	0.1
ADAMTS10	ADAM-TS10	ENSG00000142303	"ADAM metallopeptidase with thrombospondin type 1 motif 10"	Q9H324	19	8580242-8610735	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 7.6;Ductal cells: 6.3;Leydig cells: 6.9;Sertoli cells: 6.5;Smooth muscle cells: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.5;hTERT-RPE1: 5.9;NB-4: 28.4;REH: 7.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 5.4"	"Low region specificity"	"Detected in all"			HPA040223	Uncertain				"Secreted to extracellular matrix"	NA	NA					"HPA040223: AB_10795376"	"unprognostic (2.60e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.91e-4)"	"unprognostic (4.98e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (6.86e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-2)"	13.8	7.1	15.2	8.5	8.0	6.0	8.2	1.8	14.0	10.2	5.7	5.5	3.2	3.9	13.4	5.1	3.4	8.5	7.7	7.0	12.5	8.2	6.9	5.4	8.0	11.1	6.8	11.5	8.0	7.1	1.8	3.8	6.8	7.6	7.6	2.8	10.6	4.8	6.7	9.2	10.0	6.4	6.3	7.6	7.5	3.5	3.0	5.7	5.7	5.5	3.0	5.7	4.6	8.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	3.6	1.9	0.0	0.3	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	4.5	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	5.9	0.1	0.2	0.1	0.0	0.0	0.0	0.3	28.4	1.4	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	1.0	0.1	0.3	1.7	2.6	3.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.7	0.0	0.5	0.0	0.0	0.0	0.1	15.2	8.0	1.8	14.0	12.5	8.2	6.8	11.5	7.6	5.7	0.0	0.0	0.0	0.6	1.4	0.1	1.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.5	4.0	0.0	0.0	0.4	0.0	4.2	0.1	0.0	0.9	0.9	0.0	0.0	4.9	2.1	1.4	6.9	2.8	0.0	1.0	0.1	0.8	0.6	0.0	5.6	0.0	0.1	6.5	6.2	0.1	0.4	0.6	0.3	1.3	0.0	0.3
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	16	"Ito cells: 17.8;Leydig cells: 20.4;Peritubular cells: 16.6;Sertoli cells: 51.8;Smooth muscle cells: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 20.2;hTERT-RPE1: 36.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"	NA	NA			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: AB_2732278"	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavorable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.4	0.3	10.4	0.0	15.4	7.3	0.0	5.4	13.9	7.1	8.8	0.0	0.0	0.0	0.0	3.7	12.6	0.3	0.2	7.0	10.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	5.8	0.0	20.2	5.3	36.2	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	12.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	12.2	15.6	0.1	3.2	1.8	1.3	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.8	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.2	3.3	0.4	0.0	0.0	0.2	0.2	12.8	0.1	0.0	0.0	0.5	0.0	0.0	17.8	0.3	2.5	20.4	0.0	6.8	0.0	0.0	6.7	0.2	0.0	16.6	2.2	0.2	51.8	14.2	0.2	1.7	0.6	0.7	0.0	0.0	0.1
ADAMTS15		ENSG00000166106	"ADAM metallopeptidase with thrombospondin type 1 motif 15"	Q8TE58	11	130448974-130476641	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 47.4"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 9.6;Fibroblasts: 8.2;Leydig cells: 4.6;Melanocytes: 3.3;Smooth muscle cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 36.6;ASC TERT1: 22.1;EFO-21: 18.4;hTERT-RPE1: 9.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA042867	Uncertain		Approved	Cytosol	"Secreted to extracellular matrix"	NA	NA			Cytosol		"HPA042867: AB_10794535"	"unprognostic (7.64e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.07e-3)"	"unprognostic (7.07e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.95e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.63e-5)"	47.4	1.1	0.2	1.7	0.3	0.1	14.5	0.1	0.8	3.4	3.8	0.8	3.0	0.6	3.7	9.8	3.8	9.3	9.1	12.6	0.4	0.3	9.1	0.4	6.6	5.6	0.8	0.2	7.0	1.6	0.9	1.0	16.4	1.3	3.7	2.1	10.9	1.0	1.3	1.6	4.1	3.1	6.9	1.4	1.9	4.9	2.4	0.6	0.7	9.8	2.5	0.8	8.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.4	36.6	22.1	0.0	1.3	2.6	0.5	0.1	0.2	0.6	0.0	18.4	0.1	1.3	3.4	0.3	0.3	0.1	0.0	0.8	0.0	1.6	0.0	0.3	0.0	0.0	7.2	0.0	0.3	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	2.8	0.0	2.0	0.0	0.0	0.0	0.3	0.0	5.9	0.0	0.0	2.7	1.9	0.0	0.0	0.3	4.3	3.5	1.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.4	0.3	0.8	0.2	1.3	0.6	0.0	0.0	0.0	0.1	0.5	0.0	9.6	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.5	8.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.6	0.0	3.3	0.0	0.5	0.0	0.7	0.0	0.7	0.8	0.0	0.0	3.3	0.1	0.3	0.3	0.7	0.0	2.1	0.0
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79006718	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.9"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 232.9;Ito cells: 348.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 19.6;HUVEC TERT2: 64.3;RPTEC TERT1: 14.0;TIME: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		1800000			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	98.9	4.7	3.6	5.6	5.7	0.0	43.8	3.2	6.1	14.6	7.8	1.5	6.6	2.8	12.9	7.1	12.4	6.8	12.3	12.3	4.3	3.7	11.3	8.8	16.2	8.5	5.4	1.4	9.3	3.0	5.7	7.8	12.8	6.2	12.2	3.6	5.9	4.8	5.7	16.1	5.3	4.8	16.0	4.7	34.8	4.9	6.8	4.3	1.1	13.9	8.0	3.9	16.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.6	5.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.8	0.0	11.1	0.0	19.6	64.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	78.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.7	3.2	6.1	4.3	3.7	5.4	1.4	6.2	4.3	0.0	8.9	2.2	0.3	0.0	0.0	4.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	232.9	0.0	0.0	0.2	0.0	0.3	1.1	0.0	2.0	0.5	1.6	0.0	348.0	29.4	42.9	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	1.2	1.4	1.1	0.0	0.0	0.0	0.0	0.6
ADHFE1	"ADHFe1, FLJ32430"	ENSG00000147576	"Alcohol dehydrogenase, iron containing 1"	Q8IWW8	8	66430185-66471601	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 44.5"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	12.5	3.2	10.3	2.2	9.7	1.8	4.3	2.2	10.7	5.9	3.8	10.9	4.8	2.7	4.2	8.6	3.1	5.9	5.0	34.6	6.9	5.4	11.8	44.5	3.6	2.3	8.6	7.5	5.2	8.3	11.6	9.8	3.7	6.9	7.3	3.1	10.7	6.6	10.5	35.7	2.4	2.4	6.9	4.8	2.8	8.6	3.2	7.3	0.0	4.5	12.9	2.5	6.2	1.9	1.3	0.4	3.4	1.1	2.2	2.6	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	0.4	0.3	0.0	0.0	1.7	0.0	0.0	0.7	0.3	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.0	3.0	0.0	0.2	2.7	0.0	0.0	1.3	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.2	0.9	0.0	0.5	1.2	1.4	2.0	0.0	0.0	0.3	0.2	0.0	0.0	1.2	0.1	0.1	0.8	0.0	0.3	3.4	1.1	0.0	2.6	0.0	2.4	1.3	0.5	2.2	0.4	0.8	0.7	2.2	0.1	2.2	0.0	0.3	0.0	0.6	10.3	9.7	2.2	7.8	6.9	5.4	8.6	7.5	6.9	7.3	8.9	12.4	2.7	3.8	0.9	1.4	32.1	15.3	20.1	13.6	8.7	9.8	7.1	10.0	1.1	0.3	1.6	2.0	0.0	0.6	0.8	2.7	4.3	8.1	23.7	2.1	0.0	3.5	7.4	1.0	1.0	22.2	1.4	0.0	0.0	1.5	6.7	0.8	5.8	25.5	10.9	7.6	0.0	3.3	0.2	0.2	0.9	97.4	8.7	1.8	2.0
AL049634.2		ENSG00000260861			20	1540144-1620009	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.0;blood: 36.1;lymphoid tissue: 21.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 22.5;neutrophil: 36.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.1;monocytes: 11.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 5.3;HMC-1: 11.3;hTERT-RPE1: 2.4;NB-4: 3.7;THP-1: 4.3;U-937: 3.2"															NA	NA																							18.0	2.4	0.9	6.0	3.8	6.4	0.8	0.7	7.5	0.8	0.8	1.1	0.0	0.6	0.9	1.0	0.8	0.7	0.9	5.2	1.4	1.1	0.8	5.4	14.7	14.8	4.7	0.1	1.0	1.0	0.0	0.7	2.5	2.4	0.8	0.3	0.9	0.9	1.0	0.9	0.8	1.5	1.4	5.2	21.9	0.8	4.6	2.6	1.5	0.8	0.0	1.8	1.6	1.0	0.0	3.8	36.1	11.3	0.0	0.2	5.9	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	0.0	0.1	0.4	0.0	2.4	0.0	0.1	0.0	0.0	0.2	0.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	4.3	1.4	0.0	0.0	0.3	1.7	0.1	0.0	0.1	0.1	3.2	0.1	0.2	11.1	22.5	0.2	8.2	0.1	0.0	0.0	0.1	3.8	0.0	0.0	0.0	36.1	0.0	11.3	3.4	0.0	5.9	0.9	3.8	0.7	2.0	1.4	1.1	4.7	0.1	2.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL355315.1		ENSG00000249967			10	97584374-97673910	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"kidney: 22.2;liver: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;EFO-21: 3.4;GAMG: 2.8;HBEC3-KT: 2.6;hTERT-RPE1: 5.1"									HPA076857			Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA076857: AB_2686817"																		2.4	1.1	1.9	0.3	2.3	0.3	1.0	4.6	3.3	1.9	0.9	5.5	0.6	0.3	1.1	2.5	0.8	2.7	2.3	4.9	2.6	1.0	22.2	15.1	0.8	0.3	6.4	3.3	0.8	2.4	5.7	0.9	0.6	4.8	0.8	0.3	2.1	0.8	3.9	2.2	0.9	0.8	0.8	5.5	0.9	0.9	0.9	4.6	0.0	0.8	2.5	0.4	1.0	0.9	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	3.2	0.0	1.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	3.4	0.5	2.8	1.7	0.0	2.6	1.8	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.6	0.0	1.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.9	2.3	4.6	2.3	2.6	1.0	6.4	3.3	4.8	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALDH1A3	"ALDH6, RALDH3"	ENSG00000184254	"Aldehyde dehydrogenase 1 family member A3"	P47895	15	100877714-100916626	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Glandular cells: 329.1;Leydig cells: 180.1;Peritubular cells: 127.3;Urothelial cells: 421.1"	"Group enriched"	"Detected in many"	7	"melanoma: 16.8;prostate cancer: 80.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 1.0;eosinophil: 2.1;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.6;HaCaT: 53.0;HBEC3-KT: 131.3;hTERT-RPE1: 43.5;U-2197: 75.5;U-87 MG: 60.0;WM-115: 62.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA046271, HPA064749"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA046271: AB_10965992, HPA064749: AB_2685344"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.20e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (6.07e-3)"	30.3	5.7	2.3	14.9	1.6	0.0	11.1	4.1	2.6	14.2	11.5	1.6	10.5	5.2	5.9	37.9	10.5	11.5	15.0	6.1	2.1	2.0	3.7	1.7	4.2	5.5	2.6	1.7	9.0	7.4	3.2	13.2	5.1	3.9	51.9	3.2	49.9	41.5	19.2	6.1	1.7	15.6	14.2	6.4	1.5	5.3	15.9	0.7	0.6	0.9	15.2	18.9	18.0	9.8	0.3	1.5	2.1	0.2	0.0	0.0	0.1	42.6	5.7	0.0	0.0	9.4	4.2	0.1	0.3	0.3	0.2	0.1	0.1	34.1	0.3	0.5	11.5	6.8	53.0	1.0	131.3	0.8	0.0	0.2	0.2	2.3	0.0	3.2	0.1	0.2	3.0	3.6	2.9	0.5	43.5	0.4	0.0	0.0	0.3	0.2	0.4	0.0	0.2	1.1	1.1	34.7	0.0	0.5	0.2	0.0	35.8	0.0	3.0	13.2	11.7	4.0	0.4	1.1	0.3	6.7	0.0	0.1	75.5	1.6	0.0	0.4	0.2	60.0	0.0	62.0	1.0	0.2	2.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.1	2.3	1.6	4.1	2.6	2.1	2.0	2.6	1.7	3.9	0.7	14.9	7.5	0.0	119.5	0.6	0.0	1.2	0.0	38.8	62.6	97.7	0.0	7.4	3.3	68.6	0.8	5.6	0.2	0.0	1.2	0.3	4.7	329.1	5.7	0.0	1.0	0.0	3.4	1.3	0.0	2.5	180.1	1.3	0.0	1.0	1.5	0.0	18.3	0.0	127.3	0.5	0.0	12.9	0.9	0.5	0.7	1.4	4.1	0.0	0.2	421.1
AMIGO2	"ALI1, DEGA"	ENSG00000139211	"Adhesion molecule with Ig like domain 2"	Q86SJ2	12	47075707-47079951	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.4"	"Cell type enhanced"	"Detected in many"	8	"Intestinal endocrine cells: 58.0;Ito cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 40.9;fHDF/TERT166: 39.3;hTERT-RPE1: 69.7;LHCN-M2: 39.3;RT4: 53.8;U-2 OS: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054004, HPA059601"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	Yes		160000	"Golgi apparatus, Plasma membrane"	Cytosol	"HPA054004: AB_2682339, HPA059601: AB_2684078"	"unprognostic (2.63e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (2.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.29e-3)"	5.6	11.9	5.4	4.0	8.8	1.4	14.5	1.6	6.5	18.3	20.3	3.5	1.9	1.6	19.7	12.4	3.1	21.2	12.4	3.4	2.7	7.5	4.3	2.9	11.9	6.7	2.9	5.1	43.4	2.3	2.0	9.5	7.6	16.2	12.8	5.6	6.7	3.1	7.1	1.5	2.3	7.1	21.0	3.0	9.8	3.5	13.1	3.6	1.6	2.5	4.1	4.5	16.6	15.1	2.8	7.4	0.1	0.2	6.6	14.2	4.3	9.0	22.5	1.4	0.0	0.5	0.0	3.7	3.1	8.5	1.0	0.8	0.0	40.9	0.0	10.3	39.3	25.8	13.6	0.0	25.1	1.2	1.7	0.1	0.0	2.2	0.0	0.8	0.2	0.3	0.2	4.4	26.9	13.3	69.7	3.2	0.2	1.7	0.0	39.3	0.4	0.7	0.0	0.9	4.5	5.7	0.0	10.1	0.0	11.6	53.8	4.1	0.0	16.2	1.9	0.1	0.8	2.4	0.2	0.8	0.5	32.6	0.3	25.1	0.3	0.0	0.0	2.1	0.7	0.6	0.0	0.1	0.0	4.0	0.2	5.4	2.8	6.2	6.2	0.6	1.3	14.2	11.1	0.1	6.6	0.0	7.4	3.6	4.3	5.4	8.8	1.6	6.5	2.7	7.5	2.9	5.1	16.2	3.6	8.9	1.9	5.9	10.4	2.2	21.1	0.8	0.0	2.7	6.8	1.8	0.0	0.7	1.7	4.3	1.2	4.5	0.0	0.0	17.0	23.1	6.7	5.2	6.9	0.8	4.4	0.0	58.0	30.7	3.8	0.9	2.3	2.3	1.7	8.2	2.5	14.9	26.7	0.8	0.7	0.0	4.1	0.0	25.5	0.3	0.7	0.4	7.1	4.4	0.2	13.4
ANKRD1	"ALRP, C-193, CARP, CVARP, MCARP"	ENSG00000148677	"Ankyrin repeat domain 1"	Q15327	10	90912096-90921276	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	81	"heart muscle: 398.9;skeletal muscle: 333.3"	"Cell type enriched"	"Detected in some"	15	"Cardiomyocytes: 12578.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038736	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA038736: AB_2676184"	"unprognostic (2.45e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.39e-1)"	"unprognostic (9.14e-3)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.72e-5)"	"unprognostic (3.40e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.16e-3)"	1.5	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0.0	0.0	0.1	0.1	4.5	0.2	0.0	0.0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0.0	0.8	0.1	333.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	2.9	1.6	0.5	0.3	0.0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0.0	0.4	0.5	0.0	1.7	0.1	0.5	0.9	38.0	1.4	0.0	104.9	0.1	4.0	1.0	0.1	0.2	1.3	0.1	0.1	0.0	0.2	11.7	2.3	0.0	0.0	3.7	0.0	0.7	1.8	57.1	35.8	0.0	0.0	0.0	128.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	8.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	41.0	0.0	0.1	179.4	0.3	13.8	0.2	14.1	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	848.6	37.7	0.0	1.3	0.0	0.0	12578.5	10.2	1.4	9.1	0.0	0.0	0.1	0.0	19.0	2.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	3.5	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1
ANKRD37	Lrp2bp	ENSG00000186352	"Ankyrin repeat domain 37"	Q7Z713	4	185396021-185400628	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Melanocytes: 135.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036626, HPA058127"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA036626: AB_10671963, HPA058127: AB_2683614"	"unprognostic (9.08e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.36e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.08e-1)"	7.7	8.9	11.0	3.9	15.2	3.3	10.9	9.9	20.9	17.2	7.5	6.0	5.4	4.8	4.9	4.1	35.8	8.0	4.8	13.6	12.0	9.6	6.4	14.2	12.4	3.0	12.3	5.8	14.8	13.5	1.7	11.7	10.7	16.8	24.1	7.0	8.4	35.4	21.9	22.1	7.3	4.9	5.0	16.1	4.6	5.2	8.7	14.2	1.5	14.2	18.6	12.2	14.3	22.8	7.7	4.2	10.2	3.9	3.2	8.1	3.0	6.2	0.9	0.7	3.6	4.9	3.1	3.4	2.9	2.2	2.1	4.7	1.5	1.8	3.0	1.2	5.3	4.4	2.4	3.4	3.7	2.7	8.5	0.9	2.0	3.2	4.5	2.1	1.9	4.7	0.6	4.0	2.0	2.8	15.7	2.7	2.0	3.1	5.1	5.9	1.6	1.6	7.5	1.0	0.6	5.0	0.5	1.0	8.2	2.6	0.5	5.0	8.9	2.0	2.0	8.6	2.7	1.8	1.2	3.5	4.6	3.7	2.6	3.3	9.6	2.8	1.3	13.1	1.4	5.3	0.4	3.8	10.2	5.5	3.5	4.7	7.6	4.3	8.1	2.6	7.7	3.3	4.7	2.0	3.2	3.9	4.2	5.1	3.0	11.0	15.2	9.9	20.9	12.0	9.6	12.3	5.8	16.8	14.2	20.8	23.7	16.6	23.8	52.8	24.8	1.2	0.0	101.7	22.7	8.7	27.5	15.7	21.6	17.9	3.7	11.7	61.7	23.3	20.0	36.6	28.6	40.4	63.2	20.4	13.8	9.5	115.1	10.4	6.7	2.0	8.6	24.5	135.0	28.9	93.8	89.4	40.5	35.1	11.0	15.7	103.2	6.5	35.0	13.3	15.1	42.0	70.6	11.7	31.3	16.2
AP000295.1		ENSG00000249624			21	33229901-33297160	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 8.7"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 1: 3.0;Ciliated cells: 1.4;Club cells: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"neutrophil: 8.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.7;monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.7;hTERT-RPE1: 5.7;MOLT-4: 6.1;RH-30: 5.9"															NA	NA						"unprognostic (2.39e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.00e-1)"		"unprognostic (6.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.33e-2)"	1.7	0.5	0.1	0.4	0.3	2.6	1.0	0.3	0.9	0.9	0.7			0.0	1.0	0.0	0.7	0.5	1.2	0.6	0.1	0.3	1.5	3.2	1.8	0.5	0.3		0.9	1.0	0.9	0.3	1.7		0.5	0.3		0.8	0.0	0.7	0.4	0.8	0.0	0.3	1.7	0.8	0.3			0.5		1.3	2.1	0.2	0.3	0.9	8.7	3.9	1.3	1.1	1.5	0.2	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.7	0.0	1.1	0.0	0.0	0.9	0.0	1.5	0.0	0.0	1.0	0.0	0.7	0.0	5.7	0.0	0.0	0.0	3.0	3.9	2.9	0.3	0.0	3.3	5.7	0.9	2.5	0.6	1.7	0.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	5.9	1.6	0.3	0.0	2.8	0.0	3.5	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.6	0.0	0.0	2.2	3.9	0.3	0.8	0.0	0.0	0.0	1.3	4.5	0.3	2.8	0.8	0.3	0.9	0.8	0.9	0.1	0.7	0.5	8.7	1.3	3.9	0.6	1.1	1.5											3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOLD1	"DKFZP434F0318, FLJ25138"	ENSG00000178878	"Apolipoprotein L domain containing 1"	Q96LR9	12	12725917-12829975	"Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 109.5"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 5.8;olfactory region: 24.7"	"Low region specificity"	"Detected in all"			"HPA052462, HPA058882"	Approved		Approved	"Nucleoplasm,Plasma membrane"		No	No			"Nucleoplasm, Plasma membrane"		"HPA052462: AB_2681841, HPA058882: AB_2683844"	"unprognostic (1.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.58e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.15e-2)"	109.5	8.8	11.2	9.2	17.7	0.6	34.4	9.8	17.5	25.5	9.0	7.7	2.9	2.5	7.1	7.0	18.8	14.0	18.7	22.3	13.0	11.8	7.4	9.3	7.1	3.4	16.6	3.3	10.0	12.8	17.2	4.7	44.8	16.7	7.2	7.1	8.1	4.4	3.7	16.6	7.4	6.0	28.0	13.9	4.7	5.3	5.4	12.4	5.7	34.4	9.9	3.3	10.9	7.1	2.3	1.7	4.8	0.9	0.8	2.7	0.3	4.3	0.1	26.2	0.8	0.8	1.5	0.2	4.2	7.0	4.3	6.3	1.7	4.6	1.3	0.4	1.6	1.5	1.4	1.0	0.2	7.3	13.2	1.0	0.4	1.3	0.0	1.6	0.6	0.4	1.0	1.2	1.5	3.4	10.9	3.2	2.4	0.4	1.8	2.2	0.9	0.7	0.7	0.1	1.0	0.8	2.0	0.5	0.6	0.5	0.4	2.3	2.4	4.0	0.4	9.6	0.4	0.1	2.1	3.9	1.0	1.4	5.8	3.8	1.3	0.6	1.0	1.5	2.8	4.9	4.8	0.9	0.7	0.9	0.4	1.1	2.2	2.0	1.3	0.6	2.3	1.6	1.0	4.4	0.8	0.6	1.7	2.7	0.3	11.2	17.7	9.8	17.5	13.0	11.8	16.6	3.3	16.7	12.4	6.0	4.0	21.4	2.2	16.1	4.2	7.0	7.6	8.1	9.1	0.0	3.9	1.5	0.0	0.9	1.6	140.0	1.1	70.0	0.4	1.1	8.4	3.7	7.0	1.6	5.1	3.2	3.5	65.7	14.5	1.1	4.0	5.7	27.0	3.6	4.7	64.4	0.8	0.0	0.4	0.3	3.3	109.9	101.3	3.2	0.7	13.6	0.8	20.8	6.3	2.8
ARHGAP22	RhoGAP2	ENSG00000128805	"Rho GTPase activating protein 22"	Q7Z5H3	10	48446034-48656265	"Predicted intracellular proteins"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 32.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 51.6;Late spermatids: 92.5;monocytes: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.2;myeloid DC: 2.9;naive B-cell: 2.6"	"Group enriched"	"Detected in many"	29	"B-cells: 2.6;dendritic cells: 2.9;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 28.1;LHCN-M2: 25.4;TIME: 26.9;U-87 MG: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020696, HPA040391, HPA064439"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266"	"unprognostic (1.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.16e-8)"	"unprognostic (7.40e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.66e-2)"	2.6	3.1	10.2	6.7	12.5	3.0	2.0	7.3	12.2	1.8	2.7	32.3	1.0	1.7	2.1	1.9	1.6	2.2	4.4	3.3	12.5	9.6	1.2	0.8	2.9	6.0	18.3	6.6	7.7	1.5	2.7	1.8	2.2	24.6	3.2	2.8	1.6	3.4	3.2	3.9	3.4	2.5	3.4	27.3	6.2	2.3	4.6	18.4	2.0	6.0	0.4	5.4	3.1	1.9	2.6	2.9	0.0	3.2	0.0	0.0	0.9	2.4	0.5	0.1	0.0	2.1	8.6	1.7	13.1	6.0	1.2	1.7	2.7	0.3	0.0	0.5	5.1	0.9	4.8	0.1	4.4	2.1	0.2	4.5	6.9	0.0	0.0	1.1	0.7	0.8	2.0	4.5	15.0	1.2	28.1	8.2	0.0	6.5	1.2	25.4	0.1	0.1	0.0	2.8	0.0	0.2	0.0	0.0	3.1	2.5	0.2	0.4	2.6	0.6	0.0	0.2	0.2	0.1	0.1	26.9	12.3	0.1	1.6	9.1	0.0	0.0	0.0	33.5	0.1	1.9	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.9	2.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	10.2	12.5	7.3	9.2	12.5	9.6	18.3	6.6	24.6	18.4	0.0	1.7	1.3	4.2	3.1	1.0	2.4	0.0	6.7	4.5	0.0	2.0	9.2	0.0	2.5	51.6	1.4	0.0	0.0	3.9	0.2	2.6	1.0	0.0	0.0	10.4	0.0	0.0	2.5	9.5	92.5	2.6	11.0	1.7	23.4	0.0	1.5	2.0	0.0	5.6	0.0	1.4	0.0	0.5	1.4	4.2	0.5	0.8	0.0	0.0	0.5
ARHGEF25	"GEFT, p63RhoGEF"	ENSG00000240771	"Rho guanine nucleotide exchange factor 25"	Q86VW2	12	57610180-57619379	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 17.5;Leydig cells: 23.0;Peritubular cells: 43.2;Sertoli cells: 25.8;Smooth muscle cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 26.2;cerebellum: 54.2;cerebral cortex: 47.7;hippocampal formation: 59.8;olfactory region: 39.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.8;RH-30: 49.9;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052016	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052016: AB_2681695"	"unprognostic (8.43e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.13e-3)"	"unprognostic (6.95e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (4.20e-7)"	"unprognostic (1.41e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.82e-3)"	"unprognostic (3.22e-3)"	10.4	7.6	26.2	6.1	11.1	0.5	10.5	54.2	47.7	15.4	41.1	3.6	19.8	6.3	40.0	27.0	17.9	24.3	13.9	11.5	59.8	10.5	4.6	1.7	7.6	3.6	7.5	39.3	22.6	3.7	4.9	7.8	5.8	11.2	23.5	12.0	6.1	7.9	49.2	6.3	3.5	10.3	40.7	8.9	7.9	15.0	4.6	6.2	0.0	4.2	3.7	3.1	21.8	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	15.9	9.9	0.0	0.0	1.3	4.8	14.1	6.3	7.8	1.9	3.0	1.3	4.1	8.7	2.9	0.1	6.1	0.2	5.3	4.3	5.3	2.7	2.1	4.1	4.6	0.0	7.4	4.5	1.3	2.8	0.4	22.8	2.4	0.7	5.6	6.1	4.6	1.1	0.9	0.1	10.2	0.1	0.1	0.0	49.9	0.2	0.3	0.2	9.3	22.7	0.9	0.4	1.7	5.9	1.6	3.2	0.0	5.7	5.5	3.7	1.7	12.9	1.9	0.0	4.8	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	11.1	54.2	47.7	59.8	10.5	7.5	39.3	11.2	6.2	0.0	0.0	0.0	1.8	1.8	17.5	12.3	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.7	0.2	2.1	0.0	0.0	1.2	0.4	8.7	0.7	0.0	0.0	0.4	7.9	0.0	10.4	0.0	0.2	23.0	0.0	0.0	0.0	0.0	3.5	0.5	0.0	43.2	0.3	2.8	25.8	30.9	0.5	1.1	1.0	0.2	0.0	0.0	0.4
ARL4C	"ARL7, LAK"	ENSG00000188042	"ADP ribosylation factor like GTPase 4C"	P56559	2	234493041-234497053	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 168.9;Kupffer cells: 128.2;T-cells: 193.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;RPTEC TERT1: 72.9;U-2197: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028927	Uncertain		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA028927: AB_10602387"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-3)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (8.01e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (3.69e-8)"	"unprognostic (8.57e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (6.99e-5)"	9.3	6.8	11.1	17.7	9.6	30.3	12.8	19.2	21.2	6.4	6.2	4.9	3.1	3.9	3.6	9.4	13.9	7.6	19.2	3.6	9.1	16.5	8.5	7.9	9.9	28.9	9.4	11.8	2.6	3.6	0.8	5.4	16.8	23.9	6.7	7.4	5.9	14.2	3.6	1.7	15.1	8.1	3.6	5.3	28.0	7.9	1.9	1.8	44.7	2.5	4.4	20.1	14.0	10.8	5.9	17.8	18.7	0.5	18.2	29.7	8.7	7.2	22.5	2.9	0.3	2.6	0.8	7.5	0.7	3.4	0.9	1.6	10.4	14.3	0.0	1.9	1.9	27.4	5.5	2.9	15.6	1.0	6.7	1.0	0.0	0.1	0.1	2.7	0.0	0.6	1.6	10.4	8.8	5.4	38.6	1.5	19.2	0.0	24.2	4.1	1.0	21.0	0.0	3.0	5.4	5.1	0.0	13.0	4.1	72.9	8.1	10.6	1.9	0.2	1.7	1.1	4.8	0.2	0.4	3.3	14.6	5.6	39.9	14.0	12.1	4.4	0.3	25.1	0.0	7.6	18.7	0.4	8.4	29.7	0.5	29.2	5.9	20.7	23.5	3.2	5.7	18.7	20.9	0.7	18.2	0.2	17.8	25.8	8.7	11.1	9.6	19.2	21.2	9.1	16.5	9.4	11.8	23.9	1.8	68.5	22.3	38.9	97.5	110.8	168.9	8.1	50.9	6.7	44.3	14.0	7.9	25.6	0.0	15.7	7.5	16.9	0.2	0.0	4.9	3.3	28.8	51.3	25.6	3.0	29.0	101.7	1.7	9.8	128.2	4.2	0.3	83.9	40.5	43.3	0.0	30.9	11.5	0.0	0.0	1.0	10.8	0.0	16.0	0.4	0.8	37.5	12.2	193.9	0.4	46.5
ARNT2	"bHLHe1, KIAA0307"	ENSG00000172379	"Aryl hydrocarbon receptor nuclear translocator 2"	Q9HBZ2	15	80404350-80597937	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 73.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 29.2;Intestinal endocrine cells: 22.0;Late spermatids: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.9;BJ hTERT+ SV40 Large T+ RasG12V: 16.0;hTERT-RPE1: 16.7;LHCN-M2: 14.3;SK-MEL-30: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001056, CAB005081"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005081: AB_2243005, HPA001056: AB_1845042"	"unprognostic (2.04e-3)"	"unprognostic (8.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (1.46e-6)"	"unprognostic (2.20e-1)"	"prognostic favorable (7.51e-4)"	"unprognostic (2.53e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.62e-2)"	1.4	2.3	30.6	2.3	35.5	1.0	1.8	9.1	73.2	4.2	2.4	14.3	0.0	2.0	5.3	7.2	2.3	4.9	2.7	3.7	32.8	17.4	11.5	1.0	4.4	2.3	19.2	23.4	9.3	3.2	4.2	3.6	1.7	11.9	5.1	2.4	2.0	1.5	4.8	7.0	2.3	2.5	3.7	13.2	3.2	3.9	8.0	12.7	0.0	6.0	0.0	2.9	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.8	15.9	0.0	0.1	2.0	0.0	6.7	9.5	7.8	16.0	0.0	0.0	0.0	1.7	8.0	4.1	0.2	5.8	0.3	10.1	0.0	1.6	0.2	0.0	0.5	0.5	0.0	4.0	7.6	0.3	3.4	0.1	16.7	0.0	0.0	0.0	0.1	14.3	7.5	0.0	0.0	3.1	0.0	0.1	0.0	0.2	0.0	3.4	11.2	8.4	11.6	0.8	0.1	17.1	1.0	0.3	0.0	0.0	12.5	2.5	0.3	7.9	0.0	0.0	0.0	4.8	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	35.5	9.1	36.0	32.8	17.4	19.2	23.4	11.9	12.7	0.0	2.9	0.0	1.1	1.1	15.4	5.9	0.0	2.7	7.9	3.5	7.9	0.1	11.6	6.4	29.2	0.8	0.0	0.0	0.2	3.3	0.9	1.9	2.3	0.0	0.2	1.6	22.0	0.6	0.0	28.4	0.6	0.6	6.8	0.0	0.9	5.7	3.0	2.8	2.8	0.6	9.2	6.5	2.8	1.1	1.5	0.3	2.3	0.0	0.8	1.1
ARR3	ARRX	ENSG00000120500	"Arrestin 3"	P36575	X	70268305-70281840	"Predicted intracellular proteins"	"Sensory transduction, Vision"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"retina: 62.9"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 1449.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 3.7;Karpas-707: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063129	Enhanced					NA	NA					"HPA063129: AB_2732696"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.70e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.77e-7)"	"unprognostic (8.64e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.43e-1)"	0.3	0.5	0.3	1.0	0.3	0.7	0.3	0.3	0.3	0.3	1.2	0.3	0.3	1.4	0.7	0.3	0.3	0.4	0.7	0.7	0.3	0.2	0.4	0.3	0.3	1.9	0.3	0.3	0.6	0.7	0.0	0.4	0.4	0.3	0.4	0.2	62.9	0.4	0.3	0.5	5.6	3.6	0.3	0.3	0.9	0.8	0.4	0.3	0.3	0.9	0.3	0.3	0.8	0.3	1.3	0.7	0.5	0.4	0.0	1.6	0.3	0.4	0.7	3.2	2.1	0.0	0.0	1.8	1.7	0.0	0.0	0.0	0.6	1.1	1.2	0.3	0.0	0.3	0.7	0.0	0.0	0.0	1.4	3.2	0.4	1.1	0.0	0.0	0.7	1.6	0.1	0.0	0.0	0.0	3.7	0.0	1.0	0.4	5.8	0.0	0.5	1.2	0.6	0.9	0.5	0.6	1.1	0.6	0.1	0.0	1.5	0.4	0.9	0.6	0.2	0.1	2.1	0.1	0.4	2.4	1.5	2.0	1.4	0.1	1.4	0.8	0.8	1.3	2.0	1.4	0.0	0.4	0.5	0.9	0.2	0.0	1.3	0.4	0.0	0.5	0.4	1.6	0.1	0.1	0.0	0.0	0.7	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	45.6	0.2	0.0	0.0	0.0	0.0	1449.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	102.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARSH		ENSG00000205667	"Arylsulfatase family member H"	Q5FYA8	X	3006613-3033571	"Predicted membrane proteins"		Hydrolase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 3.1;epididymis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.0;hTERT-RPE1: 1.2;OE19: 1.7;RT4: 1.2;SK-BR-3: 1.2"															NA	NA						"unprognostic (3.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-2)"	"unprognostic (8.90e-2)"		"unprognostic (6.79e-2)"		"unprognostic (2.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.48e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.63e-1)"		"unprognostic (2.65e-2)"	"unprognostic (6.75e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.2	0.0			0.0	0.0	3.7	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.5	0.0	0.0	0.0		0.2	0.0		0.9	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.1			0.0		0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASIC1	"ACCN2, BNaC2, hBNaC2"	ENSG00000110881	"Acid sensing ion channel subunit 1"	P78348	12	50057548-50083611	"FDA approved drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.7"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 3.1;Ciliated cells: 6.7;Club cells: 2.3;Horizontal cells: 3.2"	"Cancer enhanced"	"Detected in many"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 23.0;SH-SY5Y: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058870			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"		"HPA058870: AB_2683841"	"unprognostic (5.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.97e-7)"	"unprognostic (7.19e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.78e-3)"	"unprognostic (8.27e-5)"	2.5	1.7	13.9	1.8	20.3	0.8	2.9	20.1	43.7	5.3	3.1	12.8	0.3	2.3	2.5	1.2	3.4	3.6	4.0	2.2	12.3	14.3	1.6	0.9	1.3	1.3	12.9	8.5	1.4	1.4	5.2	0.5	1.5	10.2	4.5	2.5	1.8	5.6	3.4	1.3	1.5	2.5	3.6	5.4	1.1	4.3	1.4	11.0	0.4	1.1	0.0	1.0	2.6	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	1.9	4.3	5.7	12.9	1.7	2.7	3.2	1.4	3.7	2.5	2.5	3.0	1.5	1.2	3.0	0.8	1.5	2.0	5.6	4.7	1.4	1.2	15.4	3.9	6.1	1.8	2.5	5.7	14.5	6.8	2.3	0.4	0.6	23.0	0.4	15.2	2.5	0.1	2.0	2.4	5.5	11.3	2.4	4.4	7.6	5.6	5.4	2.6	1.2	0.2	8.5	17.9	3.2	1.1	2.0	1.0	7.0	3.8	0.4	2.5	8.4	1.7	0.7	0.0	0.0	0.0	3.2	5.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.3	13.9	20.3	20.1	18.3	12.3	14.3	12.9	8.5	10.2	11.0	0.0	0.0	0.0	0.2	0.0	3.1	0.9	0.0	6.7	2.3	1.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.6	0.0	0.0	0.3	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.1	0.8	0.5	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.1
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell type enriched"	"Detected in some"	43	"Distal tubular cells: 376.4"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced					NA	NA					"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.8	1.3	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	376.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AZIN2	"ADC, KIAA1945, ODC-p, ODC1L, ODCp"	ENSG00000142920	"Antizyme inhibitor 2"	Q96A70	1	33081104-33120530	"Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 23.1;testis: 22.9"	"Group enriched"	"Detected in many"	23	"Early spermatids: 190.6;Late spermatids: 686.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 17.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;SK-MEL-30: 18.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028527			Approved	Cytosol		NA	NA			Cytosol		"HPA028527: AB_10602077"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.50e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.15e-4)"	"unprognostic (9.19e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.41e-1)"	1.5	5.3	7.8	3.1	11.9	0.2	3.6	5.8	14.6	5.1	4.4	23.1	0.5	1.4	3.8	3.4	1.7	7.0	4.1	5.7	10.1	7.8	3.5	0.9	2.5	1.9	10.2	12.2	9.9	3.0	4.4	2.9	1.4	13.6	3.9	3.0	3.4	3.5	3.6	0.9	1.8	1.3	3.4	18.1	1.9	1.8	22.9	10.1	0.7	4.3	0.0	3.0	2.3	1.9	0.2	17.9	3.5	0.0	0.0	1.6	0.7	0.5	0.6	2.0	1.2	1.0	4.5	0.6	0.7	3.1	3.2	2.6	0.3	2.6	0.0	0.9	0.5	1.7	1.4	1.4	0.6	0.9	0.0	0.0	0.1	0.1	0.5	4.9	0.0	0.2	4.4	2.8	2.6	1.0	14.3	0.4	0.7	0.1	0.2	2.3	0.0	0.2	0.9	1.0	0.3	0.4	1.4	1.9	0.1	2.2	0.1	0.4	2.1	0.5	0.0	18.4	1.9	0.8	0.3	0.1	0.7	1.4	2.2	0.4	1.1	0.0	0.0	4.9	0.0	0.8	3.5	0.0	0.0	1.3	0.0	1.4	0.2	1.4	1.4	0.0	0.0	1.6	1.6	0.0	0.0	0.0	17.9	0.0	0.7	7.8	11.9	5.8	12.8	10.1	7.8	10.2	12.2	13.6	10.1	0.0	4.8	2.0	2.4	0.0	7.1	0.8	0.0	4.0	1.2	1.8	17.7	0.4	0.0	1.3	190.6	1.1	4.2	0.0	1.2	0.4	1.2	1.5	0.0	0.0	1.1	6.4	1.2	1.8	0.3	686.4	5.8	0.4	0.0	2.8	1.2	9.9	1.2	4.8	7.1	2.6	7.6	6.5	0.9	18.8	5.9	0.0	0.2	1.5	2.5	0.8
BEX1		ENSG00000133169	"Brain expressed X-linked 1"	Q9HBH7	X	103062651-103064240	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 150.2;pituitary gland: 64.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 321.5;Horizontal cells: 343.2;Muller glia cells: 473.7;Rod photoreceptor cells: 119.7"	"Cancer enhanced"	"Detected in many"		"glioma: 111.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 60.3;HBF TERT88: 67.4;HL-60: 147.5;hTERT-RPE1: 104.5;SCLC-21H: 46.2;U-937: 46.2"									"HPA045384, HPA078630"	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA045384: AB_2679305, HPA078630: "	"prognostic favorable (6.43e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.09e-1)"	"prognostic favorable (8.16e-8)"	"unprognostic (1.14e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.34e-2)"	1.8	37.4	66.4	2.8	65.1	16.3	1.9	44.7	150.2	1.8	3.0	6.2	0.0	3.3	7.7	25.2	1.6	10.1	1.8	3.6	77.4	81.0	4.5	3.0	2.1	1.7	38.9	67.8	9.5	30.9	48.1	64.3	1.5	35.8	3.8	3.1	4.7	2.2	2.9	1.3	1.5	3.9	3.3	24.3	2.3	5.0	27.5	12.0	0.0	12.1	0.0	1.5	1.5	0.4	2.4	0.2	6.4	0.5	1.7	3.1	1.5	0.0	0.0	3.7	0.0	0.0	0.0	0.1	2.1	0.0	40.6	60.3	0.0	0.0	0.0	0.0	15.1	13.0	0.0	0.0	0.0	67.4	0.0	0.1	12.3	0.0	8.0	0.7	147.5	0.2	0.9	0.0	8.8	0.0	104.5	0.0	11.8	0.0	0.0	8.1	0.0	27.7	0.0	33.6	9.3	6.0	0.0	0.0	0.7	0.0	0.0	46.2	26.6	0.0	0.0	0.1	0.6	0.0	41.7	0.0	0.0	13.9	0.1	1.5	7.2	0.2	0.0	5.4	46.2	2.6	0.6	0.5	6.4	0.7	0.1	0.7	1.2	2.0	1.2	0.1	2.4	3.1	1.4	1.2	1.7	0.4	0.2	0.9	1.5	66.4	65.1	44.7	89.0	77.4	81.0	38.9	67.8	35.8	12.0	0.0	0.3	0.5	7.8	7.7	321.5	8.2	20.4	0.0	1.2	5.2	37.3	0.3	61.3	6.4	9.3	2.8	0.4	0.0	11.5	0.1	0.4	6.9	0.0	0.0	1.3	343.2	76.4	28.8	7.5	16.7	7.5	0.3	6.8	1.8	0.4	473.7	10.3	2.3	2.5	12.7	119.7	0.0	2.2	15.4	14.7	5.6	0.5	0.0	0.9	1.4
BFSP1	"CP115, CP94, filensin, LIFL-H"	ENSG00000125864	"Beaded filament structural protein 1"	Q12934	20	17493905-17569220	"Disease related genes, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Ito cells: 3.7;Late spermatids: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 6.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.5;T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.0;RPTEC TERT1: 18.2;SK-BR-3: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040748, HPA042038"	Enhanced		Supported	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA040748: AB_10963786, HPA042038: AB_10964054"	"unprognostic (2.24e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"prognostic favorable (1.39e-4)"	"unprognostic (1.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-6)"	"unprognostic (5.11e-2)"	"unprognostic (5.53e-1)"	"unprognostic (2.10e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.35e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.78e-2)"	"unprognostic (7.50e-2)"	2.5	1.8	3.5	2.5	5.6	0.8	2.6	2.8	4.4	3.5	1.8	0.9	5.5	0.8	10.7	5.4	5.1	2.2	4.8	2.4	3.2	3.7	6.1	1.1	4.1	0.6	3.3	1.7	5.3	2.7	4.8	1.3	4.5	3.0	3.3	1.2	2.3	2.0	4.0	3.0	1.8	0.9	2.7	6.9	0.8	1.1	8.0	0.7	0.6	5.3	2.3	1.5	5.1	1.1	0.0	0.0	0.7	0.0	1.5	6.1	0.5	0.7	7.4	2.4	0.3	0.6	2.5	0.4	1.8	8.7	1.2	1.1	3.3	6.4	0.0	1.5	1.0	4.7	1.1	2.6	1.4	1.0	1.6	2.0	0.5	1.0	1.0	1.4	0.4	0.8	2.9	4.6	0.7	2.1	10.0	5.2	0.5	0.2	0.4	3.9	1.4	0.0	1.0	5.6	4.7	2.0	0.0	1.7	0.4	18.2	1.3	2.5	0.3	2.1	9.8	3.8	1.2	4.7	1.6	5.9	0.3	0.6	0.6	1.7	0.0	0.1	0.0	1.3	0.0	1.5	0.1	0.0	0.0	6.1	0.0	0.2	0.0	1.7	1.0	0.0	0.0	0.1	0.5	0.7	1.5	0.0	0.0	0.0	0.5	3.5	5.6	2.8	4.4	3.2	3.7	3.3	1.7	3.0	0.7	3.0	1.7	0.0	0.4	0.8	0.2	1.1	2.5	1.4	0.0	0.0	0.0	0.8	1.7	0.7	0.7	2.1	0.0	0.0	0.8	1.5	0.6	0.3	0.0	0.0	0.4	0.0	0.0	3.7	0.0	4.7	1.7	0.0	1.7	0.0	0.0	1.0	0.7	0.0	0.0	0.2	0.0	0.0	0.9	0.7	1.6	0.6	0.3	0.0	0.2	0.5
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156241962-156243321	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0"	"Cell type enhanced"	"Detected in some"	13	"Melanocytes: 3.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"NK-cell: 2.2;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 4.2;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;U-87 MG: 6.4"														"Secreted to blood"	NA	NA	15500000	430000				"unprognostic (2.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.82e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.44e-5)"	"unprognostic (2.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.70e-2)"	"unprognostic (9.67e-6)"	"unprognostic (3.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.64e-3)"	1.6	0.7	6.0	6.7	6.9	2.2	1.4	5.2	11.0	1.1	9.3	6.2	0.0	3.2	4.8	1.4	0.8	2.3	1.7	0.7	4.3	2.9	1.2	1.6	1.4	2.3	6.2	6.8	3.4	0.8	1.5	1.3	3.1	9.7	2.1	3.4	0.0	3.6	2.8	2.2	6.8	6.4	3.9	8.4	2.1	2.3	0.3	4.1	0.6	1.6	0.0	1.2	0.7	1.2	0.0	4.2	0.2	0.0	2.2	0.1	0.1	0.3	0.7	1.6	0.5	0.0	0.5	1.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.4	0.0	0.7	0.6	0.0	0.4	0.0	1.8	0.9	0.0	2.0	1.1	0.5	0.0	0.4	0.0	0.6	0.6	0.6	7.5	0.6	1.5	0.5	2.2	0.0	1.9	0.0	1.4	0.8	0.1	0.3	0.9	0.1	1.4	0.6	0.0	0.2	1.8	0.6	0.3	0.7	0.3	1.1	0.0	0.0	0.0	0.4	0.4	0.4	2.7	2.5	1.4	6.4	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	4.2	0.0	0.1	6.0	6.9	5.2	11.0	4.3	2.9	6.2	6.8	9.7	4.1	0.0	0.0	0.0	0.9	1.3	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.2	1.1	0.6	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	1.4	0.0	3.3	0.0	0.1	0.3	0.0	0.0	0.4	1.1	0.5	6.5	0.0	0.5	0.9	1.1	0.3	0.0	0.6	0.7
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	7.6	3.5	1.7	0.8	1.3	0.1	0.5	0.0	4.8	0.0	0.7	1.5	11.4	4.0	0.1	0.6	0.4	0.0	0.6	0.3	0.0	0.0	0.3	1.9	0.1	0.5	0.4	2.8	5.5	33.8	0.0	0.0	0.0	14.3	0.8	0.4	0.0	1.3	3.7	1.3	2.8	0.0	0.6	10.9	1.8	44.7	0.0	0.0	0.5	0.2	10.1	0.2	0.0	0.0	2.3	2.6	3.1	0.3	2.0	19.2	11.0	0.0	16.5	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0	0.0	0.6	22.9	50.0	5.4	333.3	33.5	33.1	42.8	10.3	27.9	172.8	22.2	0.0	35.8	0.2	4.8	10.8	0.0	19.8	2.4	18.8	38.9	5.7	0.0	71.2	236.8	12.6	3.1	2.7	0.4	27.9	35.2	13.5	47.7	3.0	283.4	13.9	5.7	25.1	2.1	289.4	6.5	6.6	0.5	0.4	2.9	5.9	0.0	3.3	52.5
BLID	BRCC2	ENSG00000259571	"BH3-like motif containing, cell death inducer"	Q8IZY5	11	122115354-122116215	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"ovary: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.0;hTEC/SVTERT24-B: 2.8;hTERT-HME1: 2.5;hTERT-RPE1: 2.7;LHCN-M2: 3.8;U-87 MG: 4.6"															NA	NA																							0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.0			0.0	0.1	1.1	0.3	0.8	0.3	1.1	0.5	0.2	0.4	0.5	0.2	0.0	0.2		1.4	0.0	0.0	0.2	0.1		0.5	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7			0.7		0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.6	0.8	0.0	2.3	1.4	0.6	0.4	0.0	0.1	0.0	0.1	1.0	5.0	0.1	0.0	1.4	1.5	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.6	2.8	2.5	2.7	0.4	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.8	0.1	0.2	1.1	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMF	FLJ00065	ENSG00000104081	"Bcl2 modifying factor"	Q96LC9	15	40087890-40108892	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 81.0"	"Cell type enhanced"	"Detected in many"	5	"Exocrine glandular cells: 12.7;monocytes: 14.4;Pancreatic endocrine cells: 13.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 19.8;HMC-1: 22.4;hTERT-RPE1: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010120	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010120: AB_1845385"	"unprognostic (2.94e-1)"	"unprognostic (4.92e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.83e-4)"	"prognostic unfavorable (6.32e-4)"	"unprognostic (1.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.06e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.35e-2)"	5.3	2.9	1.3	13.5	1.9	15.8	6.1	2.3	2.0	10.9	9.9	2.1	13.0	11.9	12.4	4.7	2.8	8.3	6.7	3.4	1.3	1.6	6.5	3.9	7.7	18.4	2.8	0.9	8.9	8.1	1.8	2.8	5.7	2.5	7.0	4.5	7.2	9.2	10.8	4.6	4.0	23.2	5.8	3.0	18.1	6.7	4.1	2.1	81.0	18.6	3.1	15.0	7.5	3.7	5.1	3.3	5.2	6.0	0.0	1.4	0.9	0.4	0.6	11.5	2.5	0.3	0.5	7.8	0.0	1.8	0.2	0.5	11.5	0.8	3.3	3.7	0.5	3.5	2.4	2.8	0.0	0.0	7.9	2.3	1.7	19.8	2.6	1.1	0.3	22.4	5.8	0.6	0.2	0.2	29.0	3.0	2.4	0.9	1.4	1.0	0.6	1.1	8.4	3.1	5.7	0.4	2.1	2.6	9.5	0.5	2.6	6.1	5.0	2.2	5.8	5.1	12.9	3.4	6.7	2.3	0.4	1.6	0.3	0.1	14.2	13.3	2.0	0.8	1.6	1.3	0.1	4.2	3.6	0.2	4.9	0.4	5.1	0.4	1.4	2.7	1.8	0.7	0.1	5.2	0.0	6.0	3.3	1.2	0.9	1.3	1.9	2.3	2.0	1.3	1.6	2.8	0.9	2.5	2.1	3.0	2.1	10.0	1.0	1.0	0.0	1.6	7.6	0.0	5.7	0.0	0.0	0.6	0.0	8.9	1.0	2.1	5.1	0.0	12.7	1.1	1.9	2.6	0.0	0.9	7.6	0.0	1.2	1.8	10.8	0.0	1.7	6.1	0.0	14.4	1.5	0.3	13.9	0.3	0.7	2.2	0.4	0.0	0.8	0.2	1.1	0.5	1.5	0.7	1.3	0.9
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 391.8;Proximal tubular cells: 579.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	72.0	5.8	4.2	11.7	11.2	11.9	21.6	17.6	16.3	13.3	38.0	1.2	1.6	0.1	28.6	10.1	15.5	4.4	8.8	25.0	50.1	3.8	6.7	2.5	3.7	16.7	15.0	3.3	2.0	8.2	6.3	12.9	13.1	56.2	9.2	4.5	6.6	0.2	21.7	5.7	1.6	18.4	3.5	0.5	17.5	4.0	2.1	6.1	14.5	1.2	5.5	12.9	3.6	7.4	10.0	18.6	4.5	4.6	10.5	18.8	6.3	7.0	13.9	12.3	10.5	10.0	68.2	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1	44.7	40.9	23.1	75.3	26.6	87.6	141.4	101.9	89.7	48.9	80.3	37.3	149.9	255.4	174.2	61.9	44.2	3.5	0.0	75.7	295.7	56.6	118.1	0.0	391.8	65.8	314.6	77.8	54.6	21.8	85.4	65.0	16.1	32.1	39.7	6.7	125.3	189.3	1.9	97.2	579.1	50.2	38.8	23.8	33.5	100.7	11.4	206.9	25.4	4.8	42.9
BTBD19		ENSG00000222009	"BTB domain containing 19"	C9JJ37	1	44808482-44815585	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.0;HUVEC TERT2: 6.4;TIME: 14.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042633, HPA076404"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA042633: AB_2678091, HPA076404: AB_2686796"	"unprognostic (4.69e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-4)"	"unprognostic (5.32e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.18e-8)"	"unprognostic (2.20e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.70e-1)"	6.7	8.7	3.5	3.6	1.9	2.7	4.9	0.6	2.8	13.5	2.0	2.4	6.2	1.6	13.9	21.4	2.1	6.4	4.2	3.8	1.3	1.4	4.2	2.2	4.1	1.8	1.4	4.0	8.4	1.5	3.2	11.9	7.9	6.3	5.6	1.8	7.6	1.7	8.3	1.8	1.2	2.2	5.6	1.9	2.3	2.2	3.5	0.6	0.1	6.0	2.0	1.4	2.1	4.3	0.0	0.2	2.3	0.1	0.0	0.2	0.0	0.1	1.1	1.0	1.1	2.3	2.6	0.7	2.1	1.3	1.0	2.0	0.0	0.8	0.1	1.0	3.7	0.5	0.3	0.0	1.1	0.4	0.9	0.2	2.0	0.3	1.1	2.3	0.0	1.6	3.9	0.1	3.7	0.7	7.0	6.4	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.3	0.1	1.2	1.3	0.0	0.0	14.9	3.8	3.0	1.8	1.6	0.5	0.1	0.0	2.3	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	3.5	1.9	0.6	2.8	1.3	1.4	1.4	4.0	6.3	0.6	3.0	3.4	0.0	1.6	1.8	0.0	1.0	2.5	1.4	4.5	1.8	0.0	0.2	0.0	0.9	0.4	3.5	2.1	0.0	0.5	0.2	3.8	0.9	2.3	2.8	2.7	0.0	0.0	3.7	6.0	0.0	2.8	4.6	3.3	0.0	1.3	1.5	0.8	0.8	1.1	2.7	0.0	0.0	4.6	0.7	0.2	1.9	1.0	0.0	0.7	1.3
C10orf55	bA417O11.3	ENSG00000222047	"Chromosome 10 open reading frame 55"	Q5SWW7	10	73909969-73922777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"testis: 14.0"	"Cell type enhanced"	"Detected in some"	13	"Basal glandular cells: 6.4;Distal tubular cells: 6.6;Early spermatids: 11.8;Sertoli cells: 6.5;Urothelial cells: 5.4"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.1;CAPAN-2: 4.8;HaCaT: 4.9;hTERT-RPE1: 3.4;RPTEC TERT1: 7.6;U-251 MG: 3.3"									HPA045739	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045739: AB_10961861"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.71e-2)"	"unprognostic (9.68e-3)"	"unprognostic (5.61e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.13e-2)"	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0			0.0	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.7	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.0	0.4		0.0	1.1	0.5	1.0	0.0	0.0	0.0	0.1	0.0	14.0			0.1		0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.3	0.0	0.0	0.0	0.1	0.0	0.3	1.6	0.4	0.3	0.0	4.8	0.0	0.3	0.2	1.5	4.9	0.0	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.4	0.6	1.0	3.4	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	2.1	0.0	7.6	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.4	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	6.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.5	11.8	0.0	0.0	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	6.5	0.3	0.0	0.2	0.1	0.0	0.0	0.0	5.4
C17orf47	FLJ40121	ENSG00000181013	"Chromosome 17 open reading frame 47"	Q8NEP4	17	58541587-58544368	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"testis: 26.7"	"Group enriched"	"Detected in some"	57	"Early spermatids: 7.5;Late spermatids: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.0;hTERT-RPE1: 1.1;Karpas-707: 1.5;MCF7: 2.6;SCLC-21H: 1.5;T-47d: 1.6"									HPA028424	Uncertain					NA	NA					"HPA028424: AB_10601690"	"unprognostic (4.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.62e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.37e-3)"	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.4	0.3	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.4	0.3	26.7	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.0	0.1	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.4	0.0	1.5	0.0	2.6	0.0	0.1	0.1	0.3	0.3	0.2	0.0	0.0	0.0	0.1	1.5	0.3	0.1	0.2	0.0	0.4	1.6	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338939-119340940	"Disease related genes, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 30.5"	"Cell type enriched"	"Detected in single"	4	"Ductal cells: 4.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;HHSteC: 19.0;hTERT-RPE1: 14.9;HUVEC TERT2: 28.0;TIME: 25.6"	"Low region specificity"	"Detected in all"							"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	NA	NA	219000000	1600000			"CAB025607: , HPA038604: AB_2676110"																		13.6	3.2	3.7	4.3	4.0	0.0	6.4	3.1	7.1	6.4	6.1	7.9	1.5	5.5	7.1	8.3	3.7	3.8	19.0	10.2	3.9	3.6	7.3	3.2	8.9	3.6	8.1	2.3	6.2	3.1	1.2	4.2	5.0	9.6	4.3	2.7	30.5	3.2	3.2	4.2	3.1	5.8	10.9	5.4	5.7	4.3	3.1	5.2	0.0	4.1	4.6	1.1	8.1	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	9.4	2.6	0.1	2.3	0.1	0.3	1.4	0.0	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	19.0	0.0	0.0	4.5	0.0	0.1	0.0	14.9	28.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.5	0.5	0.0	0.0	25.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.0	3.1	3.2	3.9	3.6	8.1	2.3	9.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C21orf140		ENSG00000222018	"Chromosome 21 open reading frame 140"	B9A014	21	34400317-34401072	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"Early spermatids: 26.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 4.3"									HPA045123	Uncertain					NA	NA					"HPA045123: AB_10961912"																		0.9	2.2	1.0	1.0	1.9	0.4	1.1	2.8	6.1	1.3	1.6			0.9	2.2	0.2	3.9	1.1	1.9	1.4	1.3	0.9	0.9	0.4	2.0	2.4	1.0		2.4	2.4	0.2	1.5	0.8		1.4	0.2		1.3	0.2	3.2	1.5	0.7	0.2	0.8	0.8	5.0	7.4			2.2		0.2	2.6	1.3	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.2	0.1	1.6	0.8	0.0	0.0	0.6	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.9	0.2	2.3	2.4	0.0	1.3	1.4	0.0	0.0	0.0	0.0	4.3	0.0	1.1	0.0	1.3	0.0	0.2	0.6	0.4	0.9	0.4	0.0	0.1	0.2	1.3	0.0	0.0	0.1	1.4	1.2	0.2	0.3	0.6	2.9	2.2	0.0	1.2	0.7	0.6	0.9	1.2	0.7	0.1	1.0	2.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C22orf15	"FLJ36561, N27C7-3"	ENSG00000169314	"Chromosome 22 open reading frame 15"	Q8WYQ4	22	23763021-23765861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"fallopian tube: 22.3"	"Cell type enriched"	"Detected in some"	13	"Ciliated cells: 200.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 1.7"					"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0"														"Secreted in female reproductive system"	NA	NA						"unprognostic (2.37e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (8.53e-5)"	"unprognostic (1.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.60e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.08e-3)"	0.0	0.1	1.0	0.0	1.7	0.4	0.1	0.0	0.0	0.8	0.1			0.0	0.2	0.0	0.0	22.3	0.2	0.0	1.4	1.9	0.0	0.0	2.7	0.2	0.0		0.5	0.0	0.0	1.5	0.2		0.1	0.0		0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.6			0.0		0.0	0.0	0.0	0.6	2.9	0.0	0.0	0.0	1.8	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	4.8	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	6.5	0.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	1.0	0.6	1.0	0.8	0.4	0.5	1.8	0.5	0.0	0.0	0.0	2.9	0.0	0.2											0.0	2.6	0.0	0.0	0.1	0.5	0.0	0.0	200.8	15.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.6	0.1	2.3	0.0	0.0	0.0	0.0	1.3	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	12.7	3.8	0.3	0.0	0.0	0.0	0.0
C2orf73	FLJ40298	ENSG00000177994	"Chromosome 2 open reading frame 73"	Q8N5S3	2	54330034-54383742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.8;pituitary gland: 11.9;testis: 39.2"	"Group enriched"	"Detected in some"	10	"Early spermatids: 988.4;Late spermatids: 409.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 1.3;CAPAN-2: 1.3;HSkMC: 1.5;hTERT-RPE1: 4.3;RPTEC TERT1: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055221, HPA059596"	Uncertain					NA	NA					"HPA055221: AB_2682744, HPA059596: AB_2684077"	"unprognostic (1.56e-2)"	"unprognostic (7.00e-3)"		"unprognostic (1.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.46e-2)"		"unprognostic (2.74e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.69e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.80e-2)"	0.4	0.9	2.0	0.3	6.4	0.3	0.4	0.9	1.6	0.7	0.4	4.1	1.6	0.3	0.6	3.5	0.4	7.3	0.3	0.4	2.7	1.2	0.8	0.4	1.6	0.3	0.9	4.4	0.9	0.9	1.0	11.9	0.3	11.8	0.6	0.3	0.3	0.4	0.6	0.4	0.4	0.4	0.3	1.5	0.4	0.4	39.2	1.7	0.0	1.7	0.0	0.3	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.4	0.6	0.0	2.1	0.0	0.0	1.3	0.0	0.7	0.0	1.3	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.3	0.8	0.0	4.3	0.1	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.4	0.9	1.6	2.7	1.2	0.9	4.4	11.8	1.7	0.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	68.3	14.8	3.5	0.0	0.0	5.0	0.1	988.4	0.5	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	409.8	7.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.9	2.5	2.0	0.0	0.0	57.5	7.3	0.1	0.0	0.0	0.0	0.1
C4orf22		ENSG00000197826	"Chromosome 4 open reading frame 22"	Q6V702	4	80335720-80963756	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.0;fallopian tube: 19.8;testis: 34.8"	"Cell type enhanced"	"Detected in some"	25	"Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 8.4;pons and medulla: 22.0"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.2;naive B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6"	"Low region specificity"	"Detected in many"							HPA043383	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA043383: AB_10797140"	"unprognostic (4.77e-4)"	"unprognostic (1.52e-1)"		"unprognostic (4.06e-2)"	"unprognostic (1.45e-2)"			"unprognostic (7.24e-2)"		"unprognostic (3.27e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.61e-2)"	0.1	0.1	1.4	0.1	8.4	0.1	0.3	0.6	0.2	0.9	0.1	5.1	0.1	0.3	0.4	7.8	0.2	19.8	0.3	0.1	2.8	2.5	0.4	0.1	5.9	0.3	0.1	0.1	3.5	0.1	0.1	1.2	0.1	22.0	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.1	34.8	2.4	2.9	0.7	0.0	0.2	0.1	0.0	2.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	1.9	0.0	4.0	0.7	0.1	0.1	0.0	0.0	1.1	0.0	1.4	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.6	0.0	0.0	1.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.4	8.4	0.6	0.2	2.8	2.5	0.1	0.1	22.0	2.4	0.0	1.0	0.0	0.1	0.0	0.6	0.0	0.0	163.3	23.9	0.0	0.0	0.0	0.0	0.0	74.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.5	0.0	0.0	40.9	2.3	0.0	0.0	0.0	0.0	0.0
C4orf47	LOC441054	ENSG00000205129	"Chromosome 4 open reading frame 47"	A7E2U8	4	185426249-185449826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.8;fallopian tube: 20.3;testis: 20.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 125.8;Early spermatids: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043662, HPA063485"	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA043662: AB_10964715, HPA063485: "	"unprognostic (3.38e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.78e-3)"	"unprognostic (2.84e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (5.82e-5)"	"unprognostic (3.72e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.50e-1)"	0.9	0.5	4.4	0.7	13.3	0.8	3.7	1.7	4.0	1.8	0.7	3.6	0.8	0.6	2.2	12.3	0.7	20.3	1.8	1.2	3.8	3.8	2.4	1.0	3.3	0.5	2.4	2.9	3.0	1.3	1.0	7.1	0.7	20.8	1.2	0.7	2.1	1.0	1.4	0.6	1.9	0.7	1.0	4.7	0.8	0.5	20.6	5.5	0.0	7.3	0.0	0.6	1.0	0.6	0.1	0.7	4.1	0.6	0.9	0.6	0.2	3.9	0.0	0.4	2.1	0.8	4.1	1.2	0.1	0.3	0.3	0.5	0.6	2.4	0.1	0.8	0.1	0.4	0.3	0.5	0.6	0.9	0.8	0.7	0.0	0.1	0.6	1.0	0.0	0.3	0.9	0.9	1.0	0.4	8.3	0.0	0.9	0.5	0.2	3.0	0.5	0.0	0.0	0.5	0.0	1.5	0.1	0.0	0.3	1.1	0.1	2.2	1.0	0.7	0.1	2.4	0.8	0.2	0.6	1.2	0.6	0.3	0.0	0.1	1.7	0.0	0.0	10.0	0.0	0.2	0.0	0.6	0.6	0.2	0.1	0.4	0.0	0.6	0.6	0.2	0.1	0.1	0.2	4.1	0.9	0.2	0.7	0.0	0.2	4.4	13.3	1.7	4.0	3.8	3.8	2.4	2.9	20.8	5.5	3.0	1.0	0.0	0.5	0.6	0.6	0.5	0.0	125.8	17.0	3.5	9.8	0.1	1.7	1.2	125.8	0.6	0.0	0.0	0.5	1.2	0.8	1.2	0.0	0.0	0.2	1.6	0.0	1.3	0.3	7.5	0.6	0.4	1.7	0.0	0.0	1.6	1.4	0.0	0.7	3.2	14.2	0.0	1.0	3.5	4.3	0.5	0.2	0.0	0.0	0.3
C5orf46	"MGC23985, SSSP1"	ENSG00000178776	"Chromosome 5 open reading frame 46"	Q6UWT4	5	147880726-147906538	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"salivary gland: 107.9;skin 1: 42.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 262.3;Late spermatids: 107.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.3"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 23.8;PC-3: 39.1;SiHa: 8.7;U-2 OS: 25.5;U-251 MG: 9.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058999, HPA079692"	Supported		Approved	"Nuclear speckles,Mitochondria"	"Secreted in other tissues"	NA	NA			"Nuclear speckles"	Mitochondria	"HPA058999: , HPA079692: "	"unprognostic (1.72e-1)"	"prognostic unfavorable (3.98e-4)"	"unprognostic (1.26e-4)"	"unprognostic (9.75e-3)"	"unprognostic (2.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.75e-9)"	"unprognostic (6.48e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.79e-2)"	0.2	0.0	0.1	0.1	0.1	0.0	5.2	2.0	0.1	0.6	0.1	0.1	0.1	0.0	0.3	0.6	0.2	0.0	0.2	3.0	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	0.6	0.0	0.1	4.3	0.4	0.4	0.0	0.2	107.9	0.4	0.6	42.7	0.1	1.0	0.1	0.1	0.0	6.5	0.2	0.2	0.1	1.1	0.6	0.2	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.1	5.1	0.0	0.0	0.0	4.6	25.5	0.3	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.0	0.1	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.5	0.0	8.7	25.5	0.0	0.0	1.8	0.0	0.1	0.0	12.4	262.3	0.0	0.0	0.0	2.9	0.1	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	107.1	1.7	0.0	3.3	1.0	0.0	6.7	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.8	18.1	1.1	0.0	0.0	0.1
C8orf89		ENSG00000274443	"Chromosome 8 open reading frame 89"	P0DMQ9	8	73241329-73259502	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"blood: 8.8;testis: 10.5"	"Group enriched"	"Detected in some"	5	"Early spermatids: 6.8;Spermatocytes: 16.8"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory B-cell: 3.2;naive B-cell: 8.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;BJ hTERT+: 1.1;HEK 293: 1.3;HHSteC: 1.2;hTCEpi: 1.8;hTERT-RPE1: 1.0;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.52e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.92e-1)"		"unprognostic (1.98e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.62e-4)"	"unprognostic (5.50e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.26e-2)"	"unprognostic (6.32e-2)"	0.3	0.0		0.0		0.0	0.3		0.0	1.4	0.0			0.0	0.5	0.9	0.0	0.0	0.4	0.0			0.0	0.0	0.0	1.3			0.7	0.6	0.0		0.2		0.0	0.0		0.0	0.2	0.0	0.6	0.0	0.2		0.1	0.0	10.5			0.0		1.0	0.0		8.8	0.9	0.0	0.2	1.1	0.3	0.3	0.2	0.0	0.4	0.0	3.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.2	0.2	0.0	0.9	8.8	0.3	0.2	0.0	1.1	0.0	0.1	0.0	0.3											0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.2	0.1	0.6	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.8	0.2	0.0	0.2	0.0	0.0	0.1
C9orf50	FLJ35803	ENSG00000179058	"Chromosome 9 open reading frame 50"	Q5SZB4	9	129612225-129620776	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 9.4"	"Group enriched"	"Detected in some"	16	"Early spermatids: 60.3;Late spermatids: 168.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 2.9;MCF7: 4.4"									HPA026743	Enhanced					NA	NA					"HPA026743: AB_1845829"	"unprognostic (2.23e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (5.28e-2)"	0.0	0.4	1.5	0.1	1.2	0.2	0.0	0.9	2.5	0.2	0.2			0.0	0.2	0.0	0.0	1.5	1.5	0.0	1.0	1.4	0.4	0.0	0.1	0.1	1.1		0.0	0.0	0.1	0.5	0.2		0.1	0.0		0.8	1.5	0.0	0.0	0.0	0.4	0.8	0.3	0.1	9.4			0.5		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.7	0.3	1.9	0.2	0.8	0.0	0.5	1.7	1.2	0.5	0.0	0.6	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.1	0.0	0.0	1.4	0.3	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.6	4.4	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.6	0.2	0.1	1.6	0.4	0.2	0.0	0.1	0.4	0.0	0.0	1.2	0.3	0.2	0.1	0.0	0.0	0.0	0.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.3	0.1	0.3	2.5	0.0	0.0	3.5	0.0	0.0	5.0	0.2	60.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	168.5	0.9	0.0	0.0	0.0	0.0	7.0	0.2	0.0	1.8	0.5	0.2	0.0	0.5	1.2	2.2	0.0	0.0	0.0	0.0	0.1
CA11	"CARP2, CARPX1"	ENSG00000063180	"Carbonic anhydrase 11"	O75493	19	48637942-48646312	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.7"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.3;hTERT-RPE1: 24.4;SCLC-21H: 16.7;U-266/84: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041778			Approved	Vesicles,Microtubules	"Secreted in brain"	NA	NA			"Vesicles, Microtubules"		"HPA041778: AB_10794525"	"unprognostic (1.39e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (2.59e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.80e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (2.11e-5)"	"unprognostic (3.79e-2)"	"unprognostic (2.98e-1)"	"prognostic favorable (8.60e-5)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.75e-1)"	2.3	9.6	60.2	2.3	58.2	1.5	4.1	54.1	87.7	3.8	2.5	4.5	1.7	5.3	17.7	16.0	3.5	10.5	3.5	2.9	44.1	12.2	4.2	1.2	3.2	3.0	18.5	31.6	24.6	3.3	16.7	5.4	1.3	8.9	4.6	2.0	2.7	4.0	8.4	5.0	6.6	4.0	10.7	11.0	2.8	3.1	2.7	17.8	0.1	4.3	0.8	3.4	2.1	1.8	3.4	4.5	0.0	1.1	2.6	3.7	1.4	1.0	6.3	11.6	23.3	1.6	0.6	0.3	0.7	7.4	0.8	1.7	1.5	8.1	3.8	0.9	0.8	2.2	2.5	4.7	2.3	0.7	0.8	6.7	1.7	3.4	0.1	1.5	0.1	5.2	2.8	4.7	0.7	1.0	24.4	0.9	10.4	2.9	10.7	0.3	2.4	2.0	0.7	5.1	3.7	2.5	1.3	0.5	7.9	5.1	0.2	16.7	9.7	0.8	0.9	1.4	3.3	3.3	0.4	0.0	2.1	7.8	0.0	0.2	10.2	17.0	0.7	2.9	2.2	1.0	0.0	0.9	0.0	3.7	1.1	3.1	2.4	2.9	2.8	1.6	3.4	3.6	3.3	0.0	2.6	0.0	4.5	3.0	1.4	60.2	58.2	54.1	63.8	44.1	12.2	18.5	31.6	8.9	17.8	3.0	7.2	9.7	6.4	6.4	72.7	5.3	20.4	8.1	9.1	29.6	15.7	0.6	21.6	6.9	10.0	7.1	7.4	0.0	8.7	0.3	5.1	4.8	5.8	34.1	5.9	27.0	12.6	8.0	21.9	4.7	20.4	8.8	8.5	4.6	4.2	24.9	4.6	3.5	25.1	19.8	25.0	6.5	8.0	0.9	3.6	9.5	0.3	8.7	4.5	5.8
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673856-35681159	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 70.4;pancreas: 47.4;stomach 1: 70.8"	"Cell type enhanced"	"Detected in some"	25	"Cholangiocytes: 53.5;Early spermatids: 178.0;Exocrine glandular cells: 46.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 7.3"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 40.0;HDLM-2: 20.8;hTERT-RPE1: 25.5;U-87 MG: 83.9"	"Region enriched"	"Detected in some"	4	"cerebellum: 13.8"	"Low region specificity"	"Detected in some"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	1.0	0.1	0.0	0.1	0.3	0.0	0.0	7.3	0.7	0.5	7.2	0.1	0.2	6.7	0.1	1.5	0.3	0.1	70.4	0.7	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.7	47.4	0.0	0.2	0.7	0.4	0.2	0.0	0.1	0.0	0.0	0.0	2.6	8.0	0.0	0.4	0.0	70.8	1.4	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	1.1	0.0	0.0	0.4	0.1	0.0	40.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.2	0.3	20.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	1.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.0	0.3	7.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	3.9	0.0	0.3	53.5	0.0	0.0	0.0	0.0	0.0	0.0	27.8	178.0	0.0	0.0	0.0	46.4	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	12.2	1.4	0.0	0.0	1.0	0.1	1.5	33.9	0.0	0.7	0.0	0.0	0.0	0.4	0.9	2.7	2.8	0.2	0.0	0.2	0.3
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443798	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 89.3;Early spermatids: 53.8;Intestinal endocrine cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 49.0;HUVEC TERT2: 20.6;SH-SY5Y: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		310000000			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	9.9	13.4	15.7	4.2	18.1	0.7	4.3	8.8	20.8	5.7	11.3	7.3	1.0	5.0	7.1	2.9	5.4	4.1	6.3	25.8	12.7	14.9	8.0	1.8	3.6	2.2	6.3	15.6	7.8	2.0	1.9	8.3	4.2	8.6	12.8	5.3	1.9	3.3	6.6	59.0	4.7	3.5	13.0	5.6	4.3	5.5	3.7	8.0	0.0	16.9	14.6	3.3	6.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.0	0.0	7.1	9.0	0.0	8.7	5.6	4.3	4.3	0.0	1.3	0.0	0.0	7.5	5.4	0.0	4.2	0.0	5.7	0.0	5.6	0.2	5.6	0.0	4.6	1.9	0.0	5.3	0.0	15.1	0.0	49.0	20.6	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.7	0.0	1.8	0.8	0.8	0.0	0.3	0.3	8.0	23.9	1.7	0.0	0.0	4.4	0.0	0.0	14.7	7.7	5.8	7.6	0.0	0.0	0.0	0.0	6.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	18.1	8.8	20.8	12.7	14.9	6.3	15.6	8.6	8.0	0.0	1.7	0.0	4.0	5.0	30.7	89.3	0.0	1.4	2.3	7.0	17.7	0.0	0.0	0.0	53.8	9.0	0.0	0.0	0.0	0.0	11.0	11.4	24.3	0.0	0.2	23.8	37.2	1.3	0.0	25.0	9.5	0.4	1.7	1.0	0.2	5.8	0.6	0.0	5.6	9.9	6.0	6.5	17.6	1.0	2.3	5.6	0.1	0.0	0.0	1.4
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909335-53943941	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"brain: 54.4"	"Cell type enriched"	"Detected in some"	17	"Horizontal cells: 127.1"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			1.2	1.8	22.2	1.3	15.6	1.2	1.2	22.7	54.4	1.2	1.3	8.3	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	21.4	13.7	1.2	1.2	1.3	1.2	16.5	10.3	1.2	1.3	1.2	1.8	1.2	9.9	1.2	1.2	0.3	1.2	1.3	1.2	1.2	1.4	1.3	13.5	1.2	1.3	1.5	4.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	26.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	20.9	0.2	0.0	0.0	0.0	26.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	1.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	15.6	22.7	25.9	21.4	13.7	16.5	10.3	9.9	4.5	0.0	0.0	0.0	0.0	0.0	7.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.9;HSkMC: 41.0;hTERT-RPE1: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		11000	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	31.6	18.9	30.9	13.6	45.6	14.2	27.7	88.2	46.5	22.5	34.9	27.7	23.5	13.7	27.3	29.7	24.0	25.5	28.0	44.8	32.1	15.4	19.7	14.6	35.0	13.6	28.8	25.3	29.1	26.0	36.9	28.1	23.2	30.3	26.1	15.6	27.1	33.0	33.8	59.2	54.4	20.3	35.8	20.5	22.1	30.7	14.4	38.7	11.1	22.5	20.4	16.3	34.6	23.0	8.1	5.4	34.7	10.3	8.3	14.7	10.1	4.8	4.8	6.9	8.6	42.9	28.6	4.7	9.0	21.4	7.8	10.0	2.0	17.0	1.9	9.7	24.0	3.8	5.1	3.3	9.1	6.8	7.8	5.9	3.4	9.8	1.6	22.2	1.4	7.8	41.0	21.0	7.8	6.7	48.7	14.1	8.8	2.8	15.9	13.6	2.0	3.9	4.8	1.5	4.1	5.2	4.8	4.1	6.2	11.6	2.9	4.3	7.6	6.7	2.5	9.2	14.6	7.6	4.3	15.6	3.1	4.6	3.6	1.4	15.8	5.0	0.7	15.3	1.6	4.3	34.7	9.2	33.4	12.7	10.2	9.3	6.7	9.0	10.1	5.4	8.1	8.0	8.6	32.6	8.3	10.3	4.0	14.7	10.1	30.9	45.6	88.2	46.5	32.1	15.4	28.8	25.3	30.3	38.7	32.8	11.8	13.7	16.2	28.7	34.6	9.9	30.6	16.0	12.5	21.0	33.4	18.1	5.0	13.9	41.1	16.9	10.4	0.0	10.0	7.3	22.0	19.8	7.0	15.3	13.6	25.4	27.4	28.3	20.2	37.9	44.0	16.8	18.6	14.4	19.4	30.7	17.0	16.1	38.9	9.8	41.6	19.4	16.5	19.5	7.7	44.4	38.1	21.8	12.3	12.9
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Group enriched"	"Detected in some"	6	"Peritubular cells: 6.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.6;hTERT-RPE1: 6.9;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	1.9	0.3	0.8	0.2	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	11.6	0.0	6.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	1.6	0.0	0.0	0.2	2.0	0.2	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.3	0.3	0.0	6.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
CAPS2		ENSG00000180881	"Calcyphosine 2"	Q9BXY5	12	75275979-75390928	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 21.7"	"Cell type enriched"	"Detected in many"	4	"Ciliated cells: 96.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA039542, HPA040004"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			Nucleoli	"Nucleoplasm, Vesicles, Centrosome"	"HPA039542: , HPA040004: AB_10794758"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.69e-1)"	2.6	4.2	8.0	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5.0	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2.0	4.4	5.5	3.6	3.8	2.6	1.9	2.0	8.7	2.6	3.2	8.0	9.5	1.4	9.3	2.2	1.4	2.6	2.0	0.1	0.6	0.0	0.7	1.1	1.8	0.1	1.3	3.7	1.0	0.3	1.9	1.4	0.1	0.7	0.2	2.0	2.2	0.0	1.7	0.3	3.3	0.5	0.8	0.8	0.0	1.6	1.4	1.2	0.6	1.5	0.6	0.0	0.0	0.2	0.0	0.6	1.0	1.7	0.3	12.1	0.2	1.3	0.3	0.6	2.6	0.0	1.8	1.4	0.5	0.0	0.5	0.0	0.0	0.2	2.6	0.0	2.1	1.0	0.2	0.1	1.2	0.2	1.2	0.5	0.8	1.9	0.8	0.4	0.3	0.2	0.0	0.0	1.6	0.0	1.5	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.7	0.0	0.0	0.1	0.6	0.9	0.0	1.1	0.7	0.6	1.8	0.1	8.0	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5	8.9	3.2	0.0	2.5	1.5	0.7	7.1	2.5	96.4	17.0	5.2	3.9	1.0	5.0	0.8	21.6	1.7	0.0	0.0	1.5	0.5	1.7	1.5	0.0	1.5	0.5	1.6	0.0	2.5	1.8	11.5	5.8	0.9	0.0	0.0	1.7	5.8	0.4	0.0	6.7	2.5	20.8	0.0	1.4	9.1	0.9	0.5	0.2	0.0	0.6	0.5
CATSPERE	"C1orf101, MGC33370"	ENSG00000179397	"Catsper channel auxiliary subunit epsilon"	Q5SY80	1	244454377-244641177	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 26.9"	"Cell type enriched"	"Detected in some"	5	"Ciliated cells: 16.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.7;hTERT-RPE1: 2.6"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.22e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.39e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.37e-4)"	"unprognostic (4.43e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.85e-2)"	0.9	1.1	1.3	0.5	3.2	1.1	1.2	1.7	2.7	1.2	0.5	4.6	0.4	0.5	1.6	4.1	0.6	2.1	0.9	0.5	3.1	1.3	1.4	1.5	1.0	1.8	1.2	1.3	1.4	2.4	2.6	2.2	0.9	3.2	1.0	0.5	1.3	0.9	1.1	1.0	0.7	0.7	1.5	2.8	0.9	0.7	26.9	0.7	0.5	1.6	0.0	0.6	1.0	0.8	0.8	0.9	0.8	0.1	0.1	0.8	0.1	0.3	0.0	0.6	0.0	1.3	2.7	0.2	1.5	1.5	0.2	0.2	0.0	0.7	0.5	1.8	1.7	0.0	0.7	0.4	0.2	0.5	0.0	1.5	0.0	0.4	0.1	0.9	0.0	1.4	2.2	0.7	0.2	0.0	2.6	0.7	0.7	0.2	0.5	0.2	0.0	0.2	0.3	0.3	0.0	0.2	1.4	0.0	0.0	0.8	0.0	1.6	1.0	0.7	0.0	0.3	0.4	0.1	0.8	1.8	0.1	0.0	0.0	1.0	0.9	0.1	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.7	0.0	0.2	0.8	0.1	0.3	0.0	0.6	0.8	0.1	0.0	0.1	0.1	0.9	0.2	0.1	1.3	3.2	1.7	2.7	3.1	1.3	1.2	1.3	3.2	0.7	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	16.0	2.3	1.8	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CCDC184	"C12orf68, LOC387856"	ENSG00000177875	"Coiled-coil domain containing 184"	Q52MB2	12	48183584-48185926	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 51.8;Sertoli cells: 45.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 4.2;AF22: 9.9;hTERT-RPE1: 3.8;SH-SY5Y: 6.7;U-2 OS: 4.0;U-87 MG: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039947, HPA041715"	Uncertain		Approved	Mitochondria,Cytosol		No	No			"Mitochondria, Cytosol"		"HPA039947: AB_2676764, HPA041715: AB_2677634"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.87e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.36e-2)"	2.0	11.4	9.0	2.3	14.4	0.8	1.3	14.9	30.5	3.0	1.8	2.2	0.1	1.1	6.1	1.3	1.7	1.3	3.3	1.9	9.3	17.6	1.3	1.3	1.5	1.0	11.5	10.6	8.8	1.3	8.7	7.3	5.1	23.7	1.6	1.5	0.8	0.9	2.3	2.2	1.5	2.1	3.6	3.6	1.4	1.5	5.1	0.4	0.0	1.2	0.5	0.8	2.1	1.8	0.0	0.3	0.6	0.2	0.0	1.2	0.3	0.0	4.2	9.9	0.4	0.8	0.8	0.0	0.3	1.8	0.5	0.8	0.5	0.1	0.0	0.2	0.3	2.6	0.1	1.0	0.2	0.1	2.3	0.2	0.0	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.1	0.0	3.8	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	6.7	0.8	0.1	0.2	0.2	0.0	0.0	0.2	1.1	4.0	0.0	0.2	0.0	0.0	0.0	5.0	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.2	0.4	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	9.0	14.4	14.9	30.5	9.3	17.6	11.5	10.6	23.7	0.4	0.0	0.0	0.0	0.2	0.0	2.3	0.6	0.0	9.4	1.2	0.0	0.0	0.7	0.0	0.2	51.8	1.0	0.0	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.9	4.8	5.1	8.6	0.0	10.9	0.3	0.0	0.0	0.0	0.0	2.8	0.2	0.0	2.1	0.0	6.6	45.3	2.7	5.6	0.9	0.0	1.3	0.0	0.0	0.0
CCDC190	"C1orf110, MGC48998"	ENSG00000185860	"Coiled-coil domain containing 190"	Q86UF4	1	162824458-162868815	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;lung: 7.2;tongue: 7.5"	"Cell type enriched"	"Detected in some"	27	"Ciliated cells: 48.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028579, HPA028584, HPA028592"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001"	"unprognostic (4.29e-1)"	"unprognostic (8.37e-2)"		"unprognostic (1.75e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"		"unprognostic (8.33e-3)"		"unprognostic (3.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.41e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.26e-1)"	"unprognostic (1.70e-1)"	0.2	0.1	1.1	0.2	1.7	0.0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0.0	0.2	0.8	8.3	1.1	1.3	1.0	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.0	0.2	0.2	0.4	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	4.1	2.6	5.1	5.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.4	0.0	9.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	48.2	0.0	1.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3
CCDC3	DKFZp761F241	ENSG00000151468	"Coiled-coil domain containing 3"	Q9BQI4	10	12896625-13099652	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 89.3"	"Cell type enhanced"	"Detected in many"	14	"Basal keratinocytes: 44.5;Peritubular cells: 57.0;Sertoli cells: 32.3;Smooth muscle cells: 95.9;Suprabasal keratinocytes: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 7.5;HAP1: 13.6;HDLM-2: 22.3;hTERT-RPE1: 10.7;U-2 OS: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA062425			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA			Nucleoplasm	Cytosol	"HPA062425: AB_2684759"	"unprognostic (2.26e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (1.38e-5)"	"unprognostic (1.54e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-2)"	37.1	5.0	14.0	2.5	9.0	0.2	33.6	4.9	15.0	23.0	4.2	2.9	3.4	2.9	16.2	18.6	26.9	21.8	89.3	11.0	8.0	3.0	4.2	8.5	8.0	12.3	4.3	8.7	39.1	2.9	3.8	4.2	9.6	3.2	14.3	3.4	8.8	2.8	10.3	12.0	55.7	5.5	11.8	3.4	9.8	5.8	11.0	3.1	10.4	8.3	9.6	2.0	12.4	14.2	0.1	0.0	0.0	0.0	0.0	0.9	1.0	0.0	0.2	1.2	6.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.7	0.0	0.0	0.5	0.0	7.5	1.3	13.6	2.5	0.4	22.3	5.7	0.0	0.2	0.0	0.5	0.0	0.0	1.7	1.6	0.3	0.0	10.7	0.6	0.5	0.0	0.1	0.7	0.1	0.0	3.7	1.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	2.6	1.1	4.9	0.7	0.0	3.3	0.0	0.0	0.0	0.0	14.8	0.8	0.2	0.0	0.0	0.0	0.1	0.0	4.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	14.0	9.0	4.9	15.0	8.0	3.0	4.3	8.7	3.2	3.1	0.0	0.0	0.0	6.2	44.5	1.0	4.4	0.0	0.0	1.2	0.0	0.0	0.2	1.7	0.0	0.2	8.3	0.0	0.0	0.0	0.1	9.1	1.9	0.0	0.2	0.3	0.0	0.0	8.0	0.0	1.1	20.8	1.6	13.5	0.0	0.0	0.5	0.1	0.0	57.0	0.3	1.9	32.3	95.9	0.0	3.8	32.5	0.2	0.0	0.0	1.0
CCDC80	"DRO1, SSG1, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596794-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 130.0;endometrium 1: 143.8"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 452.4;Fibroblasts: 524.3;Late spermatids: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.6;fHDF/TERT166: 113.6;hTERT-RPE1: 221.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		57000			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	49.5	3.3	1.4	16.4	3.1	0.0	39.4	3.1	3.3	130.0	14.9	3.4	54.7	1.1	143.8	94.7	34.2	17.4	39.7	87.6	2.3	2.8	10.7	2.1	17.0	10.1	3.0	1.0	53.3	6.6	2.5	2.7	6.0	7.2	28.6	12.7	8.7	8.7	21.7	4.1	19.2	8.6	81.3	14.0	19.8	12.0	14.0	3.3	4.1	20.4	29.6	10.8	57.3	33.8	2.9	3.0	2.9	1.3	1.3	2.1	0.2	2.2	0.9	11.6	0.5	48.6	38.7	0.6	32.1	9.7	10.8	15.8	0.2	0.1	0.1	1.2	113.6	1.0	3.0	0.4	0.4	11.4	2.1	0.1	0.0	2.6	0.0	10.2	0.0	0.0	38.2	1.3	15.9	1.0	221.6	2.5	0.0	0.0	0.1	31.8	0.0	0.0	0.0	2.8	0.0	0.3	0.0	1.2	0.0	0.3	0.0	0.0	0.2	4.7	0.2	0.1	2.2	0.1	0.0	12.6	31.8	5.2	6.0	13.9	0.1	0.0	0.1	9.4	0.0	5.1	2.9	1.3	0.9	1.6	0.8	1.6	1.7	1.6	1.3	0.5	2.9	2.1	1.9	1.7	1.3	0.8	3.0	1.1	0.2	1.4	3.1	3.1	1.7	2.3	2.8	3.0	1.0	7.2	3.3	6.0	12.8	0.0	3.8	54.1	0.6	19.6	0.0	33.5	9.1	5.2	0.0	40.0	1.7	22.1	452.4	12.8	0.0	0.0	1.1	85.3	524.3	1.2	1.1	0.5	8.3	0.0	0.0	56.4	2.7	232.6	71.4	5.8	136.7	3.6	0.4	119.7	10.8	0.0	32.5	0.0	1.7	19.4	127.8	6.0	3.2	45.2	23.3	0.0	0.0	1.7
CCDC9B	"C15orf52, FLJ43339"	ENSG00000188549	"Coiled-coil domain containing 9B"	Q6ZUT6	15	40331452-40340967	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.7;Collecting duct cells: 19.2;Ductal cells: 27.2;Pancreatic endocrine cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.7"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 37.9;hTERT-RPE1: 35.2;WM-115: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040484, HPA041834"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA040484: AB_10794742, HPA041834: AB_10795643"	"unprognostic (5.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.51e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.68e-2)"	2.8	4.8	3.6	9.4	5.8	1.5	4.5	3.4	6.2	9.4	29.6	6.3	38.1	5.7	11.5	14.1	19.8	5.0	12.3	30.5	5.8	3.2	5.1	2.1	6.8	1.7	6.7	4.7	2.6	12.0	9.7	4.8	2.3	5.7	10.3	7.6	12.9	13.9	40.6	35.0	7.7	8.3	16.2	3.6	2.5	11.0	5.3	6.3	0.3	21.3	16.1	6.1	13.0	7.2	0.5	0.5	6.7	0.6	0.9	0.3	0.4	14.9	2.1	0.0	0.1	0.3	1.5	0.8	4.5	4.5	5.1	5.0	0.1	13.9	0.1	6.4	14.6	18.5	37.9	0.0	12.4	4.8	0.0	0.1	4.5	17.7	1.4	2.7	0.0	0.9	1.8	2.8	2.2	6.4	35.2	3.6	0.2	0.0	0.2	8.6	0.0	0.1	0.0	0.1	7.0	4.0	0.0	1.3	0.0	15.3	0.8	0.0	1.1	2.7	6.0	2.6	0.0	0.6	0.7	19.1	9.5	15.2	2.5	11.9	0.0	0.0	0.1	11.5	0.8	43.1	6.7	0.6	0.6	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.3	0.2	1.2	0.9	0.2	0.5	0.0	0.4	3.6	5.8	3.4	5.3	5.8	3.2	6.7	4.7	5.7	6.3	11.9	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	19.2	0.0	0.0	1.7	27.2	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832843-839831	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA		680000			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	63.1	28.1	7.4	19.1	8.1	3.4	133.2	7.9	11.3	39.8	36.0	9.5	37.8	23.2	55.7	45.3	43.1	29.3	63.0	85.2	7.3	7.9	52.8	47.2	45.8	16.3	7.5	10.3	29.8	82.7	27.8	14.1	58.6	10.7	52.0	16.5	31.2	62.9	41.1	19.2	17.1	46.0	62.4	6.7	15.8	31.7	20.8	5.5	2.4	43.2	27.1	16.1	35.9	34.9	2.1	8.1	14.9	14.3	5.2	4.8	6.5	38.1	52.9	7.6	22.8	109.5	45.6	11.9	59.8	40.9	30.2	25.6	27.5	54.6	0.0	24.0	89.4	40.3	34.9	6.7	52.8	7.6	14.3	26.0	10.5	16.3	21.0	41.7	8.5	14.7	44.0	35.3	17.7	31.2	112.1	35.6	1.7	12.9	5.0	45.0	21.4	0.2	10.1	5.0	21.6	63.5	1.9	15.8	8.2	67.2	11.1	10.5	11.8	55.4	30.9	10.4	7.9	12.4	10.3	60.9	41.1	20.4	13.2	33.1	6.6	6.8	0.4	40.5	8.9	22.7	14.9	12.0	9.6	4.2	12.6	4.8	2.1	3.5	3.6	8.1	1.5	1.5	2.2	5.7	5.2	14.3	1.3	2.1	6.5	7.4	8.1	7.9	11.3	7.3	7.9	7.5	10.3	10.7	5.5	193.5	73.9	15.2	121.9	62.7	15.1	156.1	160.5	32.1	73.9	235.5	3.9	213.2	16.6	600.9	2.2	178.4	409.1	0.0	557.1	348.4	135.3	228.7	81.7	50.8	127.0	35.0	122.5	247.9	64.9	8.8	114.5	96.8	121.4	92.8	320.3	85.6	610.0	308.6	266.2	116.1	12.3	207.0	270.6	1.4	13.0	47.6	155.3	44.9	214.1	153.3
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 139.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavorable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	39.7	35.9	0.3	0.0	21.7	60.0	0.1	77.9	60.9	43.4	24.2	2.4	12.5	0.0	10.4	110.3	89.3	68.5	0.8	84.7	59.6	8.5	0.4	1.4	17.7	0.0	21.4	20.2	93.5	27.0	66.8	58.3	47.4	139.4	15.1	0.0	0.3	13.0	41.6	0.2	1.8	13.3	0.7	0.7	10.6	0.1	7.4	0.6	63.6	11.5	0.1	0.1	14.7	0.4	35.2	3.4	2.1	1.2	43.5	54.1	9.8	66.3	80.0	22.5	24.3	0.2	82.1	11.4	78.6	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3	89.3	339.9	168.9	263.7	888.0	0.0	4.0	25.5	18.7	135.4	19.2	2.0	4.0	1.7	858.7	30.1	53.0	5.0	23.3	741.5	3.7	143.9	293.1	733.4	2.5	234.7	0.0	96.2	20.3	427.0	13.8	20.8	611.7	573.6	514.0	84.8	26.6	787.6	8.6	0.4	0.6	1.6	155.2	254.2	0.4	0.4	895.8	15.0	244.8	66.1	304.0
CDH18	"CDH14, EY-CADHERIN"	ENSG00000145526	"Cadherin 18"	Q13634	5	19472951-20575873	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 105.4"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 68.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 105.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014416	Uncertain				"Intracellular and membrane"	NA	NA					"HPA014416: AB_2668996"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"		"unprognostic (5.26e-7)"	"unprognostic (6.36e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.44e-2)"		"unprognostic (1.20e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.30e-2)"		"unprognostic (1.51e-2)"	"unprognostic (8.69e-2)"		"unprognostic (1.76e-2)"	0.7	9.3	6.9	0.7	7.1	0.7	0.6	105.4	23.2	1.0	0.6	0.0	0.0	0.7	0.6	0.6	0.7	0.7	0.7	0.6	4.6	8.1	0.9	0.6	0.7	0.8	1.8	8.3	0.7	1.2	2.1	11.3	0.6	7.1	0.8	0.7	2.2	0.6	0.8	0.9	0.8	0.7	0.6	2.2	0.7	0.6	3.7	1.3	0.0	0.6	0.0	0.6	0.6	0.3	0.7	0.3	1.2	0.5	0.6	0.4	0.5	1.5	0.0	0.3	0.0	0.9	3.8	3.4	0.2	2.1	0.1	0.6	0.0	0.0	0.0	5.8	0.0	10.1	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	2.3	5.3	0.0	0.1	0.2	0.7	0.4	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.0	1.8	9.1	8.0	0.0	2.2	0.0	0.0	2.6	0.0	0.0	1.1	0.5	0.3	0.4	0.1	0.2	0.3	0.2	0.2	0.2	0.7	0.4	0.4	1.2	0.6	0.4	0.3	0.2	0.5	6.9	7.1	105.4	14.1	4.6	8.1	1.8	8.3	7.1	1.3	0.0	0.0	0.0	0.8	0.0	3.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	68.6	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.3	0.0	0.0	2.1	2.4	0.0	0.2	0.0	0.0	0.0
CDK18	"PCTAIRE3, PCTK3"	ENSG00000117266	"Cyclin dependent kinase 18"	Q07002	1	205504595-205532793	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.7;heart muscle: 58.9"	"Cell type enhanced"	"Detected in many"	12	"Collecting duct cells: 69.8;Paneth cells: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 20.1;HeLa: 17.7;hTERT-RPE1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045429	Approved		Approved	"Actin filaments"		No	No			"Actin filaments"		"HPA045429: AB_10961257"	"unprognostic (7.95e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (5.07e-6)"	"unprognostic (6.07e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (2.81e-5)"	2.6	4.3	13.6	2.7	31.8	1.0	2.4	4.2	25.0	7.6	6.9	38.1	20.2	17.3	3.4	4.0	2.7	5.7	6.4	58.9	22.1	16.2	13.7	4.7	6.5	1.9	47.8	16.7	7.5	10.7	3.7	4.0	9.6	22.1	3.1	6.1	5.3	16.5	23.5	3.9	1.6	15.1	4.8	98.7	3.5	9.1	0.9	36.4	0.4	4.8	1.4	2.5	3.7	4.7	0.1	1.4	0.0	2.1	0.6	0.9	0.6	11.7	0.8	0.1	0.6	0.0	0.0	12.7	0.2	2.4	0.5	3.1	5.3	8.8	7.0	1.8	0.1	1.0	10.6	2.6	20.1	0.5	1.9	2.3	1.6	17.7	5.4	2.3	0.0	0.0	1.3	1.0	0.0	0.4	17.2	0.0	10.0	0.1	8.5	0.1	9.5	0.6	0.3	10.0	3.4	0.4	0.9	0.0	8.8	1.9	7.5	4.1	1.6	3.6	1.7	7.8	14.7	7.9	3.4	0.0	0.0	4.8	0.0	0.0	2.4	1.1	1.4	0.1	5.0	2.0	0.0	0.8	0.0	0.1	2.1	0.9	0.0	0.2	0.0	1.4	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.6	13.6	31.8	4.2	19.7	22.1	16.2	47.8	16.7	22.1	36.4	0.0	0.3	0.0	6.7	3.1	4.7	25.0	7.6	0.0	1.2	69.8	0.0	4.9	6.6	15.9	1.6	1.9	20.6	0.0	5.8	1.9	4.8	1.9	0.0	3.9	5.1	0.0	5.8	1.3	1.6	2.8	0.9	3.6	3.3	7.2	12.9	19.1	6.3	98.2	1.4	15.4	1.2	6.5	12.5	1.4	10.0	1.1	1.6	0.5	11.5	5.9
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009363	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 140.1;Pancreatic endocrine cells: 107.4;Urothelial cells: 219.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9"	"Lineage enriched"	"Detected in single"	16	"monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7;HaCaT: 16.2;HeLa: 15.3;hTERT-RPE1: 28.4;SiHa: 20.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	22.4	1.4	1.4	7.3	1.1	0.0	25.1	0.8	1.2	6.6	35.4	1.4	1.5	14.1	2.6	0.8	27.0	1.2	1.4	1.4	1.6	0.8	0.5	0.6	9.9	2.3	2.0	0.8	0.8	1.0	3.9	7.8	3.7	3.4	3.1	13.4	0.7	5.1	3.2	6.5	8.6	47.0	3.2	1.0	4.4	3.9	3.3	1.3	1.1	0.8	9.8	12.5	2.8	16.6	0.0	0.6	0.0	10.9	0.0	0.4	1.3	0.0	0.0	0.1	0.9	13.6	18.7	0.3	0.6	0.0	2.1	5.9	1.5	4.1	0.0	1.7	1.0	0.0	16.2	0.3	3.2	2.6	1.1	5.0	0.0	15.3	0.7	6.9	0.4	2.7	3.9	0.0	2.7	12.0	28.4	2.0	0.0	0.0	7.2	3.4	1.2	0.0	0.0	0.7	0.8	9.4	0.0	0.9	0.3	4.6	0.0	2.6	0.0	20.5	5.3	14.7	12.6	1.1	0.0	5.3	0.0	0.3	0.0	0.0	6.9	3.9	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.1	3.9	0.0	0.0	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.1	1.3	1.4	1.1	0.8	1.2	1.6	0.8	2.0	0.8	3.4	1.3	62.5	7.9	0.9	16.4	4.7	1.2	2.4	2.5	4.0	3.4	5.2	0.0	0.8	0.0	50.3	4.4	2.5	140.1	0.0	34.0	0.4	7.2	41.1	0.0	0.0	1.2	0.0	7.5	2.5	14.8	1.7	0.6	4.0	3.3	1.8	21.9	3.7	107.4	49.1	1.1	0.0	6.7	0.0	6.3	13.8	3.3	21.1	2.6	0.0	11.2	219.8
CEACAM19	CEAL1	ENSG00000186567	"Carcinoembryonic antigen related cell adhesion molecule 19"	Q7Z692	19	44662278-44684359	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.7;RPTEC TERT1: 13.7;TIME: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014462, HPA052865"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"	Nucleoplasm	"HPA014462: AB_2669006, HPA052865: AB_2681976"	"unprognostic (2.91e-1)"	"unprognostic (5.29e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.26e-9)"	"unprognostic (8.01e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-1)"	1.6	2.9	1.1	0.8	1.9	1.0	2.4	4.3	1.7	3.1	2.4			2.7	2.7	1.4	2.4	4.3	2.1	4.1	1.2	1.8	3.3	4.3	3.8	0.6	0.6		4.0	4.7	1.2	3.9	1.8		4.1	3.3		2.9	3.0	12.5	10.8	2.9	3.0	0.9	1.8	2.0	3.0			3.4		1.7	1.0	4.4	1.7	0.5	1.7	1.0	1.0	0.7	0.6	4.2	8.8	1.3	0.9	3.1	3.6	3.3	2.4	3.6	0.8	1.6	0.3	1.0	0.1	0.8	3.2	0.9	5.3	2.2	0.9	0.7	1.2	5.0	0.1	4.6	1.4	3.2	0.2	0.8	1.1	8.7	2.2	5.4	10.7	2.0	0.6	0.3	0.2	1.2	1.0	0.0	0.5	0.8	1.1	1.0	0.0	1.6	0.2	13.7	1.0	1.7	0.4	0.9	0.9	0.8	1.3	1.2	0.3	17.7	0.3	6.1	1.3	0.7	0.1	0.3	0.0	0.4	1.7	1.4	1.7	1.0	0.6	0.6	0.4	0.3	0.5	0.3	0.6	0.2	1.7	0.4	0.7	1.6	1.0	0.5	0.5	0.3	0.6											3.0	2.1	0.0	0.9	1.8	2.6	4.1	2.5	1.4	2.3	0.0	0.0	0.0	0.0	1.6	0.7	3.1	1.7	0.0	2.9	0.1	0.9	1.3	0.0	1.9	0.2	0.0	1.7	4.9	1.2	0.2	2.8	0.5	0.0	0.0	2.6	0.1	3.5	3.5	2.5	0.2	0.5	0.0	2.8	3.2	0.4	5.3	0.0	0.0	2.2	0.9
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 2.5;Club cells: 7.9;Cone photoreceptor cells: 5.9;Fibroblasts: 7.2;Horizontal cells: 3.2;Intestinal endocrine cells: 4.6;Rod photoreceptor cells: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 42.9;BJ hTERT+: 67.9;fHDF/TERT166: 53.9;HSkMC: 37.1;hTERT-RPE1: 40.5;U-138 MG: 19.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	42.9	67.9	1.1	0.9	0.5	0.2	0.2	0.1	53.9	0.2	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.1	0.0	8.4	0.0	40.5	0.0	0.2	0.2	0.1	1.0	0.9	0.1	0.1	0.2	14.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.6	0.2	0.0	0.2	19.6	0.1	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1	0.0	1.0	0.0	0.4	0.0	2.5	0.8	0.0	0.0	7.9	0.0	5.9	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.1	7.2	0.8	1.1	0.0	0.3	3.2	4.6	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.8	0.4	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.9
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 1052.9"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA	396000000000	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113"	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	13.6	0.0	0.0	21.4	12.1	0.0	5.5	13.5	0.7	2.9	0.0	2.5	0.0	2.0	0.0	0.0	0.4	0.0	5.0	0.5	0.2	0.0	4.1	16.2	0.0	26.9	0.1	0.0	26.3	0.0	4.0	1.7	81.0	16.8	0.0	15.3	0.5	19.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.6	4.3	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	16.2	0.2	0.1	0.1	0.1	0.0	0.0	2.9	0.0	1.2	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21.0	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0.0	0.0	0.0	1.9	1.5	55.0	0.0	0.0	0.7	0.0	200.9	8.6	3.5	1052.9	0.9	0.0	0.0	57.1	34.9	3.6	262.9	6.0	42.2	0.0	0.0	0.3	6.4	0.0	130.4	0.0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0.0	49.2
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23754627-23758951	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 105.8;skin 1: 36.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 496.3;Paneth cells: 262.3;Undifferentiated cells: 147.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 8.3;hTERT-RPE1: 11.8;NB-4: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB072806	Approved					NA	NA					"CAB072806: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.3	0.0	0.3	8.8	0.5	0.0	0.5	0.4	0.7	2.3	37.4	0.7	0.8	54.8	0.4	0.6	0.4	0.1	0.3	0.3	0.3	0.1	0.5	0.3	0.5	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.8	0.8	1.4	26.2	0.4	0.6	0.5	0.3	36.8	105.8	0.9	0.9	0.3	0.0	2.9	0.6	0.5	0.3	0.5	0.4	6.2	1.4	1.5	1.3	2.5	0.9	0.4	0.9	0.1	1.1	2.5	0.8	0.7	1.5	1.5	1.5	3.3	1.2	0.5	1.2	0.7	2.6	0.5	1.1	2.8	1.4	1.6	0.5	3.2	0.7	0.7	0.2	0.5	4.6	1.9	1.9	0.4	0.8	1.1	1.0	2.9	8.3	11.8	1.4	0.5	1.4	1.2	1.4	0.2	0.1	9.6	0.4	0.5	2.4	0.3	0.2	1.5	1.2	1.3	0.7	0.9	1.0	0.3	0.1	0.8	0.2	0.2	1.4	0.6	0.9	0.9	0.2	0.5	0.2	0.3	0.0	0.6	0.6	1.2	0.9	0.2	0.9	0.5	0.5	0.7	0.6	0.7	0.4	1.5	0.9	0.8	2.5	0.4	0.5	1.3	0.3	0.1	0.3	0.5	0.4	0.7	0.3	0.1	1.2	0.3	0.8	0.6	0.0	0.0	0.0	7.7	9.2	0.0	0.0	0.0	5.3	7.9	1.8	0.0	0.7	0.0	0.0	0.4	0.0	496.3	0.0	0.0	2.0	0.2	1.5	4.6	0.0	0.1	0.0	8.7	0.0	0.0	0.2	0.0	0.3	1.7	0.0	59.0	0.0	0.0	262.3	0.0	6.3	0.0	0.0	0.1	0.0	0.1	59.0	0.6	0.0	147.7	26.8
CLGN		ENSG00000153132	Calmegin	O14967	4	140388455-140427968	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;pituitary gland: 23.6;testis: 52.6"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 243.4;Early spermatids: 78.2;Muller glia cells: 200.1;Spermatocytes: 280.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 21.7;U-251 MG: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020709, HPA048761, HPA058627"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782"	"unprognostic (6.74e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.73e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.01e-1)"	0.4	3.6	2.1	0.7	3.7	1.2	1.6	5.9	3.5	0.8	1.4	0.5	0.0	0.4	1.0	1.6	0.9	7.0	0.4	40.3	0.9	3.4	0.4	3.7	0.5	0.5	1.4	1.6	1.8	1.6	0.2	23.6	0.3	8.6	11.9	0.8	2.4	0.6	0.6	0.4	0.3	0.8	0.9	0.8	0.3	1.6	52.6	0.3	3.1	1.5	0.0	0.8	0.6	0.4	0.5	1.0	3.4	1.1	0.0	0.0	0.1	0.0	4.0	4.2	2.7	1.7	8.8	1.0	0.0	3.7	4.0	7.5	0.1	0.3	0.0	11.5	0.4	3.5	0.1	2.9	0.0	6.6	0.2	3.4	1.1	4.0	2.9	17.5	14.6	0.2	1.0	16.1	0.4	0.4	21.7	0.1	3.9	0.7	0.0	0.0	0.2	18.3	0.2	4.8	0.1	11.4	12.2	0.0	0.1	0.0	0.1	6.8	12.3	2.5	1.6	0.7	1.6	0.8	2.2	0.0	11.0	2.0	4.0	28.9	5.8	12.6	7.9	17.7	0.6	1.2	3.4	1.1	1.5	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	3.7	5.9	3.5	0.9	3.4	1.4	1.6	8.6	0.3	0.0	2.1	0.0	1.0	0.0	8.5	243.4	0.0	28.1	4.5	0.0	3.9	0.3	0.0	0.9	78.2	1.1	0.0	23.3	3.7	0.1	0.5	35.3	0.0	2.6	0.1	23.8	5.1	0.0	0.0	42.6	4.6	0.0	1.7	0.0	0.0	200.1	1.4	0.0	4.2	0.0	11.8	0.0	0.3	280.7	9.8	0.1	0.2	0.0	0.4	0.9
CLIP3	"CLIPR-59, RSNL1"	ENSG00000105270	"CAP-Gly domain containing linker protein 3"	Q96DZ5	19	36014660-36033343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 108.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 31.5;Horizontal cells: 39.7;Leydig cells: 20.4;Muller glia cells: 27.8;Peritubular cells: 23.0"	"Cancer enhanced"	"Detected in all"		"glioma: 65.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 30.7;fHDF/TERT166: 21.4;HHSteC: 19.8;HSkMC: 34.0;hTERT-RPE1: 29.1"									HPA079430	Uncertain					NA	NA					"HPA079430: "	"unprognostic (1.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavorable (1.56e-10)"	"unprognostic (6.31e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.09e-2)"	6.4	10.9	38.4	7.5	35.2	1.6	4.1	52.9	108.3	17.6	15.1	14.9	2.8	5.7	24.0	10.4	12.7	10.6	17.0	5.1	33.3	37.6	4.8	2.3	4.2	5.5	30.6	37.8	28.2	3.6	2.1	10.9	7.5	30.2	16.7	7.4	4.9	3.9	25.4	2.4	3.7	5.8	27.7	20.3	6.3	6.7	6.6	16.9	2.9	2.2	0.1	5.4	17.4	7.4	1.2	0.7	1.7	0.9	2.6	1.8	0.8	0.4	1.3	11.7	0.5	19.6	30.7	0.4	6.6	16.2	5.6	8.5	1.4	0.4	0.6	2.8	21.4	0.4	0.5	0.2	0.0	4.0	0.8	0.4	0.3	1.2	0.2	19.8	0.3	0.3	34.0	0.3	4.8	0.1	29.1	6.2	4.5	0.6	1.2	12.4	1.0	6.2	0.4	1.4	0.4	0.3	0.8	0.2	0.3	0.2	0.4	11.5	13.4	0.7	0.3	0.3	5.1	0.4	0.1	1.7	9.6	8.1	0.4	0.4	1.0	0.8	0.5	14.8	0.6	3.5	0.0	0.6	1.7	1.1	0.9	0.3	1.2	1.7	0.6	0.2	1.0	1.8	1.2	0.5	2.6	0.4	0.7	1.1	0.8	38.4	35.2	52.9	50.6	33.3	37.6	30.6	37.8	30.2	16.9	0.0	0.0	0.0	0.7	0.6	31.5	1.7	0.0	1.4	0.0	1.8	2.0	0.5	0.0	0.1	9.4	3.1	0.2	0.0	0.2	0.4	8.7	0.2	0.0	0.0	0.7	39.7	2.4	4.3	0.0	15.7	20.4	0.6	3.3	0.0	0.7	27.8	0.4	0.0	23.0	0.0	9.4	6.5	9.5	2.2	2.9	1.1	1.0	0.0	0.2	0.0
CLSTN2	"CDHR13, CS2, CSTN2, FLJ39113"	ENSG00000158258	"Calsyntenin 2"	Q9H4D0	3	139935185-140577397	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;ovary: 59.4"	"Cell type enhanced"	"Detected in some"	13	"Early spermatids: 17.1;Late spermatids: 10.8;Leydig cells: 25.9"	"Cancer enriched"	"Detected in many"	7	"breast cancer: 15.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 21.0;SCLC-21H: 9.3;SuSa: 28.6;THP-1: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031342, HPA061800"	Approved		Uncertain	"Vesicles,Cytokinetic bridge"		Yes	No		9100	Vesicles	"Cytokinetic bridge"	"HPA031342: AB_10602800, HPA061800: AB_2684615"	"unprognostic (7.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.51e-3)"	"unprognostic (5.52e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.58e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.63e-5)"	"unprognostic (7.22e-5)"	14.2	5.0	4.9	1.0	9.8	0.8	8.5	1.5	19.7	4.1	1.8	2.4	0.3	1.2	5.2	1.8	1.6	3.6	2.6	5.9	15.4	4.0	4.5	1.5	1.7	2.8	4.1	14.3	59.4	2.0	1.5	1.3	1.5	23.7	5.4	1.4	3.0	1.6	1.8	1.9	2.1	1.5	6.6	1.4	0.8	1.4	1.9	0.5	0.0	2.9	0.5	1.0	1.9	4.7	0.3	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	3.3	0.0	1.4	0.4	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	1.3	0.0	0.0	0.0	28.6	1.4	5.8	0.0	0.7	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	4.9	9.8	1.5	19.7	15.4	4.0	4.1	14.3	23.7	0.5	0.0	0.0	0.0	0.2	0.5	0.7	5.3	0.0	5.3	1.2	3.5	0.0	0.2	1.7	0.0	17.1	0.7	0.0	0.0	0.2	0.0	1.6	5.3	0.0	0.0	0.1	0.0	0.0	3.1	0.8	10.8	25.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	7.9	3.7	0.0	6.1	0.7	0.7	0.0	0.0	0.0	0.0	0.1
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339341	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.6"	"Cell type enhanced"	"Detected in some"	20	"Hofbauer cells: 25.9;Kupffer cells: 51.2;Macrophages: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 11.9;plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	31	"dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.9;ASC TERT1: 33.3;BJ hTERT+: 23.7;hTERT-RPE1: 8.0;LHCN-M2: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain					NA	NA					"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	11.3	6.3	2.5	8.5	3.5	0.3	5.1	0.9	3.6	6.7	5.2	5.1	1.7	3.1	9.6	12.0	4.1	5.4	6.4	9.3	2.9	2.3	4.3	7.1	10.5	17.2	5.6	1.5	3.9	3.2	1.6	4.1	18.9	4.0	5.3	6.5	10.7	5.6	3.7	2.9	4.6	5.4	12.1	5.1	42.6	3.4	4.6	4.8	3.2	9.9	5.9	5.8	6.9	3.2	0.0	15.2	0.2	11.9	0.3	6.3	3.1	0.0	0.0	0.1	0.0	7.9	33.3	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	8.0	0.4	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.2	0.0	6.3	11.9	0.0	0.0	1.0	4.2	0.8	0.0	0.4	3.4	0.2	0.3	2.0	15.2	0.3	3.1	2.5	3.5	0.9	2.6	2.9	2.3	5.6	1.5	4.0	4.8	0.0	0.0	0.9	0.0	0.8	0.0	1.2	0.0	1.4	1.2	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.0	25.9	0.0	0.0	5.5	51.2	0.0	0.3	10.6	3.3	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	6.5	5.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 39.8;hTERT-RPE1: 41.0"	"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.5	9.8	11.9	9.2	9.1	27.9	4.4	5.3	8.0	7.4	5.0	39.8	0.0	13.8	5.3	9.9	5.0	12.1	20.5	7.1	0.0	9.6	5.3	0.0	11.6	37.6	1.3	8.5	9.6	2.7	8.2	13.1	41.0	18.0	0.0	4.4	12.0	5.9	0.1	0.0	12.3	11.8	2.0	20.9	25.6	3.7	24.4	11.3	8.8	0.5	10.2	0.6	0.7	22.8	4.4	6.2	13.8	10.3	7.6	7.6	8.3	15.4	3.4	1.2	0.0	2.7	16.7	15.9	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6	23.8	14.7	40.7	17.6	8.8	0.2	1.5	15.3	14.7	23.9	17.4	0.0	19.8	0.0	83.6	0.1	15.7	1.3	23.3	13.6	6.7	16.0	11.2	28.9	1.0	104.7	1.6	16.6	18.4	102.2	1.0	1.4	86.9	23.6	120.0	3.4	1.3	59.3	8.6	1.1	24.0	0.2	6.5	14.5	1.2	7.2	4.8	5.7	43.6	3.0	10.2
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740549	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 16.1;pancreas: 21.7"	"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 26.6;Early spermatids: 14.0;Late spermatids: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.8;hTEC/SVTERT24-B: 24.9;hTERT-RPE1: 14.1;NTERA-2: 9.2;U-266/70: 13.3;U-87 MG: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	2.0	0.8	7.0	0.5	5.1	0.2	1.3	1.0	16.1	1.7	0.6	0.6	0.0	0.8	1.5	0.9	0.6	1.9	1.2	0.6	9.8	5.0	1.5	0.6	0.9	0.9	5.4	8.0	3.6	21.7	0.3	0.7	0.4	3.5	0.9	0.7	0.2	0.6	1.1	0.7	0.4	0.6	1.0	1.4	0.6	0.6	3.9	0.1	0.2	1.0	0.0	0.9	0.7	0.9	0.9	0.3	0.0	0.0	1.8	0.9	0.1	0.2	0.2	0.3	0.3	0.3	0.5	0.1	1.8	9.8	0.2	0.5	0.0	2.2	0.0	0.9	4.2	0.7	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.7	0.3	0.0	24.9	0.3	14.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	3.0	9.2	0.1	1.1	0.0	0.5	0.0	1.5	0.9	0.3	0.2	0.0	0.0	6.1	1.0	0.0	0.2	0.0	0.0	2.3	0.0	0.2	13.3	0.5	0.0	29.6	0.1	3.7	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.3	0.3	0.0	0.6	0.0	1.8	0.0	0.0	0.9	0.1	7.0	5.1	1.0	11.1	9.8	5.0	5.4	8.0	3.5	0.1	0.0	1.3	0.5	2.4	2.5	3.3	1.2	2.5	13.4	0.0	1.8	0.0	1.5	26.6	0.6	14.0	2.7	0.4	0.0	2.6	0.4	3.2	2.0	2.3	1.7	5.2	0.0	1.2	1.8	0.0	26.2	2.6	1.9	0.0	1.0	2.3	9.2	0.7	0.0	1.1	9.0	0.5	0.0	0.9	2.3	9.6	1.9	4.2	1.8	1.7	1.3
COL13A1		ENSG00000197467	"Collagen type XIII alpha 1 chain"	Q5TAT6	10	69801867-69964275	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Osteogenesis"	"Developmental protein, Heparin-binding"	"Congenital myasthenic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.6;epididymis: 22.3"	"Cell type enhanced"	"Detected in some"	21	"Fibroblasts: 4.1;granulocytes: 19.7;Melanocytes: 5.0;Smooth muscle cells: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	18	"cerebellum: 54.6"	"Group enriched"	"Detected in some"	18	"gdT-cell: 1.9;NK-cell: 1.9"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.9;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 19.6;BJ hTERT+: 18.2;hTERT-RPE1: 25.5;HUVEC TERT2: 31.8;PC-3: 29.2;TIME: 45.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050392	Approved					NA	NA					"HPA050392: AB_2681110"	"unprognostic (2.79e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.67e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.36e-5)"	"unprognostic (2.66e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.93e-2)"	0.7	1.2	0.5	3.3	1.0	0.0	1.3	54.6	1.3	3.5	3.1	0.6	4.3	1.8	1.4	22.3	1.3	2.0	2.7	2.7	0.6	0.5	1.3	0.5	8.2	0.7	0.9	0.7	1.1	1.2	0.9	2.7	0.9	3.0	10.7	2.3	3.8	1.0	6.2	2.7	3.1	2.9	2.0	1.7	5.0	3.9	0.9	0.7	0.3	1.0	1.1	0.6	2.2	1.2	0.0	0.0	0.1	0.0	1.9	1.9	0.4	0.4	0.1	7.0	0.0	0.0	1.3	0.0	19.6	18.2	3.3	1.6	0.0	0.4	0.0	3.3	8.7	0.3	0.7	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	2.8	0.0	8.3	2.6	25.5	31.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.3	0.0	29.2	0.0	0.0	3.5	0.1	0.0	0.7	0.0	0.0	0.0	0.9	0.2	0.0	0.0	45.4	0.1	5.4	1.7	14.9	4.3	0.0	0.0	11.6	0.0	16.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.4	0.5	1.0	54.6	1.3	0.6	0.5	0.9	0.7	3.0	0.7	0.0	1.1	0.0	0.3	3.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	4.1	0.3	19.7	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	5.2	0.5	0.5	2.6	0.1	0.0	0.0	0.1
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120372036	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 87.4"	"Cell type enhanced"	"Detected in many"	21	"Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		2000000	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.01e-4)"	20.0	3.3	0.8	20.8	0.9	0.0	21.6	0.7	0.9	87.4	13.9	1.0	9.6	1.3	64.6	39.2	20.0	15.6	38.6	27.8	0.8	1.0	8.3	5.0	8.8	4.5	1.1	1.1	62.1	4.4	1.1	1.8	30.8	3.0	41.7	10.5	4.2	21.8	5.8	7.6	5.4	12.2	45.2	6.5	15.4	10.1	13.3	0.4	1.1	15.7	32.5	9.9	30.4	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	18.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.6	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	5.3	0.1	0.0	4.7	0.1	1.0	0.0	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	48.7	0.1	2.1	0.0	0.2	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	0.9	0.8	1.0	1.1	1.1	3.0	0.4	0.0	1.4	0.0	0.2	10.1	0.0	7.8	0.0	0.0	7.9	1.8	0.0	32.7	0.0	0.0	0.8	2.9	0.0	0.0	0.0	2.9	157.1	0.4	3.5	0.0	5.4	0.0	0.0	25.8	0.0	0.4	13.6	0.8	5.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.2	0.0	54.7	3.5	2.9	8.4	21.2	0.0	0.0	0.4
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 157.8;Cone photoreceptor cells: 375.0;Muller glia cells: 214.6"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 15.4;hTERT-RPE1: 13.4;Karpas-707: 9.0;RPTEC TERT1: 10.1;U-266/70: 8.3"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.0	0.0	0.2	1.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	1.1	0.0	9.0	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	0.0	2.8	10.1	2.0	0.4	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	8.3	2.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4	157.8	24.8	4.7	0.0	0.1	58.0	1.7	0.0	0.0	17.0	40.1	375.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.8	0.0	1.7	0.0	0.0	214.6	0.9	0.0	11.3	1.0	11.5	12.9	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002711-227164453	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.7"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 68.5;Collecting duct cells: 43.6;Cone photoreceptor cells: 53.0;Muller glia cells: 117.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"memory B-cell: 8.0"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.0"	"Cell line enhanced"	"Detected in some"		"HeLa: 23.1;hTERT-RPE1: 19.7;Karpas-707: 6.3;RPTEC TERT1: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.6	8.8	1.2	7.2	2.4	0.2	1.3	1.0	1.8	1.0	1.1	0.7	16.1	1.2	4.8	12.7	2.4	3.0	13.7	11.5	1.4	1.5	28.7	1.9	15.8	13.0	2.4	0.0	3.2	6.6	0.5	15.3	0.7	7.4	7.2	1.2	8.3	1.4	10.9	7.5	0.9	3.3	12.0	4.6	3.7	1.9	1.9	1.5	0.9	12.1	6.6	6.2	3.9	3.7	8.0	0.0	0.1	0.0	1.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	0.0	0.5	0.0	1.2	0.0	0.5	0.0	2.2	0.7	0.2	0.0	2.4	0.0	23.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	19.7	0.0	0.7	0.0	6.3	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	10.6	3.9	0.6	0.0	1.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.2	4.8	3.5	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	2.4	1.0	1.8	1.4	1.5	2.4	0.0	7.4	1.5	68.5	17.9	2.2	0.4	0.5	29.8	2.6	15.3	0.0	11.4	43.6	53.0	0.0	1.7	0.2	0.7	0.3	0.0	0.0	3.2	0.0	0.7	0.1	0.0	0.5	0.1	0.0	1.2	2.5	0.3	2.1	23.3	0.7	0.0	0.0	0.0	117.3	3.3	0.0	25.5	2.2	7.4	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 229.3;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.3	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.2	0.2	0.0	0.0	11.6	23.4	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	63.4	17.4	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	64.9	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.2	0.0	32.0	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6	229.3	23.2	0.0	0.4	0.7	0.4	4.2	0.0	1.4	6.8	8.7	0.0	0.1	0.0	0.2	0.7	1.5	0.0	0.0	0.0	0.2	2.4	0.1	4.7	0.8	0.1	0.0	0.0	85.3	1.9	0.4	2.0	0.9	1.7	0.0	0.0	0.5	0.1	0.0	8.9	0.8	0.5	0.0	8.3	0.3	0.2	0.5	0.3	1.0	0.0	0.2
COL8A2	"FECD, FECD1, PPCD, PPCD2"	ENSG00000171812	"Collagen type VIII alpha 2 chain"	P25067	1	36095236-36125220	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"		"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 39.4"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 9.8;Fibroblasts: 13.4;Hofbauer cells: 6.5;Melanocytes: 6.8;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.0;intermediate monocyte: 1.2;myeloid DC: 2.8;plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	15	"dendritic cells: 2.8;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 4.1;HHSteC: 14.2;hTERT-RPE1: 18.1;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA049788	Uncertain		Uncertain	"Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA			"Golgi apparatus"		"HPA049788: AB_2680882"	"unprognostic (9.98e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.41e-3)"	"unprognostic (8.76e-2)"	"prognostic favorable (9.44e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (3.50e-2)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.08e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.16e-3)"	4.4	1.2	1.7	8.1	3.4	0.3	7.2	6.0	1.3	9.6	4.8	4.5	1.0	1.4	5.2	3.1	6.4	3.4	6.3	11.1	1.7	1.4	1.1	0.4	4.8	2.9	3.8	0.9	4.2	1.8	0.1	3.7	13.7	7.6	5.5	2.1	39.4	6.5	13.4	1.4	4.6	1.8	16.3	4.8	7.5	9.6	1.9	2.5	1.9	7.7	4.7	3.5	10.1	5.5	0.0	2.8	0.1	1.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	5.6	1.6	1.5	0.9	0.2	0.1	0.0	0.8	4.1	0.0	0.3	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.1	14.2	0.0	0.0	1.7	0.1	0.7	0.0	18.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.0	0.2	0.4	0.0	4.5	0.1	2.3	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.1	0.0	0.2	2.4	0.0	0.2	1.7	3.4	6.0	1.3	1.7	1.4	3.8	0.9	7.6	2.5	0.0	2.6	0.0	1.6	1.9	0.0	9.8	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.2	0.2	13.4	0.7	2.3	0.0	6.5	0.0	0.0	0.6	1.9	0.0	2.8	5.1	6.8	0.0	0.0	0.3	0.4	0.0	5.6	0.0	0.0	6.5	2.3	0.0	0.1	1.1	0.7	0.0	0.0	0.4
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell type enhanced"	"Detected in some"	18	"Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0"	"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"	NA	Yes		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	19.4	1.0	0.0	0.0	0.1	0.3	0.0	15.6	29.6	15.9	3.9	0.1	1.7	0.0	3.0	6.6	16.1	1.1	0.0	8.6	16.5	0.0	0.0	0.0	6.3	0.4	0.4	0.0	0.0	0.2	13.9	1.4	2.0	55.9	0.0	0.0	0.0	0.0	60.1	0.0	0.0	0.0	0.1	0.1	2.3	0.0	16.1	0.0	7.5	0.8	0.0	0.0	10.3	4.9	0.1	6.3	0.1	0.0	11.9	3.9	32.8	1.3	1.5	0.0	0.0	0.0	59.0	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1	3.0	0.3	0.0	0.5	15.8	0.0	0.3	0.0	2.7	2.3	0.0	0.0	3.7	0.0	0.5	0.3	0.1	0.0	0.0	45.1	1.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	1.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	27.0	7.9	0.0	0.0	0.9
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939554-206969474	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 71.1"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.8;hTCEpi: 2.1;hTERT-RPE1: 2.4;NB-4: 3.9;SuSa: 2.5"					"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.2	0.4	0.2	0.1	0.9	0.0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	10.3	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	2.8	1.0	1.6	0.4	0.0	0.0	0.1	0.3	0.2	0.1	0.7	0.0	0.0	0.0	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.7	0.2	0.8	2.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.2	0.0	0.1	3.9	0.2	0.3	0.6	0.1	0.0	0.2	1.4	0.1	0.3	0.0	0.0	0.3	0.0	2.5	0.2	0.5	0.0	0.0	1.0	0.6	0.3	0.1	0.9	0.0	0.0	0.2	0.5	10.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.0	42.5	0.5	11.3	17.1	4.0	8.4	1.3	0.7	1.0	9.2	17.8	5.8	0.6	0.7	0.8	3.9	10.2	1.5	9.6	1.8	5.6	8.2	2.3	12.5	22.2	2.0	4.6	1.1	34.7	1.8	0.6	9.3	30.9	9.1	0.6	0.3	4.7	1.2	0.8	1.9	2.1	0.3	0.5	8.3	4.3	1.2	0.8	4.0	0.4	8.7	10.1	4.3	9.3	8.1	17.7	2.1	0.8	4.2	3.1	0.7	0.4	11.2	7.7	11.7	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5	11.9	12.2	10.4	23.2	17.2	13.3	24.2	48.4	5.3	9.1	45.4	27.5	10.3	14.9	15.7	4.0	23.3	10.7	0.0	9.4	1.2	64.4	11.1	36.9	37.7	48.7	9.5	13.3	50.3	56.8	5.7	67.0	38.8	74.2	14.4	6.1	41.4	11.7	8.6	68.6	42.8	14.9	51.8	32.1	4.7	3.6	11.4	5.0	17.9	10.9	12.0
CPZ		ENSG00000109625	"Carboxypeptidase Z"	Q66K79	4	8592660-8619759	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 63.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 29.5;BJ: 17.0;BJ hTERT+: 22.9;hTERT-RPE1: 13.7;RH-30: 25.1;U-2197: 18.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA078608			Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA			"Plasma membrane"		"HPA078608: "	"unprognostic (2.58e-1)"	"unprognostic (7.16e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.23e-8)"	"unprognostic (4.30e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.13e-4)"	"unprognostic (5.51e-2)"	4.3	0.9	0.3	2.8	1.1	0.0	5.4	1.1	1.6	15.7	1.8	1.5	27.1	0.1	7.9	24.1	3.0	7.4	12.9	2.4	0.4	0.3	1.5	0.8	2.9	0.7	1.5	0.4	63.2	1.1	0.3	2.3	18.9	2.3	4.1	0.5	4.4	0.8	20.6	0.3	5.5	1.2	10.3	1.3	0.7	1.7	4.4	0.1	1.6	3.5	0.1	2.2	9.8	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.0	0.7	2.2	0.2	29.5	17.0	22.9	6.4	2.6	0.7	0.3	0.0	1.6	9.3	0.1	0.0	0.0	0.0	2.4	0.0	1.2	0.0	0.1	0.3	2.0	0.0	0.0	4.2	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.4	2.5	0.0	0.0	3.9	0.1	9.3	0.0	25.1	0.0	0.0	0.5	0.0	0.0	0.6	0.2	0.0	3.8	0.1	0.0	0.0	0.9	1.2	18.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	1.1	1.6	0.4	0.3	1.5	0.4	2.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	NA	NA	270000	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: AB_2686810"	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.5	29.2	1.0	6.6	30.6	5.3	4.9	0.2	0.8	0.0	8.4	16.3	29.0	1.2	1.2	2.2	2.0	18.5	0.9	2.0	3.3	1.9	70.7	0.0	2.6	45.2	0.6	11.6	7.0	32.5	1.0	0.5	0.4	1.1	6.3	0.1	0.0	0.3	0.9	0.4	0.5	0.2	1.5	0.1	2.1	1.5	0.1	0.3	1.9	0.5	2.3	3.7	0.4	0.2	3.5	5.5	1.9	24.4	3.7	0.5	0.2	0.0	14.0	0.0	20.6	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3	8.9	47.6	2.4	5.4	6.5	0.2	2.4	22.9	0.0	5.7	3.5	0.0	0.5	0.0	23.8	0.3	19.0	0.6	0.0	2.0	0.4	28.2	4.8	111.9	2.5	9.2	0.0	7.5	54.0	3.5	0.0	23.3	11.7	10.1	2.8	0.8	1.9	8.1	0.9	8.1	1.1	0.1	58.2	25.9	0.6	0.6	4.8	0.7	8.5	0.6	1.8
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Enterocytes: 1407.0;Hofbauer cells: 3678.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 190.9;hTERT-RPE1: 255.7;SK-BR-3: 182.5"									"CAB000109, HPA003001"	Supported				"Secreted to blood"	NA	NA		540000000			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favorable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	151.9	148.7	21.4	32.8	27.0	83.7	67.7	18.6	47.4	56.3	59.3	41.4	41.9	61.6	25.9	48.2	46.2	34.2	90.0	86.0	25.3	27.6	150.5	163.5	102.6	81.1	49.6	25.7	41.2	62.3	21.3	24.9	56.1	42.8	33.9	33.7	234.4	64.1	42.3	76.2	50.8	90.9	23.3	36.7	87.6	47.0	29.8	29.7	21.1	36.3	42.9	41.4	64.6	43.5	4.9	22.7	51.1	83.8	28.4	26.1	58.7	13.8	37.5	4.3	18.0	54.9	18.8	7.0	10.3	32.0	13.8	16.4	9.3	190.9	3.3	26.6	26.5	103.7	74.7	6.2	11.5	3.8	14.3	13.6	5.1	7.1	11.6	58.0	11.8	54.6	30.2	50.5	7.4	13.7	255.7	10.1	4.4	6.1	20.6	24.4	51.1	3.0	6.6	10.2	56.8	15.1	4.3	5.3	12.5	48.7	43.4	6.0	5.9	12.2	182.5	34.6	6.5	71.4	16.3	12.7	42.1	6.4	5.8	16.4	28.3	35.5	2.1	61.3	31.9	35.2	29.0	83.8	25.2	26.1	47.6	15.1	4.9	12.2	18.3	22.7	3.2	14.3	18.3	51.1	28.4	38.5	19.2	13.5	58.7	21.4	27.0	18.6	47.4	25.3	27.6	49.6	25.7	42.8	29.7	104.2	261.1	102.1	219.0	64.0	155.9	226.4	366.9	115.1	126.3	519.9	104.1	198.5	92.9	592.1	2.7	92.6	1407.0	70.0	321.5	138.5	112.5	108.8	466.1	497.1	3678.7	249.5	153.3	833.5	1087.5	9.0	100.4	573.5	215.9	205.6	341.0	186.6	426.0	610.2	120.6	259.1	69.6	109.9	103.0	22.4	56.8	71.8	394.2	188.4	260.3	345.7
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558133	"Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 205.4;Leydig cells: 187.0;Peritubular cells: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.0;intermediate monocyte: 12.4;myeloid DC: 11.7;neutrophil: 6.7;non-classical monocyte: 9.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 11.7;granulocytes: 6.7;monocytes: 12.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 144.2;ASC TERT1: 62.7;BJ hTERT+: 54.3;HSkMC: 44.4;hTERT-RPE1: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	75.2	26.0	10.1	9.3	13.2	4.0	78.9	6.1	8.0	44.5	56.3	14.7	16.3	49.5	44.3	28.5	29.6	26.1	38.8	43.1	12.1	5.5	8.6	6.2	35.6	10.6	11.0	11.2	49.5	5.4	2.0	9.5	9.5	11.4	41.7	10.2	32.0	21.5	21.1	17.5	26.7	111.3	41.1	12.8	7.3	18.1	20.1	11.7	2.1	103.8	23.9	10.0	43.8	56.0	0.0	11.7	6.7	12.4	2.5	1.2	4.4	3.2	2.4	1.3	2.6	144.2	62.7	0.2	11.8	54.3	6.2	7.8	0.1	4.5	0.0	2.0	27.7	6.3	1.6	1.1	0.9	7.3	2.4	0.3	2.7	3.7	0.0	30.3	2.8	0.2	44.4	9.2	9.6	1.8	37.0	3.9	1.6	0.9	0.0	16.9	0.0	0.9	2.6	0.7	0.0	0.6	0.3	17.0	0.1	0.9	0.1	0.1	0.6	13.7	0.0	7.3	0.5	4.8	1.7	7.8	13.9	2.0	12.9	5.0	0.0	0.0	0.0	6.6	2.4	7.4	0.0	12.0	0.5	1.2	12.4	0.2	0.0	0.2	0.1	11.7	0.0	0.0	0.0	6.7	2.5	9.4	0.5	0.0	4.4	10.1	13.2	6.1	8.0	12.1	5.5	11.0	11.2	11.4	11.7	205.4	82.9	0.0	33.8	107.6	0.0	17.1	28.1	8.1	48.9	24.4	0.0	1.6	0.0	1.0	0.9	40.3	13.6	46.7	5.8	1.3	122.8	21.6	2.3	2.1	39.6	0.0	0.0	57.7	57.5	2.1	187.0	28.5	42.2	12.6	3.8	29.3	1.3	8.6	208.2	0.3	1.8	19.4	57.5	0.9	1.3	52.6	1.1	2.5	4.8	13.8
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease mutation, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.0;lung: 39.2"	"Cell type enhanced"	"Detected in many"	11	"Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"classical monocyte: 45.0"	"Lineage enriched"	"Detected in many"	22	"monocytes: 45.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	9.1	3.1	0.5	9.4	1.2	0.0	11.4	1.0	1.2	11.4	2.1	0.7	4.5	0.0	12.8	5.9	3.5	15.0	6.9	17.5	1.2		8.8	3.5	39.2	26.3	3.1	1.0	6.1	3.6	0.0	1.3	0.8	3.3	10.7	0.0	19.3	0.0	13.0	4.8	0.5	1.4	10.6	5.1	15.7	0.3	3.9	0.5	5.1	2.5	1.1	4.2	6.9	2.1	0.0	0.4	2.0	45.0	0.0	0.0	16.2	1.2	13.2	0.4	0.0	24.6	26.4	0.0	0.1	0.8	0.2	2.3	0.0	5.5	0.0	3.6	3.2	0.5	10.8	0.0	0.7	0.4	1.0	0.7	0.0	4.0	0.0	6.8	0.0	0.0	105.7	10.3	5.7	0.2	24.4	0.0	0.0	0.1	0.0	0.1	5.2	0.0	4.0	1.4	1.8	2.5	0.0	0.0	0.0	2.5	0.1	0.1	0.4	49.2	7.2	0.0	1.4	9.1	1.9	0.0	0.2	0.0	20.2	0.0	0.0	0.0	0.0	26.8	0.0	2.2	0.4	45.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	0.0	5.5	0.2	0.0	16.2											17.9	50.6	0.5	98.2	15.8	0.9	2.7	0.0	12.0	35.2	43.6	0.0	0.4	13.3	5.0	11.7	36.8	0.0	0.0	0.5	0.7	41.1	345.6	3.5	9.7	12.6	0.0	1.7	5.5	116.2	8.6	147.9	28.1	16.9	39.7	0.3	0.5	0.4	0.0	160.5	0.8	0.3	19.4	20.8	1.0	1.8	12.4	0.2	0.0	0.8	295.9
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127184120-127220078	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.6"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 7.9;Collecting duct cells: 3.5;Leydig cells: 6.9;Pancreatic endocrine cells: 4.4;Suprabasal keratinocytes: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.4;HDLM-2: 12.1;hTERT-RPE1: 12.8;TIME: 12.1;U-138 MG: 12.4;U-251 MG: 8.1"					"Low region specificity"	"Detected in many"			"HPA062460, HPA068731"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	2.7	1.0	0.6	2.4	2.4	0.8	0.6	0.4	1.8	5.2	1.9	1.5	0.4	0.5	1.3	0.8	4.4	1.0	1.5	2.0	0.4	0.9	0.4	0.4	0.4	0.6	2.9	0.4	0.4	0.4	0.0	0.4	0.4	0.7	2.2	0.7	4.2	0.4	1.5	0.8	10.6	1.0	0.4	0.4	0.4	0.5	0.7	3.6	0.4	0.4	2.2	1.6	2.7	4.5	1.5	1.3	3.6	1.0	1.8	1.4	0.2	1.3	3.8	1.9	0.1	0.1	0.0	0.2	0.5	3.6	2.0	0.8	0.1	3.0	0.2	0.1	2.2	1.4	8.4	3.1	1.8	0.6	12.1	1.4	0.0	2.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	1.2	12.8	0.5	0.3	0.1	0.5	2.3	0.1	0.3	0.1	4.3	0.0	1.0	0.1	0.2	0.0	6.3	1.1	0.1	0.7	5.3	0.0	0.0	1.5	0.2	0.1	12.1	12.4	2.2	6.0	8.1	0.2	0.1	0.1	0.1	0.1	0.9	2.4	1.0	0.7	1.2	0.7	1.0	0.9	1.0	0.8	0.3	1.5	1.1	1.4	3.6	1.8	0.7	1.3	0.8	0.2	0.6	2.4	0.4	1.3	0.4	0.9	2.9	0.4	0.7	3.6	0.0	1.1	0.0	1.2	1.5	0.0	0.3	0.0	0.0	7.9	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	6.4	0.0	0.0	0.0	3.0
DCBLD2	"CLCP1, ESDN"	ENSG00000057019	"Discoidin, CUB and LCCL domain containing 2"	Q96PD2	3	98795941-98901689	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 66.0;Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 59.8;hTERT-RPE1: 84.9;LHCN-M2: 99.6;RPTEC TERT1: 62.4;U-87 MG: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016909	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		1800000	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA016909: AB_1847510"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.97e-3)"	"unprognostic (9.29e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (3.32e-5)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.59e-3)"	13.1	14.6	4.5	6.4	7.2	1.1	19.3	9.7	9.6	12.0	13.1	5.1	8.1	2.7	16.8	9.2	8.8	13.9	11.7	24.2	4.5	6.2	11.3	9.2	13.1	3.2	6.7	3.5	19.0	6.4	17.6	12.7	9.9	6.5	11.2	6.8	19.3	11.1	14.7	6.6	7.7	5.2	16.7	7.1	2.1	8.6	33.8	7.3	8.1	18.7	6.3	3.6	15.1	6.8	0.6	1.2	1.7	0.5	0.1	1.1	0.2	6.8	50.2	6.7	5.3	9.0	21.4	2.9	15.5	7.4	10.6	12.0	4.2	21.9	0.0	48.8	26.6	32.5	6.4	3.0	25.2	24.4	0.1	1.0	2.4	1.6	6.4	5.5	1.1	1.1	8.4	3.9	30.4	59.8	84.9	6.9	0.9	0.4	0.6	99.6	1.8	0.9	0.6	4.7	0.0	17.4	1.0	12.7	0.6	62.4	1.8	1.8	3.1	4.2	0.8	18.1	4.8	3.4	0.9	11.4	27.3	21.9	6.9	54.2	0.8	1.1	0.9	76.2	0.4	11.8	1.2	0.5	1.7	0.0	0.1	0.0	0.6	0.1	0.1	0.5	0.2	1.1	0.1	0.9	0.1	0.3	1.2	0.0	0.2	4.5	7.2	9.7	9.6	4.5	6.2	6.7	3.5	6.5	7.3	29.8	44.4	4.5	12.4	20.3	11.2	66.0	12.7	18.7	20.5	17.4	72.6	9.6	0.0	20.3	2.5	7.1	0.9	0.0	7.0	8.2	18.1	10.1	36.9	18.7	3.5	12.7	3.5	4.9	1.6	3.6	20.4	2.6	8.5	1.8	7.3	44.0	17.8	3.5	47.4	6.9	49.1	0.0	19.1	15.8	23.3	13.7	3.3	0.0	10.7	5.9
DCDC2B		ENSG00000222046	"Doublecortin domain containing 2B"	A2VCK2	1	32209094-32216196	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 11.1;fallopian tube: 26.6;lung: 10.1"	"Cell type enriched"	"Detected in some"	13	"Ciliated cells: 115.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045832	Uncertain					NA	NA					"HPA045832: AB_10962048"	"unprognostic (6.45e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.87e-3)"	"unprognostic (7.66e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.71e-3)"	"unprognostic (8.73e-2)"	"unprognostic (6.18e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	11.1	0.0	26.6	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	5.5	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.0	0.6	0.1	0.2	0.3	0.0	0.1	0.8	1.6	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.2	2.9	0.0	0.9	0.1	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.2	0.4	0.0	0.0	0.6	0.2	0.5	0.8	0.1	3.6	0.1	0.7	1.0	0.7	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	115.1	9.1	1.8	3.9	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	3.2	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0
DDIT4L	"REDD2, Rtp801L"	ENSG00000145358	"DNA damage inducible transcript 4 like"	Q96D03	4	100185870-100190782	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 106.4"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 21.0;Distal tubular cells: 18.3;Extravillous trophoblasts: 14.7;Sertoli cells: 19.4;Smooth muscle cells: 16.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 19.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.9;BJ: 18.8;fHDF/TERT166: 10.2;HSkMC: 9.8;hTERT-RPE1: 21.5;RPTEC TERT1: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050903			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA050903: "	"unprognostic (2.21e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.66e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.53e-5)"	"unprognostic (4.99e-3)"	1.4	0.5	1.5	0.3	6.3	0.3	0.6	2.0	1.6	7.9	0.6	1.7	0.0	0.2	0.9	3.0	2.6	0.9	0.3	3.5	2.1	0.7	6.2	0.2	0.4	0.3	1.5	1.6	2.8	0.2	0.3	1.2	1.3	2.7	3.8	0.5	5.2	6.3	2.6	106.4	0.4	0.3	0.8	2.4	0.5	0.2	1.1	1.7	0.0	0.6	18.6	1.2	0.5	0.9	0.2	0.0	0.0	0.2	0.0	2.0	0.2	0.0	1.4	5.5	0.0	2.5	12.9	0.8	18.8	1.6	0.3	0.1	0.1	0.5	0.0	0.4	10.2	0.4	0.0	3.9	0.3	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	9.8	0.1	0.2	1.0	21.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.3	0.0	0.0	13.4	0.0	0.0	0.0	0.3	0.7	2.5	1.4	0.0	0.0	0.1	0.0	0.0	0.0	1.4	2.5	0.0	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.1	2.0	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	1.0	0.2	1.5	6.3	2.0	1.6	2.1	0.7	1.5	1.6	2.7	1.7	0.0	0.0	0.0	0.1	2.4	0.0	4.7	0.0	0.0	0.0	21.0	0.0	1.7	18.3	0.1	0.6	1.5	0.0	0.0	0.0	14.7	5.0	0.8	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	6.8	0.0	0.0	8.3	0.5	0.0	2.1	1.3	0.0	19.4	16.0	0.7	0.1	1.3	3.3	0.0	0.0	0.1
DHRS3	"RDH17, retSDR1, Rsdr1, SDR1, SDR16C1"	ENSG00000162496	"Dehydrogenase/reductase 3"	O75911	1	12567910-12617731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"gdT-cell: 33.5;MAIT T-cell: 24.2;memory CD4 T-cell: 18.3;memory CD8 T-cell: 15.7;myeloid DC: 8.6;naive CD4 T-cell: 31.6;naive CD8 T-cell: 19.7;NK-cell: 13.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 8.6;NK-cells: 13.8;T-cells: 33.5"	"Cell line enhanced"	"Detected in many"		"A549: 27.6;CAPAN-2: 56.6;hTERT-RPE1: 55.9;SK-BR-3: 30.4;WM-115: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010844	Supported		Approved	Nucleoli,Mitochondria		NA	NA			"Nucleoli, Mitochondria"		"HPA010844: AB_1847653"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.65e-4)"	"unprognostic (5.48e-2)"	22.7	4.4	6.3	6.2	8.6	2.5	30.6	4.0	7.9	16.7	16.3	3.4	9.2	13.6	7.6	15.5	19.0	12.2	11.2	16.1	6.8	8.6	12.3	45.6	11.6	8.3	9.0	4.5	11.8	20.3	0.5	8.9	11.5	9.8	16.3	5.6	20.3	11.8	14.3	10.2	5.6	18.9	11.1	9.8	4.2	12.3	5.2	4.2	3.1	40.5	5.4	5.2	21.0	9.4	0.2	8.6	2.1	0.3	13.8	33.5	15.6	4.8	27.6	0.0	12.2	16.0	1.3	3.2	1.6	0.0	0.0	0.1	3.3	56.6	0.0	1.3	16.2	4.9	22.3	6.0	3.1	0.0	0.0	9.9	4.3	2.8	15.4	2.4	0.0	0.0	8.1	3.7	0.0	0.1	55.9	5.2	0.1	6.5	0.0	0.1	0.8	1.1	0.2	1.8	5.2	11.2	0.1	0.0	5.6	0.0	9.5	0.3	0.5	9.3	30.4	1.7	3.9	2.9	1.2	3.8	0.1	0.6	8.5	0.1	0.8	0.0	0.0	6.4	0.3	52.5	2.1	0.2	0.0	33.5	0.1	24.2	0.2	18.3	15.7	8.6	0.2	31.6	19.7	1.7	13.8	0.3	1.0	0.5	15.6	6.3	8.6	4.0	7.9	6.8	8.6	9.0	4.5	9.8	4.2	89.3	49.3	3.7	141.7	22.8	0.8	31.9	38.2	58.9	55.7	19.2	17.7	22.8	19.9	81.6	86.2	36.5	70.9	23.3	142.3	39.4	26.7	66.3	15.1	157.8	60.3	0.0	24.1	62.0	40.2	235.9	21.0	19.3	6.8	17.2	30.8	13.7	112.0	49.1	9.2	39.4	2.0	0.0	30.1	1.4	1.4	23.6	22.0	22.3	29.9	124.6
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 118.1;granulocytes: 85.8;Syncytiotrophoblasts: 223.7;Urothelial cells: 225.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 10.1;HUVEC TERT2: 8.9;NB-4: 14.7;THP-1: 42.9;TIME: 19.1;U-2197: 14.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"	NA	NA					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.7	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.2	0.2	0.6	2.7	10.1	8.9	0.0	0.4	0.0	0.0	0.0	0.0	14.7	0.0	0.1	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	19.1	0.0	0.1	14.1	0.1	0.0	0.0	0.0	0.3	7.7	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6	0.0	2.2	0.9	6.8	1.4	0.0	26.4	0.0	57.6	10.3	0.0	0.0	1.7	0.0	0.3	118.1	0.6	34.9	0.0	21.0	1.1	1.1	5.5	85.8	0.5	25.7	0.0	1.7	0.0	5.7	33.8	1.1	6.4	0.0	0.0	38.5	3.5	40.1	9.5	0.4	0.0	0.0	6.5	0.1	0.7	0.6	1.3	223.7	0.0	1.3	225.8
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 489.8;Muller glia cells: 1823.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.1	93.0	26.6	30.3	1.3	0.4	0.0	6.6	87.0	14.2	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	17.0	0.0	0.0	6.7	8.7	9.0	22.3	54.3	28.2	0.0	0.0	0.0	36.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	7.8	0.2	0.0	0.0	7.3	0.0	0.0	49.9	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5	3.0	4.8	0.0	55.5	40.5	22.0	489.8	0.0	4.0	20.5	0.0	11.8	0.4	0.0	0.6	98.7	37.6	0.0	0.0	0.2	0.6	30.9	9.6	1.1	0.0	15.3	12.7	1.7	47.3	1.0	66.1	19.0	2.3	60.8	0.0	0.0	1823.0	1.0	0.0	54.1	0.0	52.9	187.5	74.5	0.5	1.3	12.9	0.7	4.9	0.1	2.6
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7189890-7219702	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 35.6;Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;hTERT-RPE1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB001999: , CAB002000: , HPA010122: AB_1855169"	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	5.5	16.0	58.3	7.5	73.3	4.1	4.5	47.4	83.2	9.7	4.1	5.4	4.3	4.7	13.8	5.0	5.0	9.2	10.7	8.9	58.7	24.2	3.3	3.1	6.0	4.2	14.4	53.9	12.8	4.6	11.5	15.1	8.7	14.8	7.3	3.8	3.1	6.3	12.5	3.6	4.0	4.4	10.7	11.3	7.8	5.7	10.1	17.0	1.7	5.8	0.0	3.5	7.0	4.2	0.0	1.6	0.0	0.9	0.0	1.6	0.6	0.2	7.4	18.5	6.2	7.1	10.5	0.5	9.7	8.5	7.3	7.0	0.3	3.0	1.3	4.3	8.4	0.9	0.7	1.0	3.9	3.6	9.6	1.9	5.5	13.3	0.9	6.0	0.1	30.9	11.6	0.4	6.2	6.3	28.1	8.6	7.7	2.2	4.9	10.9	0.2	4.2	3.3	2.6	0.2	0.5	7.6	0.7	0.7	5.3	0.2	7.6	6.0	0.2	0.4	1.1	3.3	4.4	3.5	10.5	17.6	8.5	3.5	5.1	0.8	0.5	0.7	13.2	3.5	5.4	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.6	0.0	0.6	58.3	73.3	47.4	71.2	58.7	24.2	14.4	53.9	14.8	17.0	0.0	1.0	3.7	1.7	2.4	35.6	3.1	2.5	1.4	2.3	3.5	96.2	0.4	0.0	0.7	1.5	5.0	0.3	0.0	0.2	0.4	6.2	1.4	6.9	1.5	3.3	19.1	14.5	5.5	10.2	0.9	6.6	5.5	3.3	1.8	0.7	6.0	0.3	0.0	9.6	0.0	58.6	0.0	2.3	6.5	1.9	1.6	0.5	0.5	0.6	0.7
DMRT3	DMRTA3	ENSG00000064218	"Doublesex and mab-3 related transcription factor 3"	Q9NQL9	9	976964-991731	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 34.2;testis: 11.7;thyroid gland: 11.5"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 3.0;Spermatocytes: 14.4;Spermatogonia: 5.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.6"	"Region enriched"	"Detected in some"	7	"hippocampal formation: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;HEK 293: 3.8;hTERT-RPE1: 5.7;SCLC-21H: 2.3;SuSa: 2.2;THP-1: 6.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 0.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	HPA077685	Approved					NA	NA					"HPA077685: AB_2732357"	"unprognostic (2.42e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.28e-1)"		"unprognostic (2.21e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.12e-3)"			"unprognostic (2.91e-2)"	"unprognostic (5.84e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.11e-1)"	4.0	0.0	0.4	0.0	0.2	0.0	6.4	0.0	1.1	0.2	0.0	1.8	0.0	0.0	0.1	1.0	0.6	0.7	0.0	1.4	8.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	2.5	0.7	0.0	0.2	0.4	0.0	0.0	11.7	0.0	0.2	11.5	0.6	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	5.7	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.4	5.1	0.0	0.0	0.0	0.0	0.0
DMRTA1		ENSG00000176399	"DMRT like family A1"	Q5VZB9	9	22446841-22455740	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 12.2;salivary gland: 16.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 2.5"	"HPA044764, HPA062253"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA044764: AB_10959788, HPA062253: AB_2684726"	"unprognostic (1.47e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.74e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.65e-3)"	"unprognostic (2.92e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.53e-3)"	2.1	0.2	0.7	1.4	0.7	0.0	5.6	0.8	0.7	2.4	1.0	0.7	1.1	0.7	1.2	1.8	5.5	0.3	1.2	0.6	0.6	0.5	5.5	12.2	1.1	1.4	0.8	0.4	0.6	2.7	6.1	2.9	0.0	0.9	2.4	0.4	1.9	16.3	0.5	0.9	0.5	0.8	0.7	0.7	0.4	2.8	0.6	0.0	1.1	5.0	0.6	2.0	0.9	1.7	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.0	0.4	0.1	0.2	0.0	9.0	0.3	0.3	0.1	0.1	0.0	2.0	0.0	0.2	0.3	1.8	2.4	0.3	0.0	0.6	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.6	1.7	11.0	0.6	0.0	0.0	3.3	4.2	0.9	0.0	0.0	1.8	0.4	3.0	0.0	0.2	1.2	4.3	0.0	0.1	0.0	1.1	0.7	2.0	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.8	0.7	0.6	0.5	0.8	0.4	0.9	0.0	0.0	2.4	0.0	4.7	0.0	0.5	1.1	2.5	4.0	4.5	5.2	0.0	0.0	13.3	5.4	0.0	0.0	2.6	0.0	6.0	0.0	1.3	5.6	0.0	25.3	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	4.8	5.6	0.0	0.0	21.4	0.0	0.0	0.4	0.0	0.6	0.4	0.1	0.0	1.9	6.2
DNAH10OS	FLJ45278	ENSG00000250091	"Dynein axonemal heavy chain 10 opposite strand"	P0CZ25	12	123926424-123934984	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 7.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 3.3;Cone photoreceptor cells: 3.9;Horizontal cells: 1.6;Rod photoreceptor cells: 1.1"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.0"									HPA039786	Enhanced					NA	NA					"HPA039786: AB_10795115"	"unprognostic (1.62e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.69e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.12e-3)"	"unprognostic (3.45e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.15e-2)"	0.9	0.3	3.6	0.4	5.2	0.8	1.2	7.6	6.3	0.4	0.7			0.3	0.8	0.8	0.5	0.5	0.6	1.0	3.7	1.5	3.7	0.5	1.5	0.4	1.4		1.6	2.7	2.1	1.1	0.6		1.1	0.4		0.9	1.8	1.7	0.6	0.4	1.3	1.0	0.8	1.4	0.9			1.8		0.4	0.4	0.3	0.6	0.3	3.3	0.7	0.3	1.0	0.3	0.5	3.8	3.1	4.2	2.0	1.9	1.1	0.6	3.3	0.5	0.5	0.3	0.3	0.4	1.3	1.6	0.5	0.3	0.9	0.2	0.2	1.8	0.5	0.7	0.3	0.2	0.7	0.3	2.8	0.3	1.1	0.8	0.2	9.0	0.7	3.1	0.2	0.7	0.7	2.5	0.3	0.6	0.3	0.1	0.4	0.2	0.2	0.1	3.2	1.2	0.7	3.1	0.3	0.3	0.7	3.1	0.7	0.3	1.2	4.4	0.2	1.0	0.4	2.0	0.8	0.2	2.7	0.4	1.6	1.1	0.7	0.3	1.0	0.4	0.8	0.6	0.3	0.8	0.1	0.6	0.4	0.5	3.3	0.3	0.3	0.3	0.3	0.3											0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	1.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
DNALI1	"dJ423B22.5, hp28, P28"	ENSG00000163879	"Dynein axonemal light intermediate chain 1"	O14645	1	37556919-37566857	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 50.5;testis: 59.5"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 307.9;Early spermatids: 530.7;Late spermatids: 878.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.1;ASC TERT1: 9.0;hTERT-RPE1: 13.5;RPTEC TERT1: 12.1;SH-SY5Y: 8.4;T-47d: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028305, HPA031633"	Enhanced					NA	NA					"HPA028305: AB_10601807, HPA031633: "	"unprognostic (1.21e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"prognostic favorable (6.02e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-3)"	"unprognostic (8.00e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.52e-2)"	2.4	6.3	9.7	1.3	10.8	0.6	7.7	2.6	7.2	9.2	3.9	17.2	10.5	1.7	8.4	20.6	3.2	50.5	8.8	2.9	10.1	13.2	11.9	11.3	9.9	1.3	8.5	6.2	13.9	8.7	8.5	19.2	2.1	23.9	6.9	2.8	7.5	4.1	8.7	1.5	0.9	1.9	5.2	9.1	1.5	6.0	59.5	8.1	0.0	12.1	1.1	1.2	3.3	1.8	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.1	0.9	2.1	9.0	0.1	1.3	2.8	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	6.8	0.0	0.0	4.0	0.0	6.6	0.0	13.5	1.1	0.0	0.7	0.0	5.4	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.7	0.0	12.1	0.0	1.2	8.4	0.0	0.0	0.0	1.7	21.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	10.8	2.6	7.2	10.1	13.2	8.5	6.2	23.9	8.1	17.9	25.9	0.0	16.8	0.8	2.6	3.9	17.8	307.9	42.1	19.2	7.9	2.6	24.9	24.8	530.7	3.4	0.0	0.0	8.9	6.5	7.1	30.3	2.3	8.5	2.2	3.2	20.1	4.3	0.3	878.1	12.7	1.8	0.0	0.0	9.8	15.1	16.1	0.0	11.3	26.7	18.7	6.5	4.8	82.2	15.6	0.5	2.9	1.3	3.7	7.4
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009919	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	11.0	4.8	3.7	8.3	3.6	5.8	8.4	9.2	4.4	13.0	24.9	3.2	23.0	14.5	15.6	11.1	8.2	9.2	10.2	6.0	3.1	2.6	11.1	8.6	6.6	4.5	2.3	3.0	13.8	22.3	24.6	5.0	8.5	3.5	11.6	13.8	8.5	7.2	23.3	10.2	20.0	38.3	15.9	3.1	6.2	15.3	8.6	2.3	30.4	7.1	8.8	7.7	17.4	16.8	4.3	0.8	1.6	2.7	5.3	1.7	1.2	10.4	8.6	7.8	12.3	14.3	12.1	1.9	18.9	18.3	9.2	8.9	5.8	15.9	10.9	8.1	14.4	5.0	8.3	9.1	10.8	12.9	0.5	2.8	1.5	9.7	4.0	7.4	1.0	0.7	5.6	2.4	11.3	10.0	32.4	21.9	3.5	1.4	0.0	18.5	1.3	1.8	2.0	7.5	7.3	5.2	2.2	8.0	0.5	15.6	9.1	1.3	1.8	3.1	0.8	2.3	11.3	0.6	1.0	26.3	6.9	6.6	5.5	12.3	0.9	0.6	15.3	6.5	3.4	5.1	0.0	1.8	0.4	1.7	2.7	1.6	3.0	0.4	1.2	0.8	4.3	0.4	0.8	1.6	5.3	2.7	0.6	0.0	1.2	3.7	3.6	9.2	4.4	3.1	2.6	2.3	3.0	3.5	2.3	8.9	8.3	4.9	7.1	31.1	6.5	5.2	12.7	26.8	14.8	12.2	33.4	6.4	3.3	6.0	1.0	10.8	34.6	0.0	12.4	1.0	11.3	5.5	2.3	13.1	4.1	12.7	3.5	9.2	12.7	2.5	12.7	7.5	3.3	0.0	25.4	3.3	13.5	23.0	8.5	2.9	24.9	0.0	8.2	2.1	8.5	39.9	3.1	1.5	22.8	17.8
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 66.7"	"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 31.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		No	No			"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: AB_2684097"	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.2	24.4	0.0	0.0	0.0	0.1	5.0	12.9	11.0	11.2	4.2	13.2	4.4	7.6	10.8	0.1	5.1	0.0	0.6	7.8	11.0	1.5	2.5	12.6	4.4	18.8	0.0	0.0	9.3	6.1	8.4	0.1	31.5	12.3	0.0	0.0	15.0	8.4	6.8	13.4	0.1	19.2	2.5	0.7	0.0	20.3	0.2	1.0	8.2	17.7	28.1	3.9	1.1	2.4	6.1	14.1	6.7	0.0	14.4	5.8	6.6	7.1	24.6	18.4	0.0	9.2	0.0	7.5	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6	14.9	14.1	2.2	9.6	5.6	45.2	9.4	5.1	32.1	15.9	12.2	47.1	0.3	11.6	7.6	1.0	4.5	0.0	0.0	1.7	0.2	9.3	8.6	5.7	0.8	0.6	66.7	15.0	14.1	1.6	1.6	31.7	0.5	3.3	1.0	1.1	25.9	3.3	0.0	29.7	2.9	41.2	45.3	29.3	3.5	4.1	2.5	1.0	10.1	0.3	2.5
EDIL3	DEL1	ENSG00000164176	"EGF like repeats and discoidin domains 3"	O43854	5	83940554-84384793	"Predicted secreted proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.3"	"Cell type enriched"	"Detected in many"	6	"Bipolar cells: 147.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 105.9;LHCN-M2: 32.2;TIME: 38.1;U-2 OS: 32.4;U-87 MG: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020415	Approved				"Secreted to blood"	NA	NA					"HPA020415: AB_2670434"	"unprognostic (9.93e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.19e-2)"	"unprognostic (6.64e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-3)"	7.9	12.6	29.3	7.2	45.3	0.2	3.6	5.5	46.2	10.9	20.1	77.0	0.3	9.3	15.6	26.2	9.9	4.9	19.2	10.8	42.6	24.7	6.5	1.1	11.7	0.5	67.3	22.5	6.1	2.0	0.9	2.1	2.6	37.1	8.1	21.8	5.0	2.5	13.5	1.2	5.5	14.3	14.4	85.3	1.8	10.6	1.4	61.6	0.0	2.4	0.1	2.1	7.7	5.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.9	0.0	2.4	3.2	0.0	4.0	0.0	0.0	0.0	1.7	3.7	0.0	0.1	1.8	0.0	1.7	0.0	11.5	0.0	19.7	0.1	0.0	5.0	0.5	11.7	1.6	105.9	4.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	1.6	0.0	7.5	0.0	7.9	0.0	5.4	0.0	0.8	0.1	0.0	0.0	0.0	5.2	0.0	0.0	38.1	11.8	32.4	0.4	10.5	0.3	0.0	0.0	21.8	0.0	3.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	29.3	45.3	5.5	30.1	42.6	24.7	67.3	22.5	37.1	61.6	8.9	5.9	0.0	1.5	10.8	147.4	10.0	0.0	1.4	2.3	3.5	2.0	0.2	0.0	0.1	25.1	3.5	0.0	0.0	0.0	0.0	17.5	0.7	5.7	0.0	0.2	4.8	22.0	2.5	0.0	12.5	2.3	0.0	3.3	0.0	8.3	4.1	0.7	5.8	3.5	0.7	9.6	6.5	24.5	1.1	0.6	14.1	0.3	0.0	9.7	0.4
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.4	0.0	20.0	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	1.3	20.9	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.0	0.0	0.0	64.6	6.9	1.5	17.2	129.3	263.2	0.0	0.0	0.0	5.6	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.3	6.5	0.0	0.4	20.2	0.0	233.1	0.1	7.0	25.8	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5	232.3	83.7	0.0	78.5	70.5	1.6	12.3	10.2	99.0	89.9	26.2	0.0	1167.9	8.3	27.4	0.3	12.2	0.0	0.0	23.4	127.3	186.9	9.1	2.3	0.4	83.0	0.0	0.0	68.7	0.6	0.8	39.4	4.3	16.9	1.0	0.0	149.0	2.2	0.0	0.0	6.9	3.9	0.0	22.5	0.0	0.2	27.7	744.0	0.0	0.0	3.9
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 114.5;Leydig cells: 86.6;Peritubular cells: 100.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.5;gdT-cell: 4.4;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.5;NK-cells: 2.3;T-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.8;BJ: 27.4;BJ hTERT+: 34.2;fHDF/TERT166: 49.4;HSkMC: 33.2;hTERT-RPE1: 34.7;LHCN-M2: 29.8;U-138 MG: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	NA	NA		1100000			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	22.1	10.5	9.4	10.1	9.9	1.6	13.4	6.2	7.3	38.9	16.4	7.7	19.8	4.8	29.3	28.4	13.0	16.3	29.7	29.4	7.0	6.0	14.7	5.4	14.5	15.1	8.4	5.7	39.7	12.2	14.1	7.6	21.9	6.5	26.5	4.0	24.5	9.6	22.1	11.9	6.9	6.9	23.6	7.6	8.4	10.4	19.9	4.8	2.8	25.3	11.3	4.8	23.1	15.2	0.1	0.3	1.5	0.2	2.3	4.4	0.5	0.1	0.0	0.5	9.1	11.8	23.8	0.2	27.4	34.2	10.8	9.7	0.0	0.8	0.1	2.3	49.4	0.1	0.2	0.0	0.3	2.7	1.4	0.0	0.2	0.7	1.8	18.7	0.0	0.0	33.2	0.0	4.2	0.2	34.7	6.1	0.2	0.0	1.7	29.8	0.1	0.0	4.2	0.3	0.0	0.1	0.1	0.1	0.7	0.3	0.1	0.1	2.9	0.0	0.3	0.3	1.3	0.3	2.2	13.7	23.8	5.8	11.4	0.1	3.0	0.1	0.0	9.1	0.2	4.2	0.0	0.2	1.5	4.4	0.1	0.1	0.1	0.5	0.0	0.3	0.0	0.1	0.5	0.6	2.3	0.2	0.0	0.0	0.5	9.4	9.9	6.2	7.3	7.0	6.0	8.4	5.7	6.5	4.8	32.8	9.0	1.9	33.1	11.9	4.1	37.6	10.2	12.0	15.9	17.4	0.0	2.4	6.6	23.0	12.3	21.2	0.0	0.0	0.2	3.2	114.5	14.2	0.0	1.6	8.0	6.4	0.0	50.3	4.6	22.0	86.6	2.5	23.6	1.0	0.0	54.8	3.5	0.0	100.8	17.0	4.4	38.8	45.0	27.4	3.1	8.8	4.9	1.8	0.1	10.4
EFHC1	"EJM, EJM1, FLJ10466"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 49.3"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 243.6;Early spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035307	Approved					NA	NA					"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.1	5.2	12.5	4.1	25.5	5.2	8.7	12.6	18.3	10.1	10.2	29.4	12.5	4.0	10.6	10.9	4.1	49.3	6.1	4.3	16.7	9.7	6.8	2.9	8.5	4.1	37.8	13.4	10.9	6.0	8.1	18.8	6.1	23.0	6.5	5.9	3.5	5.5	22.4	3.7	8.9	14.9	6.2	21.3	4.9	5.9	23.1	29.3	2.9	13.3	0.8	3.7	5.2	6.0	5.6	8.6	2.8	0.8	1.9	1.2	0.6	2.7	3.0	7.3	5.1	7.1	12.4	1.4	3.1	8.2	4.3	6.9	1.9	3.1	1.1	7.4	5.2	8.2	2.7	2.1	5.8	5.6	0.6	2.6	1.0	7.5	2.4	5.0	1.0	1.3	5.8	3.3	6.1	5.7	20.6	9.0	1.3	2.3	1.9	6.5	2.2	1.1	1.8	2.2	2.0	1.3	1.6	3.9	1.3	5.9	1.0	15.1	4.1	0.8	1.4	6.3	9.6	5.2	1.3	2.9	3.1	4.3	1.2	2.3	1.6	2.2	1.9	8.6	0.4	5.6	0.8	0.8	2.0	1.2	0.3	0.6	5.2	0.5	1.0	1.9	5.6	0.6	1.0	2.8	1.9	0.5	8.6	0.4	0.6	12.5	25.5	12.6	18.3	16.7	9.7	37.8	13.4	23.0	29.3	6.0	12.2	17.9	27.6	16.1	22.9	3.1	5.1	243.6	38.7	40.1	56.9	10.3	0.0	14.7	178.6	12.1	12.3	0.0	7.1	14.4	23.0	22.5	8.1	4.9	7.0	12.7	24.0	11.6	9.2	47.8	26.2	11.0	15.1	8.2	9.6	15.2	9.0	16.9	20.8	3.1	40.4	32.3	18.9	79.6	24.7	10.7	3.8	12.8	10.0	20.5
EFNB3	"EPLG8, LERK-8"	ENSG00000108947	"Ephrin B3"	Q15768	17	7705202-7711378	"Cancer-related genes, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.6"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 6.7;Early spermatids: 6.8;Intestinal endocrine cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 30.0;AN3-CA: 17.8;hTERT-RPE1: 18.3;SH-SY5Y: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001623	Approved					NA	NA					"HPA001623: AB_1848026"	"unprognostic (5.17e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.00e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.20e-2)"	1.7	2.8	10.6	1.1	26.5	0.4	4.3	1.1	34.6	4.8	1.0	4.0	0.0	0.8	12.3	1.0	2.2	6.7	1.8	1.1	10.9	19.0	1.4	2.3	1.5	0.7	3.0	11.8	3.2	1.8	1.1	3.0	1.8	4.3	2.7	1.1	1.4	1.7	1.0	0.8	6.9	1.0	4.7	1.3	0.5	1.3	2.1	2.1	0.0	1.2	0.1	1.4	2.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	30.0	17.8	0.5	0.4	0.2	0.3	3.9	2.6	1.7	1.1	1.8	0.0	0.6	1.1	0.2	0.2	7.6	3.7	1.5	0.0	3.7	0.1	0.0	0.0	0.8	0.0	0.0	1.7	0.7	0.8	0.6	18.3	0.2	0.3	0.0	0.0	0.5	2.8	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	4.1	0.4	1.9	15.7	0.0	0.0	0.6	5.5	1.6	0.0	0.0	1.8	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	26.5	1.1	26.3	10.9	19.0	3.0	11.8	4.3	2.1	0.0	0.0	0.0	4.1	3.7	0.4	1.6	0.0	6.7	1.2	0.0	0.0	0.2	0.0	0.8	6.8	0.1	0.0	0.0	0.2	0.8	2.7	1.3	1.1	0.0	0.4	4.8	6.4	3.7	0.0	4.2	4.4	0.0	0.0	0.0	0.0	1.3	0.3	0.0	3.2	0.0	0.6	0.0	0.8	0.2	0.2	2.5	0.2	0.0	0.0	0.6
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 94.8;U-87 MG: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"		NA	NA		89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	12.2	7.7	2.8	0.1	4.2	4.5	0.2	9.5	6.1	14.1	21.7	1.4	1.0	17.2	1.5	4.1	18.6	1.8	29.3	2.6	21.4	34.4	2.7	23.8	7.9	10.3	3.0	1.3	28.6	2.3	0.1	10.4	2.1	94.8	2.9	22.5	1.5	0.2	9.4	1.6	11.1	1.5	14.9	5.3	4.4	12.4	2.3	3.8	6.9	1.6	22.5	15.8	2.5	0.1	16.2	14.3	0.7	0.7	3.7	12.3	13.0	16.6	12.2	12.6	12.6	2.5	70.7	0.0	2.5	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3	32.8	30.1	5.4	2.3	5.6	242.1	12.0	0.0	21.4	10.3	12.2	294.5	0.2	0.0	16.0	0.3	7.1	0.0	0.0	1.5	0.3	6.6	1.7	65.8	0.0	1.7	405.2	23.0	6.2	0.0	0.0	5.2	2.5	11.8	5.4	0.0	91.6	10.4	0.2	9.2	0.0	613.6	12.9	21.7	1.8	1.3	1.9	0.2	11.4	0.4	1.6
EPHA5	"CEK7, EHK1, Hek7, TYRO4"	ENSG00000145242	"EPH receptor A5"	P54756	4	65319563-65670495	"Enzymes, Predicted membrane proteins"	Neurogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.5"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 12.1;Late spermatids: 12.5;Muller glia cells: 6.4"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.8;PC-3: 7.1;TIME: 9.5;U-138 MG: 19.9;U-2197: 12.1;U-251 MG: 15.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.02e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.89e-4)"	"unprognostic (7.43e-4)"	"unprognostic (1.60e-1)"		"unprognostic (6.68e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.25e-2)"		"unprognostic (5.88e-3)"	"unprognostic (2.55e-2)"	"unprognostic (5.97e-4)"	"unprognostic (3.81e-3)"	0.9	2.7	17.6	1.0	9.0	0.8	0.8	1.9	25.5	5.9	1.2	1.5	1.8	0.9	1.9	0.9	1.1	1.0	0.9	2.7	17.3	6.8	0.9	0.8	1.1	0.9	5.4	13.2	6.2	0.8	0.8	6.5	2.7	10.2	4.2	1.1	2.6	1.2	4.1	0.8	1.2	0.9	1.4	17.7	1.5	1.1	2.2	0.7	0.0	3.0	0.0	0.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	0.3	0.0	0.3	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.8	0.2	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	7.1	0.0	2.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	9.5	19.9	2.5	12.1	15.3	0.0	0.0	0.0	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	9.0	1.9	24.7	17.3	6.8	5.4	13.2	10.2	0.7	0.0	0.0	0.0	0.0	0.5	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.1	1.6	0.0	0.0	0.0	12.5	0.9	0.0	3.3	0.0	0.0	6.4	0.0	0.0	0.0	0.0	1.4	0.0	0.4	1.0	0.2	0.1	0.0	0.0	0.0	0.0
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"Q03468, P0DP91, Q8N328"	10	49455368-49539538	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 25.1;hTERT-RPE1: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"HPA071297: AB_2732177"	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	7.9	6.9	11.5	6.0	12.3	13.9	11.1	21.0	13.9	9.8	7.0	8.9	10.6	6.4	9.3	8.6	13.5	8.1	7.7	9.1	12.7	6.5	10.1	10.0	8.0	7.9	9.2	11.4	12.5	13.1	20.3	14.2	9.7	10.1	10.5	8.8	9.2	10.5	13.7	9.6	14.4	9.1	7.9	11.8	9.2	7.6	7.8	12.4	7.8	13.6	8.2	9.6	9.9	11.6	7.9	5.1	10.9	8.1	1.6	5.3	2.1	4.8	2.5	1.9	1.2	3.3	5.5	1.5	8.7	12.1	6.0	4.2	2.6	3.0	2.1	1.6	7.8	2.9	4.6	2.7	6.9	6.1	3.4	1.7	1.6	9.6	1.4	1.9	2.2	1.7	1.9	9.4	5.8	25.1	57.2	8.7	1.5	3.2	0.6	7.7	3.5	1.5	1.3	1.7	1.9	4.5	1.4	2.8	1.2	2.0	3.5	2.5	2.7	6.4	2.3	3.9	4.4	4.2	1.2	16.7	3.3	2.7	4.0	2.2	2.3	2.2	2.0	4.1	2.4	2.4	10.9	4.1	9.7	5.3	3.7	4.2	7.9	3.1	2.9	5.1	6.3	3.8	1.8	9.8	1.6	8.1	2.8	4.0	2.1	11.5	12.3	21.0	13.9	12.7	6.5	9.2	11.4	10.1	12.4	14.9	10.4	2.4	1.3	3.2	0.0	4.9	7.6	13.4	12.5	8.7	0.0	1.9	5.0	4.6	8.2	2.0	3.8	0.0	5.3	1.5	3.5	2.3	7.0	4.0	2.3	0.0	1.2	3.7	3.8	10.6	2.6	3.9	1.7	14.4	4.5	0.0	4.8	3.5	2.1	2.8	0.0	6.5	1.9	5.4	4.2	3.6	1.5	5.0	2.4	1.6
ETDA		ENSG00000238210	"Embryonic testis differentiation homolog A"		X	135252061-135253583	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"testis: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.1;Daudi: 1.2;hTERT-RPE1: 3.0;PC-3: 1.2"															NA	NA															"unprognostic (5.34e-1)"								0.0	0.0		0.0		0.4	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.2	0.0			0.0	0.0	0.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.1	0.0	0.0	1.0	0.0	0.0		0.0	0.0	11.4			0.1		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ETV1	ER81	ENSG00000006468	"ETS variant 1"	P50549	7	13891228-13991425	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 90.0;salivary gland: 45.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 112.4;Cardiomyocytes: 72.8;Intestinal endocrine cells: 190.4"	"Cancer enhanced"	"Detected in all"		"glioma: 22.5"	"Region enriched"	"Detected in all"	8	"cerebellum: 90.0"	"Cell type enriched"	"Detected in single"	5	"T-reg: 3.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 22.2;hTERT-RPE1: 25.6;SCLC-21H: 26.3;U-87 MG: 51.8;WM-115: 25.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 418.9"	"HPA068389, HPA077249"		Supported	Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA068389: , HPA077249: AB_2686829"	"unprognostic (2.45e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.64e-7)"	"unprognostic (7.08e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	2.5	12.4	8.1	1.1	11.7	0.2	4.4	90.0	35.2	1.4	2.4	3.1	0.1	1.2	2.4	1.3	1.5	1.1	9.2	18.0	7.0	4.5	2.1	2.0	14.9	0.7	4.5	6.9	1.0	1.6	11.4	7.4	1.9	8.3	3.1	2.4	0.9	45.8	7.1	0.9	1.5	1.9	2.0	3.5	4.5	1.7	4.5	2.9	0.3	6.5	0.9	4.7	1.8	1.3	0.0	0.0	0.0	0.6	0.0	3.1	0.2	0.0	1.6	11.6	22.2	4.1	12.2	0.0	1.0	3.9	0.6	2.6	0.0	5.3	0.0	1.2	1.8	3.2	0.1	0.4	1.2	1.4	0.3	0.5	0.6	1.0	0.0	2.4	3.8	1.5	3.6	0.0	7.6	0.6	25.6	5.0	0.3	3.4	0.1	4.7	0.0	0.0	0.0	17.5	0.6	11.8	0.0	7.1	0.9	7.9	0.1	26.3	5.1	0.0	0.4	6.3	4.2	0.4	0.1	2.7	2.3	0.7	4.5	4.3	4.0	1.2	0.0	51.8	0.2	25.6	0.0	0.2	0.0	0.1	0.6	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	8.1	11.7	90.0	10.9	7.0	4.5	4.5	6.9	8.3	2.9	17.9	112.4	0.0	2.5	0.9	4.2	72.8	38.2	1.4	1.2	3.5	0.0	0.4	5.0	2.7	18.7	5.2	0.0	0.0	0.8	0.3	4.2	0.2	2.3	11.0	2.6	4.8	190.4	1.8	6.0	6.6	1.4	0.8	11.8	0.0	0.7	12.2	0.9	0.0	32.5	2.7	0.4	19.4	8.2	0.5	1.0	1.1	0.2	0.7	1.1	0.3
EVC	DWF-1	ENSG00000072840	"EvC ciliary complex subunit 1"	P57679	4	5711197-5814305	"Disease related genes, Predicted membrane proteins"			"Ciliopathy, Disease mutation, Dwarfism, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Fibroblasts: 8.0;Melanocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.4;hTERT-HME1: 26.4;hTERT-RPE1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008703, HPA016046"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA008703: AB_1078765, HPA016046: AB_1848299"	"unprognostic (1.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.82e-1)"	"prognostic favorable (5.60e-9)"	"unprognostic (3.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (9.47e-5)"	5.0	2.9	2.5	4.6	2.7	0.0	4.1	1.9	2.3	13.2	4.3	1.8	8.4	0.6	17.2	10.1	6.0	8.1	16.0	3.8	2.2	2.2	26.5	3.7	6.4	1.0	2.3	1.4	20.2	9.2	14.9	2.3	1.8	2.9	10.2	1.6	12.0	9.1	5.7	2.4	4.2	2.8	15.8	2.4	2.1	3.6	5.3	1.0	1.0	6.9	3.9	3.8	7.5	9.0	0.1	0.3	1.2	0.1	0.1	0.5	0.0	3.0	3.9	2.2	5.7	14.3	20.7	0.8	6.9	26.4	8.0	10.4	0.0	0.0	0.0	2.2	10.9	13.4	3.7	2.3	5.7	6.6	5.1	1.5	0.0	2.2	1.0	10.6	0.0	0.6	10.2	8.4	10.7	26.4	22.9	5.5	0.0	0.0	0.0	18.5	0.0	0.0	0.0	2.4	0.0	3.6	4.7	6.0	0.0	2.8	0.5	1.2	3.7	0.0	0.0	2.8	2.2	1.4	0.2	9.6	6.8	1.3	4.8	6.0	4.2	3.4	0.3	19.6	0.0	6.4	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.3	0.5	0.0	2.5	2.7	1.9	2.3	2.2	2.2	2.3	1.4	2.9	1.0	3.0	2.9	0.0	1.6	3.1	0.0	1.6	2.5	1.4	1.2	3.5	0.0	0.0	1.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.7	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.9	0.0	5.0	0.0	0.0	2.1	0.2	0.0	0.7	1.1	0.0	0.0	1.7	0.0	0.0	2.5	0.1	0.0	0.0	1.1
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716043-76735781	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.5"	"Cell type enriched"	"Detected in many"	9	"Ito cells: 323.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 17.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 17.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.1;HUVEC TERT2: 71.3;WM-115: 67.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved					NA	NA					"CAB008973: , CAB012962: AB_2533198"	"unprognostic (3.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.76e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavorable (2.21e-7)"	"unprognostic (2.72e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.74e-3)"	12.3	11.2	1.5	7.5	2.2	1.1	8.9	0.8	3.5	11.7	14.0	3.3	20.1	5.9	17.6	8.6	9.3	3.5	20.8	19.2	1.4	1.7	19.5	22.6	24.4	10.4	1.5	1.8	6.2	4.0	1.6	4.7	32.0	2.5	9.6	5.1	9.6	26.4	14.0	7.2	23.7	15.5	8.4	3.5	67.5	4.5	16.6	1.4	4.0	9.1	11.4	13.5	10.7	4.7	0.4	0.2	0.8	0.3	4.2	17.6	6.4	1.0	3.3	10.5	1.7	19.8	34.7	0.5	5.8	20.0	3.8	13.9	0.7	9.1	0.0	9.9	2.5	17.4	2.5	4.5	3.5	7.3	0.8	3.7	22.8	0.7	2.8	29.9	0.1	0.9	19.5	11.9	7.3	2.0	39.1	71.3	4.1	4.2	4.3	7.8	0.4	1.7	0.0	3.3	0.0	18.2	3.2	6.3	0.8	18.1	0.1	1.2	5.7	1.7	0.0	8.5	9.9	0.1	0.2	32.6	24.3	5.4	0.2	10.8	11.7	3.4	0.0	6.4	0.4	67.2	0.5	0.2	0.3	17.6	0.3	4.4	0.4	4.1	12.1	0.0	0.1	0.7	9.1	0.8	4.2	0.1	0.2	0.4	6.4	1.5	2.2	0.8	2.1	1.4	1.7	1.5	1.8	2.5	1.4	0.0	11.6	1.5	0.5	15.2	2.5	2.0	10.2	4.0	3.4	7.0	0.0	0.1	0.0	1.9	8.8	22.6	0.2	0.0	1.9	0.3	28.8	1.2	5.8	2.5	1.6	0.0	6.3	323.5	25.7	3.6	0.9	1.3	11.8	0.0	3.2	0.0	6.7	0.0	9.9	2.2	1.6	0.0	17.5	6.7	4.1	35.0	0.2	30.2	1.0	0.4
F2RL2	PAR3	ENSG00000164220	"Coagulation factor II thrombin receptor like 2"	O00254	5	76615482-76623434	"G-protein coupled receptors, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 34.2"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 1.8;Ito cells: 9.2;Kupffer cells: 2.7;Rod photoreceptor cells: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 20.8;HBF TERT88: 13.4;HEL: 28.0;hTEC/SVTERT24-B: 13.7;hTERT-RPE1: 29.0;U-138 MG: 21.5;WM-115: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.35e-3)"	"unprognostic (5.71e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (6.71e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.56e-2)"	"unprognostic (9.71e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-8)"	"unprognostic (7.64e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	0.7	0.7	0.4	2.7	1.3	0.3	6.1	0.1	0.8	2.3	6.7	0.5	0.0	2.5	5.9	0.5	5.9	0.6	11.4	2.6	0.9	3.8	1.0	5.1	1.1	0.1	4.7	0.7	0.3	4.2	0.2	1.5	0.4	7.0	0.9	2.9	34.2	7.4	0.2	0.3	4.6	6.3	6.3	1.1	0.5	2.9	0.4	0.1	4.1	0.6	10.2	3.1	2.1	0.8	0.3	1.6	10.2	0.7	1.8	1.2	0.1	0.0	0.8	0.0	0.0	0.9	4.9	0.0	12.0	20.8	3.3	12.0	0.0	0.0	0.0	0.7	0.0	9.7	0.0	0.0	0.0	13.4	0.0	0.0	28.0	0.2	0.1	1.9	0.0	0.0	2.6	0.0	13.7	0.0	29.0	1.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	21.5	6.5	0.9	0.1	1.0	0.0	0.0	2.5	0.0	26.8	10.2	0.7	0.2	1.2	0.3	1.0	0.1	1.1	0.6	0.2	0.3	0.5	1.2	1.4	1.8	0.2	1.6	1.2	0.1	0.4	1.3	0.1	0.8	0.9	3.8	4.7	0.7	7.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	9.2	2.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	5.0	0.0	4.1	5.2	0.0	0.2	1.2	0.8	0.2	10.3	0.0	0.0	0.0	0.3	0.0	0.2	2.0	0.4	0.7	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	6.5	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.3	16.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	16.4	0.5	0.2	1.2	0.0	1.1	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.4	0.6	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6
FAM13C	FAM13C1	ENSG00000148541	"Family with sequence similarity 13 member C"	Q8NE31	10	59246129-59363181	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 36.1;Early spermatids: 31.6;Sertoli cells: 38.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 5.3;HSkMC: 6.9;hTERT-RPE1: 4.6;NTERA-2: 5.7;SCLC-21H: 11.4;SH-SY5Y: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037888	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037888: AB_10962981"	"unprognostic (3.68e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.69e-5)"	"unprognostic (8.54e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.51e-6)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.66e-3)"	11.8	17.0	16.1	3.8	22.3	0.3	7.7	12.4	24.9	9.4	6.4	36.6	3.2	4.5	9.0	8.7	14.4	15.3	11.6	7.8	18.9	15.9	3.8	2.3	10.0	4.5	23.8	18.8	22.2	2.5	4.0	8.3	2.9	21.2	17.9	6.7	16.5	4.9	8.7	15.3	7.3	5.0	12.5	33.2	5.0	3.9	5.2	28.9	0.0	6.0	7.6	2.5	7.4	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.3	0.1	0.0	1.6	0.0	5.3	2.4	0.2	0.0	0.0	6.9	0.8	0.3	0.0	4.6	0.0	0.0	0.0	0.3	2.8	0.0	0.0	0.0	5.7	0.0	0.5	0.0	1.1	0.0	0.0	1.7	11.4	6.7	0.0	0.3	0.0	0.5	1.0	0.0	0.0	3.3	3.1	0.1	2.6	0.0	0.0	0.1	4.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	22.3	12.4	23.4	18.9	15.9	23.8	18.8	21.2	28.9	0.0	0.0	0.0	9.5	4.2	10.0	2.8	0.0	36.1	1.2	0.0	5.9	0.0	6.6	0.0	31.6	12.6	0.0	0.0	0.0	0.0	3.0	4.5	0.0	0.6	0.0	3.2	0.0	2.5	0.0	17.2	21.3	0.5	3.3	0.0	0.0	8.8	0.0	0.0	19.8	0.4	13.1	38.8	18.6	0.9	0.7	5.5	0.0	0.0	0.0	0.5
FAM155A		ENSG00000204442	"Family with sequence similarity 155 member A"	B1AL88	13	107163510-107866735	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.0;pituitary gland: 10.3"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 18.2;Bipolar cells: 15.9;Early spermatids: 42.2;Horizontal cells: 35.0;Late spermatids: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.4;RPTEC TERT1: 11.7;SCLC-21H: 7.2;SH-SY5Y: 16.3;U-87 MG: 10.4"	"Low region specificity"	"Detected in all"							"HPA039453, HPA058768"	Enhanced		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Nucleoplasm, Vesicles"	Centrosome	"HPA039453: AB_10795290, HPA058768: AB_2683813"	"unprognostic (8.40e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.26e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.02e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.69e-3)"	0.9	2.7	10.7	0.6	4.3	0.4	0.6	6.9	19.0	1.5	0.7	0.6	0.0	0.5	1.7	4.0	0.7	0.7	1.3	0.7	8.8	10.8	0.7	0.4	1.2	0.5	6.4	4.9	0.7	0.5	0.4	10.3	1.2	2.0	2.7	0.7	0.7	0.3	3.8	0.4	0.5	0.7	1.2	2.7	0.6	0.7	2.3	0.5	0.0	1.3	0.0	0.9	1.4	0.2	0.2	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.7	0.0	2.5	0.1	5.4	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	4.4	0.0	0.0	0.2	0.0	11.7	1.9	7.2	16.3	0.0	0.0	0.0	0.2	4.1	0.0	0.2	5.0	2.0	1.7	0.2	0.0	0.0	0.0	10.4	0.0	3.5	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.4	0.8	0.0	0.0	0.0	0.0	10.7	4.3	6.9	12.3	8.8	10.8	6.4	4.9	2.0	0.5	3.0	18.2	0.0	0.4	0.1	15.9	0.7	0.0	0.0	3.4	3.5	0.0	0.0	0.0	1.4	42.2	2.9	0.0	0.0	0.0	0.1	1.8	0.8	0.0	0.0	0.2	35.0	0.0	1.8	0.0	14.6	1.7	0.0	0.0	0.0	0.0	7.0	0.3	0.0	1.1	0.0	1.5	6.5	0.2	1.1	0.9	0.0	0.0	0.0	0.0	0.1
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 52.4;Hepatocytes: 80.0;Hofbauer cells: 49.0;Peritubular cells: 53.0;Proximal tubular cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 50.3;hTERT-RPE1: 39.1;U-87 MG: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"	NA	NA		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.3	6.5	0.2	9.3	11.9	19.7	0.0	11.9	20.2	6.5	5.2	0.7	8.2	0.0	6.6	17.8	8.8	11.6	1.0	0.5	1.6	2.8	0.6	0.0	3.1	3.5	9.0	0.0	0.9	50.3	1.5	0.2	0.7	39.1	4.5	0.0	0.0	0.1	1.7	1.8	0.0	0.7	6.3	0.1	0.4	1.5	0.3	0.0	4.8	0.0	3.1	0.1	12.4	0.0	1.8	1.2	8.8	6.1	12.5	8.1	4.0	6.9	3.6	0.0	0.0	0.0	31.0	0.8	23.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8	6.0	3.2	2.4	1.9	9.0	20.6	8.1	33.1	5.3	0.0	52.4	0.0	0.5	5.0	1.3	0.0	2.4	3.5	0.0	4.1	0.6	13.5	6.8	3.5	80.0	49.0	1.6	11.3	9.8	15.6	1.1	15.0	14.7	1.7	11.8	4.2	16.6	6.5	3.5	53.0	46.8	8.0	12.9	15.3	0.2	0.7	7.0	0.5	0.0	7.3	1.4
FAM228A	"C2orf84, FLJ30851"	ENSG00000186453	"Family with sequence similarity 228 member A"	Q86W67	2	24175069-24200849	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	15	"testis: 54.1"	"Group enriched"	"Detected in some"	10	"Early spermatids: 71.6;Spermatocytes: 138.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 5.5;hTERT-RPE1: 2.6;TIME: 8.5"															NA	NA						"unprognostic (2.57e-1)"	"unprognostic (7.14e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.98e-3)"	"unprognostic (7.13e-4)"	"unprognostic (2.19e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.44e-5)"	"unprognostic (1.73e-2)"	"unprognostic (1.04e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-2)"	1.4	0.9	1.1	0.6	0.9	0.0	1.0	0.6	1.4	0.7	1.4	0.5	3.0	0.2	0.7	0.9	0.9	0.3	1.1	1.2	0.8	0.9	0.3	0.3	1.5	0.7	0.8	0.2	0.6	0.2	0.0	0.2	1.1	0.6	1.0	0.3	0.8	0.6	3.2	0.3	0.3	0.4	3.6	0.7	0.3	0.4	54.1	0.2	0.6	0.7	0.2	0.5	1.1	0.2	0.0	3.1	0.7	1.1	0.0	1.6	0.5	0.2	0.0	0.8	0.0	0.4	0.2	0.0	0.6	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	5.5	0.1	0.2	0.4	0.0	0.0	0.0	2.6	0.9	0.0	0.0	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.5	1.1	0.0	0.0	0.4	0.7	0.0	0.2	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	1.2	0.0	0.0	0.6	0.0	0.6	1.1	1.6	0.0	0.3	0.6	0.0	0.0	0.6	0.8	0.7	0.0	0.3	3.1	0.0	0.5	1.1	0.9	0.6	1.1	0.8	0.9	0.8	0.2	0.6	0.2	3.0	0.3	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	71.6	0.1	0.0	0.0	0.4	0.2	1.4	0.1	0.0	0.0	0.4	1.6	0.0	0.6	0.0	10.5	2.6	0.2	0.0	0.0	0.0	0.5	0.9	0.0	4.2	0.0	0.0	6.5	1.6	138.4	6.8	0.1	0.1	0.0	0.0	0.1
FAM231C		ENSG00000268674	"Family with sequence similarity 231 member C"	"P0DMU3, P0DMU4, P0DMU5"	Unmapped	35407-35916	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	5	"blood: 1.6;brain: 5.6;parathyroid gland: 3.2;testis: 1.4"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.1;U-698: 1.3"									"HPA043267, HPA043292, HPA077864"	Uncertain		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA043267: , HPA043292: , HPA077864: AB_2686862"																		0.0	0.3	0.1	0.0	0.1	0.1	0.0	5.6	0.3	0.1	0.3			0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0		0.2	0.1	3.2	0.0	0.1		0.1	0.0		0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	1.4			0.0		0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM90A26	FAM90A26P	ENSG00000229924	"Family with sequence similarity 90 member A26"		4	9170409-9176730	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTERT-RPE1: 1.1"									HPA060078			Approved	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA060078: "	"unprognostic (1.80e-2)"				"unprognostic (3.76e-1)"			"unprognostic (1.56e-1)"		"unprognostic (1.37e-2)"			"unprognostic (2.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.41e-1)"		0.0	0.6	0.1	0.0	0.3	0.1	0.1	0.2	1.6	0.0	0.0			0.0	0.1	0.1	0.0	0.3	0.4	0.3	0.1	0.1	0.0	0.1	0.2	0.0	0.0		0.7	0.3	0.0	0.2	0.0		0.2	0.0		0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FANK1		ENSG00000203780	"Fibronectin type III and ankyrin repeat domains 1"	Q8TC84	10	125896539-126009592	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.3;fallopian tube: 24.7;testis: 44.7"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 171.3;Early spermatids: 463.3;Late spermatids: 423.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	14	"T-reg: 28.3"	"Lineage enriched"	"Detected in single"	284	"T-cells: 28.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.7;hTCEpi: 8.6;hTERT-RPE1: 11.4;RPTEC TERT1: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038413			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038413: AB_10697249"	"unprognostic (4.25e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.02e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.44e-1)"	0.5	2.4	4.1	1.3	8.3	0.7	3.4	0.8	1.8	2.5	2.2	4.0	3.8	1.6	2.3	18.5	2.2	24.7	4.9	0.5	4.9	6.4	4.5	0.1	4.0	0.8	2.7	1.3	5.6	3.1	2.3	7.8	2.0	14.1	1.5	3.3	2.0	1.5	2.9	0.2	3.9	1.9	1.3	2.1	0.3	3.5	44.7	2.4	0.4	5.8	1.1	1.7	1.7	1.4	0.0	0.0	0.0	0.0	0.0	28.3	0.1	6.0	2.1	0.5	3.5	2.7	2.7	3.9	2.4	1.7	0.6	0.5	0.1	16.7	0.0	0.4	1.7	0.9	8.1	0.0	2.9	0.5	0.2	0.1	0.0	0.7	0.0	1.0	0.3	0.6	0.8	8.6	2.3	0.8	11.4	0.9	0.0	0.3	0.0	1.0	5.1	0.0	1.2	0.4	5.5	0.2	0.0	0.2	0.5	11.9	1.7	0.4	1.8	1.8	3.9	0.4	6.7	0.6	0.3	0.8	1.2	2.0	1.6	0.1	0.0	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.1	4.1	8.3	0.8	1.8	4.9	6.4	2.7	1.3	14.1	2.4	11.9	4.6	0.0	3.4	4.5	1.5	0.4	2.5	171.3	28.4	12.2	31.4	1.9	11.6	9.8	463.3	2.1	2.0	0.0	7.7	4.4	1.3	3.6	3.5	0.0	0.8	3.2	0.0	1.8	0.3	423.7	3.4	2.2	1.7	0.0	13.0	5.8	9.3	6.8	4.2	6.7	9.5	0.0	1.0	66.4	16.4	3.0	4.2	1.3	4.1	3.3
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 30.0"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 25.9;Muller glia cells: 68.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 45.4;ASC TERT1: 48.2;BJ hTERT+: 38.0;hTERT-RPE1: 48.7;U-138 MG: 38.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA059739	Uncertain				"Secreted to blood"	NA	NA		34000000			"HPA059739: AB_2684117"	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	19.8	0.7	2.6	3.2	1.2	0.0	7.5	0.6	3.7	17.6	4.5	0.4	4.0	0.1	30.0	13.7	4.1	5.1	14.9	5.2	3.1	0.9	2.0	0.9	4.7	0.8	2.6	1.2	4.1	2.3	0.5	1.0	17.0	1.9	4.1	1.5	2.4	5.3	3.9	8.1	2.9	1.4	17.9	2.2	0.9	1.7	9.8	3.4	0.0	3.5	9.0	0.8	12.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.4	48.2	0.0	18.5	38.0	3.9	5.9	0.0	0.0	0.0	0.1	7.0	0.0	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	15.5	0.2	6.4	1.2	48.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	1.9	0.0	0.0	0.0	19.0	38.7	0.7	9.4	0.0	0.0	0.0	0.0	8.7	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.6	3.7	3.1	0.9	2.6	1.2	1.9	3.4	0.0	0.0	0.0	0.1	3.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	2.9	0.0	0.0	0.2	1.6	25.9	0.1	0.0	0.0	0.8	1.6	4.7	2.5	0.0	2.3	7.8	0.3	3.3	0.0	0.0	68.0	1.6	0.0	0.0	0.6	1.5	0.0	1.4	0.2	0.0	3.8	1.5	0.0	0.0	0.0
FAXDC2	"C5orf4, FLJ13758"	ENSG00000170271	"Fatty acid hydroxylase domain containing 2"	Q96IV6	5	154818491-154859252	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.9;parathyroid gland: 112.1"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 38.7;Leydig cells: 43.7;Muller glia cells: 45.6;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;ASC TERT1: 16.1;HSkMC: 14.3;hTERT-RPE1: 15.3;SK-MEL-30: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.38e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-2)"	"prognostic favorable (3.87e-5)"	"unprognostic (8.29e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.42e-2)"	"prognostic favorable (9.71e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.94e-1)"	15.9	15.7	14.5	2.9	25.1	12.2	12.9	7.7	31.6	11.9	19.9	77.9	6.7	4.1	14.9	23.7	7.7	16.8	12.7	13.7	19.8	12.3	11.2	55.3	15.3	3.4	29.0	15.3	25.8	6.7	112.1	6.6	5.7	35.9	12.6	8.1	25.6	16.7	14.1	5.0	10.1	7.2	16.9	38.7	5.6	9.0	8.8	33.6	0.0	29.7	5.6	3.1	11.4	8.3	1.9	1.4	6.7	1.2	4.3	0.9	8.8	0.9	0.8	3.0	6.1	21.4	16.1	2.4	2.1	6.2	0.9	3.9	0.8	7.8	1.1	1.3	3.7	0.2	0.8	0.0	1.0	0.8	0.6	0.9	11.8	1.9	4.6	3.2	1.6	1.1	14.3	4.1	2.1	0.5	15.3	4.7	0.8	7.0	0.4	5.3	0.3	1.0	2.4	1.4	2.9	0.2	1.0	2.0	0.4	1.5	0.9	0.3	5.2	0.9	0.5	13.4	6.8	0.4	0.4	1.7	2.2	1.3	0.9	0.6	0.9	0.6	0.7	2.9	0.9	1.3	4.4	1.2	2.2	0.7	0.9	0.6	0.7	0.8	0.7	1.4	1.9	0.7	0.9	6.7	4.3	0.7	1.1	0.4	8.8	14.5	25.1	7.7	31.6	19.8	12.3	29.0	15.3	35.9	33.6	38.7	10.2	0.0	10.9	2.6	1.2	16.9	12.7	20.1	11.4	8.7	0.0	2.8	8.3	2.2	9.9	16.7	1.7	0.0	0.6	0.4	9.7	3.7	5.8	35.5	1.8	3.2	2.9	20.9	8.8	7.3	43.7	5.8	5.0	1.0	17.3	45.6	7.6	5.8	47.7	2.2	1.6	0.0	9.0	1.9	0.9	3.1	1.1	1.3	1.1	3.5
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.5	0.0	1.9	1.4	0.0	3.8	12.5	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	9.2	1.0	0.2	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	4.4	0.2	0.0	11.3	9.0	0.0	0.0	0.5	0.1	0.5	0.1	3.6	0.6	0.5	18.1	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1	3.0	0.3	0.0	0.7	3.9	3.7	0.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	1.9	2.1	0.0	0.0	0.2	5.9	4.7	0.4	1.1	1.0	0.4	3.2	0.0	0.6	0.0	1.7	0.3	0.0	16.9	0.0	0.0	2.2	0.4	0.0	4.9	0.5	7.2	6.5	4.7	0.1	0.2	3.3	1.3	4.4	0.0	0.3
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	NA		540000000	Cytosol		"CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (7.44e-5)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.9	79.9	0.0	28.8	10.4	8.6	5.5	0.0	0.0	0.0	1.3	68.5	0.0	0.1	0.6	0.1	7.8	3.3	0.2	0.3	14.7	0.0	20.8	0.1	0.0	43.2	0.0	22.7	2.6	35.7	9.2	0.2	0.0	0.0	9.2	0.0	0.2	0.0	0.6	0.0	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	2.7	0.0	0.2	17.4	35.1	1.0	51.0	6.0	0.2	0.1	0.0	23.5	0.0	2.3	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6	0.0	2.2	0.0	1.1	22.8	4.5	9.3	0.0	5.3	10.3	12.2	0.0	91.8	0.0	0.2	6.3	21.7	0.0	0.0	0.5	16.3	78.5	0.5	1.1	0.6	13.5	0.0	0.0	38.1	1.0	15.7	218.7	4.4	40.5	3.6	0.0	0.5	2.0	0.0	213.6	0.6	0.1	25.8	44.7	3.0	2.1	18.1	55.0	0.0	0.0	0.1
FBXL2	"FBL2, FBL3"	ENSG00000153558	"F-box and leucine rich repeat protein 2"	Q9UKC9	3	33277025-33403662	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 23.6;Early spermatids: 41.5;Late spermatids: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 8.9;LHCN-M2: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061783			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA061783: AB_2684605"	"unprognostic (5.73e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.92e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (3.30e-3)"	"unprognostic (9.72e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.90e-2)"	3.2	5.2	8.0	2.2	15.0	1.9	4.1	7.2	18.1	3.7	2.9	4.1	1.8	3.2	5.2	8.2	2.3	6.0	3.0	2.7	8.7	11.3	5.5	1.4	4.6	1.8	6.6	13.4	4.5	3.5	7.7	16.1	5.5	13.1	4.3	1.5	6.4	3.1	6.5	1.5	2.9	2.0	3.5	4.5	2.3	2.5	4.3	2.8	0.0	8.6	0.6	1.5	2.6	2.5	1.3	0.9	2.8	1.0	0.9	1.1	0.1	3.9	1.1	1.6	1.8	2.3	3.8	0.6	3.1	2.5	2.8	4.1	0.8	4.7	0.2	0.9	2.0	1.3	1.0	1.4	3.4	1.9	0.4	1.9	0.7	3.2	0.8	2.8	0.3	0.7	1.5	2.5	1.8	1.3	8.9	5.0	2.8	0.9	0.3	9.4	0.4	0.8	0.7	1.2	0.5	0.9	0.1	1.0	0.1	7.1	1.1	2.0	2.0	1.3	0.8	2.3	2.7	2.2	1.2	3.9	1.4	1.3	1.1	1.7	0.4	0.2	0.2	1.3	0.3	0.9	1.5	1.0	0.7	0.9	0.5	0.7	0.5	0.7	0.9	0.3	1.3	1.1	1.1	2.8	0.9	0.7	0.9	0.4	0.1	8.0	15.0	7.2	18.1	8.7	11.3	6.6	13.4	13.1	2.8	3.0	8.2	0.0	5.1	1.0	16.5	2.0	2.5	13.4	4.5	5.2	23.6	0.4	3.3	3.5	41.5	2.2	0.0	0.0	0.3	1.0	3.6	2.9	0.0	0.0	0.4	17.5	0.0	3.1	0.3	37.9	1.4	1.2	1.7	0.0	0.1	6.7	3.4	0.0	3.9	2.1	14.2	6.5	2.9	11.7	7.9	1.0	0.6	1.3	0.0	3.3
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.7	0.3	0.0	0.0	3.8	0.9	0.6	0.3	3.9	0.2	0.4	0.0	1.0	0.0	1.1	2.9	17.4	0.1	0.0	0.3	0.3	59.1	1.3	0.0	2.0	0.0	5.2	0.0	0.2	7.6	2.6	0.9	1.1	20.6	0.2	0.8	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.5	0.1	0.3	0.4	6.7	6.8	0.4	6.6	0.1	0.2	1.1	0.3	0.3	17.7	6.1	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6	0.0	3.0	0.9	172.4	10.2	7.9	242.3	2.5	2.7	20.5	7.0	33.4	13.8	8.3	11.6	2.6	7.7	43.7	23.3	26.4	10.2	11.3	165.2	0.0	1.5	4.9	20.6	98.1	0.6	3.2	2.7	36.8	2.9	42.2	1.0	40.8	51.7	39.4	23.2	57.7	3.3	92.8	19.4	73.6	5.4	1.3	5.5	91.3	21.0	19.3	65.2
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.2	2.3	0.8	0.0	0.0	0.0	0.0	5.0	5.9	0.3	0.8	0.0	2.5	0.0	1.8	0.2	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	0.2	0.0	0.1	2.7	0.0	9.4	0.0	0.0	0.6	0.0	0.0	21.2	0.0	2.2	1.5	15.0	0.5	0.0	4.4	0.3	16.5	0.0	0.1	0.0	0.7	0.0	0.5	0.7	1.3	8.2	0.0	0.9	11.3	0.1	9.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	7.7	0.0	0.3	14.5	0.1	4.7	0.0	27.4	0.4	1.8	0.7	0.0	0.0	0.9	3.2	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	12.2	0.8	16.7	3.5	3.2	0.0	0.1	0.0	0.3	1.1	15.1	0.0	3.3	0.0	4.7	1.7
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436172	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 235.4;placenta: 433.0"	"Cell type enhanced"	"Detected in many"	19	"Extravillous trophoblasts: 2156.8;Fibroblasts: 526.4;Hepatocytes: 963.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 845.3;HSkMC: 395.4;hTERT-HME1: 232.5;hTERT-RPE1: 257.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	NA	NA		47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (3.44e-8)"	"prognostic unfavorable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (3.33e-4)"	20.2	4.5	3.1	13.0	5.2	0.2	13.1	2.2	4.3	21.9	57.1	4.4	235.4	3.5	25.1	27.5	37.4	26.5	20.9	57.3	3.9	2.9	5.8	166.3	81.5	7.9	4.6	5.0	16.9	3.3	1.7	3.5	433.0	6.1	17.1	25.1	5.1	10.4	141.2	9.8	7.0	13.5	114.9	4.6	1.9	21.8	9.0	2.7	9.4	5.4	17.4	2.6	64.7	16.9	0.2	0.8	0.0	0.6	0.0	0.3	0.0	0.2	1.9	2.6	0.5	107.3	845.3	0.1	43.6	29.1	44.2	31.4	26.4	1.0	0.0	0.2	144.9	1.2	4.5	0.4	99.3	23.8	0.0	0.1	0.0	0.6	82.3	77.6	0.0	0.1	395.4	0.6	104.4	232.5	257.3	51.2	0.0	0.1	0.1	88.0	0.3	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.1	1.1	0.3	0.1	0.6	5.2	2.7	28.3	119.4	0.4	0.0	98.1	63.9	6.8	70.0	8.0	0.1	0.0	0.0	76.0	0.0	16.6	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	3.1	5.2	2.2	4.3	3.9	2.9	4.6	5.0	6.1	2.7	62.5	83.1	7.8	3.5	48.9	5.1	27.2	35.7	24.1	28.4	15.7	0.0	51.6	0.0	4.9	1.5	166.7	0.0	0.0	8.1	2156.8	526.4	18.4	17.4	963.3	368.5	1.6	20.2	165.1	27.1	2.6	172.6	39.4	104.6	1.8	4.3	1.4	19.0	0.0	83.1	0.6	9.7	71.1	163.2	1.1	4.5	32.6	172.1	0.9	3.7	1.6
FOXD1	"FKHL8, FREAC4"	ENSG00000251493	"Forkhead box D1"	Q16676	5	73444827-73448527	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 13.6"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 8.0;Muller glia cells: 26.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 23.6;hTERT-RPE1: 27.7;U-138 MG: 31.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (7.06e-4)"	"unprognostic (1.02e-3)"	"unprognostic (3.00e-5)"	"unprognostic (1.48e-4)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.61e-10)"	"unprognostic (3.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (9.65e-4)"	1.5	6.2	0.9	0.7	3.2	0.3	0.6	0.4	3.2	1.5	0.5	2.8	0.2	0.2	0.3	0.8	6.4	0.4	1.7	0.4	2.1		3.9	0.2	0.6	1.2	5.1	3.0	0.4	0.1	0.2	1.6	4.3	3.9	1.5	0.4	13.6	1.9	0.6	1.0	1.7	1.7	0.9	5.2	0.5	0.5	6.8	1.6	0.0	0.3	5.1	1.8	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.9	1.0	0.1	5.4	2.8	2.7	0.5	11.2	5.6	13.8	12.3	0.0	17.6	0.0	0.4	10.7	9.4	5.0	1.8	7.0	15.2	4.1	7.9	0.1	0.1	0.0	1.1	0.7	0.0	3.0	4.9	23.6	7.4	27.7	0.0	2.4	0.1	0.0	14.5	3.4	0.0	0.0	3.3	0.0	2.3	3.4	2.6	0.3	5.3	1.1	2.1	0.5	3.6	0.1	0.5	1.6	0.4	19.2	0.0	31.6	18.1	9.4	0.1	0.0	0.0	0.0	17.4	0.9	10.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.7	8.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	26.0	0.1	0.0	1.8	0.0	2.4	0.0	1.9	2.1	0.7	0.4	0.0	0.0	0.0	0.0
FOXS1	"FKHL18, FREAC10"	ENSG00000179772	"Forkhead box S1"	O43638	20	31844301-31845619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	28	"Peritubular cells: 53.4;Sertoli cells: 129.4;Smooth muscle cells: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;hTERT-RPE1: 13.3;RH-30: 11.1;U-2 OS: 14.8;U-251 MG: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042475	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA042475: AB_10964265"	"unprognostic (2.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-1)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (1.09e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.00e-2)"	5.9	3.1	2.7	3.0	4.7	0.3	11.7	2.7	4.9	9.7	2.6	4.8	1.8	0.9	15.5	6.2	2.8	3.6	11.7	14.0	3.2	2.6	5.5	0.9	6.5	4.6	4.1	4.8	4.0	1.1	0.8	3.2	14.4	5.2	5.0	1.6	7.0	2.0	7.0	4.5	1.8	1.8	3.7	2.6	5.5	1.6	9.7	0.6	3.0	4.9	7.0	3.1	4.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.1	0.0	14.8	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	4.7	2.7	4.9	3.2	2.6	4.1	4.8	5.2	0.6	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.4	0.0	3.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	4.0	4.6	0.0	1.7	0.0	0.0	0.0	3.3	0.0	53.4	0.0	0.0	129.4	31.6	0.5	0.5	0.3	0.2	0.0	0.0	0.0
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 17.9;Muller glia cells: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 10.8;PC-3: 27.5;U-138 MG: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: AB_2686349"	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	3.3	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	10.8	2.3	0.0	0.1	0.0	0.9	1.2	0.0	0.0	2.7	0.2	27.5	2.7	1.7	0.0	5.2	0.2	8.3	0.2	0.6	0.2	0.0	4.0	0.0	0.4	5.5	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5	17.9	3.5	0.0	0.6	0.2	0.2	8.9	2.5	1.4	0.0	0.0	2.0	0.1	0.0	2.2	0.0	4.4	5.3	0.0	2.7	0.1	1.1	0.8	0.0	3.4	0.5	0.0	1.2	9.2	0.6	0.0	1.1	0.8	0.0	0.0	2.9	31.4	2.6	0.0	2.1	3.1	1.0	6.5	2.3	0.1	1.1	1.0	0.1	0.0	3.5	0.1
GALNT10	GalNAc-T10	ENSG00000164574	"Polypeptide N-acetylgalactosaminyltransferase 10"	Q86SR1	5	154190730-154420984	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 43.7"	"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 47.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.0;TIME: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007525	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		830000	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"HPA007525: AB_1849443"	"unprognostic (6.99e-2)"	"unprognostic (4.33e-2)"	"unprognostic (9.85e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.63e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (2.88e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.08e-1)"	9.5	13.5	8.4	15.4	9.1	10.1	8.7	3.2	6.2	15.9	10.6	14.4	1.0	8.8	4.9	11.5	5.9	9.2	17.8	7.7	6.9	7.5	6.8	3.4	10.1	11.5	7.2	5.2	43.7	9.2	14.1	9.7	5.2	10.1	8.3	9.4	31.6	11.6	2.4	5.6	4.0	12.4	14.1	7.7	16.7	13.8	4.3	9.2	5.6	10.6	4.2	9.3	7.5	10.0	4.7	3.1	5.7	3.8	3.9	7.5	2.1	6.2	21.4	5.2	4.5	11.1	9.9	4.0	18.1	10.1	7.2	6.9	3.0	14.4	4.1	12.8	30.4	12.9	1.1	2.4	14.1	6.6	10.6	1.7	11.2	4.1	4.0	8.5	2.4	10.9	12.3	3.3	5.8	8.6	74.0	13.8	3.1	2.5	13.0	12.3	6.5	0.2	1.6	2.0	17.6	4.4	1.2	2.7	4.1	10.0	4.3	0.7	1.7	8.0	30.0	2.3	8.0	11.6	1.8	40.5	17.6	4.2	4.3	19.2	3.7	3.6	2.2	11.5	4.8	5.3	3.4	2.7	5.3	7.5	3.6	6.6	4.5	4.3	4.8	3.1	4.7	1.9	5.3	5.7	3.9	3.8	2.7	3.5	2.1	8.4	9.1	3.2	6.2	6.9	7.5	7.2	5.2	10.1	9.2	8.9	36.1	12.3	3.5	4.2	3.5	4.1	5.1	0.0	12.5	14.0	3.9	0.6	8.3	9.3	10.6	13.4	15.5	23.3	26.2	1.2	9.1	9.9	10.3	4.7	7.2	0.0	2.9	19.0	15.4	16.0	35.4	9.7	0.0	6.4	16.1	20.8	26.5	11.5	47.0	2.9	11.4	6.5	7.3	1.7	3.1	3.1	0.7	13.8	9.3	2.8
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 38.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		250000	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	13.6	15.5	20.0	2.9	17.9	0.8	14.5	16.1	21.7	7.8	4.1	5.0	4.0	3.2	6.4	6.0	5.1	6.5	4.8	27.6	18.3	27.2	5.6	3.0	4.2	4.2	6.6	25.2	2.8	5.6	4.0	4.1	1.2	13.0	4.6	3.4	1.7	28.9	6.6	5.3	7.0	5.0	11.3	8.7	14.3	2.4	3.3	3.3	0.0	3.5	6.3	2.2	5.0	3.8	0.5	0.2	1.3	0.5	0.3	0.3	0.2	0.0	0.6	7.4	0.2	9.8	4.5	0.0	1.0	0.0	1.3	1.9	0.4	0.0	0.0	0.2	1.2	0.6	0.0	2.4	0.0	0.2	0.1	5.1	0.0	0.1	0.3	0.1	0.0	0.5	0.4	0.0	13.9	0.0	14.2	0.8	0.0	0.0	0.0	2.3	0.3	0.0	0.0	1.4	0.0	0.1	0.0	3.9	0.0	0.5	0.0	7.3	2.4	1.6	0.3	0.0	0.3	0.2	0.0	0.1	1.5	16.7	1.9	1.5	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.5	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.0	0.5	0.3	0.2	1.3	0.3	0.1	0.2	0.1	0.2	20.0	17.9	16.1	16.2	18.3	27.2	6.6	25.2	13.0	3.3	0.0	0.0	0.0	0.5	3.7	1.9	38.2	0.0	0.0	0.0	0.0	2.0	0.1	3.3	0.0	6.4	0.1	0.0	0.0	0.0	0.0	5.2	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.4	0.9	0.0	3.3	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.6	6.5	9.2	0.7	1.9	2.9	0.0	0.0	0.0	0.4
GALNTL6	"GalNAc-T6L, GALNT17"	ENSG00000174473	"Polypeptide N-acetylgalactosaminyltransferase like 6"	Q49A17	4	171812254-173041559	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.5;lymphoid tissue: 7.3;testis: 6.4"	"Group enriched"	"Detected in some"	5	"Club cells: 3.4;Early spermatids: 11.9;Exocrine glandular cells: 3.7;Late spermatids: 13.6;Melanocytes: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.5;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	8	"B-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.2;Karpas-707: 2.2;SCLC-21H: 2.3;SK-MEL-30: 1.8;U-266/70: 2.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031019	Uncertain				"Intracellular and membrane"	NA	NA					"HPA031019: AB_10601653"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.50e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.25e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.73e-2)"	0.2	0.7	3.9	1.2	8.3	1.1	0.7	1.0	9.5	3.3	1.0	0.6	0.0	0.7	0.3	0.3	0.2	0.3	0.5	0.5	3.6	4.1	0.3	0.5	0.5	1.3	7.6	2.4	0.1	0.5	0.1	0.0	0.1	1.8	2.2	0.7	1.3	0.3	0.2	0.5	0.6	1.2	0.3	0.5	7.3	2.9	6.4	1.2	0.0	0.5	1.1	0.4	0.5	0.6	4.5	0.5	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.5	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.2	0.0	0.7	1.1	0.0	1.2	0.0	0.3	0.6	0.0	0.0	0.0	3.2	0.0	0.3	0.7	2.2	0.2	1.0	0.3	0.5	1.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.9	0.0	0.5	1.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	2.6	0.0	0.0	0.3	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	8.3	1.0	5.9	3.6	4.1	7.6	2.4	1.8	1.2	0.0	1.0	0.0	0.0	0.2	0.6	1.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	3.7	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.6	13.6	0.3	0.0	5.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.9	0.3	0.0	0.0	0.1	0.1
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169443-22202528	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 77.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 78.9;Mucus-secreting cells: 48.1;Undifferentiated cells: 48.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 5.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 26.8;CACO-2: 32.6;hTERT-RPE1: 12.5;OE19: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	9.7	26.6	0.2	8.4	0.2	0.0	9.4	0.2	0.2	9.8	24.7	0.9	1.5	12.5	19.5	10.3	3.3	15.3	51.3	40.4	0.2	0.2	3.9	15.5	14.9	11.1	0.2	0.1	77.2	52.2	0.1	0.5	5.2	0.7	24.3	6.0	0.4	1.5	1.1	1.5	0.9	43.5	32.2	0.4	18.9	26.9	9.7	0.0	0.1	6.3	0.7	0.6	30.3	16.5	0.0	0.0	5.7	0.0	0.0	0.4	0.0	4.7	0.7	0.0	0.0	1.0	0.5	26.8	0.1	0.1	0.4	0.4	32.6	1.8	0.0	1.6	0.5	1.7	5.2	0.2	2.1	0.7	0.0	6.5	0.0	2.0	2.8	7.1	0.2	0.3	0.2	4.2	5.9	4.4	12.5	4.5	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	17.4	4.6	0.0	0.5	0.1	0.2	1.3	0.4	0.0	5.0	2.9	1.3	1.4	0.8	0.0	0.3	0.7	0.8	5.5	0.8	0.0	0.0	0.0	3.0	0.1	4.7	5.7	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.7	0.0	41.7	27.5	0.0	3.5	0.8	0.0	78.9	25.5	2.7	7.9	0.0	0.0	0.5	0.0	22.6	47.7	6.2	29.3	0.0	16.9	9.5	20.0	2.8	4.7	8.3	1.4	0.0	25.0	17.8	0.3	5.9	3.1	0.8	0.0	0.0	48.1	0.0	30.5	17.5	9.6	0.0	0.0	32.3	5.5	0.9	1.0	0.6	1.6	0.0	48.1	2.1
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435692-121449727	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	19.7	65.2	78.6	5.5	69.7	0.4	14.2	32.4	44.4	64.5	4.0	23.8	6.1	4.2	23.5	5.5	17.3	7.8	23.0	36.0	87.3	25.5	3.6	2.5	15.2	4.4	42.9	39.9	10.5	4.5	94.7	5.7	63.8	53.7	20.0	4.8	26.3	7.1	35.7	3.4	86.3	4.4	25.6	38.7	1.1	6.4	8.3	64.3	0.5	38.9	9.9	7.6	14.8	32.2	0.5	0.5	0.4	0.5	0.0	0.4	0.0	0.0	6.6	29.3	0.0	16.0	9.9	0.0	21.9	44.6	7.4	18.1	0.1	0.0	0.0	2.4	8.5	6.3	2.8	0.7	13.4	24.1	0.0	8.0	0.3	2.7	0.0	20.0	0.0	0.0	26.4	14.5	27.1	9.8	73.4	56.2	0.0	0.0	0.6	1.4	1.2	0.0	11.7	57.2	0.0	7.3	0.0	0.0	0.5	29.6	3.2	0.0	0.4	0.0	0.0	0.0	74.9	2.3	0.0	41.3	22.8	6.3	19.2	14.1	0.0	0.0	0.0	55.7	0.0	3.2	0.4	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.4	0.4	0.0	0.0	0.1	0.5	0.1	0.0	78.6	69.7	32.4	42.8	87.3	25.5	42.9	39.9	53.7	64.3	232.3	73.8	0.0	121.0	208.6	0.2	174.1	0.0	5.3	14.8	1.8	2.0	46.7	0.0	69.9	0.3	111.0	0.0	0.0	3.5	8.1	139.5	19.9	8.1	0.0	7.5	0.0	0.0	22.7	0.3	1.1	2.3	2.8	42.2	1.0	0.0	0.1	17.0	0.0	3.9	0.0	0.2	0.0	27.8	0.3	0.1	330.6	16.7	0.0	0.0	45.0
GLIS1	FLJ36155	ENSG00000174332	"GLIS family zinc finger 1"	Q8NBF1	1	53506237-53738106	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 8.9;seminal vesicle: 14.7"	"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 6.0;Early spermatids: 2.7;Late spermatids: 2.5;Melanocytes: 3.3;Proximal tubular cells: 5.0;Spermatogonia: 2.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.0;BJ hTERT+: 5.9;GAMG: 7.8;hTERT-RPE1: 6.3;PC-3: 9.5;U-138 MG: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA001409	Uncertain					NA	NA					"HPA001409: AB_1078974"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.37e-4)"	"unprognostic (1.98e-4)"	1.1	0.1	0.5	0.6	1.2	0.0	0.9	3.9	1.6	4.2	0.5	0.5	0.5	0.6	1.4	1.0	0.6	0.8	1.0	1.0	2.3	0.7	3.3	0.5	0.5	0.5	0.5	0.5	1.0	0.5	0.0	0.5	1.2	0.8	8.9	0.1	5.5	0.5	14.7	0.5	1.7	0.6	0.5	0.5	0.5	0.9	4.1	0.5	0.5	0.5	0.5	1.0	2.7	4.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	3.8	5.0	0.0	2.6	5.9	2.3	1.7	0.0	0.0	0.0	0.1	2.7	7.8	0.0	0.0	0.0	0.7	0.0	1.7	0.0	1.7	0.1	1.3	0.0	0.0	3.5	0.2	2.8	2.6	6.3	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	1.2	0.1	1.7	0.0	0.0	4.2	0.5	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	3.9	1.6	2.3	0.7	0.5	0.5	0.8	0.5	0.0	0.0	0.0	0.0	6.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.1	5.0	0.0	0.0	1.4	1.9	2.8	1.5	0.1	0.0	0.0	0.0
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076057-157172090	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 43.1;parathyroid gland: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 12.6;Cholangiocytes: 7.6;Ciliated cells: 8.1;Muller glia cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.5;hTERT-RPE1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA					"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.5	7.2	12.6	1.5	20.9	0.7	10.3	15.9	43.1	9.4	2.3	2.8	0.1	1.1	3.3	5.4	1.5	7.4	3.5	9.9	18.3	17.3	4.1	1.6	3.4	0.8	11.1	21.3	1.8	14.2	37.0	6.7	2.9	16.5	6.5	1.4	0.7	16.7	5.2	3.3	1.5	1.2	4.0	6.1	0.6	2.2	1.9	4.5	0.0	1.5	0.5	0.7	1.9	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.8	2.0	5.8	17.5	11.3	4.6	0.0	9.6	6.2	4.7	8.9	0.0	14.8	0.0	2.3	9.7	5.8	0.0	4.4	1.5	8.9	0.0	5.8	2.9	2.2	0.2	5.2	3.7	0.0	4.1	1.3	8.2	1.2	23.3	4.2	3.1	0.0	0.0	8.5	0.0	0.4	0.0	0.3	0.0	1.3	0.0	7.9	0.0	12.7	0.8	6.3	3.8	0.0	4.5	0.7	0.9	4.1	0.9	6.2	2.8	8.3	4.7	9.3	0.0	0.0	0.0	6.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.6	20.9	15.9	43.1	18.3	17.3	11.1	21.3	16.5	4.5	0.0	0.6	0.0	0.7	1.0	6.9	12.6	7.6	8.1	3.4	0.0	2.0	0.3	0.0	6.9	0.2	1.0	0.0	0.0	1.5	0.0	2.6	0.6	1.1	0.0	0.1	1.6	0.0	1.8	0.0	0.0	0.3	0.0	3.3	1.0	0.0	11.6	1.9	0.0	3.2	0.4	1.6	0.0	1.1	1.1	3.0	0.3	0.1	0.0	0.0	0.1
GLT8D2	FLJ31494	ENSG00000120820	"Glycosyltransferase 8 domain containing 2"	Q9H1C3	12	103988984-104064183	"Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 28.7;Fibroblasts: 28.3;Ito cells: 20.9;Leydig cells: 51.8;Peritubular cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.9;BJ hTERT+: 34.4;HSkMC: 25.8;hTERT-RPE1: 20.6;RPTEC TERT1: 17.6"	"Group enriched"	"Detected in many"	5	"amygdala: 8.0;cerebral cortex: 20.1;hippocampal formation: 16.6"	"Low region specificity"	"Detected in many"			"HPA012740, HPA026904, HPA070791"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA012740: , HPA026904: AB_1849731, HPA070791: "	"unprognostic (4.02e-1)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (9.53e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (1.58e-6)"	"prognostic unfavorable (7.92e-4)"	"unprognostic (7.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (7.03e-3)"	10.2	5.2	2.2	9.9	3.3	0.2	12.0	0.7	2.4	32.8	10.3	1.4	8.8	2.5	24.5	23.1	13.5	13.3	19.1	18.8	2.2	1.8	3.4	2.8	6.9	2.2	2.1	2.1	25.5	2.5	5.9	12.5	6.9	3.5	19.6	5.3	21.8	6.7	8.3	4.0	2.7	6.7	17.3	2.2	1.0	5.5	7.8	0.8	1.0	26.0	10.9	5.7	11.2	13.1	0.8	0.9	0.2	0.6	0.0	2.1	0.0	0.1	0.2	0.2	8.7	11.4	27.9	0.2	12.5	34.4	3.2	4.2	0.1	0.0	0.3	0.7	14.3	0.1	0.0	0.1	4.6	2.8	0.6	3.9	0.2	4.6	0.0	5.1	0.3	0.2	25.8	0.2	3.9	5.5	20.6	1.7	0.2	0.1	0.5	14.1	0.1	0.2	0.1	1.0	0.0	2.6	0.3	13.4	0.1	17.6	0.1	0.5	0.7	13.1	0.3	0.1	1.0	2.3	0.2	0.2	5.3	2.5	0.5	0.7	1.5	0.3	0.1	0.4	0.2	0.4	0.0	0.0	0.0	2.1	0.6	0.7	0.8	0.3	1.3	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.9	0.0	0.0	2.2	3.3	0.7	2.4	2.2	1.8	2.1	2.1	3.5	0.8	0.0	5.8	0.0	3.5	2.5	0.8	2.4	0.0	0.0	0.0	0.0	2.0	3.5	0.0	0.0	28.7	5.9	0.0	0.0	0.0	0.8	28.3	0.5	0.0	0.2	0.5	0.0	1.7	20.9	0.6	9.6	51.8	0.0	3.3	1.0	0.4	0.3	0.5	0.0	48.8	0.0	0.3	6.5	17.0	1.1	0.9	2.0	1.1	0.5	0.0	0.0
GPC6		ENSG00000183098	"Glypican 6"	Q9Y625	13	93226842-94407401	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 47.6;Hepatocytes: 39.9;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"NK-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;HHSteC: 17.5;HSkMC: 29.7;hTERT-RPE1: 26.6;SuSa: 17.0;U-87 MG: 21.9"	"Low region specificity"	"Detected in all"							HPA017671	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		360000	"Golgi apparatus, Vesicles"		"HPA017671: AB_1849833"	"unprognostic (5.24e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.79e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.21e-3)"	"unprognostic (7.42e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.35e-3)"	11.0	3.2	3.7	9.7	6.8	0.4	6.5	3.2	7.3	7.6	10.6	3.7	2.6	3.1	5.7	9.9	6.3	6.9	19.9	7.9	3.0	3.0	9.5	21.3	6.6	4.9	2.5	4.7	11.1	2.3	1.2	7.5	1.8	5.1	12.8	8.2	20.8	3.6	19.2	1.8	3.0	7.1	13.7	19.8	3.4	8.1	2.4	2.1	0.2	4.4	1.5	1.4	14.3	15.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	1.9	4.2	1.8	26.2	8.9	0.0	2.9	0.0	2.0	2.7	0.0	0.0	0.1	0.0	6.3	0.0	0.0	2.3	0.5	3.8	0.0	1.7	0.0	0.0	7.9	17.5	0.0	0.0	29.7	0.2	4.8	3.3	26.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	1.4	0.0	0.6	0.0	2.3	0.0	1.7	7.0	0.0	0.8	0.0	17.0	5.7	0.0	0.0	11.1	9.5	10.4	4.8	6.5	0.0	0.0	21.9	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	3.7	6.8	3.2	7.3	3.0	3.0	2.5	4.7	5.1	2.1	0.0	0.3	0.0	0.6	0.6	47.6	1.6	5.1	0.0	1.2	7.0	9.8	0.2	0.0	0.2	4.9	0.5	0.0	0.0	0.0	0.1	6.1	2.0	0.0	39.9	0.4	0.0	0.0	8.0	1.0	3.1	4.4	0.4	1.7	0.0	0.0	2.3	0.1	0.0	1.8	14.3	84.5	0.0	16.1	2.6	0.7	0.4	0.1	0.0	0.0	0.1
GPR162	"A-2, GRCA"	ENSG00000250510	"G protein-coupled receptor 162"	Q16538	12	6821545-6829972	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.6"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 75.9;Ciliated cells: 49.5;Horizontal cells: 38.1;Muller glia cells: 46.3"	"Cancer enriched"	"Detected in many"	6	"glioma: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.3;intermediate monocyte: 3.7;neutrophil: 14.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 14.7;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.0;AN3-CA: 15.4;hTERT-RPE1: 13.4;NTERA-2: 14.5;SH-SY5Y: 9.9;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055135	Enhanced		Approved	"Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Centriolar satellite"		"HPA055135: AB_2682710"	"unprognostic (4.76e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (4.29e-5)"	"unprognostic (3.82e-3)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (3.10e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.64e-2)"	2.7	6.7	19.6	4.2	13.2	1.5	2.4	41.3	47.6	2.1	3.4	4.7	0.8	3.1	3.8	2.8	1.9	16.9	5.7	4.2	25.9	18.4	1.4	3.7	6.0	1.7	9.9	17.7	2.0	1.7	5.3	8.4	4.3	10.2	2.1	3.0	3.6	1.3	2.1	1.6	1.7	4.2	5.7	5.3	2.8	2.0	1.2	3.6	0.1	1.1	0.0	1.1	2.4	0.5	0.0	1.8	14.7	6.3	0.0	0.0	1.7	0.0	2.9	13.0	15.4	1.4	1.0	0.0	1.0	3.4	2.9	1.7	0.2	0.0	0.0	0.1	1.8	0.1	0.0	2.0	0.0	1.4	0.0	0.9	1.5	0.1	0.0	2.2	0.3	0.0	2.4	0.0	4.4	0.2	13.4	7.9	1.1	0.7	0.1	1.0	0.0	0.4	1.1	14.5	0.0	0.1	0.0	1.6	2.6	1.0	0.0	1.1	9.9	0.0	0.0	0.4	9.3	0.1	3.8	5.2	2.0	12.3	1.0	1.7	0.0	0.9	0.0	2.2	2.7	0.2	0.0	6.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	14.7	0.0	1.3	1.6	0.0	1.7	19.6	13.2	41.3	32.4	25.9	18.4	9.9	17.7	10.2	3.6	0.0	0.0	0.0	0.1	0.7	75.9	1.1	0.0	49.5	1.2	1.8	3.9	0.1	1.7	0.0	0.0	2.4	0.0	0.0	0.0	0.1	2.1	0.5	0.0	0.4	2.2	38.1	0.0	5.5	3.4	0.4	6.9	3.2	0.0	0.0	0.0	46.3	0.1	0.0	13.8	0.3	7.8	0.0	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.7	5.4	9.6	2.3	12.2	3.4	2.4	17.2	23.9	2.7	6.9	4.9	1.3	1.2	3.8	2.7	2.4	4.5	2.6	5.6	21.7	8.9	3.8	0.3	0.6	2.6	5.0	5.3	5.3	3.5	17.8	9.1	0.3	5.5	4.5	1.6	5.8	0.7	8.9	1.0	1.1	1.4	6.7	7.6	1.8	2.7	13.6	3.5	1.0	10.3	0.3	1.0	2.2	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.2	9.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.4	0.0	0.4	0.0	0.1	0.1	0.0	8.9	0.1	0.0	24.4	0.0	0.1	4.0	0.0	7.0	15.5	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	12.2	17.2	12.7	21.7	8.9	5.0	5.3	5.5	3.5	0.0	0.0	0.0	0.1	0.3	21.4	2.3	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.6	0.0	0.0	17.5	0.0	0.0	0.0	2.2	0.9	0.0	0.0	0.0	0.0	8.3	0.1	0.0	0.4	0.0	20.6	0.0	0.9	3.8	1.5	0.4	0.0	0.0	0.0	0.0
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182754	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.2"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 14.9;Early spermatids: 13.4;Late spermatids: 13.0;Muller glia cells: 17.7;Rod photoreceptor cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.8;hTERT-RPE1: 3.4;RPMI-8226: 2.9;U-138 MG: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA					"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.9	1.0	5.4	0.5	5.9	0.4	0.6	8.5	25.2	0.6	0.7	1.5	0.0	0.9	0.8	4.5	2.1	4.1	0.5	4.0	8.0	1.9	0.9	0.4	1.0	0.5	1.7	10.3	0.5	0.6	0.4	0.3	0.4	1.4	0.5	0.7	1.4	0.7	1.0	0.5	1.2	0.7	0.9	1.2	0.4	1.1	5.2	0.8	0.0	0.8	0.0	0.7	0.6	0.5	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.9	0.6	1.4	0.0	0.1	0.0	0.0	7.8	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	8.5	0.8	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.4	5.9	8.5	17.9	8.0	1.9	1.7	10.3	1.4	0.8	0.0	0.0	0.0	1.9	1.6	3.6	14.9	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.4	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	1.6	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	17.7	1.2	0.0	0.0	0.0	12.1	0.0	4.2	3.2	3.8	0.4	0.0	0.0	0.0	0.3
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 113.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.1	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	1.8	15.7	0.0	1.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	113.7	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
GSX2	Gsh2	ENSG00000180613	"GS homeobox 2"	Q9BZM3	4	54099523-54102505	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Dystonia, Mental retardation"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"brain: 4.8;retina: 16.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	15	"glioma: 2.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;hTERT-RPE1: 1.6;RPTEC TERT1: 1.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in single"									NA	NA										"unprognostic (4.48e-2)"						"unprognostic (1.05e-1)"				"unprognostic (7.01e-2)"	"unprognostic (1.89e-1)"		0.0	0.0	3.3	0.4	4.8	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	16.7	0.0	0.0	0.0	1.7	0.3	0.0	0.7	0.2	0.1	2.2	0.5	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.8	0.0	0.9	0.7	0.7	1.0	0.8	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTF2A1L	ALF	ENSG00000242441	"General transcription factor IIA subunit 1 like"	Q9UNN4	2	48617798-48733148	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"testis: 47.7"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 6.8;Late spermatids: 1.7;Spermatocytes: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.1;HHSteC: 2.8;hTERT-RPE1: 3.4;SuSa: 2.5"															NA	NA													"unprognostic (3.59e-1)"		"unprognostic (7.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.77e-1)"		"unprognostic (5.02e-2)"				0.7	0.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.9	4.3	0.3	0.3	0.4	2.3	0.9	0.6	0.8	0.7	0.3	0.3	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.9	0.3	0.1	0.3	0.3	0.3	0.9	0.1	0.3	0.3	0.3	0.4	0.1	0.6	0.5	0.3	0.4	1.4	47.7	0.3	0.3	0.3	0.3	0.3	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.3	0.0	0.0	3.4	0.9	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.7	0.0	2.5	0.3	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.1
H2BFM		ENSG00000101812	"H2B histone family member M"	P0C1H6	X	104039949-104042454	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 19.0"	"Group enriched"	"Detected in some"	13	"Early spermatids: 4.4;Late spermatids: 7.4;Spermatocytes: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 5.3;hTERT-RPE1: 6.3;Karpas-707: 6.9"															NA	NA															"unprognostic (1.87e-1)"					"unprognostic (1.87e-1)"		"unprognostic (1.54e-1)"	0.4	0.3	0.6	0.4	0.7	0.7	0.9	0.5	0.5	0.4	0.4	0.4	0.4	0.0	2.4	1.5	0.4	1.4	0.9	0.4	0.6	0.5	0.4	0.4	0.4	1.2	0.4	0.4	4.0	0.4	0.4	0.4	0.4	0.4	0.8	0.2	0.4	0.4	1.0	0.4	1.0	0.4	2.0	0.4	0.6	0.3	19.0	0.4	0.4	0.4	0.4	1.1	0.5	0.4	0.3	1.1	2.6	0.0	0.4	0.4	0.1	0.0	0.6	5.3	3.7	1.0	1.9	0.4	0.6	0.5	1.2	1.5	1.1	0.2	1.2	0.4	0.4	0.9	0.0	0.5	0.0	2.3	1.3	2.6	0.7	0.0	0.0	1.2	0.4	0.7	0.3	0.5	1.6	0.4	6.3	1.1	2.6	0.0	6.9	2.3	0.9	3.3	0.0	2.5	0.0	0.5	1.7	2.2	0.7	1.7	1.3	1.1	4.5	0.0	0.0	0.0	1.9	0.0	0.8	1.6	4.0	0.7	0.8	1.3	0.4	0.0	2.3	0.6	0.3	0.8	2.6	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.3	0.4	0.2	0.0	0.4	0.0	1.1	0.0	0.1	0.6	0.7	0.5	0.5	0.6	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.7	0.0	0.0	0.0	0.0	0.0
HCFC1R1	"FLJ20568, HPIP"	ENSG00000103145	"Host cell factor C1 regulator 1"	Q9NWW0	16	3022620-3024286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 247.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059647	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059647: AB_2684094"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.03e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.43e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.23e-1)"	19.7	28.9	49.3	10.2	61.0	7.8	23.9	25.4	37.5	30.4	17.5	13.5	17.7	14.3	20.5	18.4	20.7	19.4	28.0	27.8	37.2	38.6	24.9	11.1	19.1	10.6	40.9	23.9	24.3	10.4	19.9	19.5	16.5	23.0	22.8	10.0	11.5	15.1	42.4	204.8	25.0	13.9	28.7	23.2	9.1	11.2	11.4	14.7	7.5	13.5	37.0	9.1	24.7	17.2	14.1	26.2	8.4	21.6	13.7	20.2	9.6	12.4	32.9	6.6	8.0	27.1	35.7	6.3	3.9	24.9	12.3	33.8	6.9	15.0	8.7	13.5	23.3	10.7	16.4	6.6	24.2	5.7	11.9	15.6	3.8	26.2	11.5	22.2	6.3	7.5	44.1	15.7	12.8	14.0	84.8	17.1	6.6	5.2	17.4	13.7	11.2	3.8	9.9	14.4	7.2	6.9	13.7	5.9	24.3	43.8	2.5	11.4	9.6	9.6	15.4	15.5	16.8	10.2	5.8	4.9	20.3	56.9	17.2	10.6	10.6	10.3	7.6	8.6	3.9	4.6	2.7	21.6	8.4	12.3	15.5	11.6	14.1	15.9	13.3	26.2	13.5	11.8	14.2	4.5	13.7	13.5	13.0	20.2	9.6	49.3	61.0	25.4	37.5	37.2	38.6	40.9	23.9	23.0	14.7	53.6	12.9	28.9	60.6	75.9	26.6	39.3	50.9	16.0	18.2	188.5	5.9	91.7	203.9	41.6	3.8	35.9	68.0	0.0	23.5	101.8	139.4	33.1	39.3	41.9	104.8	19.1	42.0	61.4	66.0	10.1	89.2	41.2	60.8	50.5	33.1	31.3	26.9	48.9	167.6	247.7	19.7	122.9	137.0	14.0	37.3	57.5	45.1	20.8	42.9	31.5
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		360000000	Vesicles	"Plasma membrane"	"HPA010952: AB_2668389, HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (1.16e-4)"	23.6	8.2	5.8	12.1	8.4	0.7	16.4	2.6	8.9	12.2	9.6	14.7	8.0	3.9	12.0	7.3	9.0	11.4	29.6	36.3	6.9	5.5	8.9	5.5	42.4	7.7	9.7	4.7	8.1	16.6	14.2	4.0	17.4	11.6	7.2	6.5	26.2	7.1	7.4	6.2	4.3	7.9	14.4	11.9	11.5	7.5	11.3	6.5	3.0	29.1	10.8	8.7	13.0	15.6	1.0	0.9	1.2	3.9	7.3	4.0	1.1	1.8	1.9	13.4	1.1	16.6	14.7	5.0	15.7	20.6	17.5	19.3	13.7	0.2	0.5	10.7	42.0	12.8	3.3	2.0	7.7	21.1	1.4	1.0	0.3	10.2	1.6	51.1	0.3	20.4	18.0	2.2	22.8	5.4	77.1	17.0	1.2	0.0	0.2	5.3	0.2	0.8	0.0	2.3	0.0	1.2	1.2	10.2	0.0	3.0	0.3	0.2	1.2	34.9	2.4	1.3	12.4	5.7	0.8	26.4	9.9	11.0	35.4	6.7	1.4	4.3	0.0	18.6	1.5	19.2	1.2	0.3	0.0	4.0	3.6	2.7	0.9	1.6	3.6	0.7	1.0	2.4	1.5	0.0	7.3	3.9	0.9	0.5	1.1	5.8	8.4	2.6	8.9	6.9	5.5	9.7	4.7	11.6	6.5	80.4	7.2	4.9	7.1	4.4	3.0	80.5	5.1	0.0	4.5	26.2	249.4	0.8	0.0	31.8	5.1	76.0	0.0	0.0	5.8	53.1	23.5	2.8	26.5	2.5	5.7	1.6	0.0	95.2	15.8	7.6	4.6	4.8	6.8	2.8	0.6	4.1	6.9	0.0	13.1	1.2	62.4	0.0	21.2	0.2	0.2	3.9	2.7	14.6	0.1	0.9
HIST1H3E	"H3.1, H3/d, H3FD"	ENSG00000274750	"Histone cluster 1 H3 family member e"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 19.9;tongue: 25.6"	"Cell type enhanced"	"Detected in some"	6	"Hepatocytes: 3.4;Mucus-secreting cells: 2.9;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.9;hTERT-RPE1: 8.5;SCLC-21H: 13.4;T-47d: 8.2"									HPA042570	Approved					NA	NA					"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	4.8	0.0	2.8	1.2	0.2	2.6	2.4	1.2	2.6	3.6	1.9	5.2	6.1	2.5	6.9	14.5	1.6	3.0	7.4	0.0		0.7	0.9	2.1	4.1	4.1	0.0	2.5	0.6	2.5	0.5	2.9	1.8	4.6	2.4	0.5	4.4	1.8	6.1	1.3	6.1	2.5	1.8	2.3	3.5	19.9	3.2	22.4	3.6	25.6	8.8	2.7	0.3	2.6	3.9	6.5	1.8	0.5	3.1	1.4	2.0	2.2	3.2	1.4	3.8	1.8	0.2	1.5	1.6	0.8	0.6	0.7	1.2	0.0	11.9	0.6	1.1	2.5	0.0	0.4	0.7	3.1	2.8	0.4	1.0	0.7	1.2	0.2	1.9	2.6	2.7	0.3	0.8	8.5	1.2	0.2	0.3	2.4	2.2	1.9	0.4	0.1	0.2	1.5	2.1	1.5	0.6	0.3	6.4	1.2	13.4	1.5	2.1	3.3	3.6	0.5	8.2	1.3	0.6	1.5	0.5	0.4	0.3	0.9	0.3	0.2	0.7	0.1	0.8	0.4	1.8	0.0	1.3	1.5	1.7	1.4	1.8	1.7	1.2	2.6	1.7	1.8	6.5	0.5	1.3	3.9	3.1	1.4											0.0	2.2	0.0	0.5	0.0	0.4	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.4	0.7	0.0	2.0	0.0	0.2	0.2	0.0	0.6	0.0	3.4	0.8	1.6	0.0	1.3	1.2	0.7	0.6	0.0	0.0	1.0	2.9	0.3	0.1	3.5	0.0	1.0	0.0	0.0	0.1	0.1	0.5	0.0	1.1	0.0	0.6	0.1
HMCN1	"ARMD1, FBLN6, FIBL-6, FIBL6"	ENSG00000143341	"Hemicentin 1"	Q96RW7	1	185734551-186190949	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell cycle, Cell division, Sensory transduction, Vision"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Endothelial cells: 8.2;Fibroblasts: 12.4;Horizontal cells: 25.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 14.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"T-reg: 3.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 10.5;hTERT-RPE1: 9.8;MCF7: 35.5;SK-MEL-30: 23.4;WM-115: 21.0"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"olfactory region: 22.1"	"HPA008220, HPA051677"	Uncertain		Approved	"Golgi apparatus,Cytosol"	"Secreted to extracellular matrix"	NA	NA		2000000	"Golgi apparatus, Cytosol"		"HPA008220: , HPA051677: AB_2681572"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (1.22e-2)"	"unprognostic (5.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.00e-3)"	14.9	1.3	1.0	4.8	2.5	0.0	10.9	0.4	1.7	9.8	8.4	0.8	0.5	0.8	5.9	3.0	12.0	1.9	6.8	13.4	0.9	0.9	2.2	7.9	23.9	2.6	1.3	0.2	4.4	1.1	0.1	6.2	7.7	2.0	8.4	2.9	8.1	7.8	1.3	4.4	4.0	3.7	4.5	1.8	13.1	1.9	2.4	0.4	0.5	3.3	15.8	6.1	3.0	4.3	0.0	0.0	0.3	0.0	0.0	3.0	0.0	0.1	0.0	0.7	0.0	2.3	2.3	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.9	0.1	10.5	0.8	2.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	2.7	0.2	9.8	1.3	0.0	0.0	0.0	0.0	35.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	23.4	2.2	0.0	0.0	0.0	6.7	0.6	0.0	2.4	0.1	0.0	0.1	1.3	0.0	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	1.0	2.5	0.4	1.7	0.9	0.9	1.3	0.2	2.0	0.4	3.0	6.5	0.0	0.2	2.9	0.7	2.3	0.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	6.5	8.2	0.0	0.0	0.0	0.6	12.4	0.1	0.0	1.5	0.1	25.4	0.0	5.5	0.8	1.5	3.4	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824131-65966295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.3"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 15.7;Hofbauer cells: 6.8;Late spermatids: 6.8;Pancreatic endocrine cells: 11.8;Undifferentiated cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 63.0;hTERT-RPE1: 46.0;SuSa: 44.3"	"Not detected"	"Not detected"							"CAB017809, HPA039076"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB017809: , HPA039076: AB_2676335"	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.86e-4)"	6.5	0.3	0.5	3.8	0.8	8.1	2.1	0.2	0.6	2.5	7.6	0.4	0.0	2.4	2.7	0.1	1.1	2.4	3.3	0.5	0.3	0.4	1.0	0.4	0.5	0.1	0.3	1.3	2.1	1.7	0.0	1.7	0.3	0.6	0.5	4.6	0.4	0.5	1.8	2.0	0.7	5.1	0.7	1.7	0.8	2.1	25.3	0.0	0.8	1.1	3.0	0.1	0.8	2.8	0.7	0.3	3.8	2.1	1.3	0.7	0.1	9.1	4.0	63.0	9.0	3.0	16.5	0.0	29.1	13.3	5.1	5.1	5.2	3.9	0.0	18.9	1.3	24.0	4.0	10.4	25.1	24.5	0.0	10.9	0.0	0.1	31.5	1.7	0.8	0.1	12.5	1.5	11.0	19.8	46.0	20.1	0.0	0.0	0.1	29.1	0.0	0.0	5.1	36.9	0.8	18.1	2.4	3.1	0.0	13.6	0.0	0.0	0.0	0.0	0.0	16.0	44.3	0.1	0.1	23.5	18.5	5.5	14.1	8.7	0.0	0.0	0.0	22.4	0.0	4.2	3.8	1.0	0.7	0.5	0.6	0.3	0.3	0.4	0.5	0.2	0.7	0.4	0.7	2.5	1.3	2.1	0.3	0.3	0.1	0.5	0.8	0.2	0.6	0.3	0.4	0.3	1.3	0.6	0.0	0.0	1.4	0.0	2.2	0.0	0.0	1.2	0.0	4.0	0.0	0.0	0.0	0.8	0.0	3.0	15.7	0.1	3.3	0.0	0.7	0.3	0.9	0.4	0.0	0.0	6.8	0.0	0.0	0.6	0.0	6.8	0.3	0.0	0.0	0.0	4.7	0.0	11.8	3.5	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.1	0.7	0.0	8.5	0.9
HSD17B14	"DHRS10, retSDR3, SDR47C1"	ENSG00000087076	"Hydroxysteroid 17-beta dehydrogenase 14"	Q9BPX1	19	48813017-48836678	"Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 44.3"	"Cell type enhanced"	"Detected in many"	19	"Distal tubular cells: 66.3;Hofbauer cells: 120.5;Proximal tubular cells: 271.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 5.9;NK-cells: 7.5;T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 23.0;HHSteC: 21.7;hTERT-RPE1: 16.3;Karpas-707: 24.6;RT4: 17.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021467	Approved					NA	NA					"HPA021467: AB_1847652"	"unprognostic (2.03e-1)"	"unprognostic (7.94e-3)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (4.32e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.54e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (4.56e-1)"	"unprognostic (5.50e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.81e-2)"	5.9	25.7	15.5	2.9	16.2	1.4	4.2	20.2	14.1	11.5	4.1	9.7	3.7	3.3	13.2	8.1	3.3	8.3	9.2	4.8	10.5	13.5	44.3	24.0	11.6	5.7	11.9	15.8	32.2	6.0	15.3	9.2	6.5	9.8	8.0	2.1	34.4	2.6	8.1	1.3	3.4	3.7	7.3	9.0	6.7	3.2	4.5	7.1	5.0	16.6	3.2	3.5	7.8	8.0	5.9	0.7	0.0	0.0	7.5	4.8	1.3	0.0	6.0	6.0	1.0	7.1	1.1	0.1	1.1	8.3	0.5	0.5	5.5	0.1	3.7	6.2	0.2	23.0	0.0	0.6	0.0	0.6	0.2	0.4	1.6	0.1	0.8	21.7	0.0	9.7	8.4	0.2	0.6	0.2	16.3	7.8	2.1	0.0	24.6	0.0	0.2	0.5	0.2	0.5	3.5	4.1	3.3	0.0	0.7	0.0	17.6	1.6	4.1	0.0	0.8	4.6	2.6	0.2	0.2	0.0	0.1	2.3	0.2	0.0	4.2	7.8	0.2	5.3	0.6	0.0	0.0	0.0	0.0	1.4	0.0	2.1	5.9	2.6	1.1	0.0	4.5	4.8	3.6	0.0	7.5	0.0	0.7	0.7	1.3	15.5	16.2	20.2	12.8	10.5	13.5	11.9	15.8	9.8	7.1	3.0	8.6	1.5	3.1	2.3	5.0	1.4	0.0	0.0	3.4	7.0	0.0	1.0	66.3	1.4	0.3	3.6	0.0	0.0	1.0	2.1	11.5	3.7	6.9	26.6	120.5	11.1	12.7	21.5	7.6	0.9	3.7	13.5	20.3	13.6	0.0	38.4	4.0	0.0	6.7	271.8	1.4	0.0	4.1	0.9	7.0	1.6	1.8	2.2	0.0	2.3
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Horizontal cells: 41.3;Leydig cells: 30.5;Peritubular cells: 20.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.9;T-47d: 11.2;U-266/70: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048584			Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA048584: AB_2680452"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	6.9	16.8	11.8	2.5	14.7	2.6	5.5	16.4	20.2	7.1	4.6	2.6	16.0	6.4	6.5	13.7	7.5	7.9	5.3	8.7	11.6	5.5	6.4	8.3	6.0	2.6	19.3	16.9	7.1	17.4	10.2	12.3	5.0	11.5	12.2	3.4	19.1	16.4	4.3	36.8	13.2	6.3	26.8	11.7	3.4	16.1	3.4	15.1	0.3	7.4	10.6	1.9	10.9	8.4	0.0	0.5	0.0	0.9	0.0	0.4	0.2	1.4	0.9	0.0	1.0	0.5	2.7	4.9	0.6	0.5	0.2	0.0	2.0	2.5	0.0	2.2	0.9	0.6	4.8	0.4	0.6	0.2	1.6	1.9	0.7	1.9	2.9	2.0	0.3	3.5	1.5	4.1	0.3	2.2	14.9	0.7	2.3	1.4	4.7	1.9	1.2	0.6	1.3	0.1	2.8	1.7	2.3	1.7	5.7	3.7	2.1	2.7	5.7	4.0	2.6	6.0	2.3	11.2	3.9	1.2	1.4	1.6	5.4	1.5	20.4	2.9	1.3	3.0	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	11.8	14.7	16.4	20.2	11.6	5.5	19.3	16.9	11.5	15.1	3.0	7.7	0.0	3.3	2.7	7.9	5.5	2.5	2.7	2.3	3.5	2.0	0.8	0.0	0.5	0.4	1.0	0.5	0.0	1.2	0.5	4.4	4.1	1.1	4.7	16.6	41.3	1.2	3.1	1.5	0.0	30.5	1.3	10.1	1.8	2.0	6.9	1.6	3.2	20.8	2.1	11.6	0.0	2.1	0.2	1.0	3.0	0.6	0.0	2.6	1.1
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23194729	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.9;intestine: 12.2"	"Cell type enriched"	"Detected in single"	12	"Cholangiocytes: 7.6"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2"	"Region enhanced"	"Detected in some"		"basal ganglia: 7.6"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.73e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.97e-4)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (3.87e-3)"	"unprognostic (8.88e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.28e-6)"	"unprognostic (9.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.02e-3)"	0.0	0.0	0.3	0.0	3.9	0.1	0.0	0.0	0.2	0.0	0.1			12.2	0.0	0.0	0.0	0.5	1.9	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2		0.0	0.1	0.0	0.1	0.0		0.1	0.1		0.0	0.0	0.0	0.1	10.4	0.0	0.2	0.0	0.0	0.4			0.0		0.0	0.5	0.0	1.0	0.7	2.2	1.2	1.2	0.9	0.2	2.5	8.5	0.0	0.0	0.0	0.2	0.7	0.0	0.6	0.3	0.3	0.5	6.1	0.0	2.5	0.3	4.3	1.8	1.7	0.0	0.4	0.0	0.7	0.0	5.0	0.1	0.3	0.0	0.0	0.1	0.1	1.0	0.3	8.2	5.0	0.1	0.0	0.0	0.2	1.0	0.0	0.0	2.0	11.4	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.0	5.7	0.3	0.1	0.7	0.1	0.0	21.3	0.0	7.2	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	1.2	0.5	0.6	0.8	0.4	1.0	0.9	0.6	0.4	1.0	0.6	0.6	2.2	1.2	1.0	0.7	0.4	0.2											0.0	0.0	0.0	0.2	0.0	0.0	0.3	7.6	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5
IFITM10		ENSG00000244242	"Interferon induced transmembrane protein 10"	A6NMD0	11	1732410-1750591	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 17.2;granulocytes: 27.7;Hofbauer cells: 21.3;Ito cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.9;hTERT-RPE1: 6.6;MCF7: 5.5;SH-SY5Y: 13.1;U-87 MG: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.89e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-6)"	"unprognostic (6.49e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.68e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.76e-2)"	1.9	13.3	0.7	1.0	2.2	4.3	0.9	1.4	2.0	0.7	0.8	4.3	2.2	1.2	0.7	1.0	0.8	0.7	3.0	0.6	1.0	0.7	1.8	6.6	2.1	0.7	7.4	0.2	0.8	0.6	0.5	0.4	1.0	4.1	2.7	0.6	31.4	6.7	4.8	1.2	2.0	1.0	1.0	8.2	2.2	0.6	1.6	2.7	0.0	0.5	10.8	1.6	2.6	3.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.1	6.6	0.1	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.1	0.0	0.0	2.0	0.0	1.4	0.0	0.0	0.5	0.0	0.0	0.2	0.3	0.8	0.0	7.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.2	1.4	2.0	1.0	0.7	7.4	0.2	4.1	2.7	3.0	1.1	2.2	10.8	1.9	17.2	1.7	2.5	4.0	5.7	0.0	0.0	1.2	1.7	2.1	0.1	0.5	3.3	0.0	2.1	0.5	2.1	0.8	27.7	0.6	21.3	1.6	0.0	54.6	6.5	0.0	0.9	3.0	0.0	3.6	0.7	2.0	2.1	3.5	1.4	0.0	1.3	0.0	1.7	0.5	1.1	0.6	2.2	2.5	1.5	10.5
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 5.7;hTERT-RPE1: 5.9;NB-4: 1.3"									HPA047557	Uncertain				"Secreted to blood"	NA	NA	10000				"HPA047557: AB_2680087"		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;hTERT-RPE1: 1.2;NB-4: 3.5;TIME: 1.5"									HPA047557	Uncertain				"Secreted to blood"	NA	NA					"HPA047557: AB_2680087"																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNE	IFNE1	ENSG00000184995	"Interferon epsilon"	Q86WN2	9	21480839-21482313	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 3.9;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"	21	"Basal glandular cells: 3.6;Glandular cells: 1.1;Urothelial cells: 3.1"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	10	"intermediate monocyte: 1.0"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ: 4.1;HeLa: 10.6;hTERT-RPE1: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (1.52e-3)"	"unprognostic (8.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.56e-5)"	"unprognostic (2.70e-1)"	"unprognostic (2.25e-1)"		"unprognostic (5.14e-3)"	"unprognostic (6.32e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.34e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.6	2.6	0.2	1.3	0.0			1.4	0.3	3.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.2	0.0		1.4	0.0		0.1	0.8	0.0	0.0	2.4	0.0	0.0	0.1	1.5	0.0			0.6		0.7	4.1	1.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	2.5	0.0	0.0	1.2	1.2	0.2	4.1	0.2	0.2	0.3	0.1	2.7	0.0	0.8	0.8	0.4	1.4	0.0	2.6	0.4	0.0	0.0	0.0	10.6	0.0	0.7	0.0	0.0	1.1	0.5	1.6	2.3	13.1	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	2.1	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 10593.1;Peritubular cells: 11028.0;Sertoli cells: 8052.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 72.1;BJ hTERT+: 67.4;hTERT-RPE1: 157.3;RPTEC TERT1: 72.4;TIME: 104.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	30300000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.4	0.1	0.0	14.6	5.5	0.5	72.1	67.4	6.3	2.0	0.2	0.0	0.0	46.2	3.4	3.7	7.2	0.0	11.5	1.6	0.1	0.5	0.2	8.4	0.0	22.6	1.7	1.8	25.4	5.9	10.2	2.8	157.3	14.5	0.0	0.0	0.0	14.9	0.0	0.0	7.5	0.6	0.0	0.1	1.3	0.0	0.2	72.4	0.0	0.1	0.1	13.5	1.0	0.0	30.7	0.1	6.6	104.5	6.4	4.9	0.8	11.7	4.3	0.0	0.1	17.0	6.0	0.1	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7	104.2	26.5	28.2	113.1	211.8	3.7	148.5	22.9	163.3	72.8	1980.3	21.6	4.6	437.7	2492.0	58.3	2171.1	0.0	0.0	12.7	4.7	511.0	37.3	15.1	7.2	25.9	0.0	1.2	2456.5	118.7	133.2	10593.1	113.8	895.8	35.1	0.0	9.3	120.5	0.0	11028.0	461.5	9.2	8052.1	3278.8	32.0	37.3	156.6	4.8	78.4	1.5	34.4
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell type enriched"	"Detected in many"	7	"Macrophages: 764.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 93.2;HBEC3-KT: 42.4;HMC-1: 34.6;hTEC/SVTERT24-B: 46.6;hTERT-RPE1: 40.3;U-87 MG: 85.2"	"Low region specificity"	"Detected in some"												"Secreted to blood"	NA	NA	2330					"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	93.2	0.4	1.0	0.0	0.0	0.0	2.6	0.0	1.6	2.1	0.0	42.4	5.8	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.6	0.1	1.3	46.6	15.7	40.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	3.5	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	85.2	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8	8.9	45.3	1.4	4.6	27.4	0.0	4.3	0.0	13.4	7.9	1.8	0.0	1.2	0.0	12.2	0.1	2.2	0.3	0.0	0.5	2.1	9.9	2.3	39.4	0.0	109.6	0.0	0.0	1.3	54.0	0.0	0.0	764.6	21.9	0.0	2.2	0.0	3.6	6.2	0.0	0.5	0.2	0.0	4.3	0.0	0.2	17.8	3.7	2.2	0.0	4.6
IL36G	"IL-1F9, IL-1H1, IL-1RP2, IL1E, IL1F9, IL1H1"	ENSG00000136688	"Interleukin 36 gamma"	Q9NZH8	2	112973203-112985665	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 31.5;skin 1: 22.1;tongue: 94.1"	"Group enriched"	"Detected in some"	6	"Suprabasal keratinocytes: 11.5;Urothelial cells: 6.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 36.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.3;GAMG: 3.7;HaCaT: 3.1;HMC-1: 3.2;hTERT-RPE1: 2.9"														"Secreted to blood"	NA	NA						"unprognostic (1.56e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"			"unprognostic (5.79e-2)"	"unprognostic (5.58e-2)"		"unprognostic (1.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	10.9	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.4	0.1	2.8	0.1	0.1	22.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	94.1	31.5	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	2.3	0.0	0.0	0.0	0.7	0.0	1.7	0.1	1.2	0.0	0.0	0.0	0.7	0.0	3.7	3.1	0.0	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.3	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.5	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.5	0.4	0.0	1.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.5	0.0	0.0	0.0	6.7
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell type enhanced"	"Detected in many"	17	"Leydig cells: 127.4;Smooth muscle cells: 270.9;Syncytiotrophoblasts: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.2;hTEC/SVTERT24-B: 58.9;hTERT-HME1: 24.3;hTERT-RPE1: 36.3;TIME: 30.4;U-138 MG: 45.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA		290000				"unprognostic (4.11e-3)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.6	0.5	2.5	0.8	0.0	0.1	0.0	0.3	1.7	3.0	3.8	0.0	19.2	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	58.9	24.3	36.3	2.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	1.7	0.0	0.0	30.4	45.9	13.3	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3	3.0	17.8	0.5	7.8	15.3	0.0	4.8	0.0	4.0	5.7	0.0	0.0	0.4	0.0	4.5	0.5	3.1	0.0	0.0	1.6	2.6	14.6	5.6	7.0	11.4	1.4	0.0	0.0	1.3	2.7	1.9	127.4	45.7	13.5	46.9	0.0	12.6	10.6	0.0	21.9	0.0	0.9	0.0	270.9	0.5	0.1	7.9	149.2	0.0	0.0	2.3
IQCA1	"DRC11, FLJ22527, IQCA"	ENSG00000132321	"IQ motif containing with AAA domain 1"	Q86XH1	2	236324147-236507542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.8;thyroid gland: 30.0"	"Cell type enriched"	"Detected in many"	5	"Ciliated cells: 163.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 4.4"	"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 4.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA057320			Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057320: "	"unprognostic (1.73e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.62e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.23e-5)"	"unprognostic (1.55e-1)"	"unprognostic (7.23e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.19e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.91e-3)"	"unprognostic (5.30e-2)"	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1.0	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10.0	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13.0	3.1	1.0	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8.0	1.4	30.0	0.0	1.6	3.0	1.0	0.7	0.0	0.0	0.0	1.2	4.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.4	0.2	0.0	0.1	0.3	0.1	0.0	0.0	4.0	0.0	1.1	0.0	0.0	3.7	0.0	0.0	0.1	0.0	4.4	0.0	0.1	0.0	0.0	0.3	2.0	0.0	0.0	8.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.1	0.0	15.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.8	0.0	0.7	1.1	4.4	0.0	1.2	0.0	0.0	0.3	0.1	13.4	19.2	3.8	10.0	12.9	10.0	8.8	9.3	13.0	8.0	14.9	15.9	0.0	6.7	0.5	20.3	0.8	12.7	163.3	30.7	3.5	15.7	0.4	0.0	10.2	19.7	3.8	0.0	0.0	1.4	3.6	0.9	1.1	1.1	0.0	0.3	0.0	0.0	1.3	0.0	11.0	2.0	0.5	0.0	0.0	0.0	0.2	1.7	0.0	5.6	7.9	1.8	0.0	0.3	23.3	27.1	0.3	0.2	0.0	0.0	2.6
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 300.3;Glandular cells: 266.4;Pancreatic endocrine cells: 350.7;Urothelial cells: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 29.9;HaCaT: 30.2;hTERT-RPE1: 28.1;HUVEC TERT2: 27.8;TIME: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	No		46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.4	5.0	0.4	0.2	1.3	2.4	1.5	19.6	29.9	0.7	1.2	9.3	13.7	0.0	3.4	8.3	11.5	30.2	1.6	22.1	2.8	0.0	1.5	1.4	1.2	5.5	4.5	0.2	0.4	0.9	3.8	19.7	3.5	28.1	27.8	1.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	5.0	10.0	0.0	0.1	0.0	6.3	10.3	0.2	1.1	1.0	1.3	2.0	0.8	3.2	0.0	23.8	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.6	0.0	15.8	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0	53.6	13.6	0.0	300.3	134.2	2.3	1.2	20.4	88.3	161.5	50.6	3.9	0.2	8.3	157.1	0.0	15.8	20.6	0.0	144.3	1.6	1.9	266.4	1.1	0.0	0.3	0.0	13.3	5.5	0.0	0.0	1.1	3.8	11.8	1.8	32.4	18.0	350.7	15.2	0.0	2.9	5.0	0.0	4.2	0.0	0.9	32.5	0.3	1.9	28.1	321.7
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 96.5;Exocrine glandular cells: 90.7;Pancreatic endocrine cells: 158.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 74.4;hTERT-RPE1: 68.2;RPTEC TERT1: 65.6;U-87 MG: 111.7;WM-115: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"		NA	NA		180000	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (3.24e-3)"	"prognostic unfavorable (6.75e-4)"	"unprognostic (9.51e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.28e-3)"	"unprognostic (2.76e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (5.95e-5)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.35e-2)"	15.7	15.8	4.1	8.6	5.1	0.1	8.7	7.7	6.5	10.9	20.9	2.3	8.9	17.1	11.6	11.6	12.8	14.5	32.6	8.4	4.2	5.4	36.0	1.7	37.6	3.2	3.2	6.7	10.7	8.0	13.0	11.2	26.4	4.3	12.0	8.9	11.6	10.0	9.7	6.6	17.3	37.3	11.6	3.3	6.5	13.7	3.9	1.5	3.3	36.1	13.3	8.3	19.0	8.1	0.2	0.0	0.0	0.0	0.0	1.1	0.2	20.4	27.1	0.1	0.8	0.5	2.1	4.4	9.6	20.7	14.5	11.1	0.6	31.9	0.0	60.6	6.9	48.4	14.6	0.2	74.4	8.9	2.5	0.4	0.0	6.8	0.1	12.8	0.0	0.6	2.6	36.7	14.5	64.6	68.2	10.6	1.0	0.0	0.3	27.3	5.9	0.0	0.0	0.6	9.2	16.4	0.0	1.4	1.5	65.6	35.7	1.1	0.4	10.4	1.4	24.0	6.9	2.4	0.2	23.0	64.8	20.4	0.6	37.3	0.9	1.5	0.6	111.7	0.2	67.3	0.0	0.0	0.0	0.8	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.2	0.6	0.0	0.0	0.0	0.0	1.1	0.2	4.1	5.1	7.7	6.5	4.2	5.4	3.2	6.7	4.3	1.5	50.6	29.6	5.7	51.4	50.9	14.4	4.4	33.1	4.0	27.3	73.3	23.6	1.8	0.0	96.5	0.4	11.2	77.3	0.0	90.7	2.6	4.5	26.1	3.5	0.0	1.1	3.2	13.9	4.9	1.5	0.0	1.7	3.8	16.9	7.2	21.8	2.3	158.1	31.7	3.9	2.2	13.1	12.9	18.6	0.2	1.6	20.3	1.5	1.3	29.6	70.4
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419460	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 137.7"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 377.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 31.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3"	"Region enriched"	"Detected in single"	7	"basal ganglia: 9.3"	"Not detected"	"Not detected"			"HPA002642, CAB009008"	Enhanced					NA	NA		23000000			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavorable (4.07e-6)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavorable (2.91e-4)"	"prognostic unfavorable (2.23e-5)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (2.18e-3)"	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16.0	66.9	2.2	19.0	3.4	19.3	13.8	18.2	12.0	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10.0	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3.0	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0.0	14.4	30.6	12.1	30.2	31.4	31.1	23.0	1.7	1.5	0.0	22.0	31.5	15.7	1.0	1.2	8.4	21.6	0.0	1.2	2.9	3.4	0.1	19.9	9.0	4.6	22.1	4.2	36.5	28.0	67.2	141.7	1.5	2.4	0.0	17.6	0.6	1.4	10.1	1.9	0.4	2.0	1.4	3.1	0.6	4.9	0.1	0.0	0.0	6.0	0.4	0.2	10.6	0.7	8.2	134.9	37.9	6.7	9.2	12.5	0.0	0.3	0.0	67.3	8.6	12.3	5.6	22.9	0.1	5.6	10.0	4.4	0.0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5	3.0	4.1	1.4	2.7	12.7	0.8	13.2	5.1	1.4	4.5	0.0	0.0	2.7	0.0	32.2	0.1	93.4	0.0	0.0	3.0	377.0	54.1	3.6	19.6	20.7	27.5	0.0	0.0	77.3	18.7	0.4	6.1	35.5	10.1	9.0	0.0	0.0	7.2	0.0	4.2	0.0	1.3	12.9	33.1	0.0	0.7	9.4	28.9	8.2	0.0	1.7
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	45.6	67.0	36.2	40.1	87.3	75.2	31.6	153.5	89.0	73.1	66.9	15.0	106.9	12.3	27.8	128.7	48.0	31.9	10.9	87.3	81.6	12.1	8.8	14.8	31.9	17.5	61.5	3.3	14.7	76.2	47.8	76.9	31.3	196.1	89.8	6.1	10.2	5.4	120.5	7.5	5.7	3.3	8.0	13.9	34.0	3.7	26.8	2.2	104.2	13.2	8.6	21.4	47.8	8.1	34.4	61.5	10.9	11.9	100.4	94.2	54.7	66.9	51.1	5.0	1.1	6.9	69.4	14.1	36.9	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8	318.6	128.6	76.4	295.7	485.6	32.6	175.3	242.0	164.6	252.5	214.6	29.5	156.7	11.6	1163.1	4.3	314.7	83.6	70.0	355.7	460.3	265.1	177.2	86.6	221.3	161.3	36.5	185.6	387.9	152.7	9.7	235.6	174.3	325.6	83.0	81.4	76.8	917.0	113.2	565.7	64.3	45.2	627.3	497.4	10.0	63.7	149.1	183.8	106.6	98.8	257.2
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"		NA	NA		95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	28.5	71.2	5.1	12.9	48.3	14.1	26.4	30.6	19.0	5.7	9.2	14.2	37.3	0.1	14.9	51.9	28.1	22.9	4.6	15.9	5.0	0.3	3.1	10.1	11.0	14.9	8.4	0.0	18.5	8.4	3.7	14.3	7.5	81.6	19.1	0.0	9.0	15.3	19.5	29.0	0.1	0.1	22.9	16.0	7.9	0.0	8.2	10.7	16.1	6.3	0.1	10.7	22.7	33.8	25.8	9.4	19.1	0.6	49.1	21.5	32.5	18.6	15.8	2.6	2.7	0.1	22.5	0.1	74.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7	6.0	7.9	2.2	18.8	15.2	6.2	26.4	43.3	5.3	10.3	27.9	3.9	56.6	10.0	34.5	7.5	22.6	19.6	0.0	16.3	4.7	30.7	22.0	0.0	32.1	60.3	33.4	3.4	41.1	27.6	2.3	18.7	16.7	10.1	0.0	13.3	47.4	43.9	27.4	15.6	10.2	15.2	38.8	35.3	1.4	6.4	19.4	46.1	0.0	15.0	12.0
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639272-25717562	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 66.7"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		17000	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	16.6	17.2	13.8	8.4	18.9	1.5	14.6	9.9	23.4	18.1	14.7	14.5	8.0	7.5	20.5	13.5	13.3	12.0	14.4	21.9	13.5	12.5	6.5	3.5	17.1	4.6	17.6	13.5	18.9	3.9	5.8	7.7	66.7	18.5	12.0	9.7	11.1	5.5	18.0	8.4	6.9	9.2	21.8	23.0	2.8	9.7	25.8	12.2	0.6	9.5	10.1	6.3	13.5	15.1	3.1	1.9	1.9	0.7	2.8	1.1	0.4	0.0	0.0	18.2	0.1	0.7	0.2	0.4	0.5	11.6	1.5	5.5	0.0	0.0	0.1	0.0	0.2	7.0	0.0	1.6	0.0	3.4	11.3	0.5	0.1	0.0	0.0	0.0	0.0	0.1	1.0	0.0	1.3	0.0	16.2	0.0	0.4	0.0	0.2	5.6	0.1	0.3	0.1	5.7	0.1	0.0	2.1	3.7	0.0	0.0	0.0	0.3	2.7	0.1	0.2	0.0	0.2	0.6	0.1	0.0	13.1	1.2	0.1	1.8	1.5	0.0	0.0	9.6	0.1	0.5	1.4	0.7	0.3	0.4	0.5	0.6	0.3	0.4	0.9	0.4	3.1	0.7	1.1	1.9	2.8	0.6	1.9	0.2	0.4	13.8	18.9	9.9	20.5	13.5	12.5	17.6	13.5	18.5	12.2	0.0	2.9	1.4	1.4	6.6	1.5	31.9	0.0	1.4	0.0	3.5	13.7	0.3	0.0	0.3	12.9	151.0	0.0	0.0	0.2	2.2	18.5	1.2	0.0	0.0	1.0	0.0	0.0	49.7	2.2	13.2	9.2	1.4	15.1	0.0	0.0	0.9	0.1	0.0	23.0	0.0	3.6	0.0	7.6	4.8	3.9	5.8	0.7	0.0	0.0	0.7
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297304-95386083	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8;parathyroid gland: 32.5"	"Group enriched"	"Detected in some"	5	"Leydig cells: 23.6;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	4.2	1.8	19.8	1.5	20.1	0.7	2.8	3.7	39.8	6.0	4.6	12.9	0.6	2.1	5.8	4.9	3.5	5.3	2.4	3.4	16.7	7.8	4.6	1.2	1.5	1.1	9.1	19.5	8.8	2.5	32.5	5.6	6.5	8.2	5.7	1.8	1.4	6.9	18.6	2.2	3.9	1.9	6.4	6.3	2.2	2.9	9.2	15.9	5.4	19.5	0.0	1.3	4.5	5.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.5	4.1	3.6	2.9	0.0	4.2	12.1	6.9	6.4	0.0	0.0	0.0	0.4	5.5	3.7	0.1	2.7	0.7	2.9	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	2.0	2.4	1.5	6.8	15.9	0.0	0.7	0.0	0.0	0.5	5.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	23.8	0.0	0.4	0.1	0.2	0.2	4.6	0.0	0.2	0.0	0.2	11.2	2.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	20.1	3.7	39.8	16.7	7.8	9.1	19.5	8.2	15.9	0.0	0.6	0.0	0.7	0.3	0.6	0.9	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.3	0.3	0.6	0.2	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	23.6	0.0	6.8	1.0	0.0	0.7	0.3	0.0	40.3	0.6	0.0	0.0	2.3	0.0	0.9	0.6	0.0	0.0	0.1	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 227.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA					"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	1.0	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.7	0.0	0.0	1.7	0.1	2.3	0.2	7.5	5.2	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.6	0.1	6.0	24.5	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	3.1	0.2	0.4	0.1	9.0	0.1	0.0	2.0	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2	0.0	2.7	0.8	5.2	7.2	6.6	14.2	0.0	5.3	1.2	1.8	0.0	0.5	0.0	0.0	0.2	8.7	2.6	0.0	0.0	0.1	0.8	1.7	0.0	0.0	5.7	227.2	10.3	3.7	28.3	0.0	1.4	5.2	3.3	1.0	2.8	5.0	0.0	11.2	1.1	0.0	4.6	0.0	2.2	0.0	0.4	2.9	1.1	0.0	6.6	0.1
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237093	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 49.1"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 1.1;Fibroblasts: 1.4;Melanocytes: 3.3;Suprabasal keratinocytes: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 31.4;fHDF/TERT166: 27.6;hTERT-RPE1: 18.9;T-47d: 42.0;U-2197: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.81e-4)"	"unprognostic (2.58e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-6)"	"unprognostic (1.63e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.46e-3)"	2.9	49.1	4.8	1.1	7.4	0.5	6.1	1.1	6.2	2.3	1.1	2.5	0.0	0.6	0.8	2.6	1.2	1.0	1.6	0.5	5.1	4.3	1.2	0.5	0.7	0.5	2.3	7.3	3.5	2.0	0.5	0.5	0.5	3.3	1.2	1.6	0.0	0.8	3.7	1.2	3.4	2.3	1.5	4.5	0.4	3.7	1.5	3.3	0.0	8.9	2.7	0.4	2.6	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	7.9	31.4	0.0	11.0	7.3	3.5	8.3	0.0	0.4	0.0	0.0	27.6	0.0	0.0	4.9	0.0	6.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	8.1	0.0	8.4	0.8	18.9	0.0	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.9	1.5	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.8	0.2	0.1	0.0	42.0	0.0	0.0	6.1	0.2	15.0	0.6	0.6	1.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	7.4	1.1	6.2	5.1	4.3	2.3	7.3	3.3	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.2	1.3	0.0	0.0	0.0	0.0
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6"	"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA053841, HPA059622"	Approved					NA	NA					"HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.6	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.5	2.2	0.2	3.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	24.5	0.0	0.0	1.5	0.8	0.1	5.0	1.5	5.2	0.0	21.9	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.6	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0	0.0	3.4	27.2	43.3	2.5	0.1	0.4	7.6	0.0	6.8	1.8	3.9	196.8	0.0	3.0	0.7	2.8	4.2	23.3	3.5	6.8	2.8	66.7	0.0	0.0	43.0	0.0	0.0	0.0	7.5	0.0	0.0	28.3	20.3	0.0	5.9	0.0	37.2	16.9	0.0	0.0	0.3	0.0	1.0	0.0	1.3	1.9	638.3	6.5	43.7	53.5
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.7;Early spermatids: 12.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	3.9	2.8	4.8	1.3	5.5	0.6	2.2	1.4	8.3	1.8	2.3	0.6	0.0	2.1	2.2	1.7	4.0	2.7	5.9	6.8	9.4	3.1	1.8	10.5	5.5	1.3	1.8	5.2	14.9	1.1	0.9	14.1	1.8	3.7	4.2	2.5	2.9	2.6	2.5	1.2	1.9	2.1	2.6	5.2	1.4	2.6	3.3	1.0	0.0	4.5	3.4	1.2	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.3	0.0	0.0	1.3	0.3	2.7	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.6	0.0	4.3	0.0	0.0	1.0	0.0	0.4	0.1	12.4	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.3	0.0	0.2	0.0	0.3	0.0	0.0	0.7	9.3	8.4	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	1.4	8.3	9.4	3.1	1.8	5.2	3.7	1.0	38.7	0.6	0.0	0.3	0.3	0.0	1.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.0	0.0	2.5	0.0	2.3	6.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 45.5"	"Cell type enriched"	"Detected in single"	4	"Melanocytes: 1.7"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 15.8;hTERT-RPE1: 9.6;RPTEC TERT1: 8.9;U-138 MG: 10.7;U-87 MG: 21.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.5	0.6	33.1	0.6	45.5	0.7	1.5	0.2	22.0	0.7	1.1	1.5	0.0	0.9	0.5	0.6	0.5	0.5	1.8	0.9	9.8	4.0	0.9	0.5	0.5	0.5	3.6	4.8	0.5	0.9	0.5	1.1	0.9	3.9	0.5	0.9	1.8	1.5	0.8	0.5	6.4	1.0	1.8	2.7	0.5	0.5	0.5	7.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.5	15.8	0.0	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.4	9.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.7	0.0	0.0	2.2	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	33.1	45.5	0.2	9.3	9.8	4.0	3.6	4.8	3.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KLHL4	"DKELCHL, KHL4, KIAA1687"	ENSG00000102271	"Kelch like family member 4"	Q9C0H6	X	87517749-87670050	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.4;brain: 16.3"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 4.0;Cone photoreceptor cells: 7.9;Endothelial cells: 5.7;Ito cells: 9.8;Rod photoreceptor cells: 4.2"	"Cancer enriched"	"Detected in some"	8	"glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.1;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;GAMG: 13.0;hTERT-RPE1: 9.2;HUVEC TERT2: 20.2;NTERA-2: 15.2;SuSa: 11.3;TIME: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029192	Approved		Supported	"Microtubules,Centriolar satellite"		NA	NA			Microtubules	"Centriolar satellite"	"HPA029192: AB_10602341"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.48e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (2.40e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.25e-4)"	2.3	34.4	6.8	1.0	12.1	0.5	1.9	1.1	11.2	2.4	1.0	16.3	0.9	0.7	4.8	1.4	1.3	3.7	2.5	1.5	7.0	4.0	2.1	1.4	1.8	1.0	15.9	7.4	11.7	0.9	0.6	0.6	0.6	11.9	1.1	1.1	0.0	0.5	2.8	0.8	0.6	0.9	8.0	12.7	2.4	0.9	9.7	16.2	0.0	1.4	0.2	0.7	1.9	0.7	0.0	0.0	0.2	0.0	0.0	2.0	0.2	0.0	2.8	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.7	0.0	0.9	0.2	0.0	1.9	0.0	8.0	0.1	0.0	1.3	3.8	4.1	1.0	9.2	20.2	0.0	0.1	1.7	5.4	0.0	0.0	0.0	15.2	0.1	3.9	0.0	8.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	11.3	0.0	0.0	22.1	0.0	4.7	0.0	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.2	6.8	12.1	1.1	11.2	7.0	4.0	15.9	7.4	11.9	16.2	0.0	0.0	0.0	0.0	0.1	2.2	1.4	0.0	4.0	0.0	0.0	7.9	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.3	0.9	0.9	0.0	0.0	0.0	0.0	1.4	0.1	0.0	1.4	2.8	4.2	0.0	0.3	0.0	0.2	0.3	0.0	0.0	0.0	0.0
KRT32	"Ha-2, KRTHA2"	ENSG00000108759	"Keratin 32"	Q14532	17	41459811-41467429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"esophagus: 12.8;skin 1: 18.0"	"Cell type enhanced"	"Detected in single"	25	"Peritubular cells: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.8;HaCaT: 1.3;hTERT-RPE1: 4.4;MCF7: 1.4;PC-3: 2.1;U-2197: 1.1;U-87 MG: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		230000000				"unprognostic (1.39e-2)"	"unprognostic (3.29e-1)"		"unprognostic (1.88e-1)"		"unprognostic (2.71e-1)"		"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"		"unprognostic (2.32e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.72e-9)"		"unprognostic (1.31e-2)"		"unprognostic (1.77e-1)"	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0			0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.0	0.0	0.0		0.0	0.0		0.9	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.7	0.2	0.0	0.1	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3
KRT38	KRTHA8	ENSG00000171360	"Keratin 38"	O76015	17	41436446-41440921	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 18.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.1;urothelial cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.1;fHDF/TERT166: 1.3;hTERT-RPE1: 1.9"															NA	NA		170000000									"unprognostic (1.37e-1)"				"unprognostic (4.05e-1)"								0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		2.5	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.1	0.4	0.8	0.0	0.0	0.0	1.3	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT86	"Hb6, KRTHB6, MNX"	ENSG00000170442	"Keratin 86"	O43790	12	52249300-52309163	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.5;skin 1: 60.4;testis: 23.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 21.8;Late spermatids: 19.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"basophil: 31.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 31.5"	"Cell line enhanced"	"Detected in some"		"A-431: 13.9;A549: 14.7;hTERT-RPE1: 7.5;MCF7: 28.9;RPMI-8226: 18.2;U-251 MG: 8.1"									"HPA039798, HPA049778"	Supported		Approved	Cytosol		NA	NA		240000000	Cytosol		"HPA039798: AB_10674986, HPA049778: AB_2680877"	"unprognostic (4.52e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.22e-2)"	0.8	0.3	0.2	0.1	0.2	3.5	0.9	0.5	1.1	0.4	0.3	0.1	1.0	0.6	0.6	2.4	0.3	1.1	1.0	0.1	0.2	0.3	3.8	0.2	1.0	0.1	0.3	0.1	0.6	7.9	0.0	0.2	0.6	0.3	0.5	0.0	0.3	6.3	0.4	1.5	60.4	0.2	0.1	0.7	0.1	0.2	23.0	0.1	0.1	7.6	0.1	0.3	1.2	0.2	0.0	0.0	31.5	0.0	3.8	0.0	0.2	13.9	14.7	0.0	0.0	0.0	0.0	0.2	0.5	0.4	0.2	0.0	0.1	0.7	0.0	0.6	0.0	0.3	0.9	0.0	2.6	0.0	6.1	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	7.5	0.0	0.0	0.0	1.0	0.0	28.9	0.0	1.6	0.0	0.1	3.5	0.0	0.0	18.2	0.2	1.8	1.7	0.0	2.6	1.1	1.1	0.0	0.8	0.0	0.4	0.0	0.7	0.0	8.1	0.0	0.0	0.0	0.0	3.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.5	0.2	0.3	0.3	0.1	0.3	0.1	0.0	1.1	0.0	3.2	0.6	0.2	0.4	2.5	0.0	1.2	0.0	0.0	0.1	0.0	2.0	21.8	0.0	0.0	0.0	4.2	1.4	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.3	0.0	1.7	0.0	0.0	0.2	2.9	0.0	0.0	0.5	0.1	0.0	0.3	0.7	0.3	0.1	1.0	3.2	0.0	3.1
L34079.1		ENSG00000268361			19	43554692-43593036	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 3.0;brain: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	30	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.5;hTERT-RPE1: 1.0;SK-BR-3: 1.7;U-266/70: 3.3"															NA	NA																							0.2	0.8	0.1	0.7	0.2	0.0	0.2	4.3	0.5	0.3	0.4			0.0	0.6	0.0	1.4	0.4	0.0	0.3	0.4	0.2	0.0	0.0	0.2	0.0	0.3		1.5	0.0	2.3	0.2	0.3		0.0	0.0		0.0	0.0	1.7	1.1	0.0	0.0	0.5	0.0	0.0	0.6			0.0		0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		350000	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	51.9	79.0	0.0	13.0	7.8	1.3	0.2	0.0	4.9	0.0	8.6	22.4	3.0	0.0	0.5	0.0	0.2	0.0	6.7	0.0	6.5	0.0	10.6	0.0	0.0	61.5	0.0	9.4	0.0	38.0	64.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	21.2	0.3	0.0	0.3	2.0	0.0	10.0	0.2	0.0	0.0	59.2	21.4	1.1	23.8	4.3	0.0	0.0	0.0	5.3	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5	3.0	5.0	0.0	1.2	20.1	1.0	47.4	0.0	0.0	3.4	3.5	0.0	0.9	3.3	0.4	76.6	56.3	0.0	0.0	0.6	71.2	77.1	1.1	1.1	28.2	2.7	0.0	0.0	19.6	2.2	34.0	154.2	1.7	54.0	1.0	0.0	0.0	0.6	0.0	76.4	0.0	0.2	64.7	100.7	0.7	0.5	16.3	2.5	0.0	0.0	5.2
LAYN	"FLJ30977, FLJ31092"	ENSG00000204381	Layilin	Q6UX15	11	111540280-111561745	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 43.8;Endothelial cells: 33.1;Peritubular cells: 51.9;Sertoli cells: 32.3;Urothelial cells: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"myeloid DC: 10.3;T-reg: 11.8"	"Group enriched"	"Detected in many"	111	"dendritic cells: 10.3;T-cells: 11.8"	"Cell line enhanced"	"Detected in many"		"BJ: 39.7;BJ hTERT+: 43.3;BJ hTERT+ SV40 Large T+ RasG12V: 27.6;fHDF/TERT166: 25.7;HSkMC: 25.5;hTERT-RPE1: 25.7;U-138 MG: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040087	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA040087: AB_10793927"	"unprognostic (2.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.75e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-2)"	7.7	2.3	9.3	5.9	12.8	1.3	8.0	1.7	12.5	11.3	21.2	28.9	3.0	4.0	15.1	10.5	5.3	12.8	17.0	5.6	12.6	7.5	4.1	1.4	9.6	12.4	20.6	5.9	39.5	2.3	1.6	5.4	13.1	12.3	13.2	3.8	10.9	4.4	17.9	4.8	2.1	8.2	21.7	10.1	7.5	12.1	4.6	13.1	4.6	26.9	4.8	5.0	11.3	10.1	0.0	10.3	0.0	0.0	0.0	11.8	0.4	0.1	1.0	0.2	0.0	7.1	13.7	1.9	39.7	43.3	20.1	27.6	0.0	0.0	0.0	0.3	25.7	5.0	0.8	2.5	0.2	20.8	0.0	0.1	0.2	0.0	0.0	12.1	0.0	0.0	25.5	0.0	8.3	0.0	25.7	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.3	4.8	0.1	0.0	0.1	9.9	0.0	0.1	0.1	29.8	22.0	0.2	19.3	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	10.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	11.8	0.4	9.3	12.8	1.7	12.5	12.6	7.5	20.6	5.9	12.3	13.1	17.9	3.2	0.0	43.8	1.9	0.2	1.4	5.1	18.7	13.6	0.0	0.0	1.1	0.0	5.9	2.2	33.1	0.0	0.0	0.2	1.2	6.5	13.4	1.1	0.0	0.7	0.0	0.0	4.3	1.2	1.3	21.0	1.3	0.0	0.0	0.0	0.2	0.7	0.0	51.9	0.0	0.1	32.3	10.8	0.0	0.7	1.9	0.5	2.2	0.0	40.4
LBH		ENSG00000213626	"Limb bud and heart development"	Q53QV2	2	30231531-30323730	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 198.3;Pancreatic endocrine cells: 178.1;Smooth muscle cells: 316.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.5;MAIT T-cell: 28.5;memory B-cell: 22.8;memory CD4 T-cell: 21.5;memory CD8 T-cell: 21.6;naive B-cell: 33.4;naive CD4 T-cell: 36.7;naive CD8 T-cell: 31.3;T-reg: 20.7"	"Group enriched"	"Detected in many"	8	"B-cells: 33.4;T-cells: 36.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 75.0;hTERT-RPE1: 38.7;U-2 OS: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034669	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034669: AB_10600820"	"unprognostic (2.13e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.77e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.67e-1)"	13.7	3.8	3.7	25.5	5.3	6.7	29.8	1.8	9.2	22.1	10.1	2.7	7.6	3.8	36.4	17.2	12.3	18.2	21.0	59.3	4.5	11.5	15.4	6.0	66.1	53.6	6.2	5.0	44.3	4.5	21.4	6.6	15.9	9.4	10.2	5.1	32.0	45.8	12.0	7.0	11.8	15.1	14.0	3.4	33.5	8.9	8.1	0.8	78.1	48.6	9.5	32.7	13.1	9.5	33.4	2.9	0.9	0.7	4.2	36.7	21.2	0.0	2.8	3.5	0.6	0.9	0.5	0.3	3.6	4.8	0.9	0.1	14.6	3.8	7.0	8.5	75.0	0.9	4.8	20.3	0.2	0.1	10.0	0.8	1.1	3.1	0.0	2.8	0.1	1.0	3.4	0.2	1.2	0.0	38.7	0.1	4.7	3.5	0.0	3.5	0.0	7.7	0.0	21.5	0.6	0.1	8.0	19.1	2.4	0.6	1.2	1.0	2.5	5.9	0.5	0.2	13.3	0.0	0.3	4.7	6.9	25.3	13.2	0.4	13.7	0.7	0.6	3.0	0.4	2.1	0.1	0.1	0.2	28.5	0.3	28.5	22.8	21.5	21.6	0.2	33.4	36.7	31.3	0.9	4.2	0.7	2.9	20.7	21.2	3.7	5.3	1.8	9.2	4.5	11.5	6.2	5.0	9.4	0.8	101.3	24.8	81.5	50.3	11.0	17.2	59.8	7.6	105.7	53.4	24.4	198.3	15.6	11.6	68.7	24.4	39.6	1.6	23.3	51.4	10.7	31.9	45.3	15.1	1.5	25.3	7.9	22.8	29.4	9.8	84.4	9.8	5.6	21.9	1.8	0.7	12.8	178.1	8.6	25.1	15.3	44.9	174.6	316.5	0.9	2.1	9.4	7.8	117.0	1.7	51.8
LCTL	"FLJ33279, KLG, KLPH"	ENSG00000188501	"Lactase like"	Q6UWM7	15	66547179-66565979	"Cancer-related genes, Predicted membrane proteins"	"Sensory transduction, Vision"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 10.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7"	"Group enriched"	"Detected in some"	5	"glioma: 1.5;melanoma: 0.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071640			Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Plasma membrane"	"Endoplasmic reticulum"	"HPA071640: AB_2686428"	"unprognostic (4.60e-2)"	"unprognostic (5.46e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.44e-16)"	"unprognostic (6.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	0.4	0.7	6.0	0.9	4.3	3.1	0.4	0.7	3.1	0.4	0.5	3.1	0.0	1.4	0.8	0.9	0.7	0.3	1.0	0.4	3.3	1.2	0.4	0.4	0.4	1.0	5.3	3.1	0.6	0.7	0.2	0.4	0.3	4.9	0.4	0.3	1.1	0.6	0.3	3.0	2.6	0.7	0.4	10.4	0.8	0.7	1.5	2.3	0.0	0.5	0.0	0.2	0.3	0.3	0.9	0.6	3.9	0.7	1.0	0.5	0.2	0.3	0.3	3.2	0.3	0.1	0.1	0.8	0.8	0.0	0.0	0.3	0.4	0.4	0.4	6.3	0.2	0.6	0.6	0.0	0.0	0.2	0.2	0.2	0.7	1.0	1.5	0.0	0.2	0.4	0.4	0.0	0.3	0.0	7.5	0.0	0.2	0.4	0.4	0.2	0.1	0.2	0.4	5.8	0.4	0.1	0.2	3.4	0.3	0.0	0.4	0.4	0.3	0.1	0.3	1.8	7.0	0.4	0.5	0.4	1.6	16.2	0.6	6.9	0.2	0.2	0.2	2.1	0.7	2.9	1.6	0.7	0.5	0.5	0.4	0.3	0.4	0.5	0.3	0.2	0.9	0.5	0.4	3.9	1.0	0.4	0.6	0.5	0.2	6.0	4.3	0.7	2.7	3.3	1.2	5.3	3.1	4.9	2.3	0.0	0.0	0.0	0.5	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.0	0.1	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	7.5	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.1	0.0	0.4	1.2	2.7	0.3	0.2	0.0	0.0	0.3
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell type enriched"	"Detected in some"	41	"Cardiomyocytes: 1579.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6"	"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"		NA	NA		450000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: AB_2680568"	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.2	0.4	3.1	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.2	0.6	0.0	0.7	0.4	0.2	0.0	0.1	0.9	0.7	0.7	0.9	0.1	0.1	0.1	1.6	5.9	0.5	0.1	0.0	5.8	0.0	0.7	0.2	1.8	0.3	1.5	0.4	0.2	0.4	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.6	1.8	0.3	0.2	4.6	1.4	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.7	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.7	1579.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	18.3	0.7	0.0	0.0	1.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.2	10.3	0.4	1.7	0.0	0.0	1.0	0.1	0.0	6.3	0.0	3.4	38.8	33.0	0.6	1.0	0.0	0.0	0.0	0.0	0.1
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell type enhanced"	"Detected in many"	18	"Endothelial cells: 59.1;Hepatocytes: 196.4"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 15.7;K-562: 46.5;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported			"Secreted to blood"	NA	NA	8240000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.7	3.9	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.5	0.5	1.1	0.9	5.2	5.5	7.0	1.5	7.7	3.6	0.1	3.0	0.5	0.6	13.2	3.0	1.2	4.7	15.7	5.9	0.6	46.5	0.9	9.5	0.3	0.6	0.1	1.8	0.8	0.1	0.1	0.9	0.3	22.5	0.6	0.7	11.4	1.4	0.6	1.6	6.7	2.1	2.1	2.2	2.1	4.4	0.4	3.2	1.3	0.9	0.2	4.5	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1	0.0	16.5	3.0	1.9	31.4	4.9	3.5	10.2	2.7	4.5	8.7	0.0	1.2	3.3	1.5	1.0	59.1	0.4	0.0	0.9	2.3	20.2	3.3	1.1	196.4	1.9	1.6	0.0	27.6	6.5	1.5	31.9	5.8	33.7	2.8	0.9	0.0	1.6	1.7	7.1	6.8	0.9	0.0	17.7	1.1	0.6	25.7	2.2	0.5	0.8	1.4
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 58.9;granulocytes: 63.7;Smooth muscle cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 27.0;hTEC/SVTERT24-B: 34.3;hTERT-RPE1: 31.7;U-138 MG: 38.2;U-251 MG: 27.6;U-87 MG: 30.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"	NA	NA			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.4	14.2	0.4	3.1	0.0	1.2	5.2	1.2	5.1	1.5	3.7	2.3	13.8	0.0	3.1	0.0	27.0	2.1	0.3	3.8	2.1	2.0	0.6	1.0	4.8	3.1	1.4	0.0	11.1	1.3	0.7	34.3	1.0	31.7	0.0	0.0	0.2	0.0	6.6	6.3	0.1	0.0	0.5	7.7	8.8	0.2	4.8	0.0	12.2	3.2	0.0	0.1	1.4	0.1	2.5	1.6	0.3	0.1	0.1	38.2	14.1	14.4	27.6	0.0	0.0	0.0	30.2	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8	20.8	58.9	0.0	12.0	3.1	0.0	0.2	17.8	4.0	13.6	5.2	0.0	0.1	0.0	27.7	0.1	0.5	3.5	0.0	3.0	0.4	11.3	13.8	63.7	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	2.9	1.2	24.9	0.0	0.0	0.6	0.1	0.0	39.8	0.0	0.2	2.5	0.2	0.5	5.5	18.0
LIMCH1	"DKFZP686A01247, LIMCH1A, LMO7B"	ENSG00000064042	"LIM and calponin homology domains 1"	Q9UPQ0	4	41359607-41700044	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 87.1"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 604.5;Cardiomyocytes: 206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"myeloid DC: 4.4"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 27.6;HeLa: 47.6;hTERT-RPE1: 38.2;RT4: 45.4;SiHa: 25.8;WM-115: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004184, HPA063840"	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA004184: AB_1078673, HPA063840: AB_2685133"	"prognostic unfavorable (5.55e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.42e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.82e-7)"	"unprognostic (2.84e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.24e-3)"	19.4	18.7	24.9	3.1	27.6	0.9	11.7	13.8	24.6	6.7	4.3	30.2	8.4	3.0	4.0	6.5	8.8	9.3	11.2	45.0	29.1	21.3	15.0	6.4	58.2	1.9	34.4	18.2	19.1	5.8	59.6	8.6	15.8	23.3	28.7	4.5	13.6	32.5	13.6	87.1	6.6	4.2	7.2	43.3	49.1	5.4	5.1	25.2	0.2	20.6	23.5	2.4	12.4	9.4	0.0	4.4	0.0	0.4	0.0	0.0	0.1	0.6	6.7	10.4	0.6	0.0	0.0	1.0	8.5	4.3	8.6	4.3	1.0	2.6	0.0	27.6	22.6	0.2	4.7	5.8	3.9	9.7	0.0	0.8	0.0	47.6	0.0	8.8	0.0	0.0	0.1	11.5	0.0	2.7	38.2	0.8	0.0	0.0	0.0	2.4	3.7	0.0	0.0	0.7	1.4	0.7	0.0	12.7	0.1	7.2	45.4	9.8	19.9	25.8	10.3	0.1	8.7	0.7	0.0	0.0	0.1	10.2	2.3	6.5	0.0	0.0	0.0	0.6	0.0	36.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	27.6	13.8	21.6	29.1	21.3	34.4	18.2	23.3	25.2	604.5	166.2	0.0	43.2	34.7	24.7	206.0	17.8	105.7	147.9	90.7	35.3	12.1	18.3	32.7	54.1	58.8	4.2	0.0	12.0	30.0	23.8	134.4	4.7	9.3	10.2	0.0	9.2	108.6	17.8	20.9	1.7	5.5	13.5	33.3	5.1	100.0	7.4	8.6	7.1	9.3	73.0	0.0	6.2	5.1	12.0	26.7	38.6	5.4	5.1	49.4
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in many"	7	"Cone photoreceptor cells: 127.6;Leydig cells: 116.2;Peritubular cells: 258.9;Rod photoreceptor cells: 66.8;Sertoli cells: 194.1;Smooth muscle cells: 158.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 9.2;BJ: 11.9;BJ hTERT+: 19.3;fHDF/TERT166: 9.6;HSkMC: 8.5;hTERT-RPE1: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol		No	No			Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favorable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	9.2	1.1	0.7	11.9	19.3	0.7	0.9	0.0	0.1	0.0	0.4	9.6	0.1	0.2	0.3	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	8.5	0.0	0.5	0.0	31.2	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	0.2	5.6	0.4	0.0	0.0	0.1	0.4	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7	0.0	1.4	0.0	0.7	1.1	4.9	22.4	0.0	1.4	0.0	0.0	127.6	1.1	0.0	0.0	1.9	2.1	0.0	0.0	0.5	0.2	13.9	0.6	0.0	0.0	0.8	3.2	0.0	13.5	0.0	3.6	116.2	0.0	3.3	0.0	0.0	4.5	0.0	0.0	258.9	0.0	66.8	194.1	158.8	1.4	0.2	1.9	1.0	0.0	0.0	0.3
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 34.9;Fibroblasts: 69.8;Peritubular cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 105.1;fHDF/TERT166: 160.3;HSkMC: 39.1;hTERT-RPE1: 42.3;U-138 MG: 53.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043930			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		290000	"Endoplasmic reticulum"		"HPA043930: AB_2678736"	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.3	0.1	18.3	21.6	0.0	105.1	22.1	8.1	28.7	0.1	0.0	0.0	2.5	160.3	0.4	0.0	0.4	0.2	17.4	0.0	0.3	0.0	2.1	0.8	23.1	0.0	0.0	39.1	0.4	13.5	0.6	42.3	10.1	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.4	0.0	0.7	3.4	0.0	0.0	0.8	53.3	3.6	31.5	1.4	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1	8.9	0.6	0.0	1.6	6.9	0.6	1.2	0.0	4.0	1.2	0.0	0.0	0.7	0.0	7.1	34.9	3.3	0.0	0.0	0.5	17.3	69.8	1.8	0.0	0.4	1.9	1.6	0.0	14.1	1.5	2.4	13.0	0.3	5.0	1.0	0.0	0.0	1.4	0.0	36.7	0.0	1.1	19.4	8.2	0.5	0.0	9.4	4.0	0.0	0.0	0.7
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 84.0;Extravillous trophoblasts: 135.9;Fibroblasts: 59.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"BJ: 23.4;BJ hTERT+: 26.8;hTERT-RPE1: 26.7;U-87 MG: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	No	No		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: AB_2685050"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.7	20.3	0.7	23.4	26.8	9.9	17.6	0.4	0.6	0.0	4.3	17.2	2.5	6.9	0.1	0.0	2.4	0.0	1.5	0.0	0.7	0.1	2.3	0.0	0.0	16.5	0.0	7.4	0.0	26.7	0.3	0.4	0.0	0.1	11.8	0.8	0.1	0.4	2.2	1.5	16.0	0.0	13.8	0.2	0.9	4.1	1.9	0.0	0.7	0.1	0.0	2.4	0.1	0.0	1.7	19.5	17.3	15.3	8.9	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3	0.0	1.1	0.0	5.2	5.3	0.4	84.0	0.0	0.0	0.0	8.7	0.0	1.8	3.3	2.5	1.2	2.9	0.0	0.0	1.2	135.9	59.0	2.9	1.1	0.0	5.6	0.0	3.4	19.0	0.0	1.0	9.2	0.0	10.1	0.0	0.1	5.2	8.2	0.0	19.8	1.4	0.2	0.0	20.5	2.6	1.9	3.0	4.2	0.0	0.9	3.1
LPCAT2	"AGPAT11, AYTL1, FLJ20481, LysoPAFAT"	ENSG00000087253	"Lysophosphatidylcholine acyltransferase 2"	Q7L5N7	16	55508998-55586670	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Collecting duct cells: 64.6;granulocytes: 165.5;Kupffer cells: 68.0;Macrophages: 64.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 28.8;eosinophil: 49.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 49.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 32.0;HaCaT: 24.5;HL-60: 27.3;HMC-1: 45.6;hTERT-RPE1: 45.8;WM-115: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007891, HPA008433"	Enhanced	Supported	Supported	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA007891: AB_1845223, HPA008433: "	"unprognostic (1.43e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (3.43e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.91e-1)"	"unprognostic (9.65e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.97e-2)"	"unprognostic (3.18e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	10.5	7.5	10.5	8.0	16.2	43.5	9.9	1.7	7.5	11.0	5.2	18.2	36.5	4.3	17.0	21.5	7.2	8.5	6.2	5.7	9.6	6.3	6.7	2.4	7.4	10.3	18.6	3.1	11.0	3.8	12.7	1.9	9.0	16.1	8.2	5.5	5.1	7.7	33.2	3.0	10.2	5.4	8.9	30.7	8.9	5.3	4.6	14.9	0.9	49.0	5.2	2.6	8.5	8.5	0.0	5.4	49.4	9.3	0.0	0.0	1.4	8.9	1.1	0.9	0.0	3.1	1.2	1.6	3.8	3.7	1.9	1.9	2.0	32.0	0.0	13.2	5.4	1.5	24.5	0.6	5.3	3.1	2.4	2.6	9.2	2.9	4.6	1.1	27.3	45.6	0.6	5.3	2.1	1.7	45.8	14.7	0.5	0.4	0.1	3.2	0.5	0.0	11.0	1.4	2.5	0.1	2.8	1.0	1.3	1.8	3.5	0.6	7.1	7.4	3.0	5.3	4.6	1.3	6.9	16.5	0.3	0.0	1.9	2.6	0.1	0.0	0.0	0.7	13.3	32.5	28.8	4.5	49.4	0.0	6.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	12.1	0.0	9.3	0.1	0.0	1.4	10.5	16.2	1.7	7.5	9.6	6.3	18.6	3.1	16.1	14.9	6.0	31.3	1.7	29.9	13.7	1.6	1.6	5.1	2.7	23.9	64.6	9.8	0.7	1.7	7.2	1.3	22.7	4.1	0.0	8.5	6.9	13.8	6.0	165.5	1.7	33.6	0.0	1.2	4.3	68.0	1.7	15.3	64.1	16.9	7.2	11.9	26.1	20.5	31.6	12.0	4.4	5.2	0.0	2.4	11.6	3.8	13.4	1.6	1.3	9.8	15.9
LRCH2	KIAA1495	ENSG00000130224	"Leucine rich repeats and calponin homology domain containing 2"	Q5VUJ6	X	115110616-115234072	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 10.5;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003233	Approved		Approved	"Nucleoli,Plasma membrane"		NA	NA			Nucleoli	"Plasma membrane"	"HPA003233: AB_2265929"	"unprognostic (9.74e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.22e-5)"	"unprognostic (2.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.09e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.16e-2)"	5.1	8.7	11.6	3.4	10.2	0.7	3.3	11.2	10.6	11.2	11.6	5.5	4.0	1.6	9.9	4.5	3.6	4.6	5.3	4.7	7.9	8.9	2.6	1.0	5.7	1.8	5.7	4.6	13.8	1.6	1.3	20.9	13.7	7.6	16.4	4.2	2.5	1.3	14.5	1.2	1.1	3.2	13.7	6.4	3.7	3.6	4.3	7.9	0.0	4.8	0.4	1.1	11.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.9	5.5	4.6	0.0	3.5	7.6	3.4	7.9	0.0	0.0	0.1	0.0	4.6	2.7	0.3	17.8	0.0	5.2	0.0	4.8	0.0	0.0	0.0	4.4	0.0	0.1	2.7	0.0	1.4	0.2	9.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	5.2	0.0	3.8	0.0	4.3	0.5	0.0	6.8	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	2.1	0.0	4.9	11.8	2.0	0.0	1.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	10.2	11.2	8.4	7.9	8.9	5.7	4.6	7.6	7.9	3.0	10.5	0.0	0.0	0.6	6.7	5.5	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	5.7	4.5	0.0	0.0	0.0	0.1	5.4	1.2	0.0	0.0	0.5	1.6	0.0	1.8	0.0	1.5	8.1	0.0	1.7	0.0	0.0	6.6	0.0	0.0	6.0	0.0	2.4	25.8	7.1	3.6	3.0	0.1	0.2	0.0	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128493-57213351	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 153.3;Leydig cells: 216.0;Peritubular cells: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.8;monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 83.1;ASC TERT1: 84.4;fHDF/TERT166: 36.2;HSkMC: 54.7;hTERT-RPE1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		88000000	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	77.8	12.0	19.8	21.5	21.3	6.1	27.7	28.1	25.3	31.4	19.7	11.9	9.0	17.8	26.9	18.2	19.2	21.0	24.1	26.0	18.6	10.4	6.3	31.4	24.7	5.5	13.9	15.6	56.9	8.8	8.5	8.0	29.4	17.1	21.4	9.5	20.0	14.8	17.0	11.3	15.7	14.2	22.4	14.3	11.3	11.8	11.1	15.4	0.3	13.2	9.3	3.1	22.9	39.4	0.0	2.8	0.1	7.6	0.0	0.2	1.9	1.2	2.3	5.1	4.0	83.1	84.4	15.3	14.0	18.1	4.6	4.5	4.3	2.0	0.0	1.7	36.2	1.0	5.5	0.8	1.4	1.6	0.1	0.2	0.0	2.7	9.0	11.4	0.0	2.4	54.7	0.5	10.3	1.2	42.1	0.2	0.1	0.0	0.2	14.4	0.2	0.0	0.0	5.8	1.7	1.4	0.5	28.8	0.2	0.3	0.3	0.2	2.8	3.1	0.1	2.2	7.4	0.4	0.2	0.2	16.2	6.0	9.0	0.8	0.1	0.0	0.0	28.4	0.0	3.1	0.0	7.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	1.9	19.8	21.3	28.1	19.7	18.6	10.4	13.9	15.6	17.1	15.4	11.9	9.6	3.7	11.4	21.3	25.5	12.1	20.4	5.3	11.4	1.8	0.0	65.3	0.0	7.8	1.6	5.8	72.1	0.0	1.6	42.2	117.6	4.4	5.8	153.3	72.0	7.9	4.1	16.0	118.9	3.6	216.0	50.7	27.0	3.6	14.3	130.1	9.9	18.6	173.2	2.2	3.8	38.8	44.2	1.4	2.2	14.1	105.3	0.9	20.9	10.2
LRRC27	KIAA1674	ENSG00000148814	"Leucine rich repeat containing 27"	Q9C0I9	10	132332154-132379918	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 52.9"	"Group enriched"	"Detected in many"	8	"Early spermatids: 394.8;Late spermatids: 739.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.5;hTERT-RPE1: 18.9"	"Low region specificity"	"Detected in all"							"HPA037595, HPA067395"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA037595: , HPA067395: AB_2732766"	"unprognostic (1.97e-1)"	"unprognostic (5.76e-4)"	"unprognostic (1.48e-3)"	"unprognostic (1.94e-3)"	"unprognostic (6.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.27e-4)"	2.1	2.8	8.1	1.5	8.4	1.0	4.1	2.2	8.9	3.6	2.1	6.1	7.5	2.0	3.8	5.6	1.6	10.5	3.5	2.2	6.6	5.4	4.4	2.4	3.1	1.9	4.3	7.3	5.4	3.1	7.5	5.8	2.1	6.5	4.1	2.1	4.8	3.1	4.0	1.2	2.1	2.6	3.4	3.5	3.3	3.0	52.9	4.5	0.7	5.1	1.0	1.2	2.5	1.8	4.7	7.8	4.4	6.8	3.1	2.8	2.7	2.5	4.7	10.3	14.5	9.1	9.3	1.0	2.5	8.1	4.2	3.8	0.8	5.2	1.4	1.5	5.8	3.2	1.8	2.3	1.2	2.6	2.9	2.0	0.3	3.3	2.4	6.5	1.1	1.7	4.0	8.0	4.2	5.7	18.9	3.0	3.6	0.8	1.0	3.2	4.3	2.2	3.2	2.9	1.8	1.6	1.9	1.7	0.8	7.5	0.6	1.8	5.2	1.2	0.8	3.3	2.2	2.3	2.6	3.9	1.7	2.1	3.8	1.5	0.7	0.3	0.8	7.7	2.2	1.0	4.4	6.8	1.1	1.7	5.7	1.3	3.4	1.1	1.0	7.3	4.7	2.8	1.6	0.5	3.1	3.6	7.8	0.7	2.7	8.1	8.4	2.2	8.9	6.6	5.4	4.3	7.3	6.5	4.5	8.9	10.9	1.3	2.4	2.5	7.8	4.4	7.6	48.2	7.9	3.5	9.8	3.1	16.6	5.9	394.8	4.5	1.7	0.0	4.6	1.0	5.2	2.9	8.1	2.1	6.6	7.9	5.2	14.7	8.0	739.5	4.4	7.1	6.8	7.2	1.9	8.9	3.3	0.0	11.0	11.9	17.7	6.5	2.3	75.2	20.4	2.8	1.1	4.9	3.3	1.4
LTBP3	LTBP2	ENSG00000168056	"Latent transforming growth factor beta binding protein 3"	Q9NS15	11	65538805-65558930	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Amelogenesis imperfecta, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 116.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 74.2;U-87 MG: 39.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		760000				"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.50e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	35.3	31.6	25.2	14.9	21.5	7.3	33.4	24.3	27.2	41.8	29.4	28.7	37.5	12.2	43.5	42.7	17.1	36.0	45.0	38.7	24.6	12.7	22.9	25.7	36.7	16.1	22.1	22.7	55.1	35.7	48.1	37.1	18.2	23.4	40.2	6.8	36.1	34.4	43.5	33.9	13.9	16.9	30.3	34.4	24.4	19.8	16.8	23.7	12.5	40.6	17.2	11.8	30.7	29.6	28.6	8.0	1.3	5.4	4.6	6.7	3.6	3.9	16.1	2.1	10.7	15.5	25.1	2.1	15.8	10.8	2.0	1.3	6.1	21.0	0.4	13.6	15.6	5.1	17.7	2.9	2.9	0.9	2.2	6.5	3.8	5.8	6.2	10.3	0.5	3.3	28.2	1.2	3.0	0.3	74.2	7.9	1.2	1.1	3.1	1.4	9.3	2.5	1.4	1.9	3.5	20.1	7.1	0.2	7.6	1.7	1.3	0.7	10.5	4.2	6.2	8.1	0.9	11.4	1.4	26.1	6.3	8.4	10.6	4.2	3.4	6.2	0.3	39.9	0.6	12.9	0.0	3.3	1.2	4.3	4.9	6.7	28.6	6.1	5.0	4.0	22.7	5.2	5.4	1.3	4.6	5.4	8.0	6.2	3.6	25.2	21.5	24.3	22.9	24.6	12.7	22.1	22.7	23.4	23.7	11.9	13.2	21.5	23.8	65.6	52.7	11.0	38.2	4.0	13.6	38.4	2.0	17.2	18.3	24.9	0.9	26.0	20.9	0.0	10.2	7.9	35.2	30.8	24.2	45.0	19.0	27.0	29.4	38.1	8.3	2.2	80.3	18.2	28.7	10.8	9.3	76.6	17.0	14.4	116.3	14.6	13.3	38.8	37.1	4.6	40.3	69.4	13.6	20.2	14.5	24.3
LURAP1	"C1orf190, FLJ25163, LRAP35a"	ENSG00000171357	"Leucine rich adaptor protein 1"	Q96LR2	1	46203334-46221261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"Early spermatids: 111.8;Late spermatids: 227.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 7.8;RPTEC TERT1: 7.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 110.5"	"HPA030060, HPA030061"	Uncertain		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA030060: AB_10599997, HPA030061: AB_10601990"	"unprognostic (3.88e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (8.81e-8)"	"unprognostic (1.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.39e-2)"	3.0	7.3	7.1	2.2	13.2	3.4	3.9	12.7	12.7	5.8	3.8	15.2	2.2	2.0	5.5	4.9	4.0	4.0	3.7	8.7	6.7	5.8	7.4	1.1	3.2	1.6	18.8	6.0	7.2	1.1	21.5	3.2	2.3	11.2	7.5	2.5	4.7	5.2	9.8	2.5	4.2	1.9	5.6	17.5	3.5	3.7	10.8	13.6	0.0	19.6	0.0	2.1	5.6	5.3	1.0	0.7	6.2	1.1	1.9	0.8	0.3	0.2	0.2	3.0	0.2	4.0	5.5	3.1	2.0	5.3	2.8	3.4	0.1	0.2	0.2	0.1	5.0	1.0	0.3	3.2	6.7	2.4	0.6	1.5	0.2	0.6	0.3	1.2	0.2	0.1	2.8	4.5	5.6	2.6	7.8	4.2	0.8	2.5	0.5	1.6	0.3	0.3	0.3	1.1	0.0	0.5	1.0	1.5	0.0	7.5	0.1	0.4	1.2	0.1	0.2	4.8	1.3	1.5	0.2	0.2	1.8	2.3	1.4	0.4	0.3	0.1	0.3	1.7	0.3	0.4	1.3	1.1	0.4	0.3	0.5	0.8	0.5	0.4	0.3	0.4	1.0	0.8	0.6	6.2	1.9	0.5	0.7	0.1	0.3	7.1	13.2	12.7	12.7	6.7	5.8	18.8	6.0	11.2	13.6	0.0	0.0	0.0	13.1	4.4	0.0	2.2	0.0	0.0	0.0	10.4	0.0	1.9	13.3	0.0	111.8	2.8	0.0	0.0	0.4	1.9	2.3	7.3	0.0	0.0	3.6	0.0	1.2	0.0	0.3	227.3	8.6	1.5	13.5	1.0	0.0	1.6	0.0	0.0	9.2	2.6	0.0	6.5	6.2	8.2	2.0	3.0	6.4	0.0	0.0	4.8
LUZP2		ENSG00000187398	"Leucine zipper protein 2"	Q86TE4	11	24496970-25082631	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 11.1;brain: 32.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 18.8;Paneth cells: 21.8"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;prostate cancer: 4.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.2;HAP1: 7.1;HeLa: 2.5;hTERT-RPE1: 6.1"	"Low region specificity"	"Detected in all"							"HPA039007, HPA046161"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted in brain"	NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA039007: AB_2676307, HPA046161: AB_2679564"	"unprognostic (4.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-2)"	"unprognostic (5.67e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.66e-2)"	"unprognostic (6.16e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.18e-3)"	"unprognostic (9.41e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.64e-2)"	1.2	11.1	14.5	0.9	10.8	0.9	1.6	2.6	32.7	0.9	2.1	5.9	0.0	0.9	1.0	0.8	0.9	0.8	1.0	1.0	10.3	13.8	1.0	2.3	1.1	0.8	13.7	5.6	0.8	0.8	0.7	1.9	0.8	26.7	4.5	1.7	0.0	1.0	0.9	0.8	0.9	1.1	1.2	30.0	0.9	0.9	1.6	14.5	0.0	0.8	0.9	0.8	1.6	0.3	0.5	0.4	1.9	0.3	0.3	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	14.2	7.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	6.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.0	0.2	0.2	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.5	0.3	0.4	0.2	0.1	0.2	0.2	0.1	0.3	0.1	0.5	0.3	0.2	1.9	0.3	0.2	0.4	0.1	0.0	14.5	10.8	2.6	9.3	10.3	13.8	13.7	5.6	26.7	14.5	0.0	0.0	0.0	0.1	0.6	2.3	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.6	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	1.8	0.2	0.1	21.8	0.0	0.6	0.6	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.9	0.7
MAATS1	"AAT1, AAT1alpha, C3orf15, CaM-IP2, SPATA26"	ENSG00000183833	"MYCBP associated and testis expressed 1"	Q7Z4T9	3	119703022-119767102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 31.6"	"Group enriched"	"Detected in many"	7	"Ciliated cells: 158.0;Early spermatids: 481.0;Late spermatids: 243.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.3;hTERT-RPE1: 2.8;RPTEC TERT1: 4.7;SCLC-21H: 7.0;SH-SY5Y: 5.0;T-47d: 3.6;U-87 MG: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074084	Enhanced					NA	NA					"HPA074084: "	"unprognostic (6.70e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.46e-2)"	1.1	3.4	2.6	0.8	7.7	0.5	3.5	1.8	3.8	5.8	2.1	4.4	10.5	0.7	6.7	12.0	1.1	23.1	3.5	0.8	3.0	4.7	4.8	1.2	3.8	0.6	1.5	3.2	6.7	7.8	7.6	31.6	0.8	17.1	4.4	1.5	7.2	2.6	12.8	0.6	0.7	1.1	3.4	1.5	4.0	2.9	19.5	2.2	0.0	7.9	0.4	0.9	2.2	1.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	3.3	0.0	0.4	0.0	0.0	0.0	0.4	0.5	2.5	0.0	2.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	4.7	0.0	7.0	5.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	3.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	7.7	1.8	3.8	3.0	4.7	1.5	3.2	17.1	2.2	3.0	2.7	0.0	1.8	0.8	3.2	1.4	7.6	158.0	20.5	7.0	41.2	0.0	0.0	2.6	481.0	1.5	0.0	0.0	2.4	0.0	0.9	1.5	1.1	0.5	0.1	11.1	3.5	0.6	0.3	243.3	6.6	1.5	3.3	1.0	0.0	4.1	0.9	0.0	8.5	2.1	26.5	0.0	1.4	33.8	4.2	0.6	0.1	0.0	0.0	0.5
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35474182-35477209	"Predicted intracellular proteins"		"Developmental protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 24.0;skeletal muscle: 8.5"	"Group enriched"	"Detected in some"	38	"Bipolar cells: 51.8;Cone photoreceptor cells: 47.1;Horizontal cells: 82.6;Muller glia cells: 136.9;Rod photoreceptor cells: 120.3"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 12.9;BJ hTERT+: 10.5;BJ hTERT+ SV40 Large T+: 14.9;HBF TERT88: 16.2;hTERT-RPE1: 31.2;SH-SY5Y: 48.0"	"Group enriched"	"Detected in some"	9	"cerebellum: 45.8;midbrain: 22.3;pons and medulla: 12.9"	"Low region specificity"	"Detected in all"			"HPA049324, HPA059864"			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.9	6.4	0.3	0.5	0.0	0.0	6.3	24.0	0.0	0.0	1.2			0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.8	0.6		1.1	0.0	0.0	0.0	0.0		1.8	0.5		3.7	0.2	8.5	1.2	1.1	0.0	0.8	0.0	0.3	0.0			0.6		0.2	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.9	10.5	14.9	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	16.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	1.2	48.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.4	0.7	51.8	0.3	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.2	2.3	0.0	0.1	82.6	0.0	1.3	0.0	0.0	0.3	0.0	1.7	0.0	0.0	136.9	0.0	0.0	0.4	0.0	120.3	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.2
MAGEC3	"CT7.2, HCA2, MAGE-C3"	ENSG00000165509	"MAGE family member C3"	Q8TD91	X	141838316-141897832	"Cancer-related genes, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.9;epididymis: 3.0;testis: 3.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.2;U-2197: 1.9;U-266/70: 2.9;U-266/84: 6.4"									HPA052067	Approved					NA	NA					"HPA052067: AB_2681717"	"unprognostic (3.45e-1)"				"unprognostic (2.39e-1)"			"unprognostic (4.01e-1)"		"unprognostic (2.95e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.35e-11)"		"unprognostic (3.21e-2)"	"unprognostic (4.29e-2)"		0.1	0.1	1.6	0.0	2.5	0.1	0.5	0.5	2.5	0.2	0.0			0.0	0.2	3.0	0.1	0.4	0.2	0.0	3.3	2.0	0.1	0.1	0.2	0.0	2.8		0.4	0.0	0.0	0.7	0.0		0.3	0.0		0.5	0.3	0.0	0.1	0.2	0.3	4.9	1.1	0.1	3.1			0.5		0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.9	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	1.9	0.3	2.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
MAP3K12	"DLK, MEKK12, MUK, ZPK, ZPKP1"	ENSG00000139625	"Mitogen-activated protein kinase kinase kinase 12"	Q12852	12	53479669-53500063	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.3"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039936, HPA071996"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA039936: AB_10795239, HPA071996: AB_2686481"	"unprognostic (4.01e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (6.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.50e-3)"	"prognostic unfavorable (5.43e-10)"	"unprognostic (1.65e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.18e-1)"	8.0	8.7	12.3	5.8	16.0	3.0	5.1	40.3	20.6	14.1	6.1	7.0	7.8	3.6	15.1	5.8	4.6	11.5	16.1	4.2	9.4	7.7	4.5	1.4	8.8	4.5	6.4	14.7	13.7	1.8	3.0	12.7	7.3	10.8	5.9	4.6	9.5	2.4	13.5	1.2	4.5	4.1	16.9	5.3	5.3	3.9	6.5	7.4	2.7	4.3	1.4	3.2	11.3	6.4	0.3	0.6	3.4	1.7	0.6	2.8	0.5	0.2	7.0	4.4	6.8	26.4	14.1	0.5	4.7	8.9	5.2	5.3	0.1	0.8	1.5	2.7	5.1	4.2	0.0	2.0	3.1	2.1	2.3	2.4	1.7	3.6	0.0	25.2	0.0	1.7	25.1	2.3	7.1	3.7	33.3	8.1	3.5	0.0	7.5	4.9	3.0	1.7	0.3	1.5	0.0	2.6	2.4	2.9	0.4	2.6	0.0	4.4	6.0	2.5	3.2	6.7	1.0	2.2	4.4	5.9	5.0	5.4	2.3	1.2	3.0	3.4	0.0	8.1	3.0	4.9	0.0	1.7	0.0	1.5	1.3	2.8	0.3	2.1	2.3	0.6	0.0	0.9	1.2	3.4	0.6	0.4	0.3	0.4	0.5	12.3	16.0	40.3	20.6	9.4	7.7	6.4	14.7	10.8	7.4	6.0	13.4	5.6	1.9	0.7	26.7	0.7	10.2	8.1	11.4	1.8	35.3	1.6	8.3	5.4	1.2	3.7	4.6	0.0	1.6	1.8	3.8	2.7	12.7	7.7	3.6	28.6	3.4	7.4	12.7	1.4	7.5	5.9	0.0	7.2	2.5	17.4	4.5	2.6	7.8	7.0	81.9	6.5	4.9	2.3	1.9	0.9	1.8	7.5	3.5	2.0
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 48.7;Distal tubular cells: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 24.5;hTERT-RPE1: 29.4;HUVEC TERT2: 16.3;TIME: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038473	Approved					NA	NA					"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favorable (3.86e-4)"	17.2	15.9	16.0	6.3	27.7	5.8	13.1	15.7	26.1	19.3	14.3	4.8	7.3	7.8	15.8	7.6	5.0	9.0	12.9	21.9	12.2	13.1	12.6	3.9	8.1	4.3	12.5	18.1	22.1	16.7	28.5	15.4	5.4	20.2	13.0	15.0	11.5	13.6	10.3	21.2	3.0	7.1	15.6	5.5	7.3	20.8	8.8	8.4	2.8	8.2	6.3	2.9	10.3	10.2	0.0	5.0	0.0	0.9	2.2	3.1	1.0	0.0	8.2	2.3	0.0	3.7	7.8	0.0	2.8	4.3	5.8	7.4	6.2	24.5	0.0	2.5	2.6	14.7	0.1	0.0	0.0	2.6	4.3	0.0	4.2	6.8	0.0	5.5	0.5	0.0	5.4	1.2	4.7	0.0	29.4	16.3	0.0	0.0	0.0	3.8	0.8	1.1	0.0	0.5	0.7	3.4	3.6	0.0	0.3	5.2	9.5	2.8	0.0	1.7	0.0	0.0	1.0	0.4	0.6	18.1	0.7	0.5	12.2	0.4	0.0	1.5	0.0	0.6	7.6	0.7	0.0	0.9	0.0	1.9	0.1	0.0	0.0	1.9	3.1	5.0	0.0	2.3	2.7	0.0	2.2	0.3	0.6	0.0	1.0	16.0	27.7	15.7	26.1	12.2	13.1	12.5	18.1	20.2	8.4	3.0	3.5	0.8	4.4	2.1	15.2	48.7	5.1	17.4	4.5	3.5	0.0	0.1	36.5	6.9	0.5	8.3	11.0	0.0	6.9	0.3	3.9	5.3	0.0	0.5	6.9	19.1	8.6	11.1	1.8	1.3	5.8	2.5	1.7	1.8	11.2	1.7	8.3	9.3	6.0	5.5	2.3	12.9	3.7	0.3	0.2	1.4	0.0	1.3	9.3	6.0
MEGF6	EGFL3	ENSG00000162591	"Multiple EGF like domains 6"	O75095	1	3489920-3611495	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 19.4;Basal keratinocytes: 16.4;Ito cells: 16.5;Melanocytes: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.8;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 22.5;HeLa: 20.3;hTERT-RPE1: 26.6;U-2197: 20.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052129	Uncertain		Approved	"Microtubules,Cytokinetic bridge"	"Secreted - unknown location"	Yes	No		580000	Microtubules	"Cytokinetic bridge"	"HPA052129: AB_2681739"	"unprognostic (1.95e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.43e-2)"	15.0	2.3	0.5	8.5	1.0	9.2	13.4	0.8	2.0	8.1	5.9	1.8	7.5	2.3	5.1	13.1	6.6	14.6	21.0	6.1	1.4	0.5	2.7	1.9	12.6	12.6	0.7	1.9	8.8	4.8	0.8	1.5	2.8	2.3	12.0	0.9	11.0	8.7	5.5	6.1	37.8	4.2	3.0	0.8	5.7	4.2	4.6	1.4	5.0	5.2	12.0	12.0	6.7	10.1	0.8	0.3	4.8	0.1	0.0	1.9	0.2	4.5	7.2	1.6	3.1	0.1	0.1	0.5	22.5	6.3	1.9	0.6	1.5	5.3	0.0	7.2	7.7	1.3	2.8	0.0	0.2	0.2	0.0	0.1	0.0	20.3	1.3	0.0	0.1	0.4	0.0	0.2	0.1	0.2	26.6	2.4	0.0	0.0	0.0	0.0	2.5	0.0	4.1	1.0	1.0	0.4	0.9	0.9	2.7	0.4	1.4	1.6	1.5	8.1	0.5	2.8	2.3	2.2	0.4	1.0	8.2	0.8	20.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	4.8	0.1	0.0	0.4	0.0	0.4	0.4	0.3	0.8	0.8	0.1	2.2	0.0	0.0	0.0	1.9	0.2	0.5	1.0	0.8	2.0	1.4	0.5	0.7	1.9	2.3	1.4	20.8	19.4	0.0	7.5	16.4	0.8	3.0	5.1	0.0	6.8	1.8	0.0	0.1	0.0	3.0	0.2	8.7	0.3	0.0	1.2	1.0	6.4	3.4	1.1	0.9	1.0	0.0	0.0	16.5	0.8	0.0	10.6	2.8	18.6	0.0	1.3	9.5	3.6	0.0	3.2	1.7	1.0	0.0	2.1	0.5	0.6	9.9	0.3	0.0	0.7	3.0
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 80.4;Cone photoreceptor cells: 200.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: AB_2681060"	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favorable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.7	10.7	9.4	2.9	13.1	8.1	3.0	2.8	2.4	0.7	1.0	0.6	1.6	10.1	4.2	2.6	3.4	11.8	13.5	4.8	2.0	8.2	3.9	1.4	20.1	4.4	5.6	4.0	8.7	3.8	14.8	4.6	3.7	26.3	6.6	5.5	3.2	4.8	7.8	7.8	7.9	1.4	0.4	6.0	2.9	6.0	10.5	4.3	19.3	8.9	9.3	7.9	3.3	2.7	7.9	1.6	8.1	4.1	7.7	2.8	1.6	10.4	4.2	8.8	10.3	3.3	4.0	4.8	16.1	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8	80.4	47.6	4.9	4.8	24.4	27.8	23.0	15.3	6.7	21.6	22.7	200.3	0.3	0.0	3.9	0.6	7.3	6.5	23.3	4.7	1.1	6.1	8.8	6.9	41.0	5.9	12.7	6.3	10.4	54.2	0.9	10.6	18.5	25.3	2.8	3.3	28.2	11.0	6.8	11.0	5.0	70.5	12.9	9.9	8.4	6.1	38.3	1.0	9.6	6.0	5.7
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77690658-77926974	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"kidney: 8.5;pancreas: 4.1;testis: 4.7;thyroid gland: 4.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 59.5;Late spermatids: 15.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 3.5;NTERA-2: 1.5;TIME: 2.6;U-266/70: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.0	1.3	0.4	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0			0.0	0.0	0.8	0.0	0.0	0.3	1.0	0.2	0.9	8.5	1.7	0.0	0.0	0.8		0.0	4.1	0.0	2.6	0.0		0.0	0.0		0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	4.7			4.6		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.4	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	3.5	0.0	0.0	0.0	4.3	2.5	0.0	0.0	0.0	0.0	0.0
MFRP	"C1QTNF5, FLJ30570, NNO2, rd6"	ENSG00000235718	"Membrane frizzled-related protein"	Q9BY79	11	119338942-119346673	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Microphthalmia, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"brain: 54.9;retina: 112.9"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	10	"pons and medulla: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9"	"Low region specificity"	"Detected in some"									NA	NA																							0.9	0.3	0.6	0.0	0.4	0.1	0.1	0.2	2.8	0.2	0.1	14.6	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.2	5.5	0.5	0.2	0.1	0.3	0.2	0.8	0.0	0.1	0.1	2.0	0.5	0.6	54.9	0.1	0.0	112.9	0.1	0.1	0.5	0.1	0.2	0.4	0.4	0.3	0.2	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.4	0.2	2.8	5.5	0.5	0.8	0.0	54.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MICA	PERB11.1	ENSG00000204520	"MHC class I polypeptide-related sequence A"		6	31399784-31415315	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 15.8;ASC TERT1: 16.1;GAMG: 37.0;HBEC3-KT: 14.4;HSkMC: 25.0;hTERT-RPE1: 16.5;RPTEC TERT1: 16.4"															NA	NA						"unprognostic (1.94e-1)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.12e-2)"	10.4	9.7	3.0	7.0	4.3	0.7	8.3	3.0	6.8	11.0	9.5	4.4	16.9	0.7	9.0	14.7	6.9	7.9	13.1	10.8	3.9	1.0	19.1	7.5	15.3	6.5	4.3	3.2	15.1	10.9	13.4	2.8	4.3	12.6	12.6	5.6	13.8	6.5	2.1	6.2	5.4	7.6	3.7	7.9	7.7	6.2	24.6	3.4	1.2	8.7	10.2	3.4	6.3	11.9	1.7	1.8	4.5	1.9	0.3	2.5	1.7	15.8	0.0	0.0	0.0	12.5	16.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	9.2	13.3	37.0	6.5	11.4	14.4	0.3	0.0	5.3	0.0	10.4	0.2	4.5	0.0	0.6	25.0	0.0	0.0	0.2	16.5	0.0	1.1	1.3	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	16.4	0.0	0.0	0.0	0.9	0.0	0.2	0.1	0.0	0.3	10.5	0.0	0.2	0.4	0.1	1.7	8.4	0.6	0.1	0.0	0.7	0.0	1.3	4.5	1.7	1.9	2.0	1.4	1.3	2.0	1.8	1.7	2.5	1.4	3.7	0.3	1.0	0.2	1.5	1.7	3.0	4.3	3.0	6.8	3.9	1.0	4.3	3.2	12.6	3.4	29.8	9.8	5.2	25.1	35.5	0.4	6.5	10.2	10.7	9.1	17.4	0.0	0.2	0.0	31.3	1.7	18.5	23.1	0.0	39.1	0.5	19.0	25.8	9.2	8.3	13.3	0.0	2.4	25.8	16.1	1.1	13.8	20.7	32.1	19.0	17.9	8.7	34.5	14.0	14.9	5.6	0.6	19.4	34.9	14.0	3.8	30.1	0.7	13.8	11.4	17.9
MMP11	STMY3	ENSG00000099953	"Matrix metallopeptidase 11"	P24347	22	23768226-23784316	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"endometrium 1: 44.1;placenta: 119.6"	"Cell type enhanced"	"Detected in many"	15	"Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	5	"B-cells: 2.4;dendritic cells: 7.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002593, HPA068864"	Approved				"Secreted to extracellular matrix"	NA	NA					"CAB002593: , HPA068864: AB_2686051"	"unprognostic (1.06e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-3)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.05e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-2)"	1.7	0.6	0.2	1.0	0.6	0.1	1.6	1.0	0.5	13.4	1.8	0.4	0.4	1.9	44.1	1.1	0.8	2.2	2.0	3.1	0.5	0.0	1.7	0.5	0.7	1.8	0.4	0.2	7.7	1.1	0.2	0.3	119.6	0.5	1.4	1.0	0.8	2.5	0.4	0.5	2.0	4.0	2.7	0.3	0.9	0.7	3.4	0.2	2.6	0.5	0.6	0.9	1.6	2.1	2.4	7.8	0.0	0.0	0.0	1.0	0.1	0.1	0.0	2.3	18.7	2.8	4.2	0.0	0.2	5.0	0.6	0.4	0.0	0.6	0.6	3.5	1.3	0.9	0.1	1.0	0.0	0.2	0.0	0.3	0.0	0.0	1.0	2.1	0.0	0.0	2.7	0.4	0.5	0.0	9.7	2.9	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.6	0.5	0.1	7.8	0.0	0.2	0.3	0.0	2.9	5.0	1.9	0.3	0.0	3.0	1.7	0.0	1.3	0.3	0.0	0.7	0.0	0.1	0.0	2.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.4	1.0	0.3	0.0	0.0	0.0	7.8	0.0	0.1	0.2	0.6	1.0	0.5	0.5	0.0	0.4	0.2	0.5	0.2	0.0	4.5	0.8	0.8	0.9	0.4	4.3	2.5	1.4	0.0	0.0	0.0	0.3	1.7	5.9	6.6	0.2	0.0	0.0	0.6	34.6	5.7	0.4	1.1	0.0	0.7	0.0	1.7	1.3	0.0	8.0	0.6	0.0	1.7	0.0	0.8	0.5	1.6	0.0	0.4	2.2	0.6	0.0	2.0	1.1	2.7	0.5	15.6	0.0	0.8	0.3
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 216.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 96.4;HHSteC: 91.2;HSkMC: 92.7;hTERT-RPE1: 91.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.8	0.1	2.4	0.1	96.4	61.3	44.3	24.7	49.8	7.5	13.4	2.3	29.4	0.1	13.8	26.0	2.3	20.0	0.0	25.7	9.6	0.1	0.1	3.6	0.1	0.5	91.2	0.0	0.1	92.7	15.5	31.2	26.8	91.6	45.3	0.1	0.0	0.2	17.6	0.1	0.0	8.8	1.4	1.7	4.3	0.3	8.5	0.0	6.8	13.5	0.0	0.0	16.1	0.0	53.5	10.8	0.1	7.9	40.0	60.9	5.2	17.7	28.1	0.1	0.1	0.1	37.1	0.0	35.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6	11.9	4.8	3.7	19.4	30.2	0.0	3.6	53.5	2.7	3.4	7.0	0.0	83.6	10.0	61.2	0.4	13.5	16.8	0.0	24.9	216.8	65.7	13.9	3.5	2.9	79.3	0.0	7.5	41.1	18.3	0.7	66.7	26.5	35.4	34.3	32.5	17.1	102.2	28.5	51.6	13.0	0.8	38.8	34.8	0.9	0.7	29.9	102.6	1.0	17.1	28.7
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA	1600000000	160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.1	9.7	0.1	292.5	85.2	15.9	25.0	57.5	5.0	4.0	0.0	0.1	0.0	20.1	44.1	1.9	2.7	0.0	0.2	2.9	0.0	0.0	0.0	0.6	0.1	27.7	0.0	0.7	72.6	0.0	26.0	0.2	329.2	32.7	0.0	0.0	0.1	16.8	0.0	0.0	0.3	7.7	0.0	0.0	0.0	2.3	0.0	0.8	0.3	0.1	17.6	4.6	0.0	0.1	45.4	0.0	1.7	45.9	79.6	7.6	15.2	3.2	0.0	0.0	0.0	93.1	1.3	14.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1	0.0	0.3	0.0	13.0	108.4	5.2	3.1	0.0	0.0	3.4	10.4	0.0	5.4	0.0	1.7	11.5	11.9	0.0	0.0	0.3	217.4	249.9	2.7	0.0	0.0	25.6	1.6	27.1	15.4	0.0	26.9	315.0	5.3	121.4	0.0	0.0	5.0	6.9	0.0	393.8	0.0	1.8	12.9	70.0	1.2	2.1	89.5	14.4	0.0	0.0	3.8
MN1	"MGCR, MGCR1, MGCR1-PEN"	ENSG00000169184	"MN1 proto-oncogene, transcriptional regulator"	Q10571	22	27748277-27801498	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 62.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 9.8;Early spermatids: 22.6;Fibroblasts: 10.0;Late spermatids: 12.6;Peritubular cells: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	8	"monocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 22.1;HeLa: 8.9;hTERT-RPE1: 9.9;RH-30: 8.9;TIME: 14.0;U-2 OS: 12.1;U-2197: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003072	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003072: AB_1079399"	"unprognostic (5.64e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.13e-7)"	"unprognostic (3.84e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.21e-4)"	3.7	2.0	3.4	4.2	17.3	2.4	1.9	1.3	5.6	5.9	4.2	2.6	2.5	2.1	3.0	9.0	7.0	3.4	11.1	5.1	2.5	2.7	1.6	1.4	4.3	1.3	3.3	3.5	12.4	1.5	1.3	2.3	2.6	4.5	3.1	2.2	10.8	2.1	2.7	62.7	2.9	2.1	5.8	1.0	1.5	3.5	2.0	5.4	0.0	1.8	14.8	2.1	5.0	4.7	0.0	0.2	0.0	1.7	0.0	0.1	0.0	0.0	1.0	22.1	0.6	0.4	0.9	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	2.2	3.9	0.9	1.8	1.1	1.3	0.0	0.0	0.6	0.0	8.9	0.0	0.5	0.0	0.2	0.0	2.5	0.5	2.2	9.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.2	2.9	0.0	2.0	3.6	8.9	0.0	0.3	0.0	0.0	0.3	1.9	0.0	0.0	5.6	0.2	0.0	14.0	0.7	12.1	12.7	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	3.4	17.3	1.3	4.2	2.5	2.7	3.3	3.5	4.5	5.4	3.0	2.9	0.5	0.1	3.8	9.8	3.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	22.6	4.1	0.0	0.0	0.9	0.1	10.0	0.1	0.0	0.4	0.2	0.0	0.0	0.6	0.3	12.6	4.6	0.7	0.0	0.0	0.0	4.3	1.7	0.0	9.6	0.0	0.6	0.0	2.1	0.5	0.9	2.4	0.0	0.0	0.0	0.1
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 75.9"	"Cell type enriched"	"Detected in many"	16	"Cardiomyocytes: 2030.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 23.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.2;hTERT-RPE1: 33.8;U-937: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014432	Enhanced				"Intracellular and membrane"	NA	NA					"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (2.17e-4)"	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19.0	39.4	3.6	20.4	4.0	40.3	15.0	23.0	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5.0	5.0	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10.0	75.9	5.0	6.5	17.2	6.1	4.8	0.4	6.0	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.5	5.6	4.9	22.8	22.2	19.7	0.1	25.8	27.8	10.1	6.1	0.2	0.3	0.0	5.6	37.2	3.2	0.5	2.3	6.5	9.2	0.0	4.7	0.0	5.0	0.2	14.5	13.5	0.1	10.3	3.6	8.5	11.9	33.8	20.4	0.0	0.1	0.1	23.0	0.8	0.0	3.1	1.6	0.0	3.1	0.0	6.7	0.1	2.3	0.3	0.1	2.4	8.9	0.5	6.3	5.3	4.2	13.0	23.4	12.9	7.0	5.8	10.0	2.4	1.8	0.0	3.5	31.3	8.0	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	4.0	4.4	0.2	6.5	0.0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5.0	5.0	4.7	4.8	11.9	4.3	0.5	13.0	5.7	20.7	2030.9	7.6	10.7	1.2	3.5	0.0	0.4	0.0	8.7	4.5	40.9	0.0	0.0	0.8	0.3	27.9	2.8	2.3	0.0	0.5	20.6	0.0	23.4	0.0	1.3	11.5	3.9	10.1	1.0	0.0	36.4	1.5	0.0	109.6	0.3	10.3	103.5	126.0	4.1	1.4	4.0	0.6	0.0	0.0	2.6
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 108.3;Mucus-secreting cells: 58.0;Paneth cells: 72.4;Undifferentiated cells: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;OE19: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030351, HPA072906"	Enhanced		Approved	Centrosome		NA	NA			Centrosome		"HPA030351: AB_10602185, HPA072906: "	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.3	5.7	2.5	2.1	7.4	8.4	4.7	2.4	8.2	3.2	4.0	0.1	10.3	0.0	5.6	8.4	4.0	3.3	0.3	4.1	1.8	0.1	0.0	0.0	1.7	0.7	1.9	0.0	0.0	5.2	1.3	3.2	5.3	13.7	3.8	0.0	0.1	0.1	6.3	7.7	0.0	0.0	0.5	16.5	2.0	0.0	0.9	0.1	4.8	0.7	0.1	0.2	1.4	2.3	0.8	1.2	2.5	0.0	2.6	3.5	4.3	2.9	1.9	0.2	0.9	0.0	3.3	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5	0.0	1.1	0.0	2.5	3.7	0.0	1.6	10.2	1.4	3.4	14.0	0.0	11.9	1.7	12.5	0.5	2.1	108.3	0.0	15.3	9.0	8.1	2.6	0.0	1.1	4.9	0.0	15.1	4.9	13.3	0.0	5.2	6.4	1.7	3.6	58.0	0.0	28.8	72.4	11.3	15.3	0.0	6.5	6.2	0.3	0.2	5.6	23.8	1.3	48.1	3.7
MXI1	"bHLHc11, MAD2, MXD2, MXI"	ENSG00000119950	"MAX interactor 1, dimerization protein"	P50539	10	110207605-110287365	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 32.0;SK-MEL-30: 52.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035319, HPA035320, HPA056762"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nucleoli rim, Cytosol"	"HPA035319: AB_10670588, HPA035320: , HPA056762: AB_2683229"	"unprognostic (1.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.26e-3)"	"prognostic unfavorable (9.17e-4)"	"prognostic unfavorable (1.02e-5)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.96e-1)"	16.9	19.4	37.2	7.5	34.9	32.7	26.5	56.4	36.9	20.3	26.4	33.9	20.1	12.0	26.0	23.8	39.5	19.1	17.4	36.0	35.1	26.6	23.9	30.5	16.5	7.1	37.0	25.9	46.4	23.1	25.6	12.1	14.4	26.2	24.5	22.1	15.8	41.2	32.7	22.8	25.4	22.5	18.2	44.7	7.8	14.7	13.5	38.1	7.0	29.2	13.4	9.8	32.8	33.9	4.5	2.2	11.0	4.7	1.4	8.6	2.3	5.4	2.2	5.6	11.2	8.8	6.7	2.4	3.2	10.8	2.1	6.6	0.9	9.8	7.2	5.2	5.5	3.5	7.1	6.7	7.6	5.6	3.6	9.0	1.9	4.4	4.1	5.8	3.8	4.3	7.1	29.0	3.7	14.8	32.0	2.0	5.7	7.1	15.6	3.5	3.5	2.5	7.8	2.4	8.9	6.7	1.6	7.3	11.4	7.3	0.5	9.5	15.7	3.1	2.3	52.2	7.3	2.6	12.5	2.0	3.7	6.4	4.0	1.6	12.9	6.8	2.6	10.0	14.2	3.9	2.2	3.1	11.0	3.1	2.5	5.8	3.9	6.7	3.6	1.7	4.5	8.6	2.2	7.8	1.4	4.7	2.2	5.0	2.3	37.2	34.9	56.4	36.9	35.1	26.6	37.0	25.9	26.2	38.1	14.9	15.6	8.3	48.3	51.5	37.3	78.1	28.1	21.4	31.8	31.4	45.2	3.4	39.7	15.1	4.1	38.3	50.6	116.8	12.7	13.2	31.9	46.8	3.5	46.4	10.1	49.3	16.3	19.6	18.4	7.0	41.7	19.0	99.5	18.0	20.8	127.5	14.4	35.1	52.3	53.0	43.0	45.3	88.6	8.6	26.0	58.8	8.1	21.3	15.6	33.1
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541484-36551447	"Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 717.2;urinary bladder: 496.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 1565.8;Peritubular cells: 1778.4;Sertoli cells: 2108.4;Smooth muscle cells: 1718.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.6;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 85.3;BJ: 110.6;fHDF/TERT166: 87.8;hTERT-RPE1: 70.2"					"Low region specificity"	"Detected in single"			"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA		92000000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	61.9	46.0	2.0	58.1	5.8	0.2	64.8	1.4	6.4	123.3	361.6	6.0	162.9	22.7	278.8	102.0	242.7	80.3	199.0	169.8	1.9	2.1	27.7	6.8	36.0	14.9	4.7	8.7	107.8	5.4	2.8	4.8	31.7	10.5	218.9	30.4	71.8	22.6	203.9	22.2	14.7	70.3	717.2	5.2	22.8	120.7	55.1	1.4	1.4	48.8	21.9	8.7	496.7	107.7	1.2	0.5	2.7	0.2	0.3	0.1	10.8	8.0	0.1	6.4	0.1	85.3	32.8	28.4	110.6	47.9	58.0	37.6	63.8	0.9	0.0	58.0	87.8	12.7	3.0	0.0	0.2	13.7	0.0	0.0	1.6	12.5	5.9	55.1	0.0	1.9	45.9	5.8	38.3	0.1	70.2	2.0	0.0	0.2	2.9	48.6	0.0	0.0	0.8	2.5	1.6	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.4	1.1	2.8	0.0	29.2	24.7	1.6	14.2	55.4	23.4	8.0	0.1	0.0	0.4	0.2	21.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.2	0.0	0.0	2.7	0.3	0.0	0.5	0.0	10.8	2.0	5.8	1.4	6.4	1.9	2.1	4.7	8.7	10.5	1.4	366.3	53.6	10.5	235.7	53.9	0.8	1565.8	30.6	20.1	50.0	85.5	0.0	24.0	23.2	211.4	5.9	105.7	0.0	0.0	105.2	66.4	237.6	45.8	15.0	1.1	29.4	1.6	0.0	219.1	4.8	25.6	307.2	19.2	69.2	26.2	0.1	179.9	56.1	0.0	1778.4	24.0	5.5	2108.4	1718.3	4.2	6.9	46.7	22.4	10.2	0.6	57.0
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416492	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 14.4;Cone photoreceptor cells: 5.9;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.8;HaCaT: 11.8;HHSteC: 12.7;hTERT-RPE1: 9.4;TIME: 15.3;U-87 MG: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA					"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	1.5	8.3	9.8	1.4	18.3	1.6	5.2	13.4	29.4	3.6	1.3	18.6	0.0	1.1	1.5	3.4	1.1	2.6	4.6	6.0	10.8	11.4	1.2	2.3	2.7	1.0	11.0	13.1	5.6	2.1	4.2	13.0	5.6	17.0	1.3	1.7	4.3	1.6	2.5	1.0	1.6	1.4	1.3	12.7	1.3	1.8	2.0	14.1	0.0	4.8	0.0	0.8	1.6	0.6	1.4	0.8	5.4	0.5	0.9	0.9	0.3	0.1	6.6	1.3	0.2	0.6	0.3	0.1	0.7	0.6	1.6	0.4	0.1	7.8	0.0	0.4	3.1	0.8	11.8	0.0	1.8	4.2	0.0	0.8	0.4	3.8	0.1	12.7	0.2	0.2	0.2	0.5	1.4	3.9	9.4	6.9	0.0	0.1	0.4	5.0	0.0	0.1	0.0	0.3	1.1	1.4	0.0	0.0	0.0	3.9	1.6	1.0	0.2	0.1	0.1	0.6	0.7	0.2	0.1	15.3	0.4	0.1	0.3	1.6	0.0	0.1	0.0	9.7	0.0	0.3	5.4	0.5	0.8	0.9	0.3	0.4	0.7	0.5	0.5	0.1	1.4	0.6	0.5	1.8	0.9	0.2	0.8	0.4	0.3	9.8	18.3	13.4	18.2	10.8	11.4	11.0	13.1	17.0	14.1	0.0	0.0	0.0	0.0	0.2	14.4	4.5	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.5	3.5	0.3	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.1	25.4	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.8	0.0	2.4	0.0	0.3	0.2	0.7	0.1	0.5	0.0	0.0	0.0
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 130.3;Cone photoreceptor cells: 137.4;Rod photoreceptor cells: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 16.5;SH-SY5Y: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.3	3.0	0.4	0.0	0.1	3.4	5.2	4.0	3.3	0.0	0.5	1.4	0.0	5.8	2.2	0.1	1.8	0.7	8.4	0.6	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	16.5	0.7	0.6	0.0	9.7	0.5	1.0	0.5	0.0	2.3	2.9	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.0	2.5	0.0	1.7	4.3	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.5	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0	26.8	8.6	0.5	5.0	0.9	130.3	43.7	12.7	61.6	14.8	8.7	137.4	0.1	1.7	7.3	14.9	6.3	0.0	0.0	1.5	0.1	8.3	8.7	23.3	0.0	0.7	44.5	22.0	9.2	2.4	11.0	16.4	2.9	6.8	1.0	1.4	66.5	2.3	0.0	18.0	7.1	84.5	6.5	12.2	4.9	5.9	0.6	0.0	0.0	0.8	13.1
NDRG4	"KIAA1180, SMAP-8"	ENSG00000103034	"NDRG family member 4"	Q9ULP0	16	58462846-58513628	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 59.2;brain: 134.1;heart muscle: 112.6"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 389.7;Horizontal cells: 487.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 23.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"EFO-21: 18.4;GAMG: 16.2;hTERT-RPE1: 15.2;SCLC-21H: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015313, HPA017587"	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015313: AB_1854343, HPA017587: AB_1854344"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.84e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.17e-2)"	3.6	59.2	28.7	2.9	49.4	1.6	2.3	65.4	134.1	3.8	3.5	11.0	15.6	3.4	10.2	5.1	10.0	3.9	3.4	112.6	30.5	32.0	2.3	1.9	6.5	3.4	33.7	35.4	2.1	2.6	10.8	11.6	2.6	81.2	2.1	3.2	8.7	2.9	18.2	5.3	3.9	3.2	8.7	11.7	11.7	2.6	19.9	7.4	0.0	2.6	0.3	3.5	2.7	8.0	1.5	0.1	0.2	0.0	0.1	0.9	0.2	0.1	9.3	8.9	1.7	0.2	1.7	0.7	2.9	4.5	1.4	0.9	3.5	2.4	0.2	18.4	2.2	16.2	0.8	0.7	0.5	1.2	0.0	1.8	0.4	1.5	2.5	2.5	0.1	0.1	2.1	0.2	0.9	0.0	15.2	11.7	0.0	0.1	0.1	1.3	2.3	0.9	0.1	0.8	0.3	6.8	0.2	2.5	0.2	0.4	5.8	27.8	10.4	0.3	0.8	0.1	1.1	0.3	0.1	4.2	1.2	3.5	0.3	0.4	0.5	0.2	3.0	6.4	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.2	28.7	49.4	65.4	63.4	30.5	32.0	33.7	35.4	81.2	7.4	0.0	3.4	0.0	4.0	1.8	38.9	389.7	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	4.6	13.5	0.0	0.0	0.2	0.1	1.5	1.4	0.0	0.2	0.0	487.8	1.7	23.9	1.0	6.2	4.0	0.7	6.8	0.0	0.0	74.2	3.2	0.0	2.5	0.0	22.6	6.5	5.7	3.9	3.6	5.1	0.0	0.0	0.0	7.5
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.1	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	2.3	0.0	1.0	0.0	0.1	0.0	4.6	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	6.4	0.0	1.7	4.0	4.4	0.0	4.9	6.3	3.1	0.8	0.0	0.1	0.0	3.9	0.0	0.0	0.0	4.1	4.3	0.1	0.0	2.1	2.9	0.0	0.2	1.5	3.8	3.8	0.0	1.6	6.0	3.6	3.1	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4	17.9	54.2	0.0	0.2	0.5	3.9	55.7	0.0	0.0	4.5	12.2	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.2	0.0	1.3	0.1	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1.0	2.3	0.7	3.3	0.0	0.0	0.3	0.1	0.0	2.1	5.6	0.5	6.5	2.7	4.3	1.7	0.6	0.0	0.0	0.0	0.0
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 165.2;Horizontal cells: 208.2;Rod photoreceptor cells: 212.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"BJ: 13.3;fHDF/TERT166: 24.1;hTERT-RPE1: 11.8;SCLC-21H: 11.2;U-138 MG: 31.3;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced					NA	NA		2100000			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	4.9	8.7	21.1	3.9	25.9	0.6	3.8	22.3	37.3	4.6	7.8	49.6	1.1	5.1	9.1	10.4	11.3	12.0	6.6	17.4	19.5	10.8	10.7	2.4	5.7	2.6	27.9	25.2	11.9	6.4	1.6	11.7	11.2	28.7	8.7	6.8	8.1	2.6	18.4	3.3	4.2	5.6	15.3	17.5	6.8	5.3	2.0	34.0	0.0	3.0	0.2	3.4	8.9	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.2	0.4	0.0	13.3	0.0	9.7	2.9	0.0	0.0	0.0	0.0	24.1	9.1	6.3	0.2	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	6.1	0.3	11.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.1	0.0	1.1	0.0	0.0	0.0	11.2	0.6	0.0	0.7	0.0	1.0	0.1	0.0	0.0	31.3	6.7	0.0	0.0	0.0	0.0	0.0	15.5	0.0	7.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	25.9	22.3	35.0	19.5	10.8	27.9	25.2	28.7	34.0	0.0	1.1	0.0	1.5	1.9	165.2	19.5	0.0	0.0	1.2	0.0	11.8	0.3	0.0	0.2	5.3	4.9	0.0	0.0	0.0	0.2	10.1	1.0	0.0	2.0	0.4	208.2	36.4	2.5	0.6	9.7	6.1	0.0	1.7	0.0	4.8	12.0	0.8	0.0	5.3	1.4	212.3	51.8	51.4	1.9	3.2	4.1	0.6	0.0	0.9	0.7
NFATC4	NFAT3	ENSG00000100968	"Nuclear factor of activated T cells 4"	Q14934	14	24365673-24379604	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 22.4;Leydig cells: 16.1;Sertoli cells: 25.8;Smooth muscle cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.3;BJ hTERT+: 24.9;hTERT-RPE1: 21.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA031641, CAB032859, HPA076526"	Uncertain		Supported	"Nuclear speckles,Cytosol"		No	No			"Nuclear speckles, Cytosol"		"CAB032859: AB_1128521, HPA031641: AB_10600826, HPA076526: AB_2686805"	"unprognostic (3.51e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (8.08e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (1.81e-6)"	"unprognostic (1.47e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.19e-2)"	9.0	11.3	4.3	5.5	6.7	0.4	10.9	4.2	5.1	28.2	14.0	3.3	8.9	3.4	19.0	11.4	9.1	13.8	21.6	7.8	4.9	1.3	6.4	0.9	5.6	3.3	8.0	4.1	33.1	2.7	8.4	8.6	14.0	6.3	14.8	3.9	9.3	4.0	13.5	4.6	6.9	5.9	20.9	2.8	4.2	7.7	9.6	3.1	1.5	11.0	5.9	5.8	22.3	14.7	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	13.2	19.3	0.0	8.6	24.9	11.7	10.3	0.0	7.2	7.3	0.2	12.4	0.8	0.0	3.5	0.1	7.1	0.0	0.3	5.6	9.0	0.0	6.4	0.0	0.0	13.9	0.1	7.1	0.0	21.8	9.1	2.3	1.8	0.0	2.2	0.4	0.0	0.8	1.1	0.5	0.0	0.5	0.8	0.9	0.0	0.1	1.5	6.1	0.0	1.7	2.8	4.6	5.2	2.2	5.2	10.9	2.3	10.2	0.0	5.3	0.7	5.1	2.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.3	6.7	4.2	5.1	4.9	1.3	8.0	4.1	6.3	3.1	3.0	7.2	0.8	1.0	3.9	0.4	5.2	0.0	0.0	5.7	0.0	0.0	0.4	0.0	1.8	2.4	3.8	0.4	0.0	0.2	0.5	22.4	0.6	0.0	0.0	0.6	0.0	7.5	1.8	0.0	4.0	16.1	0.0	6.8	0.0	4.7	11.3	0.8	0.0	7.1	0.0	1.6	25.8	25.5	13.4	2.2	3.0	0.5	0.0	1.3	2.1
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285918-115338236	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	29	"Leydig cells: 27.0;Sertoli cells: 116.4;Smooth muscle cells: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.2;BJ hTERT+ SV40 Large T+: 12.9;GAMG: 20.0;hTEC/SVTERT24-B: 12.6;hTERT-RPE1: 20.9;U-2197: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA	40000					"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavorable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	9.1	2.3	1.3	2.8	1.6	0.2	6.5	0.6	2.8	7.5	3.4	0.6	2.3	0.3	11.4	5.9	1.5	10.6	6.6	16.5	3.2	0.6	3.4	2.7	1.4	1.5	2.3	1.6	17.8	0.7	0.3	2.1	2.0	1.7	3.7	1.2	7.0	3.8	2.0	1.8	0.6	1.4	7.0	2.1	3.8	1.6	3.2	1.1	0.0	2.9	3.0	0.3	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	36.2	4.1	12.9	9.5	0.0	0.0	0.0	0.8	8.5	20.0	1.4	0.0	0.2	5.8	0.0	0.1	0.0	0.2	0.0	5.4	0.0	0.0	0.0	0.2	12.6	9.4	20.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.1	0.7	0.2	0.0	1.7	0.0	0.0	0.3	0.8	1.5	25.2	1.4	0.0	0.0	0.0	1.5	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.6	2.8	3.2	0.6	2.3	1.6	1.7	1.1	0.0	0.0	0.0	0.4	2.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.8	0.0	0.6	0.0	0.0	0.0	1.1	4.5	0.6	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	27.0	0.5	1.7	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	116.4	31.9	0.0	0.7	1.9	2.1	0.0	0.0	0.1
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	4.0	1.0	0.0	5.8	43.7	5.3	3.0	0.0	0.1	0.0	4.6	7.3	4.1	3.6	0.2	0.0	1.8	0.0	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	13.6	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	5.6	0.0	1.3	0.0	2.1	0.0	8.1	0.0	0.0	0.0	0.0	3.8	5.8	45.2	1.2	0.0	0.0	0.0	6.0	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0	0.0	1.1	0.0	0.6	16.7	0.0	1.2	0.0	2.7	2.3	36.6	0.0	0.0	0.0	7.2	0.0	12.6	0.3	0.0	1.0	0.0	15.4	14.0	23.1	0.0	1.4	3.2	9.2	0.6	1.2	0.0	2.8	0.4	74.2	0.0	1.3	0.0	0.6	2.9	0.7	0.0	0.2	0.0	20.8	0.0	0.0	14.8	0.1	0.0	9.8	0.9
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324356-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"kidney: 65.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 119.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015475			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015475: AB_1854574"	"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1.0	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1.0	0.0	0.0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	8.5	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.3	0.0	34.8	0.1	2.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0.0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	4.1	1.1	0.0	0.0	0.0	10.4	5.9	1.2	13.3	0.0	0.8	1.1	0.0	0.0	0.0	0.6	1.1	0.1	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.7	0.1	0.0	1.1	119.8	19.3	0.0	0.3	0.5	0.1	0.3	2.1	0.0	0.0	0.0
NPIPA3		ENSG00000224712	"Nuclear pore complex interacting protein family member A3"	F8WFD2	16	14708944-14726338	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"brain: 13.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Cardiomyocytes: 4.1;Ciliated cells: 4.0"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 5.0;hTERT-RPE1: 7.1;NB-4: 11.2;SK-MEL-30: 16.1"									HPA053611	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (1.44e-1)"	"unprognostic (7.83e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.11e-2)"	"unprognostic (4.58e-3)"	"unprognostic (4.87e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.20e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.71e-2)"	1.3	1.4	1.8	2.3	1.3	1.9	1.2	13.2	5.0	0.8	2.9			0.5	2.4	2.2	1.1	2.8	6.4	1.0	2.2	1.8	1.1	0.8	1.2	1.0	1.1		2.8	1.5	7.2	4.1	1.3		2.3	2.6		1.9	2.9	5.3	3.2	3.4	1.2	1.0	1.0	1.3	1.8			1.4		1.0	1.9	1.6	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.3	0.0	0.1	1.5	0.5	0.0	0.4	0.4	0.0	2.1	3.5	0.2	1.3	0.8	0.1	0.1	2.3	0.3	0.1	0.0	0.4	0.7	0.4	0.2	0.1	0.5	5.0	0.7	1.3	0.2	7.1	0.1	0.7	0.1	0.3	0.3	1.3	0.0	11.2	0.9	0.0	0.0	0.1	0.0	0.0	3.1	1.0	0.5	0.5	0.0	0.2	16.1	0.7	0.2	0.0	0.5	0.6	0.1	0.0	0.1	0.0	0.2	0.1	1.9	0.1	2.0	1.6	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	0.0	0.5	0.0	4.1	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.3	0.0	1.1	0.0	0.1	0.0	1.2	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.5	0.0
NR2F1	"COUP-TFI, EAR-3, ERBAL3, SVP44, TCFCOUP1, TFCOUP1"	ENSG00000175745	"Nuclear receptor subfamily 2 group F member 1"	P10589	5	93583224-93594615	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	16	"Ito cells: 216.7;Leydig cells: 86.6;Muller glia cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 57.1;HHSteC: 43.9;hTERT-RPE1: 38.5;PC-3: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019281, HPA058974"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB019281: , HPA058974: AB_2732629"	"unprognostic (8.07e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.75e-1)"	"unprognostic (7.68e-3)"	"unprognostic (3.18e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.24e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (1.47e-4)"	15.8	22.9	22.5	5.0	13.7	1.2	9.1	27.4	25.1	31.7	4.6	12.9	10.8	3.3	20.6	24.1	9.4	32.3	30.7	7.2	20.9	13.7	16.4	10.6	18.0	12.7	13.4	23.0	40.4	4.4	1.8	10.3	46.0	14.6	20.5	3.8	44.4	7.2	38.9	1.2	1.6	4.4	14.2	26.7	6.7	12.9	5.9	11.4	0.0	7.5	4.8	4.2	20.9	18.0	0.0	0.0	0.5	0.1	0.2	0.0	0.0	4.7	2.3	57.1	22.6	12.1	3.7	2.7	2.8	1.1	1.7	1.7	0.3	0.8	0.0	0.1	1.1	0.7	1.2	1.4	0.0	0.7	5.8	10.9	2.1	13.8	3.5	43.9	0.4	0.2	17.5	0.0	0.8	0.3	38.5	6.4	0.0	0.0	0.0	5.2	0.0	0.0	0.6	0.0	0.3	47.2	0.6	0.4	0.0	0.3	0.2	5.9	11.9	1.2	0.0	0.1	1.0	0.4	0.8	6.4	9.7	0.4	5.0	6.9	0.0	0.0	0.0	15.9	0.2	4.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	22.5	13.7	27.4	19.8	20.9	13.7	13.4	23.0	14.6	11.4	0.0	1.7	2.2	0.1	1.1	31.9	15.8	2.5	16.0	5.7	14.0	51.1	0.6	6.6	0.9	1.2	13.7	0.0	0.0	1.4	0.4	39.1	0.4	0.0	3.0	1.0	0.0	0.0	216.7	20.5	2.3	86.6	0.5	0.0	0.0	0.0	68.8	3.2	0.0	9.9	27.4	2.5	12.9	31.6	3.7	2.2	0.5	0.9	0.0	0.0	0.6
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 47.2;Mucus-secreting cells: 43.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 4.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.1;HUVEC TERT2: 6.8;Karpas-707: 7.3;PC-3: 6.8;RPTEC TERT1: 9.1;TIME: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (2.75e-3)"	"unprognostic (2.63e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.10e-11)"	"unprognostic (1.42e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	7.0	5.6	9.0	12.9	9.5	1.5	7.2	16.8	14.5	8.2	23.4	8.2	6.5	9.7	7.2	4.8	3.8	7.1	10.2	9.7	12.7	6.5	13.8	9.6	8.2	4.2	7.5	7.7	17.0	8.6	22.5	16.7	2.4	5.7	5.9	28.4	12.1	16.9	9.6	12.1	4.6	26.5	8.6	6.5	5.7	9.0	4.8	6.5	2.2	21.7	7.6	5.0	10.7	5.6	0.8	0.0	0.0	0.4	0.1	4.8	0.4	0.0	0.0	0.0	0.0	0.5	0.4	0.4	0.0	0.1	0.0	0.5	0.0	0.1	1.5	2.9	1.1	0.2	0.0	1.6	0.8	0.1	0.3	2.8	0.3	0.7	0.0	0.0	1.8	0.4	0.1	0.0	0.1	0.0	11.1	6.8	1.1	0.0	7.3	2.3	0.0	0.0	0.0	0.1	1.3	6.8	0.6	0.0	0.1	9.1	0.1	0.1	0.1	0.0	1.6	0.7	0.1	0.8	0.0	8.9	4.8	2.8	0.2	0.9	0.0	0.0	0.1	1.6	0.6	1.2	0.0	0.0	0.0	1.5	0.0	4.8	0.4	1.8	1.2	0.0	0.8	2.9	2.9	0.0	0.1	0.4	0.0	0.5	0.4	9.0	9.5	16.8	14.5	12.7	6.5	7.5	7.7	5.7	6.5	26.8	11.5	3.5	1.7	1.8	8.9	17.5	10.2	5.3	10.3	10.4	17.7	0.7	8.3	3.1	47.2	4.9	35.4	0.0	5.1	0.2	3.1	1.8	5.7	4.0	0.5	12.7	17.3	6.2	3.7	30.6	4.0	0.9	6.8	1.0	43.5	7.3	3.7	23.4	3.5	1.7	9.3	0.0	3.1	1.2	4.9	1.5	0.1	0.0	20.3	1.8
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 238.8;Sertoli cells: 278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 24.0"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 69.4;hTERT-RPE1: 59.9;TIME: 57.7;U-87 MG: 69.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		720000000			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	69.9	15.0	4.9	13.6	4.9	0.7	53.8	1.3	5.6	25.1	17.6	2.4	16.4	6.7	29.8	21.9	14.7	17.0	23.3	50.5	17.2	5.9	47.1	27.4	47.1	30.1	3.5	3.2	27.1	14.1	11.7	6.4	44.3	3.6	25.2	7.8	24.3	11.8	31.6	22.3	9.1	14.6	19.1	5.5	38.7	9.8	15.6	2.8	5.9	30.4	24.6	7.9	22.3	23.8	0.4	24.0	0.3	1.7	0.6	0.4	0.4	8.6	33.8	1.7	0.1	33.0	37.0	0.2	35.0	34.1	17.6	19.0	4.2	20.8	0.1	4.2	69.4	18.7	2.4	2.1	10.2	14.4	0.1	1.7	0.0	3.9	7.2	11.7	3.1	0.2	44.2	1.7	41.9	19.0	59.9	47.9	0.2	0.1	0.2	34.4	14.6	0.2	0.5	0.8	1.8	32.1	1.4	3.8	0.1	16.6	0.1	0.7	0.4	3.5	2.7	0.1	1.5	0.1	0.4	57.7	25.2	5.9	30.3	23.5	0.1	0.1	0.1	69.1	4.0	22.7	0.2	1.7	0.3	0.3	0.3	0.4	0.4	0.3	0.3	1.4	0.3	0.4	0.3	0.3	0.6	0.1	24.0	0.3	0.4	4.9	4.9	1.3	5.6	17.2	5.9	3.5	3.2	3.6	2.8	0.0	22.7	8.1	9.5	14.0	8.7	57.4	35.7	8.1	13.6	17.4	3.9	48.5	1.7	46.0	0.7	84.2	1.0	0.0	16.8	10.8	38.6	3.8	7.0	11.4	109.4	0.0	4.1	238.8	53.2	2.6	39.1	27.1	11.8	9.0	0.3	3.5	10.9	0.0	19.8	29.4	0.6	278.1	64.5	0.2	0.7	9.3	56.2	2.5	0.1	2.8
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ito cells: 45.4;Pancreatic endocrine cells: 72.9;Rod photoreceptor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 13.4;memory CD8 T-cell: 6.6;naive B-cell: 19.9;naive CD8 T-cell: 17.3"	"Group enriched"	"Detected in many"	47	"B-cells: 19.9;T-cells: 17.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 93.4;LHCN-M2: 105.7;TIME: 61.2;U-87 MG: 95.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1600000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	12.2	3.2	9.3	7.7	11.6	0.5	16.6	1.1	6.9	58.8	13.9	3.6	8.1	18.6	33.3	14.8	7.6	12.2	15.4	6.1	5.7	5.5	8.8	26.0	3.4	6.8	6.3	6.6	25.4	1.4	1.6	9.3	42.2	5.3	16.4	15.6	15.3	4.6	17.8	5.7	4.5	14.9	35.3	6.3	7.0	6.0	12.4	4.2	1.6	26.5	7.3	7.1	16.6	20.2	19.9	0.0	0.2	0.0	0.4	17.3	3.9	5.3	2.8	4.9	0.1	11.2	35.7	0.0	34.5	37.8	17.0	32.0	0.0	53.0	0.0	12.4	30.1	43.8	2.7	0.0	34.7	40.6	0.0	0.0	0.0	0.8	0.6	5.6	0.0	0.0	9.1	0.4	34.7	22.1	93.4	14.1	0.0	0.0	0.1	105.7	0.9	0.0	0.0	0.1	0.9	3.8	0.1	1.1	0.1	36.8	2.4	0.0	0.6	0.4	2.1	11.7	0.2	0.0	0.9	61.2	13.9	0.1	17.5	56.1	2.6	1.6	0.0	95.4	0.0	43.5	0.0	0.0	0.2	2.0	0.0	3.5	13.4	2.3	6.6	0.0	19.9	2.4	17.3	0.2	0.4	0.0	0.0	0.8	3.9	9.3	11.6	1.1	6.9	5.7	5.5	6.3	6.6	5.3	4.2	0.0	4.3	15.6	1.0	4.6	4.6	0.8	20.4	6.7	6.8	1.8	9.8	0.4	3.3	3.7	0.5	13.5	10.3	0.0	3.7	1.5	16.9	0.9	0.0	29.0	1.3	0.0	0.0	45.4	5.3	0.9	12.0	2.5	6.8	0.0	33.2	5.6	72.9	31.7	24.1	20.6	77.4	0.0	8.0	0.0	0.2	4.3	12.7	2.2	13.8	5.9
OLFML2A	FLJ00237	ENSG00000185585	"Olfactomedin like 2A"	Q68BL7	9	124777158-124814885	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 12.1;Endothelial cells: 14.2;Fibroblasts: 13.1;Sertoli cells: 12.9;Smooth muscle cells: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 58.3;GAMG: 12.1;HeLa: 14.7;hTERT-RPE1: 13.5;WM-115: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA021180, HPA022254"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA			"Nucleoplasm, Cytosol"		"HPA021180: AB_1854790, HPA022254: AB_1854791"	"unprognostic (1.12e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (5.72e-3)"	"unprognostic (3.30e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.05e-2)"	17.3	2.1	1.0	7.4	1.7	0.1	10.9	1.9	3.4	34.2	18.9	3.1	6.3	2.3	29.2	8.3	11.8	4.2	7.6	12.5	1.2	1.0	3.0	0.6	10.3	1.5	2.1	1.5	13.2	3.4	3.6	2.1	5.0	4.0	16.1	4.6	18.9	4.7	9.5	9.8	11.6	5.0	33.7	1.6	23.8	4.0	3.1	0.6	3.7	20.0	11.9	5.0	22.0	10.4	1.4	0.7	2.6	0.9	0.6	0.6	0.4	0.3	5.2	0.4	0.1	6.1	58.3	0.0	0.8	2.9	1.2	1.2	0.0	0.7	0.0	1.5	0.0	12.1	9.7	0.1	0.3	1.4	0.0	0.0	0.0	14.7	0.0	0.3	0.0	0.0	4.1	0.9	3.6	0.5	13.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	1.3	0.0	0.5	0.0	3.5	0.0	0.0	0.4	0.0	0.0	1.2	0.0	1.5	10.6	1.4	0.1	0.0	1.8	1.9	2.0	0.2	0.7	0.0	0.0	5.6	0.3	22.8	1.9	0.9	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.7	1.4	0.4	0.6	2.6	0.6	0.3	0.6	0.3	0.4	1.0	1.7	1.9	3.4	1.2	1.0	2.1	1.5	4.0	0.6	0.0	2.2	0.0	3.7	10.6	0.5	12.1	0.0	1.4	0.0	0.0	2.0	0.2	0.0	0.1	0.6	14.2	0.0	0.0	0.6	0.2	13.1	1.0	0.0	0.0	0.1	0.0	0.0	3.1	2.4	1.2	2.6	0.5	10.1	0.0	0.0	0.2	0.0	0.0	1.4	0.0	3.9	12.9	28.8	0.2	0.7	7.3	0.0	0.0	0.0	1.6
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	92	"retina: 245.8"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA034951, HPA034952"	Enhanced				"Secreted in other tissues"	NA	NA					"HPA034951: AB_10669852, HPA034952: AB_2674379"				"unprognostic (3.29e-1)"	"unprognostic (1.56e-1)"					"unprognostic (7.69e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.70e-3)"		"unprognostic (8.24e-2)"	"unprognostic (3.65e-2)"			0.3	0.0	0.2	0.1	0.2	0.0	0.2	0.4	1.0	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0.0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.4	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.7	0.0	0.1	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.9	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0
OR2A1		ENSG00000221970	"Olfactory receptor family 2 subfamily A member 1"	Q8NGT9	7	144312464-144322668	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in many"		"thyroid gland: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	4	"basophil: 1.1;T-reg: 1.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.1;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.4;SK-MEL-30: 2.4;WM-115: 1.9"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"	"unprognostic (3.98e-1)"							"unprognostic (6.53e-2)"					"unprognostic (1.13e-2)"		"unprognostic (9.14e-2)"	"unprognostic (2.22e-1)"		1.1	1.1	0.0	0.8	0.0	1.8	1.4	0.0	0.3	1.0	0.6			0.4	0.8	0.7	0.2	0.8	1.0	0.8	0.0	0.0	0.8	0.5	1.4	0.8	0.0		2.4	0.4	0.0	0.5	0.2		0.7	0.0		0.5	0.3	0.5	1.0	1.0	0.5	0.0	1.4	0.4	0.2			5.2		0.4	0.7	1.0	0.2	0.0	1.1	0.1	0.0	1.0	0.1	0.3	0.0	0.0	0.2	0.1	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.2	0.2	0.3	0.3	0.1	0.0	0.4	0.3	0.0	0.4	0.3	0.0	0.3	0.2	0.0	0.5	0.0	0.2	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.6	0.0	0.7	0.2	0.0	0.2	0.5	0.3	0.0	0.1	0.5	0.2	2.4	0.2	0.1	0.2	0.0	0.1	0.3	0.1	0.9	0.3	0.1	0.3	0.0	0.1	1.9	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2A42		ENSG00000212807	"Olfactory receptor family 2 subfamily A member 42"	Q8NGT9	7	144228244-144239605	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"thyroid gland: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.3;THP-1: 1.1;WM-115: 3.8"									HPA058272	Uncertain					NA	NA					"HPA058272: AB_2683662"													"unprognostic (1.41e-1)"			"unprognostic (3.14e-1)"		0.6	0.8	0.1	0.0	0.1	1.7	0.9	0.0	0.0	0.7	0.2			0.1	0.4	0.5	0.2	0.3	0.5	0.5	0.0	0.0	0.7	0.2	0.7	1.2	0.1		1.2	0.3	0.0	0.4	0.0		0.4	0.2		0.7	0.1	0.3	1.9	0.9	0.0	0.0	1.4	0.3	0.2			3.8		0.0	1.0	0.4	1.4	0.5	1.5	0.5	1.0	1.0	0.0	0.9	0.2	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.5	0.3	0.0	0.0	0.0	1.3	0.8	0.1	0.2	0.6	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.8	0.1	1.1	0.8	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	3.8	1.1	0.5	0.4	0.4	0.3	0.3	0.6	0.4	0.3	0.2	1.4	0.5	0.4	1.5	1.0	0.3	0.5	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"prostate: 42.1;retina: 14.6"	"Cell type enriched"	"Detected in some"	13	"Intestinal endocrine cells: 74.5"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.7	0.2	0.2	5.0	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0.0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0.0	0.2	0.0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2.0	0.2	0.1	0.5	0.7	0.0	0.0	0.2	0.4	0.0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0.0	0.0	0.1	0.1	0.7	5.9	0.2	0.0	3.3	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.1	1.1	0.3	0.0	0.0	0.3	0.4	0.0	0.0	0.1	0.0	4.3	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.3	0.0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.4	0.7	0.3	0.0	0.4	0.0	0.1	0.4	0.0	0.0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.6	0.0	0.0	0.1	0.0	74.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR52N4		ENSG00000181074	"Olfactory receptor family 52 subfamily N member 4 (gene/pseudogene)"	Q8NGI2	11	5754243-5755905	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;T-reg: 3.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.3;T-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.5;BJ hTERT+ SV40 Large T+ RasG12V: 1.5;hTERT-RPE1: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.44e-2)"	"unprognostic (2.59e-3)"		"unprognostic (4.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.86e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.41e-2)"	1.3	0.4	0.1	1.1	0.1	0.8	1.4	0.0	0.4	0.8	0.6			0.0	1.4	3.4	0.7	1.6	0.5	0.7	0.2	0.1	1.1	0.3	1.3	2.9	0.2		3.5	0.0	0.0	0.9	0.0		1.2	0.6		0.6	1.8	0.2	0.6	3.6	0.1	0.5	5.7	0.4	0.6			0.6		2.9	0.5	1.4	2.3	0.4	0.0	0.1	0.0	3.1	0.3	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.0	0.2	0.2	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	2.3	0.4	0.6	0.0	0.0	0.1	0.4	3.1	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RX6	"MGC129625, P2RXL1, P2X6, P2XM"	ENSG00000099957	"Purinergic receptor P2X 6"	O15547	22	21009808-21028830	"Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"skeletal muscle: 12.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 7.4;Ciliated cells: 4.0;Intestinal endocrine cells: 3.4"	"Cancer enhanced"	"Detected in some"		"melanoma: 2.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 11.4;LHCN-M2: 7.7;RH-30: 4.8;U-87 MG: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028776, HPA028777"	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA028776: AB_2672771, HPA028777: AB_2672772"	"unprognostic (1.81e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.79e-5)"	"unprognostic (1.70e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.88e-10)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.39e-3)"	0.2	1.6	0.0	0.2	0.2	0.0	0.0	0.9	3.2	0.0	0.0			0.0	0.1	0.0	0.1	0.3	1.1	1.9	0.2	0.8	0.1	0.0	0.2	0.0	0.6		0.3	0.0	0.0	1.6	1.1		0.2	0.0		0.1	1.1	12.4	0.0	0.0	0.0	0.8	2.3	0.1	1.2			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.8	0.3	0.1	0.0	1.0	0.1	1.9	0.8	1.4	0.0	0.0	0.0	1.3	0.5	3.4	1.6	0.0	0.1	0.1	0.3	0.0	2.1	0.8	0.0	3.3	0.0	2.8	0.4	0.0	1.4	0.1	11.4	0.0	0.0	2.3	0.7	7.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.8	0.2	0.0	0.0	0.2	3.6	1.4	0.1	0.6	0.2	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.8	0.1	7.4	2.4	0.0	4.0	0.0	1.8	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.9	0.2	2.3	0.0	0.1	1.6	3.4	2.5	0.0	1.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	1.4	0.4	0.1	0.3	0.0	0.0	0.0
P3H3	"GRCB, HSU47926, LEPREL2"	ENSG00000110811	"Prolyl 3-hydroxylase 3"	Q8IVL6	12	6828410-6839851	"Enzymes, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 28.3;Cone photoreceptor cells: 94.2;Horizontal cells: 41.3;Leydig cells: 46.1;Peritubular cells: 36.0;Rod photoreceptor cells: 26.9"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;naive CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"BJ: 22.1;hTERT-RPE1: 15.7;NTERA-2: 15.7;U-251 MG: 15.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 17.6"	HPA043695	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cytosol"	Nucleoli	"HPA043695: AB_10797146"	"unprognostic (2.54e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (4.91e-4)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.77e-3)"	3.7	3.1	1.2	2.2	2.6	0.3	3.0	10.7	2.5	12.1	2.7	0.0	7.6	1.1	11.0	8.5	2.5	2.1	5.6	4.4	1.2		1.1	0.4	1.6	1.9	0.0	2.2	9.3	3.6	12.1	7.4	2.5	0.8	5.6	0.5	8.1	5.9	6.5	0.5	1.8	1.7	8.8	0.5	1.0	2.8	2.1	0.1	0.0	3.5	1.2	1.4	5.9	4.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.8	4.2	7.9	4.9	6.0	0.1	22.1	12.7	7.0	7.7	0.3	0.0	0.0	0.3	8.3	0.2	0.0	2.5	0.2	1.6	0.0	10.6	0.5	2.3	1.0	3.4	0.5	0.0	6.5	0.2	3.4	1.9	15.7	7.4	0.7	2.0	0.0	3.3	0.0	0.0	0.2	15.7	0.0	0.6	0.0	3.9	0.1	0.3	0.0	1.6	6.0	0.0	0.0	2.4	2.1	0.1	0.1	12.9	6.9	10.3	10.6	15.3	0.0	0.1	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.9	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0											0.0	0.0	0.0	3.8	0.0	28.3	9.0	2.5	2.7	3.4	5.2	94.2	0.3	1.7	1.6	0.7	2.3	0.0	0.0	2.3	0.4	7.4	4.6	0.0	0.0	1.2	41.3	1.2	3.7	0.0	1.3	46.1	0.0	0.0	1.8	2.5	4.8	1.9	0.0	36.0	0.3	26.9	6.5	9.2	0.7	0.9	0.0	0.8	0.0	0.4	1.4
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 94.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"	Yes	No			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavorable (9.01e-4)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavorable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	15.2	3.9	11.4	22.1	35.2	27.1	9.5	44.7	40.5	17.3	41.6	6.5	11.9	5.2	17.1	44.2	10.5	17.3	7.1	16.3	37.9	6.6	2.7	4.4	3.7	7.7	14.7	8.1	3.1	16.4	9.5	14.7	19.5	94.8	8.1	4.4	6.8	2.7	14.9	4.0	3.2	7.8	4.1	7.1	17.3	2.9	7.6	9.3	9.7	6.6	1.0	6.4	9.1	27.0	10.6	26.9	4.1	7.6	7.7	21.2	8.7	5.9	10.4	15.6	5.6	2.5	38.0	11.8	10.3	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9	6.0	27.9	18.6	25.1	32.3	12.9	37.9	2.5	56.2	31.8	22.7	25.5	25.0	0.0	26.6	10.0	23.3	10.7	0.0	17.0	76.6	76.1	22.0	39.3	25.1	39.6	11.1	9.9	19.0	44.8	4.7	48.1	41.1	42.2	36.1	7.6	33.4	37.2	18.2	44.2	22.8	17.6	38.8	31.1	35.7	35.8	20.8	27.8	13.8	6.5	17.3
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 852.6;Intestinal endocrine cells: 308.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 75.3;fHDF/TERT166: 96.5;hTERT-RPE1: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: AB_2677919"	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.7	2.2	27.1	12.0	75.3	45.1	10.8	41.8	62.6	12.4	37.8	7.1	19.5	0.0	9.0	96.5	17.5	5.0	1.5	18.4	34.3	1.8	6.1	3.0	8.8	2.3	11.4	0.9	3.3	24.6	7.9	9.1	6.9	78.8	25.5	1.2	0.1	2.0	35.1	3.0	0.0	0.4	4.8	2.6	8.1	1.1	15.1	8.1	47.8	1.7	12.8	8.9	17.8	1.1	10.9	16.6	4.6	0.9	19.6	39.4	10.2	18.4	12.4	4.6	1.1	0.0	45.2	4.1	33.9	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6	50.6	28.7	3.7	10.4	25.0	10.9	852.6	0.0	10.7	27.3	57.6	2.0	0.7	6.6	11.6	5.0	54.1	6.8	0.0	18.6	37.1	102.7	20.4	9.2	2.4	5.5	7.9	308.8	70.0	12.0	4.7	55.8	6.7	35.4	5.4	12.6	13.0	34.7	2.9	55.2	41.6	2.8	19.4	47.4	1.6	2.1	20.7	5.6	15.3	6.6	13.1
PAX6	"AN, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31818062	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.3;retina: 29.4"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 249.5;Muller glia cells: 410.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 78.3"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 61.0;olfactory region: 41.2"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.8	2.0	12.6	0.8	10.4	1.1	1.0	78.3	23.5	0.8	1.1	9.3	0.0	3.5	0.8	1.8	0.8	0.8	0.8	0.8	16.0	3.7	0.9	0.9	0.7	0.9	3.9	9.1	0.8	15.8	0.8	4.6	0.8	10.8	0.8	1.4	29.4	0.8	0.9	1.9	1.6	2.0	0.8	16.1	0.8	19.4	2.8	9.8	0.0	0.8	0.0	1.0	1.1	0.3	0.2	0.2	1.6	0.4	0.4	0.5	0.1	0.0	0.1	9.4	12.1	2.9	4.0	3.6	0.0	0.0	0.1	0.0	0.7	2.2	0.0	3.8	1.2	5.5	0.2	1.0	0.0	0.2	0.0	11.3	5.3	8.8	5.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	32.3	0.0	3.3	4.2	0.0	0.1	0.0	2.2	0.3	0.2	0.0	6.1	0.0	4.4	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	3.2	0.2	0.0	9.9	0.0	0.1	0.0	5.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	0.2	0.3	1.0	0.4	0.4	0.2	0.1	0.1	12.6	10.4	78.3	12.2	16.0	3.7	3.9	9.1	10.8	9.8	0.0	0.0	0.0	0.0	0.5	15.4	4.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	249.5	71.5	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	410.0	4.1	0.6	0.0	0.0	27.5	0.0	0.3	3.7	2.9	0.0	0.0	0.0	0.0	0.0
PCDH10	"KIAA1400, OL-PCDH"	ENSG00000138650	"Protocadherin 10"	Q9P2E7	4	133149315-133208606	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.0;placenta: 31.1;seminal vesicle: 23.6"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011220, HPA073462"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA011220: AB_1855041, HPA073462: AB_2686605"	"unprognostic (7.20e-2)"	"unprognostic (8.74e-3)"	"unprognostic (4.30e-2)"	"unprognostic (8.12e-5)"	"unprognostic (8.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.27e-3)"	"unprognostic (4.51e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.68e-4)"	"unprognostic (8.88e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.16e-4)"	1.9	7.6	17.9	1.5	35.5	1.2	1.3	1.7	48.0	3.3	1.5	23.2	4.5	1.3	3.1	1.9	1.6	2.6	1.9	1.8	17.5	12.6	3.7	1.3	2.0	1.2	13.2	16.3	4.1	1.4	1.2	1.7	31.1	13.6	14.7	1.5	1.3	1.8	23.6	1.2	1.3	1.7	2.0	6.8	1.2	1.3	2.9	19.2	0.9	1.5	0.0	1.2	3.6	3.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	5.2	0.0	0.1	0.0	0.0	5.0	2.7	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	16.1	0.0	0.2	0.0	2.4	0.0	13.4	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	32.0	8.6	0.0	0.0	7.3	0.0	0.0	0.0	0.6	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.9	35.5	1.7	27.7	17.5	12.6	13.2	16.3	13.6	19.2	0.0	1.1	0.0	0.2	0.1	16.2	2.0	0.0	0.0	1.2	0.0	0.0	0.7	1.7	0.0	3.3	1.0	0.0	0.0	0.0	0.7	1.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.4	0.0	2.3	0.0	4.7	1.8	0.7	0.3	2.4	0.0	0.0	0.4
PCDHA6	"CNR2, CNRS2, CRNR2, PCDH-ALPHA6"	ENSG00000081842	"Protocadherin alpha 6"	Q9UN73	5	140827958-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.7;pituitary gland: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5"									"HPA059326, HPA078110"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA059326: AB_2683980, HPA078110: AB_2732371"	"unprognostic (1.15e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.07e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-4)"	"unprognostic (4.23e-3)"	"unprognostic (8.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.56e-1)"	"unprognostic (5.66e-3)"	"unprognostic (3.55e-2)"	1.1	1.8	2.9	0.8	7.1	0.4	1.6	10.2	10.7	1.9	0.7	2.3	0.0	1.2	2.9	2.3	0.4	1.6	1.6	0.5	3.8	3.8	2.3	0.4	1.1	0.7	4.6	4.1	2.1	3.7	4.7	11.2	0.4	3.6	1.3	0.7	1.6	0.7	0.5	0.4	0.6	1.3	1.4	3.4	0.8	0.7	1.4	3.2	0.0	0.9	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	2.1	1.3	0.2	0.6	0.0	2.0	0.0	5.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	10.2	9.6	3.8	3.8	4.6	4.1	3.6	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCDHA7	"CNR4, CNRS4, CRNR4"	ENSG00000204963	"Protocadherin alpha 7"	Q9UN72	5	140834248-141012344	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 10.1;testis: 2.9"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 1.4;Horizontal cells: 1.6;Spermatocytes: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 2.0;NTERA-2: 3.2;SCLC-21H: 2.0;SK-BR-3: 2.8;SK-MEL-30: 3.6;U-2 OS: 2.4;WM-115: 3.5"															NA	NA						"unprognostic (1.99e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.08e-2)"	"unprognostic (9.29e-3)"	"unprognostic (4.11e-3)"	"unprognostic (7.20e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (9.54e-4)"	"unprognostic (6.86e-5)"	"unprognostic (5.34e-4)"	"unprognostic (2.88e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.14e-1)"	0.9	1.1	0.9	0.6	2.3	0.2	1.0	10.1	6.8	0.6	0.8	3.2	0.0	1.2	1.3	0.9	0.2	0.6	1.5	0.6	1.8	1.1	0.8	0.3	1.0	0.5	2.2	1.8	1.4	1.1	0.7	1.4	0.4	4.3	0.6	0.6	0.3	1.1	0.4	0.2	0.5	1.0	1.3	3.7	0.3	0.9	2.9	0.4	0.0	0.7	0.0	0.3	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.9	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.5	0.0	2.8	3.6	1.4	0.9	0.0	0.5	0.5	2.4	0.6	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.3	10.1	6.8	1.8	1.1	2.2	1.8	4.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 1.9;Horizontal cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.0;ASC TERT1: 13.0;GAMG: 22.7;hTERT-RPE1: 33.8;WM-115: 20.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	1.1	12.0	13.0	0.4	2.6	5.0	2.0	3.2	0.0	0.1	0.3	4.3	2.6	22.7	1.7	0.0	0.3	3.2	0.0	1.1	0.0	0.0	0.0	2.0	0.2	0.0	9.3	0.1	3.5	0.0	33.8	3.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	5.0	0.2	1.5	3.6	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1	0.0	0.6	0.0	0.1	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480"	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.8	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.3	0.8	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.0	0.2	0.1	0.3	5.8	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.5	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5	0.0	0.0	0.0	0.1	0.0	2.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.5	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PCDHGA7	PCDH-GAMMA-A7	ENSG00000253537	"Protocadherin gamma subfamily A, 7"	Q9Y5G6	5	141382739-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.9"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 3.5;Cardiomyocytes: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ hTERT+: 17.3;hTERT-RPE1: 9.3;SH-SY5Y: 15.5;T-47d: 6.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.00e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.42e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.21e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.42e-3)"	1.7	2.0	3.1	1.3	9.0	0.6	2.1	5.3	14.9	3.5	3.0	7.1	2.1	1.0	4.2	4.1	2.2	3.3	1.9	3.0	5.1	3.3	3.2	1.9	2.2	1.0	5.1	6.6	4.7	2.5	4.6	3.4	4.8	5.4	3.7	1.5	5.8	2.6	3.3	1.6	3.8	1.2	3.0	6.3	1.3	1.4	2.1	5.1	0.0	6.6	1.5	1.0	2.4	2.5	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	1.9	0.0	5.8	9.9	0.0	2.6	17.3	3.5	5.2	0.0	0.0	0.4	4.3	0.5	0.1	0.1	0.0	0.1	2.9	0.0	0.3	0.0	0.4	0.1	1.0	0.0	0.0	4.3	0.1	0.0	0.6	9.3	1.4	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	15.5	0.0	0.1	0.1	3.3	6.8	0.0	5.2	0.1	0.1	2.5	0.0	0.1	1.5	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.0	5.3	7.7	5.1	3.3	5.1	6.6	5.4	5.1	0.0	0.0	0.0	0.4	0.0	3.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3
PCDHGA9	PCDH-GAMMA-A9	ENSG00000261934	"Protocadherin gamma subfamily A, 9"	Q9Y5G4	5	141402932-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 3.7;Club cells: 1.2;Horizontal cells: 3.2;Muller glia cells: 1.3"	"Cancer enhanced"	"Detected in some"		"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.1;HSkMC: 4.6;hTERT-RPE1: 19.1;TIME: 5.0;U-87 MG: 5.8"					"Low region specificity"	"Detected in all"			"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-3)"	"unprognostic (9.86e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.87e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.48e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-2)"	5.6	5.4	12.0	2.6	12.6	0.9	3.7	11.5	17.3	6.9	2.7	11.2	0.1	2.1	7.6	3.9	4.8	6.3	6.5	3.2	10.3	8.5	3.0	2.8	5.0	2.1	9.6	7.1	9.1	3.0	3.8	3.0	3.6	10.9	5.2	2.7	7.7	3.8	7.3	1.9	5.5	2.0	5.9	13.0	3.6	2.9	2.0	5.9	0.0	4.6	1.4	2.5	4.8	3.7	0.5	0.3	1.0	0.5	0.2	1.0	0.0	0.0	0.2	0.7	1.8	0.1	0.3	0.2	0.8	0.0	0.7	0.7	0.3	0.4	1.4	4.1	2.2	0.3	0.1	0.1	0.2	0.8	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.3	4.6	0.2	0.4	0.3	19.1	1.1	0.1	0.1	0.2	0.4	0.4	0.2	0.5	0.2	0.1	0.0	0.2	0.5	0.0	0.2	0.2	0.5	1.2	0.4	0.1	0.6	0.5	1.1	0.5	5.0	0.3	0.3	0.1	2.7	0.2	0.1	0.1	5.8	0.1	1.0	1.0	0.5	0.3	1.0	0.3	0.6	0.3	0.4	0.2	0.1	0.5	0.4	0.7	1.0	0.2	0.2	0.3	0.1	0.0	12.0	12.6	11.5	16.2	10.3	8.5	9.6	7.1	10.9	5.9	0.0	0.0	0.0	0.1	0.2	3.7	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1
PCDHGB1	PCDH-GAMMA-B1	ENSG00000254221	"Protocadherin gamma subfamily B, 1"	Q9Y5G3	5	141350102-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"brain: 32.2;pituitary gland: 13.7"	"Group enriched"	"Detected in some"	17	"Early spermatids: 5.4;Late spermatids: 5.9;Melanocytes: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.7;ASC TERT1: 7.7;hTERT-RPE1: 8.0;T-47d: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA076182"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Focal adhesion sites,Midbody"		Yes	No			"Vesicles, Plasma membrane"	"Nucleoplasm, Focal adhesion sites, Midbody"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076182: AB_2686783"	"unprognostic (1.53e-2)"	"unprognostic (1.94e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.37e-1)"	"unprognostic (9.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.78e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.63e-3)"	2.3	2.7	8.2	1.4	7.5	1.0	2.1	4.3	32.2	2.5	1.4	9.4	0.1	1.2	3.7	2.0	1.7	1.9	2.1	2.2	7.6	5.7	2.1	1.3	2.4	1.2	5.5	5.0	4.1	2.8	1.4	13.7	1.6	7.0	2.5	1.4	2.6	1.7	3.1	1.1	1.4	1.3	3.0	6.9	1.4	1.2	1.5	5.6	0.0	2.5	0.0	1.2	1.4	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	2.0	1.8	0.0	14.7	7.7	0.1	1.4	3.6	0.5	0.8	0.2	0.5	0.5	4.7	0.5	3.5	0.6	0.4	0.2	0.5	0.0	0.9	0.0	0.2	1.3	0.2	0.0	0.1	1.2	0.0	0.0	0.0	8.0	0.1	0.0	0.2	0.2	3.3	1.8	0.4	0.3	0.2	0.0	0.0	0.0	2.7	0.1	0.0	0.0	1.1	0.8	0.0	0.9	0.1	1.5	9.6	0.0	1.1	0.2	1.6	1.2	0.0	0.0	2.6	0.3	2.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	7.5	4.3	9.6	7.6	5.7	5.5	5.0	7.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	1.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
PCDHGC5	PCDH-GAMMA-C5	ENSG00000240764	"Protocadherin gamma subfamily C, 5"	Q9Y5F6	5	141489121-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 43.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"glioma: 3.1;head and neck cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.0;SuSa: 8.4;U-138 MG: 16.0;U-251 MG: 6.8;U-87 MG: 9.8"	"Group enriched"	"Detected in many"	5	"amygdala: 129.6;basal ganglia: 118.6;cerebral cortex: 130.2;hippocampal formation: 113.0;olfactory region: 85.4"					"HPA008755, HPA010580, HPA076140"	Supported		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA076140: "	"unprognostic (2.86e-3)"	"unprognostic (7.63e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.52e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-9)"	"unprognostic (6.87e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.77e-3)"	1.0	1.1	7.4	1.1	34.5	0.9	1.1	3.0	43.7	1.1	1.0	2.8	0.0	0.9	1.4	1.3	1.0	1.2	1.2	2.8	11.8	2.8	0.9	0.9	1.1	0.9	2.2	10.0	1.1	1.0	1.0	1.1	1.0	2.3	1.3	1.0	0.0	0.9	1.6	1.6	1.5	0.9	2.0	0.8	1.0	1.0	1.3	1.1	0.0	1.0	0.0	1.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.7	0.2	0.8	0.6	0.5	0.6	0.0	0.0	0.5	1.6	2.4	0.1	0.1	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.5	0.0	5.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	8.4	0.1	0.2	0.1	16.0	0.2	0.2	6.8	0.0	0.0	0.0	9.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	34.5	3.0	39.2	11.8	2.8	2.2	10.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDE1C	Hcam3	ENSG00000154678	"Phosphodiesterase 1C"	Q14123	7	31751179-32299329	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.6;heart muscle: 56.2"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 55.0;Cardiomyocytes: 112.6;Cone photoreceptor cells: 49.1;Early spermatids: 40.4;Late spermatids: 38.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.2;fHDF/TERT166: 49.0;hTERT-RPE1: 15.0;U-251 MG: 26.5;WM-115: 35.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA052375			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052375: AB_2681802"	"unprognostic (1.29e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.65e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.75e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.88e-5)"	"unprognostic (7.03e-2)"	"unprognostic (3.09e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.06e-3)"	2.9	2.7	10.6	3.2	27.7	0.9	5.1	2.4	17.1	1.2	2.7	30.1	0.0	2.3	3.1	6.8	7.4	8.4	2.4	56.2	14.8	7.5	4.0	1.0	5.0	1.4	31.1	12.0	4.9	2.7	1.3	1.3	4.0	16.3	2.9	2.7	7.9	2.6	4.2	1.4	0.9	2.8	10.4	17.1	1.4	3.8	4.2	33.6	0.0	3.9	0.2	1.0	7.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.2	0.1	0.0	15.2	6.2	7.2	5.9	0.0	0.0	0.0	0.0	49.0	0.0	0.4	0.0	0.0	9.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	10.9	0.6	0.0	1.5	0.1	15.0	2.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	7.4	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.1	3.0	0.1	26.5	0.0	0.0	0.0	0.7	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	27.7	2.4	17.1	14.8	7.5	31.1	12.0	16.3	33.6	0.0	0.0	0.0	0.8	0.0	55.0	112.6	0.0	4.0	1.2	1.8	49.1	0.0	0.0	5.6	40.4	2.9	0.0	0.0	0.4	0.0	0.0	0.2	8.1	0.0	0.1	3.2	0.0	0.0	0.0	38.3	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.4	0.0	4.4	0.0	2.1	1.1	0.7	0.0	0.0	0.0	0.0	0.0
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494395-119628991	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Peritubular cells: 98.6;Smooth muscle cells: 79.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.6;HHSteC: 35.4;hTERT-RPE1: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	Cytosol		NA	NA		3100000	Cytosol		"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (6.95e-2)"	"prognostic favorable (5.20e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (1.17e-4)"	12.3	4.9	2.0	28.2	2.3	0.4	8.1	3.0	2.3	21.3	28.0	1.7	20.1	6.5	17.3	21.4	30.7	10.7	13.3	5.3	2.0	2.8	3.8	1.2	11.4	4.1	2.4	3.4	10.0	7.8	5.1	3.4	8.9	4.4	31.8	11.7	20.2	8.5	23.7	6.8	4.2	15.6	45.6	2.0	2.1	9.1	7.6	1.2	0.9	9.1	8.1	2.2	25.9	15.9	1.5	0.5	1.4	0.4	0.6	2.1	4.2	8.1	0.4	5.7	0.6	2.0	3.0	1.0	5.5	24.6	0.2	0.5	0.5	0.7	0.8	0.2	6.8	1.5	3.0	1.8	0.8	0.7	0.2	3.7	9.1	1.4	0.4	35.4	1.9	0.9	3.3	1.7	0.6	0.0	12.9	0.7	1.9	1.0	1.5	0.8	0.4	2.4	0.3	1.2	0.9	1.4	0.3	2.9	2.1	2.1	2.5	2.2	4.6	6.3	8.0	0.6	4.4	1.4	1.0	1.2	3.2	2.8	1.7	0.7	2.1	1.0	0.7	3.1	0.5	0.4	0.0	0.3	0.0	0.6	0.1	2.1	1.5	1.3	0.4	0.2	1.0	0.6	0.9	1.4	0.6	0.4	0.5	0.4	4.2	2.0	2.3	3.0	2.3	2.0	2.8	2.4	3.4	4.4	1.2	6.0	4.6	0.0	2.3	3.1	8.1	3.5	12.7	1.4	5.7	1.8	13.7	0.2	0.0	12.0	25.6	3.3	6.3	0.0	2.5	0.2	3.8	2.4	1.1	1.0	0.2	4.8	2.4	1.3	0.0	9.4	19.2	0.7	5.0	0.0	10.1	28.4	4.2	9.1	98.6	0.5	5.9	19.4	79.9	2.9	5.5	2.0	0.2	0.0	8.6	1.6
PDGFC	"fallotein, SCDGF"	ENSG00000145431	"Platelet derived growth factor C"	Q9NRA1	4	156760454-156971394	"Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 44.1;Cholangiocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	11	"monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009134	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA			"Plasma membrane, Cytosol"		"HPA009134: AB_10601981"	"unprognostic (3.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.41e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.35e-5)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.17e-4)"	11.5	9.1	3.2	6.5	3.4	0.7	7.9	1.3	3.5	21.8	6.1	1.9	8.4	2.2	21.3	9.4	6.1	9.0	12.7	3.6	2.4	2.0	9.7	10.3	6.9	4.3	2.2	3.8	10.4	9.8	28.0	2.2	4.9	1.9	17.7	2.4	5.5	26.6	9.3	6.5	4.1	5.4	11.9	2.0	4.1	5.6	4.3	1.7	2.2	10.4	4.4	1.5	8.3	4.7	0.0	0.2	0.0	2.1	0.0	0.0	0.7	1.0	1.6	17.8	11.7	3.3	6.5	0.4	9.3	9.9	5.6	7.5	1.0	4.2	0.0	1.6	27.1	4.3	1.1	4.9	6.1	7.7	0.0	2.2	10.8	1.6	1.0	8.7	1.6	0.1	6.7	3.0	14.2	10.2	26.6	2.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	3.7	0.0	10.6	0.4	0.0	0.0	0.0	0.0	0.1	2.9	1.4	0.5	12.0	19.4	0.2	4.9	7.5	0.0	0.0	0.0	7.4	0.0	0.7	0.0	2.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.7	3.2	3.4	1.3	3.5	2.4	2.0	2.2	3.8	1.9	1.7	6.0	13.9	0.0	18.3	44.1	0.3	13.7	45.9	0.0	7.9	12.2	0.0	0.4	0.0	13.8	31.1	4.9	0.4	0.0	6.2	0.2	15.8	6.7	1.1	13.0	10.6	0.0	0.0	11.6	21.7	18.1	4.9	14.8	10.1	16.2	2.0	6.7	12.6	0.0	21.5	14.9	0.3	6.5	17.3	0.2	2.2	11.8	0.5	0.5	1.3	4.3
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 1784.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA		2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"		"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.2	24.4	9.5	3.7	21.0	14.4	3.7	20.1	16.7	11.5	9.3	22.5	18.3	3.3	20.6	20.1	5.9	8.5	12.9	18.8	19.3	5.8	5.4	12.0	15.9	8.5	30.3	3.9	10.8	19.3	16.6	27.6	21.5	51.4	25.9	3.4	5.1	3.6	24.5	8.1	4.0	1.3	3.2	18.1	10.2	1.9	7.0	2.9	12.9	26.4	4.7	6.3	11.0	25.1	5.6	8.0	2.9	1.2	32.4	30.1	4.8	13.0	12.2	2.5	3.2	3.3	16.4	2.8	7.0	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7	41.7	23.4	12.7	232.1	172.6	4.3	1784.7	58.6	30.8	37.5	47.1	29.5	9.2	11.6	82.1	14.6	128.1	146.3	23.3	81.9	91.7	90.4	234.4	50.8	159.4	34.4	1.6	105.0	135.1	57.1	6.8	38.3	60.2	59.1	29.7	89.1	79.1	115.5	83.5	62.6	63.8	35.6	77.6	141.3	13.2	30.2	137.1	19.9	15.0	51.0	185.7
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 71.4;Early spermatids: 99.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 39.5;hTERT-RPE1: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Nucleoplasm, Mitochondria, Cytosol"		"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavorable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favorable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	7.9	3.9	8.6	3.6	7.1	13.1	2.8	6.3	7.0	7.4	8.7	4.1	29.6	4.4	21.2	10.0	39.5	17.7	3.6	5.3	11.0	0.4	1.8	2.1	4.9	1.4	8.2	1.0	3.0	8.4	10.5	12.6	20.2	39.3	16.7	4.0	0.7	7.3	9.0	1.9	6.2	3.2	3.9	8.6	5.1	1.5	5.1	0.8	5.1	5.5	0.8	3.7	4.1	0.4	19.3	7.3	1.3	1.2	29.6	9.0	5.8	21.0	7.4	4.1	1.7	3.7	11.5	3.7	7.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8	11.9	5.6	13.4	11.2	11.6	34.7	71.4	22.9	22.7	17.0	15.7	7.9	3.5	5.0	24.3	99.2	14.7	6.0	0.0	11.9	3.2	11.6	13.3	5.8	2.5	5.7	9.5	9.8	14.1	20.8	22.0	10.6	16.2	10.1	2.8	5.2	19.0	22.2	7.0	12.7	8.6	10.6	6.5	12.7	7.2	9.7	9.5	3.7	10.1	8.9	17.0
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
PHLDA1	"DT1P1B11, PHRIP, TDAG51"	ENSG00000139289	"Pleckstrin homology like domain family A member 1"	Q8WV24	12	76025447-76033932	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 142.4"	"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 1037.1;Smooth muscle cells: 353.3;Urothelial cells: 680.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.4;MAIT T-cell: 3.9;memory CD4 T-cell: 2.5;memory CD8 T-cell: 2.5;non-classical monocyte: 2.5;T-reg: 4.1"	"Group enriched"	"Detected in many"	7	"monocytes: 2.5;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 65.6;RPTEC TERT1: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016160, HPA019000, HPA063520"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"CAB016160: AB_628117, HPA019000: AB_1855309, HPA063520: AB_2685028"	"unprognostic (9.09e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.51e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.55e-3)"	13.2	15.9	9.4	8.4	12.1	9.0	13.5	6.4	15.7	11.5	4.5	11.1	4.8	3.4	7.1	3.1	33.3	5.1	20.0	9.6	8.2	7.9	13.8	33.2	14.2	3.0	8.4	5.6	10.8	8.8	2.6	6.0	7.1	10.0	4.8	5.5	24.9	142.4	6.5	3.3	6.3	7.0	7.6	9.7	14.6	10.8	2.3	10.1	2.5	18.0	13.2	19.9	17.0	17.8	0.3	0.1	0.4	2.5	0.3	4.1	0.6	12.7	15.3	12.0	6.6	5.6	11.7	0.8	10.8	29.2	4.9	6.8	8.4	15.6	0.0	3.2	4.5	16.3	6.5	0.3	18.1	10.6	1.9	0.2	0.3	0.7	14.3	8.2	0.3	3.3	3.6	13.3	20.4	40.6	65.6	11.8	0.0	1.0	0.3	25.1	1.6	0.0	1.6	4.4	7.7	23.6	0.0	3.1	0.3	51.5	28.9	0.8	2.3	1.8	0.1	35.1	15.6	7.7	0.1	10.9	16.8	1.6	19.5	10.6	0.1	0.0	0.0	28.4	0.1	20.9	0.3	0.1	0.2	2.4	0.2	3.9	0.3	2.5	2.5	0.0	0.2	0.5	0.6	0.4	0.3	2.5	0.1	4.1	0.6	9.4	12.1	6.4	7.7	8.2	7.9	8.4	5.6	10.0	10.1	11.9	17.2	2.7	1037.1	173.4	1.5	29.5	10.2	6.7	22.7	29.6	2.0	4.8	71.3	68.6	1.0	95.1	0.7	0.0	35.8	6.3	85.4	57.9	80.5	117.3	97.6	1.6	112.7	23.9	10.8	1.3	8.6	53.3	271.7	41.5	10.3	90.9	162.8	3.5	14.5	32.7	4.0	265.1	353.3	0.5	0.4	66.0	6.2	23.0	8.0	680.5
PIANP	"C12orf53, DKFZp547D2210, PANP"	ENSG00000139200	"PILR alpha associated neural protein"	Q8IYJ0	12	6693792-6700800	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 55.7"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 13.9;Horizontal cells: 17.5;Peritubular cells: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 14.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 7.9;HAP1: 7.8;hTERT-RPE1: 13.1;NTERA-2: 16.5;SH-SY5Y: 15.6;U-2 OS: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010631	Enhanced		Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA010631: AB_10603680"	"unprognostic (1.82e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.03e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.41e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.30e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.34e-2)"	1.5	8.3	28.0	2.2	55.7	1.2	1.5	27.4	52.8	7.2	2.7	2.6	0.5	1.9	11.6	4.1	1.8	2.2	3.3	1.5	19.5	26.2	1.5	1.1	1.5	2.4	11.0	20.9	1.8	1.7	1.2	4.0	1.5	9.0	3.4	2.0	1.7	2.2	8.7	1.3	1.7	2.2	8.1	4.6	1.6	2.1	4.4	8.3	0.0	1.4	0.0	1.7	1.8	2.5	0.3	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.4	5.9	1.1	0.2	0.3	0.2	1.5	7.9	4.1	3.7	0.1	0.2	0.1	0.0	2.8	0.6	0.2	7.8	0.2	2.0	0.2	1.0	0.3	0.2	0.0	0.2	0.3	0.2	1.0	0.0	1.6	0.0	13.1	0.0	2.4	0.0	0.2	0.3	0.2	0.2	0.2	16.5	0.0	0.0	1.1	0.0	0.1	0.1	0.1	2.1	15.6	0.0	0.1	0.0	1.1	0.0	0.0	0.0	4.3	8.7	4.4	1.1	0.2	0.0	0.3	5.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.7	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	28.0	55.7	27.4	27.8	19.5	26.2	11.0	20.9	9.0	8.3	0.0	0.0	0.0	0.0	0.2	13.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	13.1	0.0	3.0	0.0	1.4	0.1	4.5	0.1	0.1	0.0	0.0	0.0
PIFO	"C1orf88, FLJ23853, pitchfork"	ENSG00000173947	"Primary cilia formation"	Q8TCI5	1	111346288-111353013	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 55.9;fallopian tube: 96.8"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 720.1;Early spermatids: 388.2;Late spermatids: 350.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 55.9"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	25	"B-cells: 1.6;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.5;hTERT-RPE1: 4.5;RPTEC TERT1: 6.2;RT4: 7.3;SuSa: 11.6;T-47d: 5.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in many"													NA	NA						"unprognostic (3.18e-3)"	"unprognostic (3.23e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.00e-2)"	"unprognostic (7.43e-4)"	"unprognostic (8.78e-7)"	"unprognostic (6.43e-3)"	"unprognostic (7.28e-2)"	"unprognostic (9.07e-3)"	"prognostic favorable (2.48e-4)"	"unprognostic (3.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.03e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.83e-2)"	1.1	2.0	6.6	1.2	10.1	0.8	3.8	0.7	3.9	4.4	3.0	15.9	3.5	1.1	4.9	15.5	2.8	96.8	2.7	6.4	8.6	8.6	5.4	0.8	10.8	0.9	5.0	6.5	9.2	4.2	5.1	13.8	4.3	55.9	7.5	1.4	4.2	2.2	4.3	0.9	1.6	1.1	3.4	4.2	1.0	2.6	26.5	5.4	0.4	8.8	0.1	1.1	5.4	0.6	1.6	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.1	0.7	0.8	0.8	0.9	1.4	0.0	1.7	0.4	0.0	1.3	1.4	0.0	0.3	0.0	1.5	0.0	1.2	0.2	0.0	1.8	0.2	0.0	0.2	1.1	0.7	0.0	0.0	0.9	4.5	0.0	0.0	4.5	0.0	0.4	0.2	0.1	2.6	0.1	0.7	0.0	2.6	0.1	0.0	0.0	0.0	0.0	6.2	7.3	3.1	0.3	0.0	0.2	0.2	11.6	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.4	0.5	4.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	3.3	1.6	0.9	1.0	0.0	0.9	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	10.1	0.7	3.9	8.6	8.6	5.0	6.5	55.9	5.4	3.0	14.4	0.0	7.4	3.8	0.8	12.3	0.0	720.1	70.5	5.2	3.9	7.2	18.3	11.6	388.2	0.9	0.0	0.0	1.9	3.6	3.9	10.1	0.0	0.0	1.1	0.0	2.9	0.0	0.0	350.3	5.5	2.0	8.5	0.0	0.0	10.4	1.5	0.0	3.2	19.3	5.4	6.5	2.0	97.0	7.2	2.5	5.8	0.0	0.0	2.6
PIGY	MGC14156	ENSG00000255072	"Phosphatidylinositol glycan anchor biosynthesis class Y"	Q3MUY2	4	88521573-88521789	"Disease related genes, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	8	"blood: 38.4;intestine: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 6.5;GAMG: 12.0;hTEC/SVTERT24-B: 8.0;hTERT-RPE1: 6.5;JURKAT: 6.0;MOLT-4: 13.6;OE19: 23.5;SuSa: 6.6"									HPA059018	Uncertain					NA	NA					"HPA059018: AB_2683884"																		1.4	2.9	0.5	1.1	1.2	1.1	1.2	1.8	1.4	2.0	10.6			1.1	2.1	1.1	1.7	1.1	1.1	1.6	0.1	0.3	1.1	1.7	1.1	1.1	1.1		1.3	1.4	1.1	1.2	1.1		1.1	1.1		1.1	1.1	3.1	1.1	1.1	1.1	2.3	1.2	1.3	1.1			1.5		1.1	1.4	1.3	24.8	38.4	21.0	26.6	24.3	33.1	35.9	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	8.0	0.0	6.5	0.0	6.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	16.3	26.0	21.0	27.3	26.6	28.5	24.8	27.9	27.5	38.4	19.8	30.1	29.1	4.5	24.3	21.6	14.2	33.1	35.9											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLA2G5		ENSG00000127472	"Phospholipase A2 group V"	P39877	1	20028179-20091190	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.3;retina: 58.3"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7"	"Group enriched"	"Detected in many"	5	"glioma: 13.0;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	23	"plasmacytoid DC: 2.3"	"Lineage enriched"	"Detected in single"	23	"dendritic cells: 2.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053361	Approved				"Secreted - unknown location"	NA	NA					"HPA053361: AB_2682127"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.70e-3)"	"unprognostic (6.00e-5)"	"unprognostic (2.87e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.97e-3)"	2.6	0.5	2.8	2.0	6.7	0.2	1.9	1.9	5.2	0.3	10.5	2.1	2.5	1.2	0.5	2.1	5.7	1.9	3.0	48.3	2.6	2.4	0.2	1.8	3.2	1.0	6.1	2.0	17.3	1.2	0.2	0.1	8.3	6.8	6.9	3.2	58.3	1.0	10.3	0.4	0.4	1.0	19.3	1.0	0.8	2.3	3.3	1.3	0.0	0.7	0.0	1.7	7.3	2.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	3.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.8	6.7	1.9	5.2	2.6	2.4	6.1	2.0	6.8	1.3	0.0	0.3	0.0	0.0	0.3	9.3	79.9	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	2.1	1.5	0.0	0.0	0.2	0.0	0.0	8.6	0.8	3.6	75.4	0.0	0.0	0.0	0.0	25.1	0.0	0.0	68.9	0.0	27.8	258.7	2.4	0.5	0.6	0.4	0.2	0.0	0.0	0.0
PLA2R1	"CLEC13C, PLA2-R, PLA2G1R, PLA2IR"	ENSG00000153246	"Phospholipase A2 receptor 1"	Q13018	2	159932006-160062610	"Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 46.1"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 31.4;Muller glia cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 19.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 9.2;ASC TERT1: 12.5;BJ hTERT+: 9.9;hTERT-RPE1: 16.5;TIME: 28.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB068217, CAB068218"	Approved		Approved	Cytosol	"Secreted to blood"	NA	NA		99000	Cytosol		"CAB068217: AB_2665660, CAB068218: AB_2665661"	"unprognostic (2.04e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.01e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.38e-3)"	"unprognostic (4.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.02e-1)"	4.6	2.1	0.6	2.3	1.1	0.0	9.4	19.5	1.9	11.3	7.0	1.0	2.4	2.4	17.8	4.7	4.7	4.8	6.9	2.7	0.7	1.0	15.0	0.9	2.3	1.8	0.8	0.7	8.7	0.8	14.5	2.6	6.6	3.3	3.3	2.0	7.8	46.1	2.0	0.8	9.6	9.4	5.7	2.5	3.0	1.6	1.3	0.2	0.3	27.6	6.6	5.1	4.5	9.4	0.6	0.6	2.3	0.8	1.0	0.6	0.2	0.1	1.0	0.3	0.0	9.2	12.5	0.0	4.1	9.9	0.8	1.1	0.0	2.1	0.0	0.2	4.3	0.9	2.0	0.0	3.0	0.8	0.0	0.0	0.0	6.9	0.0	0.7	0.0	0.0	5.0	3.3	1.2	1.3	16.5	5.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	7.2	1.3	0.0	1.1	1.6	0.1	28.7	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.5	0.5	0.5	0.6	0.5	0.4	0.3	0.3	0.6	0.6	0.6	2.3	1.0	0.8	0.6	0.4	0.2	0.6	1.1	19.5	1.9	0.7	1.0	0.8	0.7	3.3	0.2	6.0	3.2	0.0	2.2	8.4	0.8	3.6	5.1	6.7	2.3	31.4	0.0	4.3	0.0	0.7	0.0	3.6	2.6	0.0	1.8	1.1	6.7	2.3	1.1	0.0	0.5	15.9	1.2	8.0	0.0	0.9	15.0	0.0	6.8	0.0	6.1	30.3	3.2	5.8	15.6	1.1	1.1	6.5	2.2	0.0	0.6	4.6	1.3	0.0	6.5	2.2
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell type enhanced"	"Detected in many"	22	"Basal glandular cells: 379.6;Glandular cells: 176.4;granulocytes: 158.4;Urothelial cells: 792.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.9;HMC-1: 55.1;hTERT-RPE1: 61.0;LHCN-M2: 55.7;U-2197: 58.1;WM-115: 115.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	NA	NA	9900000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favorable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.1	32.0	7.7	6.6	0.2	85.9	0.0	0.6	2.3	3.7	1.4	0.0	4.0	15.9	7.9	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	61.0	14.4	0.0	0.5	0.1	55.7	0.0	0.0	0.0	5.6	0.0	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.6	8.2	0.1	0.0	27.5	1.5	5.7	58.1	1.8	0.0	0.1	0.0	1.2	0.0	115.5	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8	0.0	20.2	2.4	379.6	9.6	4.1	7.6	0.0	5.3	11.4	0.0	3.9	0.5	0.0	0.6	0.8	82.6	0.0	0.0	0.6	1.1	19.9	176.4	158.4	1.0	1.5	1.6	0.0	36.8	0.6	0.8	3.4	7.8	21.9	2.8	0.0	2.0	30.5	0.0	2.5	0.1	3.7	12.9	17.6	0.7	0.4	11.8	0.6	3.8	0.4	792.4
PLGLB2	PLGP1	ENSG00000125551	"Plasminogen-like B2"	Q02325	2	87748087-87758793	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	28	"liver: 105.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 67.4"	"Cancer enriched"	"Detected in single"	25	"liver cancer: 1.2"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.7;T-reg: 3.7"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 6.1;U-266/84: 4.9"														"Secreted to blood"	NA	NA						"unprognostic (1.10e-2)"	"unprognostic (8.78e-2)"			"unprognostic (3.42e-2)"	"unprognostic (7.03e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-1)"		"unprognostic (1.82e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.04e-4)"	"unprognostic (6.39e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-2)"	"unprognostic (7.11e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	105.2	0.0	0.1	0.1		0.1	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	3.7	0.2	0.0	1.3	4.3	1.4	0.0	1.3	0.0	3.7	2.2	0.6	2.5	0.0	1.4	2.7	2.6	0.5	0.1	1.0	0.5	0.0	0.8	0.0	1.1	0.9	3.2	0.0	0.3	0.6	0.5	0.0	0.0	0.3	0.4	6.1	0.5	2.6	0.3	0.0	0.9	0.0	2.5	0.0	0.0	0.4	0.0	2.4	0.0	0.0	4.3	0.3	0.0	3.2	0.8	1.0	0.1	0.6	0.2	1.7	0.0	0.0	1.9	0.9	1.3	2.8	4.9	0.4	1.5	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	2.7	0.8	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.4	7.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.1	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PLK2	SNK	ENSG00000145632	"Polo like kinase 2"	Q9NYY3	5	58453982-58460260	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 147.8;T-47d: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009624, HPA069329"	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"		"CAB009624: AB_2167745, HPA069329: "	"unprognostic (4.82e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.75e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (6.56e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.95e-3)"	11.4	3.7	19.6	4.0	40.2	4.4	23.4	1.3	39.4	20.6	5.7	3.7	5.0	5.1	19.2	7.1	17.7	9.5	18.2	28.1	18.8	5.1	6.9	17.6	17.7	3.8	4.2	20.6	11.8	12.6	3.8	3.3	25.9	8.7	8.7	8.7	12.6	22.1	6.2	8.7	20.9	6.1	15.4	2.7	54.7	4.7	19.8	7.4	1.0	8.9	16.6	7.5	14.2	15.5	1.2	2.9	3.0	1.6	10.4	1.2	0.6	16.4	14.9	5.2	0.4	2.7	4.5	2.0	3.5	5.9	11.7	6.8	1.1	14.6	0.0	23.2	12.6	28.5	20.7	0.2	8.1	10.7	0.0	0.4	0.0	6.7	1.2	14.8	0.0	0.4	2.6	11.3	4.5	12.7	147.8	23.5	0.0	0.0	0.5	23.1	6.0	0.0	0.0	0.9	1.6	2.4	0.8	14.3	0.0	30.8	3.3	0.3	0.7	10.8	2.1	9.5	9.7	51.9	0.2	30.0	3.2	8.7	1.4	28.1	0.0	0.0	0.0	2.5	0.0	14.4	3.0	0.7	2.3	0.1	1.6	0.0	1.2	0.7	0.0	2.9	0.9	1.2	0.6	1.9	10.4	0.6	2.0	0.5	0.6	19.6	40.2	1.3	39.4	18.8	5.1	4.2	20.6	8.7	7.4	17.9	18.6	2.7	128.0	125.8	2.8	105.2	22.9	18.7	68.2	17.4	3.9	55.6	8.3	96.4	5.7	109.7	37.3	0.0	69.2	180.6	32.4	45.1	9.2	6.0	13.5	0.0	80.9	51.5	8.9	2.3	11.8	11.2	23.6	5.4	25.3	3.5	71.6	40.7	10.3	2.5	2.7	0.0	79.3	72.4	10.4	90.5	108.6	6.4	24.3	54.0
PLOD2	LH2	ENSG00000152952	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2"	O00469	3	146069440-146163653	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 73.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 109.4;Pancreatic endocrine cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 82.6;hTERT-RPE1: 93.9;U-87 MG: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025898, HPA069126"	Approved		Uncertain	Nucleoli,Cytosol	"Intracellular and membrane"	NA	NA			"Nucleoli, Cytosol"		"CAB025898: , HPA069126: "	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.29e-3)"	"prognostic unfavorable (7.64e-10)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (2.97e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.99e-11)"	"prognostic unfavorable (2.83e-4)"	"unprognostic (6.07e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.41e-3)"	36.7	14.1	11.2	18.0	12.1	0.7	28.5	7.9	13.5	8.8	25.2	5.1	8.3	21.6	14.8	7.5	12.0	8.0	22.3	16.6	12.5	8.2	16.4	73.1	9.3	3.0	10.7	4.8	17.7	14.4	13.9	7.8	41.0	13.0	11.1	16.1	7.2	7.7	11.3	4.8	3.2	24.7	24.2	19.4	3.2	13.6	6.3	10.9	6.1	47.6	3.5	3.0	21.8	28.7	0.0	0.0	1.5	0.3	0.0	0.0	1.9	16.4	11.8	3.7	1.2	13.5	14.5	9.4	58.5	17.9	31.9	60.2	0.9	1.7	0.0	11.4	9.9	14.6	3.5	4.3	50.3	82.6	0.0	6.8	4.1	11.5	8.2	34.7	0.0	0.0	25.4	7.2	27.6	13.5	93.9	44.0	0.0	5.4	0.2	56.3	6.0	0.0	0.0	2.3	0.0	5.1	0.0	2.4	0.0	13.4	0.8	1.8	0.0	46.6	5.0	4.9	18.1	13.6	0.5	55.2	39.5	12.0	12.5	34.9	17.9	2.5	0.0	73.6	0.0	7.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	11.2	12.1	7.9	13.5	12.5	8.2	10.7	4.8	13.0	10.9	14.9	10.7	0.5	5.9	6.3	14.5	10.6	61.1	12.0	13.6	26.2	33.4	6.8	8.3	62.8	0.4	21.2	46.1	0.0	45.9	109.4	34.5	8.1	0.0	50.8	4.7	0.0	19.0	18.4	1.5	1.3	12.0	2.7	13.5	1.0	18.3	65.1	83.0	31.5	4.6	6.9	22.4	19.4	38.1	8.0	16.3	4.8	15.7	0.7	21.3	5.4
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.5	19.3	0.1	4.3	5.9	1.9	4.3	0.4	4.8	0.0	4.8	8.1	1.9	0.5	0.9	0.4	1.1	0.0	0.0	1.9	2.9	0.4	11.2	0.0	0.5	11.7	0.6	4.0	1.2	24.1	19.8	0.0	0.0	0.3	2.9	0.1	0.0	0.0	0.8	1.9	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.4	0.0	1.4	1.0	0.3	0.2	40.8	4.1	1.0	9.1	0.8	0.1	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6	3.0	10.1	0.0	4.4	9.6	0.3	3.2	17.8	6.7	10.3	3.5	0.0	0.7	0.0	5.0	0.9	48.7	9.1	23.3	10.2	0.2	48.9	3.1	1.1	39.0	0.7	0.0	9.9	88.4	8.6	1.3	39.7	2.5	3.3	0.0	13.5	48.4	5.7	8.6	30.4	16.5	1.3	0.0	25.0	0.7	0.4	7.5	0.7	1.0	6.6	2.2
PLXNA4	"DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B"	ENSG00000221866	"Plexin A4"	Q9HCM2	7	132123332-132648688	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.2;breast: 34.7"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 9.9;Cardiomyocytes: 9.5;Collecting duct cells: 12.2;Cone photoreceptor cells: 15.7;Early spermatids: 9.9;Leydig cells: 13.0;Muller glia cells: 10.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 6.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;HMC-1: 10.0;hTERT-RPE1: 12.9;RH-30: 10.7;TIME: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029919, HPA052141, HPA075592"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"		"HPA029919: AB_10671093, HPA052141: AB_2681745, HPA075592: AB_2732297"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (5.76e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.42e-3)"	23.2	5.1	8.7	3.5	9.0	1.1	34.7	3.9	15.1	16.2	2.0	1.0	0.8	1.5	2.3	1.0	7.7	3.0	4.2	6.9	9.7	7.2	2.0	1.3	1.8	2.5	4.0	6.6	6.2	1.0	1.0	1.6	6.7	6.6	1.4	2.1	0.7	1.2	2.4	1.7	4.1	1.4	5.1	1.5	2.4	2.8	2.4	1.8	0.0	3.3	0.0	1.3	2.1	9.4	0.0	6.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.1	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	12.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	10.7	1.1	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.1	0.0	0.0	32.6	3.3	0.1	0.7	0.2	0.0	0.0	0.0	3.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.1	0.0	6.1	0.0	0.0	8.7	9.0	3.9	15.1	9.7	7.2	4.0	6.6	6.6	1.8	0.0	0.0	0.0	0.1	0.6	9.9	9.5	0.0	0.0	0.0	12.2	15.7	0.0	0.0	0.0	9.9	0.7	0.0	0.0	0.0	0.1	5.4	0.2	1.1	0.0	0.1	0.0	1.2	1.8	0.0	5.9	13.0	0.0	6.8	0.0	0.0	10.0	0.4	0.0	6.7	0.3	1.4	0.0	1.4	0.2	0.1	1.1	0.0	0.0	0.0	0.5
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;salivary gland: 28.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 11.0;WM-115: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048046	Enhanced					NA	NA		17000			"HPA048046: AB_2680239"	"prognostic unfavorable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	3.7	17.4	15.5	2.9	34.9	1.5	4.5	16.1	46.3	3.5	14.8	45.8	1.8	3.3	8.1	5.3	6.4	3.8	6.1	3.1	19.9	9.4	1.3	1.3	2.1	1.4	39.7	17.3	1.3	5.6	1.1	0.6	1.4	18.4	9.0	3.2	2.8	28.9	10.7	1.4	11.3	3.4	8.9	25.6	1.3	4.4	7.2	40.2	0.0	1.3	0.2	1.2	6.8	3.8	0.1	2.7	0.0	0.0	0.7	0.0	0.7	4.8	0.6	0.6	0.4	0.6	0.4	0.3	4.6	0.9	0.6	1.6	0.0	0.1	0.0	3.0	1.2	0.9	0.5	0.0	3.9	0.5	0.1	0.0	3.0	5.5	3.4	1.3	0.0	0.3	1.0	2.8	2.9	1.8	11.0	1.9	0.1	0.2	1.7	1.2	4.0	0.0	0.7	0.1	3.3	7.6	1.4	0.5	0.0	0.7	2.3	1.3	4.1	0.2	4.2	10.2	0.1	5.7	0.0	8.0	4.8	2.4	3.7	5.7	1.6	0.4	0.1	10.3	0.2	38.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.7	15.5	34.9	16.1	20.8	19.9	9.4	39.7	17.3	18.4	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
PNMA2	"MA2, RGAG2"	ENSG00000240694	"PNMA family member 2"	Q9UL42	8	26504686-26514092	"Predicted intracellular proteins"		"Tumor antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 82.6"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 28.6;Muller glia cells: 27.1"	"Cancer enhanced"	"Detected in many"		"glioma: 28.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 25.6;hTERT-RPE1: 32.1;JURKAT: 17.4;SH-SY5Y: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001936	Enhanced					NA	NA					"HPA001936: AB_1079647"	"unprognostic (1.25e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.43e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.76e-2)"	"prognostic favorable (1.81e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.58e-5)"	"unprognostic (9.00e-3)"	2.6	9.5	24.4	1.9	33.2	1.3	2.5	5.9	82.6	4.1	1.9	4.3	0.0	1.7	1.8	1.9	1.5	3.0	4.0	2.9	21.6	36.7	3.0	1.7	6.1	1.4	14.5	26.8	1.4	4.0	2.1	5.1	1.5	16.6	1.7	1.8	1.7	1.2	1.8	1.4	1.6	1.9	2.5	7.0	1.4	3.4	2.3	4.6	0.0	3.1	0.0	1.3	2.6	0.4	0.9	0.4	3.0	0.3	0.4	0.5	0.1	0.0	4.7	25.6	0.2	5.1	1.0	0.0	1.3	6.9	3.2	1.0	0.2	3.4	0.0	0.9	0.4	7.9	0.1	15.8	0.0	2.4	0.0	2.8	0.0	3.5	0.0	0.3	0.0	0.2	1.8	0.0	13.6	0.1	32.1	15.1	17.4	0.0	0.0	1.9	0.1	7.4	0.0	14.1	0.2	0.0	0.0	5.2	0.0	7.6	1.7	12.6	18.4	0.0	0.0	0.8	1.9	0.0	0.5	7.4	0.3	5.3	6.5	1.0	2.4	1.8	0.0	14.8	0.0	0.4	3.0	0.3	0.2	0.4	0.1	0.2	0.3	0.2	0.2	0.1	0.9	0.3	0.5	0.9	0.4	0.2	0.4	0.2	0.1	24.4	33.2	5.9	42.3	21.6	36.7	14.5	26.8	16.6	4.6	3.0	8.8	2.2	0.2	0.0	3.8	0.4	0.0	5.3	6.8	0.0	2.0	0.0	0.0	0.0	4.1	0.3	0.0	0.0	0.0	0.1	1.1	0.0	1.1	0.0	0.1	28.6	10.4	0.6	0.6	1.5	10.3	0.0	1.7	0.0	0.0	27.1	2.1	0.0	11.3	5.4	4.4	0.0	4.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 24.5"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042807	Approved				"Secreted - unknown location"	NA	NA					"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.49e-4)"	2.4	1.6	2.2	3.5	4.1	2.2	4.5	7.9	3.2	6.7	2.3	3.0	2.2	1.9	1.7	2.5	8.7	1.7	5.9	4.4	2.0	7.5	1.4	1.0	3.8	1.3	4.2	2.3	3.1	2.5	0.7	4.7	24.5	5.0	6.1	1.5	11.1	4.2	4.1	3.7	12.7	2.7	2.6	3.8	1.3	3.0	7.6	2.1	0.8	2.4	14.9	3.9	4.8	9.9	0.9	3.4	1.3	1.7	1.0	0.8	0.6	0.4	0.5	0.5	0.3	0.8	2.1	0.1	5.5	3.3	1.1	2.2	0.4	0.6	0.3	0.4	8.8	0.2	2.1	0.2	0.2	0.6	2.0	0.9	1.1	0.4	0.1	6.8	0.3	0.7	16.2	1.0	1.5	0.2	25.7	0.0	0.1	0.5	0.4	2.2	3.5	0.3	0.3	0.2	0.4	0.5	0.2	0.1	0.0	0.4	0.1	1.0	0.6	13.0	0.1	0.4	0.6	0.1	0.6	1.0	2.7	9.4	0.7	0.3	0.4	0.0	0.1	1.1	1.2	0.2	0.7	1.7	0.7	0.8	1.4	0.3	0.9	0.6	0.3	3.4	0.5	0.4	0.3	1.3	1.0	0.2	0.5	0.2	0.6	2.2	4.1	7.9	3.2	2.0	7.5	4.2	2.3	5.0	2.1	0.0	0.3	0.0	0.8	1.1	34.2	1.2	0.0	0.0	1.2	0.0	2.0	0.4	0.0	0.1	1.2	1.0	1.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	7.5	1.6	0.0	0.6	1.5	1.6	17.0	1.1	1.7	0.0	1.3	1.6	0.4	6.2	35.7	0.0	4.0	0.0	0.5	0.7	0.5	3.8	0.7	0.0	1.1	1.2
PPFIA2		ENSG00000139220	"PTPRF interacting protein alpha 2"	O75334	12	81257975-81759553	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 48.8"	"Cell type enhanced"	"Detected in some"	16	"Bipolar cells: 98.7;Cone photoreceptor cells: 84.4;Early spermatids: 111.1;Rod photoreceptor cells: 206.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	27	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 25.2;hTERT-RPE1: 4.5;SCLC-21H: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.31e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.78e-5)"	"unprognostic (4.69e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.92e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.76e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.45e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.06e-3)"	2.6	8.3	23.0	1.4	17.7	0.9	1.8	7.2	48.8	6.0	2.3	10.5	0.0	1.4	3.2	1.8	1.8	2.4	3.2	1.2	19.2	10.6	2.0	1.3	1.9	1.1	10.1	20.9	2.2	1.7	1.0	4.5	1.0	8.6	2.7	2.7	2.5	1.2	5.5	1.0	1.9	1.7	3.7	7.7	1.2	2.0	8.2	9.7	0.0	1.3	0.0	1.1	2.4	2.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.1	0.0	1.2	0.0	8.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.6	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	17.7	7.2	38.3	19.2	10.6	10.1	20.9	8.6	9.7	0.0	1.4	0.0	0.0	0.3	98.7	0.4	0.0	0.0	0.0	0.0	84.4	0.0	1.7	0.0	111.1	0.1	0.0	0.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	46.1	15.6	0.0	0.0	45.9	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	15.6	0.0	206.9	0.0	6.2	2.8	1.7	0.5	0.1	0.0	0.0	0.0
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 32.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced					NA	NA					"HPA053419: AB_2682143, HPA054132: AB_2682393"	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.4	0.0	0.1	1.9	0.0	0.3	0.3	0.4	0.9	0.7	3.1	0.3	0.3	0.3	1.6	1.7	0.2	0.8	0.6	1.4	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.4	0.1	0.4	0.0	12.8	0.0	1.5	0.1	0.3	6.2	1.0	0.5	0.9	0.9	0.0	0.3	1.3	13.2	2.1	0.0	0.0	2.5	3.2	0.8	0.1	1.0	1.2	0.2	0.6	0.0	4.7	2.8	0.1	0.0	8.3	0.2	0.1	12.1	0.6	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3	0.0	0.0	0.0	0.1	0.0	2.4	32.2	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	6.4	0.0	1.3	0.0	1.9	0.3	0.0	0.0	0.0	0.0	2.6	0.5	0.0	1.8	0.0	0.8	0.0	0.9	0.5	1.2	0.0	0.2	0.0	0.0	0.0
PPIAL4E		ENSG00000271567	"Peptidylprolyl isomerase A like 4E"	A0A075B759	1	144372875-144373659	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;bone marrow: 2.7;skeletal muscle: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HL-60: 1.2;hTERT-RPE1: 1.9;NB-4: 1.4;SK-BR-3: 2.0;TIME: 1.9"									HPA058345	Uncertain					NA	NA					"HPA058345: AB_2683685"					"unprognostic (6.97e-2)"					"unprognostic (5.22e-2)"				"unprognostic (2.28e-1)"				0.0	0.4		0.0		2.7	0.0		0.0	0.0	0.0			0.6	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0			0.0	0.7	0.0		0.0		0.0	0.0		0.0	0.0	1.8	1.1	0.4	0.0		0.0	0.0	0.0			0.0		0.0	0.0		1.7	0.6	1.9	2.0	3.4	2.9	0.6	0.6	0.5	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.3	1.0	0.0	0.0	1.9	0.1	0.5	0.3	0.0	0.6	0.4	0.2	0.0	0.2	0.0	0.0	2.0	1.0	2.9	0.5	1.9	1.3	1.6	1.3	0.5	1.7	0.5	0.5	1.9	3.4	1.5	0.6	0.8	0.6											0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 36.5"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 187.4;Early spermatids: 262.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;ASC diff: 10.4;ASC TERT1: 12.9;hTERT-RPE1: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.5	1.4	5.5	1.1	8.6	0.7	3.6	5.0	4.8	4.6	1.7	7.2	7.4	1.9	3.8	12.7	2.0	36.5	1.7	2.6	6.0	5.4	4.9	1.2	8.9	1.1	3.4	3.2	6.3	4.3	6.6	7.6	1.6	18.3	1.8	1.6	2.6	2.8	5.0	3.9	1.7	1.1	5.4	3.2	1.3	2.3	20.4	5.3	0.0	17.2	1.4	1.1	2.9	2.0	5.1	1.7	2.0	1.3	1.7	1.3	1.1	1.8	1.0	1.2	6.5	10.4	12.9	1.1	0.0	2.3	0.5	0.2	0.1	1.8	0.0	0.5	0.6	0.9	1.2	1.0	0.0	0.3	0.5	0.9	0.5	0.1	0.0	5.2	0.6	0.3	2.7	6.2	0.2	3.9	9.3	0.8	1.4	0.9	0.3	0.4	0.6	0.1	0.6	0.2	4.2	1.3	0.8	0.0	0.6	5.0	0.1	1.5	2.5	0.2	0.3	4.3	0.3	0.5	1.0	0.4	0.1	0.2	1.1	0.2	0.3	0.1	0.1	2.1	0.1	0.4	2.0	1.2	1.2	0.9	1.3	0.9	5.1	1.2	1.1	1.7	3.2	1.1	1.0	1.6	1.7	1.1	1.7	1.3	1.1	5.5	8.6	5.0	4.8	6.0	5.4	3.4	3.2	18.3	5.3	6.0	5.8	0.0	3.5	1.9	2.1	3.3	5.1	187.4	22.7	3.5	2.0	0.5	21.6	1.6	262.5	1.5	0.7	0.0	1.0	0.7	1.7	2.9	0.0	0.0	0.3	1.6	2.9	0.6	0.0	40.8	4.9	0.5	3.3	1.0	1.8	4.9	0.7	0.0	4.9	8.0	11.5	0.0	1.2	52.6	22.0	2.6	0.6	0.5	1.7	1.1
PPP1R3C	"PPP1R5, PTG"	ENSG00000119938	"Protein phosphatase 1 regulatory subunit 3C"	Q9UQK1	10	91628442-91633054	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 259.9"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 213.5;Hepatocytes: 61.4;Muller glia cells: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.4;HHSteC: 20.8;hTERT-RPE1: 33.7;LHCN-M2: 39.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027041	Uncertain					NA	NA					"HPA027041: AB_1855649"	"unprognostic (2.11e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.48e-3)"	"unprognostic (8.44e-3)"	"unprognostic (4.86e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.61e-3)"	4.0	5.4	10.4	2.8	18.9	1.5	3.5	1.1	15.8	24.9	4.1	8.0	8.3	2.7	7.1	6.5	26.5	4.5	6.0	53.3	13.1	5.7	5.4	39.5	5.4	1.8	6.1	8.1	6.6	5.6	2.8	1.7	6.3	12.2	11.0	2.8	4.5	10.0	13.4	259.9	4.4	2.2	14.8	9.1	2.2	5.2	2.2	6.1	0.0	2.4	28.2	7.7	11.4	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.7	10.4	4.7	2.2	0.0	11.4	8.9	4.7	5.1	0.0	0.8	0.0	0.4	10.7	1.9	0.6	0.2	1.2	8.7	0.0	0.0	0.1	16.4	1.8	20.8	0.0	0.0	7.6	2.0	3.0	0.1	33.7	1.1	0.0	5.3	0.0	39.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.4	10.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.7	7.8	2.1	2.1	2.7	1.6	0.0	0.2	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	18.9	1.1	15.8	13.1	5.7	6.1	8.1	12.2	6.1	0.0	0.0	0.0	10.2	4.0	8.9	213.5	0.0	0.0	0.0	3.5	0.0	0.1	6.6	1.7	0.0	3.5	0.0	0.0	10.2	0.2	6.6	3.2	0.0	61.4	1.1	17.5	9.7	1.8	2.4	0.0	2.6	0.0	11.8	0.0	0.0	120.0	6.4	0.0	7.1	1.6	12.5	0.0	21.7	0.2	1.4	3.4	0.2	0.0	0.0	0.9
PQLC2L	C3orf55	ENSG00000174899	"PQ loop repeat containing 2 like"	A1A4F0	3	157543246-157677749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 29.8;breast: 36.0"	"Cell type enhanced"	"Detected in some"	20	"Collecting duct cells: 21.0;Ductal cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 33.9;ASC TERT1: 18.8;EFO-21: 12.8;HSkMC: 12.1;hTERT-RPE1: 13.4;LHCN-M2: 17.0"									HPA054395	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		No	NA			"Nucleoplasm, Nuclear bodies"		"HPA054395: AB_2682473"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.83e-5)"	"unprognostic (2.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.34e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.47e-7)"	"unprognostic (1.17e-3)"	"unprognostic (2.75e-1)"	"unprognostic (4.81e-2)"	"unprognostic (7.56e-3)"	29.8	1.6	0.2	1.8	1.3	0.1	36.0	0.0	0.8	5.3	4.1	0.0	0.0	0.1	1.3	2.0	3.1	1.8	4.3	5.6	0.3	1.2	4.5	0.1	8.4	1.6	0.5	0.1	0.4	1.4	0.1	5.9	2.6	1.3	3.9	1.4	4.6	4.5	1.0	4.8	2.2	1.6	3.4	0.3	0.1	3.8	2.7	0.0	0.0	11.8	3.0	0.5	4.2	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.0	0.0	33.9	18.8	0.0	1.7	3.5	0.7	1.0	0.0	2.4	0.0	12.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.5	0.0	0.0	2.7	0.0	0.0	12.1	0.6	5.2	0.3	13.4	5.3	0.0	0.3	0.0	17.0	0.1	0.0	0.0	0.1	0.6	3.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.1	0.0	0.0	4.8	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.8	0.3	1.2	0.5	0.1	1.3	0.0	0.0	0.3	0.0	0.6	0.0	0.3	0.3	2.5	1.4	1.2	21.0	0.0	0.0	0.0	5.8	4.2	0.0	0.0	0.0	1.8	0.6	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	4.2	0.3	0.0	0.0	0.0	0.0	0.2	3.5	0.0	0.7	0.8	1.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.6
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 32.8;Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"NK-cell: 5.4"	"Lineage enriched"	"Detected in single"	13	"NK-cells: 5.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.5;HEK 293: 2.9;HHSteC: 3.4;hTERT-RPE1: 11.5;MCF7: 2.6;OE19: 5.7"	"Region enriched"	"Detected in many"	5	"basal ganglia: 16.1"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	2.7	0.7	5.3	1.4	5.6	0.5	1.6	0.5	4.7	2.1	6.2	3.3	12.8	14.1	1.5	4.5	1.1	2.0	11.7	5.1	5.2	1.9	7.0	0.6	4.2	1.4	2.9	3.1	3.6	12.7	1.2	1.1	0.6	3.3	1.1	0.9	16.1	1.3	15.0	1.2	0.9	8.0	1.5	2.5	4.2	14.8	1.4	4.8	0.0	10.7	0.0	0.9	1.1	1.5	0.3	0.1	0.0	0.0	5.4	0.4	0.0	0.0	0.0	0.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.5	0.0	0.4	0.0	0.4	0.0	2.2	0.0	0.0	0.2	2.9	0.0	0.0	0.5	3.4	0.0	1.2	0.0	0.0	0.0	0.0	11.5	0.0	0.2	0.0	0.0	0.0	2.6	0.2	0.0	0.3	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.0	5.4	0.0	0.0	0.0	0.0	5.3	5.6	0.5	4.7	5.2	1.9	2.9	3.1	3.3	4.8	32.8	8.0	0.0	0.2	0.6	0.0	4.8	17.8	2.7	9.1	7.0	0.0	0.0	5.0	7.6	0.0	0.7	0.0	0.0	4.3	2.9	0.0	0.3	0.0	0.0	0.0	1.6	5.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	1.3	5.3	0.0	1.8	0.2	0.0	0.0	5.3	0.2	1.1	0.0	0.0	0.0	1.2	0.1
PRDM8	KMT8D	ENSG00000152784	"PR/SET domain 8"	Q9NQV8	4	80183879-80204329	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;prostate: 30.9;seminal vesicle: 34.0"	"Cell type enriched"	"Detected in many"	31	"Bipolar cells: 289.0"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 4.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 31.4"	"Group enriched"	"Detected in all"	4	"amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7"	HPA057253			Approved	"Nuclear bodies"		No	NA			"Nuclear bodies"		"HPA057253: AB_2683382"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.89e-11)"	"unprognostic (4.64e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.56e-1)"	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31.0	9.3	8.2	10.9	1.8	2.1	8.2	3.0	2.8	3.7	2.7	1.9	30.9	6.0	1.4	0.9	2.0	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34.0	3.0	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9.0	0.0	1.1	0.0	3.5	9.0	8.2	2.2	0.5	2.1	0.0	0.7	2.4	0.4	0.9	0.0	0.3	0.0	0.9	3.3	0.0	2.5	9.0	1.2	1.4	0.0	0.9	0.0	0.0	3.1	0.8	0.3	0.0	1.0	5.4	3.7	0.8	0.3	0.0	0.0	1.9	3.7	1.1	2.0	0.0	4.9	1.4	12.2	0.1	1.0	0.0	1.6	18.2	0.0	1.7	20.4	0.0	0.0	7.4	0.6	0.0	0.0	0.5	0.1	44.1	6.1	0.1	0.0	0.0	0.0	0.0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0.0	0.0	7.9	1.8	0.4	0.0	0.0	0.0	1.6	0.0	2.4	0.3	2.1	2.0	0.3	2.2	1.3	0.7	2.1	0.7	0.0	0.5	0.9	0.4	17.6	10.1	3.6	31.0	30.9	6.0	12.3	18.1	7.5	9.0	0.0	0.3	3.5	3.2	0.6	289.0	1.8	0.0	6.7	9.1	1.8	2.0	0.0	0.0	0.0	1.4	1.0	0.0	0.0	0.2	0.1	3.0	2.3	0.0	0.0	0.5	3.2	0.0	0.0	0.0	3.3	2.8	0.7	1.7	1.0	0.0	4.1	0.4	0.0	3.2	0.0	9.2	0.0	1.7	0.4	0.5	0.1	0.1	1.0	0.0	0.6
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780762-41787372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 2.6;Intestinal endocrine cells: 3.4;Rod photoreceptor cells: 3.4;Undifferentiated cells: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 5.3;HeLa: 6.0;hTERT-RPE1: 15.2"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	4.5	2.2	0.5	3.9	1.2	0.0	8.9	0.0	2.1	6.8	3.0	0.4	5.4	1.8	10.8	4.7	4.1	4.8	5.5	2.1	0.9		2.1	1.6	12.2	0.6	0.6	0.2	2.6	1.0	3.7	1.6	2.5	1.9	5.6	2.6	2.0	2.3	8.4	2.7	1.9	0.4	4.4	0.5	8.8	5.0	1.3	0.2	0.0	5.8	4.4	4.2	3.6	13.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	1.1	3.3	1.7	0.3	2.3	5.3	0.2	0.3	0.0	0.1	1.3	1.2	0.6	2.1	1.4	0.1	2.9	0.0	0.2	0.0	0.4	0.5	0.2	6.0	1.3	0.0	0.0	0.1	2.0	0.3	0.1	0.0	15.2	0.1	0.9	1.8	0.7	0.7	0.9	0.1	0.9	0.4	3.8	0.3	1.9	0.9	0.0	2.1	3.2	0.4	0.7	0.0	3.8	0.3	4.5	0.9	0.9	2.5	1.2	1.3	0.6	0.0	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	1.4	1.3	2.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.6	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.1	1.7	0.0	0.0	2.5	0.0	3.4	0.0	0.3	1.0	1.4	1.8	0.0	0.0	2.7	1.1
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 266.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.8;ASC TERT1: 31.9;HSkMC: 28.9;hTERT-RPE1: 24.2;SK-MEL-30: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	NA	NA	22500000000	3400000000			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.3	42.8	31.9	0.8	1.5	3.5	0.8	3.1	6.1	0.9	0.2	9.3	2.3	7.8	0.1	0.8	0.6	1.1	0.1	2.7	16.6	1.1	17.0	3.6	0.6	0.8	28.9	0.6	1.8	0.6	24.2	3.5	2.1	11.5	0.2	16.6	0.2	0.1	0.0	2.0	1.5	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	46.2	0.8	0.1	8.1	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.2	10.6	9.9	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2	59.6	29.8	3.7	2.9	13.2	0.6	40.3	12.7	76.3	12.5	1.8	9.8	0.6	3.3	5.6	2.3	47.0	2.6	0.0	4.0	0.6	62.0	4.7	29.0	266.4	9.9	1.6	15.1	69.3	24.7	4.0	26.4	7.7	18.6	1.0	14.6	22.0	3.9	7.0	34.6	36.2	7.8	12.9	26.2	0.2	0.5	29.1	1.4	4.5	13.3	2.0
PRR16	DSC54	ENSG00000184838	"Proline rich 16"	Q569H4	5	120464278-120687332	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 13.7;Early spermatids: 13.9;Fibroblasts: 10.5;Horizontal cells: 14.3;Smooth muscle cells: 8.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 13.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.5;BJ hTERT+: 25.5;fHDF/TERT166: 30.7;HSkMC: 19.7;hTERT-RPE1: 32.1;LHCN-M2: 29.7;U-138 MG: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049254	Approved		Approved	Nucleoplasm,Midbody,Cytosol		Yes	No			Nucleoplasm	"Midbody, Cytosol"	"HPA049254: AB_2680693"	"unprognostic (1.71e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.61e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.54e-8)"	"unprognostic (3.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.38e-3)"	11.6	4.4	4.7	7.0	4.9	0.9	11.3	21.1	7.6	20.3	5.2	2.2	1.8	2.9	15.7	4.6	4.1	5.8	8.2	16.9	4.7	3.8	3.6	1.5	10.0	3.1	2.3	4.9	6.9	2.4	1.8	2.5	12.8	9.6	10.9	6.7	1.4	3.2	3.9	30.4	4.4	4.9	11.6	3.0	4.3	4.3	3.2	1.6	0.0	4.9	14.2	1.8	8.7	23.2	0.5	1.4	0.7	3.2	0.2	0.2	1.0	1.0	0.0	2.5	0.0	7.0	24.5	0.0	11.1	25.5	15.9	12.2	0.0	0.0	0.0	0.0	30.7	2.8	0.0	2.4	0.2	16.8	0.0	0.6	0.0	0.3	0.0	6.7	0.0	0.0	19.7	2.7	4.7	15.0	32.1	0.5	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.2	0.0	0.4	0.0	1.9	0.0	1.3	0.0	0.0	4.9	0.0	0.0	0.3	2.0	0.0	0.0	0.1	36.7	4.2	1.1	5.7	0.1	0.0	0.0	2.1	0.0	1.2	0.5	3.2	0.2	0.1	1.8	0.1	0.2	0.1	0.0	1.4	0.5	0.1	0.2	0.7	0.2	1.1	0.5	0.1	1.0	4.7	4.9	21.1	7.6	4.7	3.8	2.3	4.9	9.6	1.6	0.0	0.0	0.0	6.4	1.1	2.0	2.5	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.0	10.5	6.0	0.0	0.0	0.5	14.3	0.0	0.6	1.2	7.4	2.6	1.2	1.7	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.5	0.0	8.3	0.6	1.5	0.5	0.5	0.0	0.0	0.5
PRR26	"C10orf108, FLJ38681"	ENSG00000180525	"Proline rich 26"	Q8N8Z3	10	649948-669581	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 39.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.9;CAPAN-2: 3.3;EFO-21: 3.7;Hep G2: 2.5;hTERT-RPE1: 3.7;OE19: 2.1;RPTEC TERT1: 6.2"									HPA066037	Uncertain					NA	NA					"HPA066037: AB_2685601"	"unprognostic (2.29e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.67e-3)"	"unprognostic (1.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.88e-3)"	18.5	0.2	0.5	3.5	0.6	0.2	3.2	0.6	0.3	3.4	18.8	0.0	1.9	8.4	5.1	1.3	7.1	1.8	18.0	10.2	0.6	0.4	9.6	13.6	0.7	0.9	0.5	0.0	2.6	17.9	0.0	2.9	0.2	2.9	5.3	7.2	2.5	0.3	3.1	2.5	0.5	15.9	8.2	0.5	1.8	6.8	1.5	0.0	0.0	0.5	0.3	0.0	4.9	3.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.9	3.3	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.3	0.0	0.5	0.3	0.0	0.1	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	6.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	0.3	0.6	0.4	0.5	0.0	2.9	0.0	0.0	0.3	0.0	0.6	0.1	2.3	4.3	7.6	2.7	0.0	1.8	3.9	0.0	0.0	5.3	0.5	0.7	12.1	0.0	7.6	0.1	0.0	0.2	0.0	6.8	0.0	4.8	39.9	1.3	0.0	0.4	1.1	0.0	1.7	0.0	11.8	3.2	2.9	11.5	3.2	3.1	9.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	9.2	0.9
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.8	7.4	1.0	3.7	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.4	3.2	0.6	2.0	2.7	0.4	0.3	5.2	1.6	1.3	8.8	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	12.2	1.0	0.6	0.2	1.6	0.6	3.3	0.5	0.6	5.7	0.0	1.0	15.1	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	3.2	7.3	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2	3.0	0.0	0.0	1.3	1.0	79.8	0.8	0.0	6.7	1.2	0.0	29.5	1.5	1.7	1.1	1.7	2.0	9.6	0.0	1.4	0.6	9.3	1.4	0.0	0.0	0.3	19.1	5.8	2.5	0.0	6.3	33.4	0.0	0.0	1.0	2.0	6.5	2.3	10.5	37.8	0.2	40.1	6.5	13.2	2.4	3.2	0.4	2.2	0.0	1.7	1.0
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Ductal cells: 178.1;Endothelial cells: 254.7;Ito cells: 438.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.4"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.2;T-cells: 36.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 114.9;hTERT-RPE1: 136.8;TIME: 116.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030591	Uncertain				"Secreted to blood"	NA	NA		290000			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	19.5	8.7	2.3	10.8	4.1	0.4	40.7	1.2	2.6	89.0	33.8	2.1	37.2	5.1	44.9	27.4	14.5	9.6	45.6	17.2	5.0	3.0	17.5	10.4	36.2	15.9	3.7	4.4	16.2	14.3	9.6	6.3	30.2	12.5	36.7	14.4	15.2	17.6	37.3	19.1	7.2	12.4	100.2	4.9	7.3	22.0	19.5	1.4	3.8	15.3	10.5	5.8	68.6	31.1	0.0	0.0	0.5	0.7	10.2	36.4	10.9	6.2	15.6	16.8	0.1	7.5	18.5	0.0	27.5	25.2	30.7	24.6	36.2	49.8	0.0	21.9	42.1	114.9	12.9	0.2	20.9	7.4	0.0	1.3	2.1	8.0	0.1	3.8	0.0	0.1	14.7	2.8	14.9	17.1	136.8	62.2	0.0	0.1	0.0	23.0	8.5	0.0	0.0	1.0	21.2	1.7	0.0	0.0	0.0	11.5	8.3	0.1	0.1	6.1	0.4	1.8	43.6	0.6	0.0	116.0	18.4	0.2	36.6	15.5	0.1	0.1	0.0	13.1	0.0	18.1	0.0	0.0	0.0	36.4	0.0	0.0	0.0	6.6	20.5	0.0	0.0	1.8	18.5	0.5	10.2	0.7	0.0	0.0	10.9	2.3	4.1	1.2	2.6	5.0	3.0	3.7	4.4	12.5	1.4	26.8	22.1	5.2	74.7	13.7	0.6	3.7	33.1	52.2	75.1	50.6	2.0	6.2	6.6	178.1	2.4	254.7	6.2	0.0	73.0	14.9	79.1	74.7	2.3	5.9	4.5	0.0	13.3	438.3	42.1	5.2	13.3	6.4	69.2	1.8	24.0	0.8	162.9	73.7	7.1	3.5	0.7	38.8	37.9	1.4	6.6	8.5	3.8	17.5	9.1	44.4
PRSS33	EOS	ENSG00000103355	"Serine protease 33"	Q8NF86	16	2783953-2787948	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"blood: 132.7"	"Group enriched"	"Detected in some"	6	"Collecting duct cells: 1.8;Melanocytes: 1.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 8.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	78	"eosinophil: 132.7"	"Lineage enriched"	"Detected in single"	422	"granulocytes: 132.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.7;hTERT-RPE1: 8.5;SK-MEL-30: 9.5;U-2 OS: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA						"unprognostic (4.78e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.86e-2)"		"unprognostic (1.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.42e-2)"			"unprognostic (2.28e-1)"	"unprognostic (1.91e-1)"		"unprognostic (2.70e-2)"	0.0	0.0	0.3	1.1	0.3	0.1	0.1	0.2	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	0.1	10.2	3.6	0.0	0.1	0.1	0.3	0.0	0.2	1.1	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.2	22.5	1.9	0.0	0.0	0.0	1.8	0.8	0.0	0.7	1.1	0.9	0.2	0.2	0.2	1.0	0.2	1.0	0.0	0.0	0.0	132.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	132.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 2783.3;Kupffer cells: 2077.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 260.8;hTERT-RPE1: 353.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	21.6	40.9	26.6	55.6	260.8	150.1	94.1	39.4	117.3	31.0	37.1	37.8	55.3	11.8	81.4	64.3	52.0	47.5	10.0	32.0	21.9	23.0	18.9	13.8	18.6	21.3	100.5	8.9	79.4	95.4	73.9	31.0	59.5	353.1	55.0	16.7	19.6	57.1	38.4	13.8	39.5	13.4	12.2	27.5	19.9	8.2	15.2	32.8	36.1	37.3	29.6	26.2	36.8	111.8	148.5	36.6	22.7	20.6	71.5	43.9	31.2	29.2	32.1	63.8	48.5	20.9	69.7	17.9	32.1	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1	235.2	379.3	166.5	219.5	202.9	179.8	542.8	254.8	219.5	234.3	451.9	119.8	794.0	59.7	786.8	15.8	344.2	354.0	46.7	402.9	741.7	528.5	293.5	382.9	394.5	2783.3	314.6	251.7	411.3	2077.6	30.6	424.6	1465.0	629.3	1297.6	227.4	506.4	336.4	285.1	518.7	243.0	122.0	271.7	278.1	42.5	119.8	173.1	897.4	139.5	183.5	185.3
PSD3	"DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942"	ENSG00000156011	"Pleckstrin and Sec7 domain containing 3"	Q9NYI0	8	18527301-19084730	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.6"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 598.4;Late spermatids: 164.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.2;hTERT-RPE1: 22.8;LHCN-M2: 22.0;U-87 MG: 23.6"					"Low region specificity"	"Detected in all"			HPA002455	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		Yes	No			"Nucleoplasm, Vesicles"	Cytosol	"HPA002455: AB_2666597"	"unprognostic (3.87e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (7.55e-4)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.45e-1)"	2.3	15.5	18.3	2.7	40.5	1.3	5.2	51.6	50.7	11.3	5.7	13.4	2.5	4.2	7.8	3.6	4.8	2.6	6.5	21.8	23.2	9.3	2.1	15.6	4.1	2.2	10.0	27.6	16.0	8.3	9.5	9.6	5.6	10.7	3.7	6.5	5.4	3.2	5.5	1.3	3.9	4.3	5.2	7.4	8.4	8.0	12.7	11.4	0.0	5.4	1.4	3.1	6.1	3.3	3.1	0.6	2.3	1.3	1.9	2.0	0.7	4.9	2.6	11.7	0.0	4.2	26.2	0.6	2.6	4.1	2.4	5.0	1.5	2.0	2.9	1.7	10.7	10.6	0.4	3.4	4.7	4.6	0.0	3.0	0.2	2.0	0.2	7.7	0.0	0.1	6.8	2.9	13.3	2.3	22.8	3.1	0.7	0.3	2.3	22.0	1.7	0.0	0.5	2.3	4.3	6.8	2.3	10.2	1.3	6.1	6.4	5.0	5.6	1.1	0.5	1.8	2.6	0.0	1.1	12.9	7.5	5.2	17.6	2.3	0.2	0.3	6.7	23.6	1.2	2.5	2.3	1.3	1.3	1.0	0.8	1.3	1.6	1.0	0.6	0.5	3.1	0.5	0.6	1.5	1.9	1.1	0.6	2.0	0.7	18.3	40.5	51.6	50.7	23.2	9.3	10.0	27.6	10.7	11.4	3.0	2.4	0.5	11.9	19.5	56.4	111.0	5.1	32.1	13.6	8.7	111.9	2.6	1.7	13.2	598.4	4.9	21.3	0.0	7.4	1.2	30.9	8.6	0.0	36.1	11.0	17.5	5.8	6.2	9.7	164.8	30.8	10.6	1.7	103.6	15.1	80.8	19.5	14.4	50.5	0.2	50.2	12.9	11.5	10.0	15.8	8.7	0.9	0.0	13.0	24.0
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.4;Ito cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.3	0.3	0.1	6.9	0.1	0.3	3.6	0.6	0.3	0.1	0.8	0.5	0.1	0.3	0.0	0.0	0.3	2.8	0.0	9.1	28.0	0.0	1.5	0.5	0.6	0.0	0.0	0.0	1.0	1.9	0.4	0.0	0.7	0.4	5.2	0.8	0.0	0.4	0.7	0.0	1.6	0.2	0.0	0.6	40.9	0.4	0.4	0.1	2.4	0.5	0.4	0.3	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3	0.0	19.9	13.7	0.8	3.3	5.4	9.2	17.8	0.0	1.2	3.5	0.0	0.0	0.0	1.4	4.3	113.4	4.3	46.7	0.8	0.0	1.9	0.6	23.3	2.0	0.3	4.8	0.0	448.7	26.3	2.5	1.1	2.0	5.0	0.0	4.8	0.3	7.2	14.4	0.0	0.0	0.8	0.0	0.9	0.7	0.5	1.4	0.0	1.7	5.2	0.6
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase, receptor type E"	P23469	10	127907061-128085855	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 91.0"	"Cell type enhanced"	"Detected in many"	10	"Kupffer cells: 141.1;Macrophages: 249.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 91.0;plasmacytoid DC: 65.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 65.7;granulocytes: 91.0;monocytes: 25.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.8;HUVEC TERT2: 19.8;NB-4: 14.9;TIME: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	16.8	18.5	12.5	24.0	12.5	39.5	11.0	7.4	15.3	4.8	9.2	14.5	1.6	9.6	5.1	8.1	8.8	6.2	10.7	12.3	15.0	12.2	4.4	4.8	22.5	20.0	12.5	6.5	4.3	3.1	3.4	6.5	8.0	9.8	4.5	9.8	4.8	7.0	3.1	1.9	4.9	12.7	7.7	14.3	26.4	7.7	4.3	10.9	11.4	6.6	6.1	12.2	10.0	5.0	1.2	65.7	91.0	25.5	4.0	5.4	4.9	1.9	0.4	0.2	0.0	1.2	0.2	3.6	0.0	0.0	0.8	1.7	0.8	12.0	1.5	1.3	1.0	2.6	1.1	1.0	5.7	0.3	1.8	0.9	0.1	0.7	0.0	2.0	7.4	5.6	0.4	3.3	2.9	5.9	18.8	19.8	4.9	0.0	0.9	1.2	1.8	2.2	14.9	0.1	2.1	0.7	8.8	1.2	2.9	3.3	8.5	0.0	1.2	3.4	0.6	0.1	0.9	0.3	9.4	37.4	0.8	0.8	3.7	4.1	0.4	0.6	2.1	5.5	5.8	0.0	17.4	25.5	19.3	5.4	9.0	3.2	0.9	2.4	3.6	13.3	1.2	1.7	2.9	91.0	4.0	6.8	65.7	3.5	4.9	12.5	12.5	7.4	12.7	15.0	12.2	12.5	6.5	9.8	10.9	77.4	67.6	24.7	47.2	52.9	2.6	15.1	5.1	9.4	33.0	3.5	0.0	33.6	0.0	4.3	1.6	49.4	12.3	0.0	4.0	40.5	9.9	8.3	30.1	1.3	53.6	0.0	6.4	46.1	141.1	1.7	0.6	249.1	23.6	4.6	14.4	0.0	28.7	11.5	0.4	1.9	0.8	0.0	8.1	0.5	1.4	56.6	14.2	52.4	10.2	34.4
PYROXD2	"C10orf33, FLJ23849"	ENSG00000119943	"Pyridine nucleotide-disulphide oxidoreductase domain 2"	Q8N2H3	10	98383565-98415184	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.8"	"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 13.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 50.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 50.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 28.6;U-937: 18.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037566, HPA037567, HPA067394"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA037566: AB_10670385, HPA037567: AB_2675550, HPA067394: AB_2685832"	"unprognostic (2.35e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic favorable (3.37e-4)"	11.0	15.5	5.1	9.0	7.0	2.7	9.2	2.6	6.3	12.2	6.5	12.0	14.2	2.5	8.3	15.5	4.1	11.6	13.1	9.5	5.3	3.8	6.7	11.7	8.6	2.9	12.6	3.0	11.5	4.3	7.5	6.0	5.0	9.6	12.9	5.8	12.5	26.9	11.3	9.6	3.2	4.1	12.2	8.1	5.2	5.5	3.7	10.7	4.3	9.2	2.3	3.0	11.9	6.9	0.0	0.5	50.8	0.0	11.3	1.8	0.4	2.1	5.3	3.0	0.1	4.7	9.5	1.1	3.5	10.9	2.0	3.8	0.0	7.4	0.0	6.3	3.7	0.5	1.0	0.9	1.2	2.1	0.2	0.8	4.3	8.8	0.4	6.1	0.0	10.0	5.6	1.6	1.6	1.9	28.6	1.5	2.0	0.1	0.1	3.0	6.5	0.1	10.2	0.9	4.1	1.8	1.3	1.1	0.0	2.9	3.3	0.2	0.1	3.8	0.5	2.6	4.3	3.1	4.8	2.0	0.0	2.3	0.6	3.4	0.7	0.4	0.0	3.5	18.7	0.3	1.1	0.0	50.8	1.8	0.0	0.4	0.0	0.6	1.5	0.5	0.0	0.3	1.1	0.1	11.3	0.0	0.1	0.1	0.4	5.1	7.0	2.6	6.3	5.3	3.8	12.6	3.0	9.6	10.7	8.9	3.2	0.0	5.5	0.5	0.0	8.1	0.0	13.4	6.8	1.8	0.0	4.5	6.6	2.1	0.2	3.1	2.0	0.0	2.2	3.3	4.6	2.8	2.3	2.4	7.5	0.0	1.2	4.3	3.8	0.2	3.1	2.5	1.7	1.0	4.9	3.1	1.1	0.0	3.5	7.3	0.8	6.5	4.2	2.6	1.5	0.5	1.5	4.4	6.0	8.4
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1"	"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	0.9	0.6	3.1	7.0	1.8	0.0	0.8	0.4	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.5	0.1	0.1	0.0	3.7	0.0	0.0	0.0	41.7	6.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	4.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.5	0.0	1.1	3.4	0.1	0.0	0.0	2.8	0.1	18.1	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8	0.0	0.3	0.0	17.9	0.1	4.2	9.3	7.6	6.7	12.5	10.4	23.6	0.1	0.0	1.4	1.3	3.8	0.0	0.0	0.8	0.1	3.1	5.5	0.0	2.0	0.3	4.8	0.0	20.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	27.5	1.1	0.0	0.0	0.5	6.1	0.0	9.2	0.2	1.1	0.1	0.2	0.0	0.0	7.1
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 2.3;Cardiomyocytes: 4.0;Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.1;SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.2"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.1	1.2	2.9	0.2	0.4	2.2	6.4	6.6	0.5	7.7	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	9.1	0.8	0.1	0.6	8.1	0.7	2.2	0.0	1.1	0.0	0.3	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	2.2	0.2	1.6	1.0	16.5	14.2	1.3	0.5	2.7	1.9	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8											0.0	1.1	0.5	0.2	0.3	2.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.7	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.9	0.2	0.0	1.0	0.1	0.5	0.0	0.1
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5"	"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	2.8	0.0	0.5	0.0	0.0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0.0	0.2	2.4	4.3	0.1	0.2	0.0	1.0	0.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	3.3	2.2	0.3	13.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.2	0.3	1.3	0.0	0.9	0.0	0.0	2.0	0.3	2.2	7.6	0.0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3	0.0	0.0	0.0	0.2	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.2	0.7	0.0	0.1	45.3	4.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1
RASGRF2	"GRF2, Ras-GRF2"	ENSG00000113319	"Ras protein specific guanine nucleotide releasing factor 2"	O14827	5	80960672-81230156	"Predicted intracellular proteins, RAS pathway related proteins"		"Calmodulin-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 23.8;ovary: 24.6"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 55.0;Extravillous trophoblasts: 22.2;Rod photoreceptor cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.8;MAIT T-cell: 7.7;memory CD4 T-cell: 3.8;memory CD8 T-cell: 2.2;naive CD4 T-cell: 6.4;naive CD8 T-cell: 4.3"	"Lineage enriched"	"Detected in single"	78	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 23.7;CACO-2: 14.3;EFO-21: 7.5;Hep G2: 19.0;HHSteC: 13.2;hTERT-RPE1: 9.6;SuSa: 10.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 41.1;cerebral cortex: 118.3;hippocampal formation: 72.9;olfactory region: 58.3"	HPA018679	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA018679: AB_1856089"	"unprognostic (1.32e-1)"	"unprognostic (6.96e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.12e-1)"	13.3	1.6	11.6	4.3	14.0	1.5	5.4	1.5	23.8	3.8	2.7	18.7	1.5	2.7	3.9	1.6	2.1	2.6	7.1	4.3	11.1	6.6	6.6	1.0	3.8	4.5	8.5	5.5	24.6	1.4	6.8	3.4	13.2	8.9	5.3	2.3	17.1	1.9	2.4	3.1	1.5	2.9	3.8	15.2	3.0	2.3	2.9	5.6	0.0	4.3	1.1	3.9	4.1	2.4	0.0	0.0	0.0	0.0	0.0	7.7	1.5	0.0	1.3	0.3	0.1	0.0	0.0	23.7	0.4	5.7	0.2	0.3	14.3	0.0	0.2	7.5	0.0	0.1	0.4	0.0	0.0	0.7	0.3	2.4	0.1	0.1	19.0	13.2	0.0	0.0	0.6	0.0	5.5	0.0	9.6	0.1	0.3	0.0	0.1	0.0	0.2	0.1	0.1	2.8	0.0	0.0	0.1	2.8	0.0	0.9	0.0	0.2	0.3	0.1	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	2.8	0.0	7.7	0.0	3.8	2.2	0.0	0.0	6.4	4.3	0.0	0.0	0.0	0.0	0.8	1.5	11.6	14.0	1.5	23.8	11.1	6.6	8.5	5.5	8.9	5.6	0.0	1.4	0.0	0.2	1.4	11.6	3.2	0.0	0.0	1.2	8.7	55.0	0.2	0.0	0.2	9.9	14.6	0.0	0.0	0.0	22.2	0.8	0.2	0.0	0.0	1.0	1.6	0.0	4.9	0.8	2.1	0.9	0.0	1.7	0.0	0.0	2.0	0.4	0.2	8.5	2.1	37.2	0.0	1.0	7.2	1.4	0.5	0.7	4.4	0.8	0.4
RASSF9	"P-CIP1, PAMCI"	ENSG00000198774	"Ras association domain family member 9"	O75901	12	85800697-85836570	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Ciliated cells: 36.1;Club cells: 58.0;Endothelial cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 19.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 4.9;hTERT-RPE1: 16.0;RPTEC TERT1: 4.8;U-138 MG: 3.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039428, HPA039678"	Approved					NA	NA					"HPA039428: AB_10795251, HPA039678: AB_10796332"	"unprognostic (1.75e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.90e-5)"	7.9	5.1	1.7	4.1	4.6	0.1	9.1	0.5	0.6	14.4	3.2	4.7	3.1	3.1	15.8	6.3	10.6	11.6	4.4	7.4	3.0	2.8	7.1	3.9	17.1	7.6	4.4	1.4	7.6	4.1	1.2	2.6	0.7	19.1	6.6	2.1	2.5	4.2	6.1	5.0	7.1	3.0	5.5	4.6	10.4	2.6	3.1	2.8	2.6	14.8	8.1	4.6	6.8	12.1	0.7	0.4	1.1	0.5	0.6	0.3	0.0	0.1	1.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.1	2.0	0.2	0.2	0.0	2.7	0.0	0.0	0.4	0.0	4.9	0.0	0.2	0.0	0.0	1.9	2.6	0.8	0.1	16.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.0	0.2	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.5	0.0	3.6	1.2	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.5	0.0	0.2	0.1	0.3	0.3	0.3	0.3	0.1	0.7	0.3	0.3	1.1	0.6	0.1	0.4	0.3	0.0	1.7	4.6	0.5	0.6	3.0	2.8	4.4	1.4	19.1	2.8	14.9	13.1	0.0	5.5	4.2	0.0	2.4	15.3	36.1	58.0	3.5	0.0	0.0	1.7	5.6	0.3	18.5	0.0	0.0	1.4	0.0	1.6	6.3	0.0	0.0	0.1	0.0	0.0	16.0	2.1	0.0	2.3	0.7	0.0	0.0	0.0	12.3	3.5	0.0	0.4	0.0	0.3	0.0	1.4	0.0	1.7	2.9	0.0	0.0	0.0	3.3
RDH5	"HSD17B9, RDH1, SDR9C5"	ENSG00000135437	"Retinol dehydrogenase 5"	Q92781	12	55720367-55724705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Steroid metabolism, Vision"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.4;retina: 127.9"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063345			Uncertain	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA063345: AB_2684992"	"unprognostic (1.04e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.63e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.12e-3)"	"unprognostic (3.27e-2)"	39.4	0.7	0.6	2.8	0.8	0.2	14.9	0.5	0.8	1.0	7.6	1.0	1.5	8.6	1.9	4.5	2.4	2.2	4.8	3.9	1.0	0.5	3.7	27.2	0.7	1.6	0.8	0.8	1.4	1.5	0.0	0.6	0.4	1.5	1.8	1.9	127.9	3.2	1.0	3.1	1.0	9.4	8.8	1.1	0.9	2.7	0.9	1.0	0.3	1.1	2.6	0.7	2.0	2.5	0.4	2.3	2.1	0.9	1.5	2.6	0.4	0.4	0.9	0.5	0.3	19.0	16.4	0.3	2.4	2.7	0.5	0.9	0.3	5.1	0.6	0.4	1.3	0.1	0.2	0.2	0.0	0.4	0.6	0.8	0.1	1.0	1.3	0.5	0.0	0.2	7.0	0.6	9.9	0.0	16.2	0.2	0.3	0.1	0.8	9.9	0.4	0.2	0.1	0.2	2.3	1.4	0.3	0.3	0.3	0.1	0.5	0.1	0.7	0.1	0.3	2.2	0.1	0.4	0.3	0.3	1.0	1.0	0.7	0.6	0.7	0.3	0.1	17.7	0.2	0.2	0.3	0.6	2.1	0.4	0.9	0.2	0.4	1.2	2.6	1.2	0.3	1.0	0.4	0.9	1.5	0.9	2.3	0.2	0.4	0.6	0.8	0.5	0.8	1.0	0.5	0.8	0.8	1.5	1.0	8.9	2.1	6.7	4.2	1.6	22.6	2.1	5.1	5.3	1.2	1.8	58.9	1.6	1.7	1.6	0.6	4.2	28.4	0.0	2.3	1.0	3.3	2.8	0.0	17.9	0.5	15.9	11.1	1.8	2.2	1.8	12.4	4.0	5.0	4.6	8.7	10.9	2.8	17.6	6.3	8.4	68.6	12.9	4.7	3.5	6.3	1.5	1.3	10.0	11.8	2.7
RGS11		ENSG00000076344	"Regulator of G protein signaling 11"	O94810	16	268301-275980	"Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 50.0"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 66.5;Cone photoreceptor cells: 113.9;Rod photoreceptor cells: 70.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;ASC TERT1: 4.0;fHDF/TERT166: 3.6;HHSteC: 5.7;hTERT-RPE1: 4.3;SCLC-21H: 5.5;SH-SY5Y: 4.2;T-47d: 4.6"	"Not detected"	"Not detected"							"HPA041692, HPA043039"	Uncertain					NA	NA					"HPA041692: AB_2677619, HPA043039: AB_2678282"	"unprognostic (8.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.46e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.56e-2)"	"prognostic favorable (1.24e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-1)"	10.9	7.6	10.7	2.0	8.4	0.5	1.9	50.0	19.8	2.4	5.0	14.1	5.3	10.5	2.0	2.9	5.1	2.5	3.4	16.7	11.0	12.7	1.4	0.8	4.3	1.1	9.3	8.3	0.8	17.7	2.1	15.6	4.7	9.7	6.1	1.6	10.4	5.6	5.0	1.7	1.9	7.4	2.5	13.3	2.0	7.9	0.9	7.4	0.0	0.8	0.8	0.6	3.1	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.8	4.0	0.0	1.2	0.1	0.0	0.0	0.5	0.1	0.0	2.7	3.6	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	1.5	0.1	0.0	0.0	0.0	4.3	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	2.5	0.0	0.0	0.0	0.2	0.0	0.0	5.5	4.2	2.5	0.3	0.8	0.0	4.6	0.1	2.9	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	8.4	50.0	14.8	11.0	12.7	9.3	8.3	9.7	7.4	0.0	0.0	0.0	0.2	0.1	66.5	7.0	0.0	0.0	0.0	0.0	113.9	0.1	0.0	0.1	0.0	0.0	2.0	0.0	0.9	0.1	5.0	0.5	0.0	0.0	0.2	9.5	9.9	5.5	0.0	0.0	0.9	0.0	1.7	1.0	0.1	3.0	0.7	2.3	1.8	0.0	70.8	0.0	5.2	0.4	1.1	0.5	0.7	0.0	1.2	0.1
RGS4	SCZD9	ENSG00000117152	"Regulator of G protein signaling 4"	P49798	1	163068775-163076802	"Disease related genes, Predicted intracellular proteins"		"Signal transduction inhibitor"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 88.0"	"Cell type enhanced"	"Detected in some"	25	"Early spermatids: 10.1;Intestinal endocrine cells: 49.4;Muller glia cells: 14.1;Smooth muscle cells: 10.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 91.6;LHCN-M2: 36.1;SH-SY5Y: 71.9;TIME: 146.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030802			Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA030802: AB_10602295"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.02e-2)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (8.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.97e-4)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (1.00e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.30e-2)"	2.9	20.9	9.1	2.1	45.3	0.5	1.4	1.1	88.0	4.0	1.7	1.0	0.0	2.9	4.8	1.4	6.3	4.9	11.2	4.7	13.9	10.1	1.5	2.6	2.1	2.3	12.1	36.2	1.1	2.7	1.2	6.2	1.3	16.0	3.3	1.8	1.0	0.9	3.9	0.7	0.6	1.6	3.0	1.9	1.5	3.7	2.1	2.1	0.0	1.5	0.2	0.7	2.8	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	3.5	18.5	0.0	12.5	13.6	1.8	4.8	0.0	0.0	0.0	5.5	8.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	19.7	2.4	91.6	19.1	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	71.9	0.0	0.0	0.0	0.7	0.0	0.0	146.6	14.9	0.7	2.9	20.7	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.1	45.3	1.1	78.8	13.9	10.1	12.1	36.2	16.0	2.1	0.0	0.0	0.0	0.8	0.2	0.2	0.5	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.1	10.1	0.5	0.0	0.0	0.2	0.0	1.7	0.5	0.0	0.0	0.4	0.0	49.4	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	14.1	4.1	0.0	0.0	0.0	1.6	0.0	10.3	0.0	0.2	0.3	0.1	0.0	0.0	0.1
RNF212B	C14orf164	ENSG00000215277	"Ring finger protein 212B"	A8MTL3	14	23185316-23273477	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 24.3;testis: 7.5"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 25.0;Late spermatids: 7.6;Proximal tubular cells: 14.6;Spermatocytes: 14.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;CAPAN-2: 2.6;Daudi: 3.8;hTERT-RPE1: 1.8;Karpas-707: 2.6;U-266/70: 3.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	HPA053574	Uncertain					NA	NA					"HPA053574: AB_2682195"	"unprognostic (2.88e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.79e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (4.45e-1)"	"unprognostic (7.33e-5)"	"unprognostic (9.60e-2)"	"unprognostic (3.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (5.39e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.3	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.1	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	7.5			0.4		0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	1.2	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	2.6	3.8	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.3	0.2	2.6	0.0	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.1	0.2	0.0	0.0	3.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.0	0.3	0.0	0.0	0.0	0.0	1.2											0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	7.6	0.9	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.4	14.6	0.2	0.0	0.1	14.2	4.2	0.0	0.0	0.0	0.0	0.0
RP1	"DCDC4A, ORP1"	ENSG00000104237	"RP1, axonemal microtubule associated"	P56715	8	54509422-54871720	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 15.4;lung: 28.7;retina: 49.2"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 212.8;Cone photoreceptor cells: 314.2;Rod photoreceptor cells: 1078.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HDLM-2: 7.1;hTERT-RPE1: 2.8;RPTEC TERT1: 14.5;U-2197: 3.3"	"Not detected"	"Not detected"							HPA042257	Enhanced					NA	NA					"HPA042257: AB_10797385"	"unprognostic (3.19e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.16e-3)"		"unprognostic (6.24e-2)"		"unprognostic (4.56e-2)"	"unprognostic (4.13e-5)"	"unprognostic (2.48e-1)"	"unprognostic (2.16e-5)"	"unprognostic (8.92e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.96e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.9	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.4	0.3	0.1	15.4	0.0	0.1	0.1	0.1	3.6	0.1	28.7	0.0	0.1	0.0	3.9	0.1	0.0	0.6	0.3	0.1	0.1	0.0	49.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.3	0.6	1.7	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	2.3	0.0	0.2	0.0	1.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	14.9	3.7	0.0	0.0	0.0	59.5	0.4	0.0	212.8	55.7	5.2	314.2	0.0	3.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	83.8	0.2	0.0	0.0	0.2	1078.1	0.0	0.0	3.4	1.6	0.0	0.0	0.0	0.0	0.1
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0.0	3.9	5.7	48.4	35.5	0.0	4.1	8.1	2.3	3.2	0.0	1.2	0.2	1.3	14.6	1.8	1.7	2.0	9.0	2.1	0.8	0.5	0.0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0.0	0.0	9.5	0.4	0.1	0.4	1.0	1.9	2.3	0.6	2.0	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1.0	0.1	3.0	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0.0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10.0	12.8	12.0	47.2	0.5	0.0	20.9	0.2	8.0	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5.0	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3.0	0.2	1.3	1.2	5.8
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118604-127197765	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Fibroblasts: 10.4;Ito cells: 16.0;Leydig cells: 25.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 5.7;hippocampal formation: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 23.5;BJ hTERT+: 4.1;hTERT-RPE1: 7.8;U-138 MG: 5.2;U-87 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 32.5"	HPA029957	Uncertain				"Secreted to blood"	NA	NA					"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	18.5	10.5	2.8	12.1	0.8	0.0	40.7	5.7	2.3	12.9	8.5	0.0	23.8	1.2	50.3	32.5	23.7	14.9	7.6	4.2	20.5	1.7	3.3	4.2	3.8	10.2	0.8	2.4	13.2	1.5	0.0	2.6	24.1	0.8	10.2	4.7	8.6	3.9	15.3	19.7	2.2	6.7	34.1	0.6	1.4	10.8	12.4	0.0	0.2	2.9	2.1	0.9	9.3	39.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	1.4	0.0	0.0	0.0	4.1	0.2	0.5	0.0	0.0	0.0	0.5	0.2	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	7.8	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	5.2	2.0	0.7	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.8	5.7	2.2	20.5	1.7	0.8	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	10.8	2.8	0.0	0.0	0.0	1.0	10.4	0.6	0.0	0.0	1.3	0.0	0.0	16.0	0.3	1.1	25.3	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	2.7	0.0	0.1	0.1	1.4	0.0	0.0	0.1
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"Runt related transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 67.7;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 16.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	3.7	2.1	4.9	13.7	7.0	15.5	5.7	1.0	7.2	13.5	6.0	5.6	7.4	4.1	3.5	2.3	3.4	2.4	6.8	1.8	7.4	3.5	3.9	1.8	5.3	8.6	6.3	3.4	5.0	1.9	1.3	3.8	3.3	7.2	9.5	7.8	5.4	19.8	14.9	2.2	4.9	10.8	3.4	10.5	6.6	6.0	2.1	7.3	6.5	4.2	4.5	11.7	7.3	8.9	0.1	11.4	5.3	0.6	16.0	10.2	0.7	1.6	0.5	0.3	0.0	1.5	4.0	0.0	1.5	3.6	5.1	7.2	0.0	0.9	0.0	1.8	2.1	2.3	2.0	0.0	1.4	9.4	6.1	0.7	0.0	1.1	0.0	8.0	6.3	0.0	10.8	1.1	4.5	5.1	18.6	0.0	2.5	0.0	29.1	9.1	0.4	0.2	11.0	0.3	1.4	0.2	0.0	24.3	0.0	5.0	3.2	0.0	0.0	1.1	0.0	1.8	4.5	1.7	0.5	0.2	5.2	4.2	8.0	5.5	9.2	0.0	25.4	5.9	2.4	2.3	5.3	0.6	3.2	1.2	0.1	10.2	0.1	2.8	3.2	1.8	0.1	0.5	1.5	4.8	16.0	0.1	11.4	2.3	0.7	4.9	7.0	1.0	7.2	7.4	3.5	6.3	3.4	7.2	7.3	0.0	2.4	3.7	14.8	2.5	0.0	1.7	0.0	4.0	4.5	3.5	0.0	0.0	0.0	0.6	67.7	0.3	0.0	0.0	0.2	0.0	2.7	15.7	2.3	0.5	3.8	0.0	0.0	1.8	4.5	13.2	1.1	7.9	6.8	20.8	0.7	0.0	0.4	0.0	2.1	2.2	0.0	6.5	2.5	0.9	0.4	1.4	0.1	17.3	0.0	18.2
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 32.8"	"Cell type enriched"	"Detected in some"	7	"T-cells: 87.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	31	"gdT-cell: 32.8;MAIT T-cell: 25.7;memory CD4 T-cell: 11.7;memory CD8 T-cell: 28.9;naive CD4 T-cell: 8.4;naive CD8 T-cell: 20.4;NK-cell: 31.9;T-reg: 10.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 31.9;T-cells: 32.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 4.0;HDLM-2: 7.1;hTEC/SVTERT24-B: 4.7;hTERT-RPE1: 4.3;NTERA-2: 3.7;PC-3: 2.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"HPA028992, HPA028993"	Uncertain					NA	NA					"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	3.3	4.1	3.2	11.4	0.9	4.6	2.1	1.8	1.0	2.8	1.4	0.6	0.5	0.6	11.7	3.6	1.2	2.4	4.1	1.4	4.4	3.1	2.0	3.0	9.8	12.0	1.2	0.7	3.3	1.4	0.0	8.0	3.0	1.6	4.1	3.0	4.8	5.3	1.2	0.9	0.6	2.2	2.3	1.4	13.9	2.0	4.4	0.4	16.4	1.5	2.7	12.6	3.8	1.5	0.6	0.1	0.6	0.1	31.9	32.8	10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.8	0.3	0.8	0.9	0.1	0.0	0.1	0.7	0.4	0.0	0.0	0.0	4.0	7.1	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.5	0.0	4.7	0.3	4.3	0.2	0.9	0.3	0.0	0.2	0.0	0.2	0.0	3.7	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.3	0.1	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.8	0.1	25.7	0.6	11.7	28.9	0.1	0.0	8.4	20.4	0.6	31.9	0.1	0.1	10.8	10.0	3.2	0.9	1.8	1.0	4.4	3.1	1.2	0.7	1.6	0.4	0.0	2.9	0.0	0.0	0.3	2.3	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	0.0	0.0	3.5	2.5	3.4	5.6	0.6	0.6	5.0	0.0	0.1	0.0	0.0	1.1	1.8	0.5	0.1	0.0	0.4	0.5	0.6	0.4	0.0	87.3	0.7	0.0
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 124.4;Intestinal endocrine cells: 272.8"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 25.5;HSkMC: 21.8;hTERT-RPE1: 21.8;SCLC-21H: 22.2;SH-SY5Y: 9.7;WM-115: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.8	4.0	1.1	25.5	0.1	0.2	0.9	1.8	4.7	0.2	0.4	0.0	0.4	0.3	2.9	0.1	0.1	0.0	2.4	0.0	0.2	0.0	0.2	0.0	0.3	0.3	2.1	21.8	0.1	2.7	0.9	21.8	0.0	0.0	0.1	0.2	2.3	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	22.2	9.7	0.0	0.2	1.1	0.8	0.0	0.0	0.0	2.5	1.0	0.1	1.6	0.0	0.0	0.1	0.7	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0	6.0	0.0	0.0	0.2	0.0	124.4	0.2	0.0	1.4	2.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	0.0	0.0	0.1	7.9	272.8	1.3	0.8	0.0	0.6	0.0	1.7	0.0	0.7	11.9	24.2	2.9	0.4	0.0	12.7	0.0	0.5	0.1	0.2	0.1	0.1	0.0	0.3	0.6
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Cell line enhanced"	"Detected in many"		"BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in all"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.4	6.5	0.0	17.2	12.8	4.0	1.3	0.5	0.0	0.0	0.0	2.1	0.2	0.0	4.9	0.6	6.6	0.0	1.6	1.3	1.5	1.4	14.8	0.0	0.0	0.4	0.2	6.8	1.3	12.0	0.8	0.9	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.0	0.5	0.7	2.5	6.5	1.8	7.2	0.8	7.2	0.0	0.0	0.3	3.8	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4	11.9	18.4	0.9	0.2	0.9	0.2	1.6	5.1	4.0	7.9	5.2	0.0	0.2	3.3	14.9	1.7	2.2	11.3	0.0	27.7	0.4	1.2	0.2	3.5	6.0	50.6	0.0	31.7	20.3	1.5	1.9	1.1	4.3	3.3	0.0	14.6	1.3	18.8	8.6	0.0	12.2	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.0	10.7	0.1
SEC14L2	"C22orf6, KIAA1186, KIAA1658, SPF, TAP, TAP1"	ENSG00000100003	"SEC14 like lipid binding 2"	O76054	22	30396857-30425317	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 43.0;liver: 112.3"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 123.4;Muller glia cells: 99.0;Pancreatic endocrine cells: 69.1;Rod photoreceptor cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 2.6;naive CD4 T-cell: 7.1;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	8	"T-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 37.7;hTCEpi: 20.5;hTERT-RPE1: 24.0"									HPA064466	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		190000	Nucleoplasm	Cytosol	"HPA064466: AB_2685270"	"prognostic favorable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.59e-3)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (7.63e-6)"	"unprognostic (1.25e-3)"	"unprognostic (3.76e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.01e-1)"	1.9	1.2	13.6	1.9	14.2	2.4	22.7	7.3	15.0	2.2	5.7	12.6	7.3	10.1	2.4	43.0	8.0	2.3	4.3	1.1	10.8	10.4	3.6	112.3	1.8	2.1	16.1	10.4	1.3	1.9	3.7	5.0	1.5	10.6	25.7	1.4	24.2	4.0	7.8	1.0	2.9	13.5	2.4	8.9	1.0	3.4	1.2	10.4	1.1	4.3	0.6	2.7	1.8	2.9	0.8	0.9	0.5	0.2	0.1	7.1	1.5	9.8	2.4	1.9	2.7	2.9	7.4	0.1	8.0	6.4	4.7	4.9	0.6	6.6	0.2	2.4	9.6	8.0	7.6	1.2	37.7	5.2	0.9	1.9	0.1	2.4	3.5	4.0	0.0	2.5	5.1	20.5	4.3	7.7	24.0	11.8	1.8	0.0	0.2	9.4	1.7	1.0	0.2	0.0	5.1	3.3	0.4	3.4	0.2	8.3	3.3	1.2	1.3	4.9	1.1	4.4	0.1	6.4	0.1	17.9	6.6	4.2	2.7	4.8	0.1	0.0	0.3	14.5	0.0	5.2	0.1	0.2	0.4	0.9	0.2	0.4	0.8	2.6	0.6	0.1	0.6	7.1	4.7	0.5	0.1	0.1	0.9	1.1	1.5	13.6	14.2	7.3	13.4	10.8	10.4	16.1	10.4	10.6	10.4	3.0	4.3	0.5	13.2	3.7	7.5	1.0	20.4	1.4	4.5	0.0	15.7	2.6	5.0	21.9	6.6	1.5	1.7	0.0	16.4	0.2	3.6	18.3	5.7	123.4	0.4	12.7	1.2	4.3	4.7	7.5	1.1	0.0	6.8	0.0	0.5	99.0	69.1	0.0	0.7	6.1	51.4	0.0	2.0	0.5	1.0	1.8	2.5	5.3	0.2	7.0
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486642-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.4;JURKAT: 12.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavorable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.8	2.4	3.3	3.2	5.0	6.4	2.6	12.1	11.8	2.7	2.8	5.4	4.3	1.9	3.0	3.5	1.4	2.9	2.6	5.6	3.1	3.6	2.7	3.4	2.4	4.3	3.3	5.6	3.9	0.8	3.9	5.0	2.4	6.3	2.9	2.7	6.1	2.8	2.5	13.6	2.4	2.9	3.2	3.4	4.9	1.9	16.2	3.4	0.0	2.6	5.2	3.6	2.3	1.9	0.9	0.0	0.1	0.2	0.0	2.1	0.1	0.2	0.2	2.8	0.9	0.9	1.6	0.3	0.5	1.3	0.2	0.9	0.3	0.4	0.6	0.8	0.0	0.1	0.3	1.5	0.4	0.8	3.5	0.8	1.4	1.8	0.3	1.2	1.0	1.2	2.4	1.4	0.2	1.7	12.4	0.5	12.5	0.3	1.7	0.0	0.0	1.8	3.1	0.0	0.2	0.6	2.7	0.1	1.1	0.9	0.0	0.2	0.9	0.3	0.0	0.6	2.1	0.7	0.3	0.0	0.4	0.4	0.3	0.2	1.3	0.6	0.8	0.1	3.4	0.4	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	0.4	0.0	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	3.3	5.0	12.1	11.8	3.1	3.6	3.3	5.6	6.3	3.4	6.0	5.0	0.0	0.8	1.0	34.2	6.5	5.1	2.7	2.3	10.4	37.3	1.0	0.0	0.4	0.9	2.1	2.1	0.0	0.2	0.3	1.9	1.8	1.1	6.4	1.9	38.1	5.2	3.1	4.3	0.8	3.1	1.8	1.7	3.6	3.9	4.3	0.3	0.0	3.9	0.6	6.7	0.0	1.2	7.5	3.2	1.0	0.7	2.6	4.0	0.9
SEMA3C	"SEMAE, SemE"	ENSG00000075223	"Semaphorin 3C"	Q99985	7	80742538-80922359	"Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"basophil: 25.8"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 25.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 49.5;hTERT-RPE1: 43.2;RT4: 45.2;T-47d: 51.2;U-2197: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042418			Approved	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted in other tissues"	NA	NA			"Golgi apparatus, Cytosol"	"Plasma membrane"	"HPA042418: AB_10797389"	"unprognostic (1.93e-2)"	"unprognostic (2.54e-3)"	"unprognostic (4.94e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.74e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (9.28e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (2.07e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.92e-2)"	27.1	4.1	3.7	11.9	5.6	0.2	25.1	1.2	6.8	37.0	31.7	7.6	21.6	4.3	26.9	25.1	20.0	7.1	16.4	12.4	5.2	6.1	5.8	1.1	12.3	0.3	13.1	3.0	23.5	1.5	0.0	4.1	5.9	25.5	29.6	14.1	27.4	13.6	19.7	7.3	9.7	10.6	48.8	8.5	8.9	13.3	11.6	6.0	0.2	2.5	15.2	1.5	35.5	14.5	0.0	2.0	25.8	3.2	0.0	0.0	0.8	1.1	14.6	30.4	0.1	6.8	16.5	0.0	9.9	11.4	5.0	6.4	2.3	27.6	0.0	0.4	3.3	49.5	5.9	0.1	8.9	8.2	0.0	3.0	1.8	13.1	0.1	8.2	0.1	0.0	7.2	5.9	12.4	12.2	43.2	0.0	0.0	0.1	0.0	8.4	21.1	0.0	0.0	0.2	4.1	2.3	0.0	14.7	0.2	26.3	45.2	0.1	15.7	27.8	7.2	1.7	13.5	51.2	0.0	23.8	27.5	12.6	66.4	17.4	0.2	0.0	0.0	10.4	0.0	27.2	25.8	3.2	0.5	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.5	0.0	1.0	1.8	0.0	0.8	3.7	5.6	1.2	6.8	5.2	6.1	13.1	3.0	25.5	6.0	8.9	12.8	0.0	33.4	23.5	0.0	35.1	0.0	109.7	19.4	7.0	5.9	0.3	1.7	3.6	0.4	3.5	25.9	0.0	5.8	0.5	25.3	36.0	4.7	0.0	9.3	0.0	5.8	1.3	2.6	1.7	7.2	8.6	52.3	4.6	16.2	1.3	40.1	15.8	49.1	0.1	0.3	0.0	16.2	0.3	0.2	16.6	0.2	0.0	23.4	52.9
SEPT4	"ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2"	ENSG00000108387	"Septin 4"	O43236	17	58520250-58540818	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 77.8;brain: 94.8"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 2070.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006855, HPA021587, HPA022905"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687"	"unprognostic (1.12e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.36e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.28e-7)"	"unprognostic (6.40e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.75e-3)"	14.8	77.8	70.5	2.6	80.0	0.9	7.2	44.3	82.7	4.0	3.3	92.4	0.0	2.7	3.5	3.9	3.2	2.7	8.3	14.3	84.8	49.9	8.5	25.0	9.5	5.9	94.8	32.3	5.4	3.9	4.8	2.4	9.9	49.7	2.5	3.1	10.0	4.4	3.8	4.2	3.9	2.9	6.0	84.0	18.0	2.8	7.3	56.5	0.0	4.5	0.5	3.8	5.1	1.3	1.7	5.5	2.9	5.5	1.4	7.6	5.6	0.0	0.4	0.9	2.6	1.1	0.1	0.4	0.1	0.3	1.6	1.9	0.1	0.1	0.0	3.9	0.6	2.4	0.2	1.4	1.1	0.4	0.1	0.7	0.9	0.2	5.5	11.0	0.1	0.5	5.7	2.2	0.4	2.0	14.9	0.5	1.4	0.0	2.6	0.1	0.0	0.0	0.1	0.5	0.0	0.7	0.1	0.0	1.2	0.0	0.0	2.8	1.6	0.0	0.1	24.2	1.3	0.4	0.3	0.0	0.1	1.2	0.0	1.0	0.8	0.4	0.0	0.9	0.0	0.3	0.0	5.5	1.1	7.6	0.7	2.4	1.7	1.6	2.0	5.5	0.6	2.9	2.3	2.9	1.4	0.0	0.3	1.0	5.6	70.5	80.0	44.3	50.5	84.8	49.9	94.8	32.3	49.7	56.5	0.0	0.6	0.0	0.0	5.5	93.8	45.3	0.0	0.0	0.0	7.0	329.9	3.6	14.9	0.0	62.0	12.7	0.0	23.3	0.0	0.3	7.0	0.0	1.1	20.8	4.7	2070.5	0.0	27.6	2.4	56.2	6.6	1.6	65.8	0.0	0.0	56.1	0.0	0.0	13.1	0.5	325.4	181.1	84.9	3.6	1.7	2.5	3.8	0.0	0.0	0.0
SGIP1	DKFZp761D221	ENSG00000118473	"SH3 domain GRB2 like endophilin interacting protein 1"	Q9BQI5	1	66533383-66748299	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 91.2;Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 22.0;fHDF/TERT166: 13.9;hTERT-RPE1: 9.2;RPTEC TERT1: 16.2;SH-SY5Y: 8.8;U-138 MG: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	6.2	7.5	19.6	3.8	30.2	1.3	2.7	26.2	36.5	7.5	2.7	11.4	1.3	3.4	17.1	8.0	5.2	4.7	8.1	6.8	22.9	12.4	14.0	1.7	9.6	2.0	10.8	26.3	3.6	1.2	1.9	7.0	3.9	26.4	5.4	3.4	5.8	3.5	9.1	3.2	1.7	3.2	7.0	11.3	1.4	5.1	7.4	14.9	0.0	8.0	0.8	1.5	6.1	5.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.4	0.0	17.0	22.0	1.3	2.0	0.0	0.0	0.0	0.0	13.9	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	3.9	0.0	0.0	2.4	0.0	1.3	0.0	9.2	6.4	0.1	0.0	0.0	7.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.4	8.8	0.0	0.0	0.0	0.3	0.0	0.6	1.1	16.1	0.0	0.4	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	19.6	30.2	26.2	35.0	22.9	12.4	10.8	26.3	26.4	14.9	0.0	0.0	0.0	0.2	0.9	91.2	1.6	2.5	0.0	0.0	8.7	329.9	0.0	6.6	0.3	0.5	11.1	0.0	0.0	0.0	0.0	4.1	0.4	9.3	0.0	0.2	69.9	0.0	0.6	0.0	0.5	2.0	0.0	10.1	0.0	0.0	55.4	0.0	0.0	10.6	0.0	347.4	12.9	52.6	0.0	0.0	0.9	0.2	0.0	0.0	0.3
SH3D21	"C1orf113, FLJ22938"	ENSG00000214193	"SH3 domain containing 21"	A4FU49	1	36306387-36324886	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 26.2"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 13.1;Late spermatids: 38.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0;NK-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2"									"HPA042212, HPA042456, HPA066168"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627"	"prognostic favorable (2.60e-4)"	"unprognostic (8.35e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (7.32e-3)"	"unprognostic (2.04e-4)"	"unprognostic (7.47e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.38e-3)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (8.88e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.59e-2)"	1.6	1.1	11.6	3.4	9.5	1.9	10.1	12.2	11.3	4.4	5.3	1.1	1.4	16.6	2.8	2.7	7.1	1.9	3.0	2.2	5.2	2.2	8.6	1.4	4.5	2.8	1.9	7.0	4.0	1.0	1.3	2.2	19.4	7.4	7.0	6.0	12.4	12.7	2.6	1.0	16.2	24.3	2.0	2.4	1.6	2.3	6.6	1.9	0.0	26.2	4.1	4.5	3.7	6.7	0.1	0.3	2.0	0.5	2.7	0.6	0.0	8.3	0.2	1.6	1.9	0.5	1.0	9.1	4.0	0.8	3.0	1.3	4.7	3.4	1.5	4.4	1.7	0.3	13.5	1.4	3.0	2.5	0.4	0.6	1.3	2.9	3.7	1.3	0.7	2.0	0.5	2.5	2.0	1.5	22.0	1.1	4.1	0.2	2.6	1.4	4.9	1.4	0.7	1.0	2.2	1.6	2.0	0.1	1.0	3.4	1.0	3.4	1.7	0.9	10.1	3.1	11.2	0.3	0.3	2.3	1.2	0.7	4.0	0.4	3.0	0.9	1.7	3.4	0.7	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.1	0.6	0.0	0.3	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	11.6	9.5	12.2	11.3	5.2	2.2	1.9	7.0	7.4	1.9	0.0	1.3	0.8	1.5	2.7	5.2	0.9	0.0	0.0	0.0	5.2	0.0	2.5	1.7	0.5	13.1	0.9	11.8	0.0	0.3	2.1	1.4	2.0	1.1	0.0	7.0	11.1	0.0	0.6	3.2	38.8	1.1	4.7	3.3	3.6	2.0	1.0	2.7	0.8	2.5	0.8	1.1	0.0	1.7	2.1	1.5	2.8	4.8	0.0	1.6	1.1
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178767	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 2: 16.0;Bipolar cells: 7.0;Muller glia cells: 6.1"	"Cancer enhanced"	"Detected in some"		"glioma: 5.1"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7"	"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"AF22: 17.1;hTERT-RPE1: 18.9;RT4: 6.3;SH-SY5Y: 6.3;U-87 MG: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031427: AB_2673877, HPA046656: AB_2679740, HPA072448: AB_2686521"	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.6	10.8	15.7	0.8	20.8	0.5	1.8	0.8	35.1	7.3	1.2	2.3	0.0	1.1	1.5	1.7	1.5	2.2	2.7	1.0	14.2	4.7	1.4	0.6	6.0	0.8	3.1	24.7	0.7	4.4	10.4	1.0	0.8	5.2	1.5	1.4	0.0	6.4	1.4	0.9	1.8	0.9	1.8	1.5	0.6	0.8	1.0	1.3	0.0	1.3	0.0	0.8	1.7	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	17.1	0.0	3.8	1.2	0.0	1.2	3.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.2	0.0	2.6	0.0	1.7	0.0	18.9	4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	2.2	0.2	0.2	0.2	0.0	3.5	3.7	6.3	2.3	6.3	0.4	0.0	0.0	0.1	0.0	0.3	2.6	0.7	0.1	1.0	0.1	0.0	0.0	0.0	9.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	20.8	0.8	31.5	14.2	4.7	3.1	24.7	5.2	1.3	0.0	16.0	0.0	0.2	0.1	7.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	0.0	0.8	0.1	0.0	0.0	0.8	0.1	1.1	0.0	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.9	1.4	0.0	1.7	0.0	0.0	6.1	0.1	0.0	3.5	0.3	0.4	0.0	0.8	0.2	0.1	0.5	0.3	0.0	0.0	0.9
SHISA2	"bA398O19.2, C13orf13, hShisa, PRO28631, TMEM46, WGAR9166"	ENSG00000180730	"Shisa family member 2"	Q6UWI4	13	26044597-26051031	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 12.9;skeletal muscle: 10.2;thyroid gland: 20.8"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 9.6;Basal glandular cells: 8.8;Urothelial cells: 18.2"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 18.9;JURKAT: 13.2;LHCN-M2: 13.2;NTERA-2: 9.6;RH-30: 30.7;U-2197: 19.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA049752, HPA050172"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA049752: , HPA050172: AB_2681041"	"unprognostic (2.08e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.41e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (3.30e-4)"	"unprognostic (4.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.51e-2)"	0.3	0.0	0.7	0.0	2.0	0.0	12.9	0.0	0.5	1.5	0.0			0.4	0.0	7.9	0.0	0.0	0.3	0.0	2.0	0.6	3.0	0.0	3.7	0.1	1.1		0.0	0.0	0.0	1.7	0.0		0.4	0.0		1.9	0.0	10.2	1.0	0.3	0.0	3.5	0.0	1.6	0.9			20.8		0.3	0.0	0.0	0.8	0.6	2.2	1.1	1.0	5.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.2	2.5	1.0	0.0	0.0	1.2	18.9	0.7	13.2	0.0	0.0	13.2	0.7	1.3	0.3	9.6	5.5	4.8	0.0	30.7	0.1	1.2	4.3	0.3	0.0	0.2	0.0	3.4	2.0	0.4	0.1	1.0	0.0	0.5	19.2	4.2	0.0	0.0	0.0	0.0	0.0	2.6	2.2	0.4	1.7	0.6	0.7	1.0	0.6	1.7	0.7	0.3	0.8	3.9	5.6	1.6	1.0	1.1	0.6	0.7	0.4											0.0	9.6	0.0	8.8	4.7	0.0	0.4	0.0	1.4	0.0	3.5	0.0	0.2	0.0	4.0	1.5	1.2	0.0	0.0	0.2	0.3	0.7	2.4	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.7	0.0	0.2	1.7	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	1.2	0.3	3.6	1.5	0.1	0.0	0.0	18.2
SHISA4	"C1orf40, hShisa4, TMEM58"	ENSG00000198892	"Shisa family member 4"	Q96DD7	1	201888680-201892306	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 175.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 18.3;intermediate monocyte: 6.4;neutrophil: 8.2;non-classical monocyte: 7.8"	"Group enriched"	"Detected in many"	9	"granulocytes: 18.3;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061273, HPA067885"	Uncertain					NA	NA					"HPA061273: AB_2684460, HPA067885: "	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.48e-3)"	"unprognostic (2.12e-3)"	"unprognostic (6.59e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.06e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"	5.2	15.8	22.2	3.8	18.8	2.5	3.3	9.6	34.8	4.7	3.3	29.1	2.1	2.7	4.4	4.5	4.0	3.9	4.7	14.7	17.5	14.6	4.1	3.8	4.0	2.7	19.2	14.8	6.8	4.1	4.1	3.8	3.8	21.3	6.2	2.9	7.2	12.1	5.1	175.2	4.2	3.2	4.7	14.0	3.4	3.2	4.2	8.2	0.0	6.3	18.8	2.7	3.9	2.6	0.0	0.7	18.3	7.8	0.0	1.5	0.5	1.1	8.8	1.0	6.3	9.5	5.7	0.9	7.7	12.6	3.2	4.5	1.5	2.3	0.0	10.5	9.5	12.6	2.2	0.1	1.3	2.1	0.9	0.5	0.1	2.6	1.0	6.7	0.0	5.6	5.8	2.8	4.1	2.0	16.6	5.8	0.1	0.0	0.3	5.6	1.0	0.0	0.0	0.6	0.6	10.7	0.1	0.0	1.7	3.1	3.4	0.4	5.7	2.7	1.3	7.8	5.3	3.6	0.7	5.9	4.6	4.5	2.5	3.9	1.5	1.2	0.0	7.4	0.0	7.9	0.0	1.4	18.3	1.5	6.4	0.6	0.0	0.3	0.3	0.7	0.0	0.0	0.3	8.2	0.0	7.8	0.0	0.0	0.5	22.2	18.8	9.6	34.8	17.5	14.6	19.2	14.8	21.3	8.2	0.0	1.7	0.0	3.6	12.6	9.2	18.3	7.6	0.0	2.3	10.4	3.9	1.5	28.2	22.4	0.5	7.4	0.0	0.0	13.5	19.0	16.6	9.5	1.1	3.4	2.9	4.8	1.7	11.6	2.9	1.5	14.7	4.2	21.9	6.4	0.0	19.3	10.6	0.0	27.6	5.0	3.4	19.4	13.3	1.4	0.7	5.9	2.3	2.2	0.0	1.8
SIK1B		ENSG00000275993	"Salt inducible kinase 1B (putative)"		21	6111134-6123739	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 19.8;Ciliated cells: 16.0;Club cells: 6.8"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	6	"B-cells: 1.6;dendritic cells: 5.0;monocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.6;hTERT-RPE1: 38.8;Karpas-707: 39.0;LHCN-M2: 26.8;SiHa: 28.1"									"HPA038211, HPA078064"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA038211: AB_2675894, HPA078064: "	"unprognostic (2.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.58e-3)"	"unprognostic (2.62e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.69e-3)"	"unprognostic (7.41e-2)"	9.7	13.7	0.4	3.0	1.7	8.4	5.2	0.4	3.1	2.9	3.0	1.3	4.6	0.9	3.1	1.9	6.8	1.0	15.5	6.2	1.5		1.7	12.3	8.5	1.2	1.8	0.6	10.2	11.2	1.6	2.2	3.2	2.6	5.1	2.3	7.6	3.9	14.3	9.1	2.9	6.1	1.7	2.1	2.0	5.0	1.7	1.0	1.0	0.9	5.6	3.2	7.1	2.7	1.6	5.0	0.0	1.7	0.3	0.5	0.1	3.0	15.1	1.1	0.9	0.2	0.1	2.7	0.3	0.2	0.6	0.3	16.8	2.2	1.0	0.5	0.0	2.4	0.3	1.8	0.0	0.2	2.7	0.5	2.3	28.6	3.2	1.0	0.3	0.2	0.4	13.3	1.5	8.7	38.8	0.6	0.4	0.9	39.0	26.8	1.4	0.3	0.7	1.6	2.7	1.7	0.6	6.9	4.5	1.5	5.1	1.4	0.7	28.1	1.8	1.5	0.8	0.3	1.2	0.7	0.4	1.5	0.6	6.2	5.4	11.7	0.5	4.3	1.0	1.8	0.0	0.1	0.0	0.1	0.8	0.5	1.6	0.0	0.1	0.7	1.6	0.1	0.1	0.0	0.3	1.7	5.0	0.0	0.1											23.8	19.8	0.0	0.0	0.0	0.0	0.0	0.0	16.0	6.8	1.8	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	5.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Not detected"	"Not detected"			HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	9.0	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	13.3	0.0	0.1	0.1	0.0	8.4	1.9	0.0	0.0	0.2	3.2	23.0	0.0	0.1	0.1	28.9	17.4	0.2	0.3	8.2	0.0	0.7	0.8	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3	0.0	0.0	0.0	8.9	0.2	0.2	2.0	0.0	0.0	0.0	8.7	0.0	0.0	8.3	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.2	0.2	0.4	0.0	0.0	0.0	1.8
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 60.1;lymphoid tissue: 44.0"	"Group enriched"	"Detected in some"	14	"Early spermatids: 20.5;Late spermatids: 9.7;T-cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 60.1"	"Lineage enriched"	"Detected in many"	6	"T-cells: 60.1"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 5.5;JURKAT: 12.1;NB-4: 15.0;RT4: 4.0;THP-1: 2.6"															NA	NA						"unprognostic (3.35e-3)"	"unprognostic (4.09e-3)"	"unprognostic (7.32e-3)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.23e-3)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (7.36e-7)"	"unprognostic (1.62e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.95e-3)"	0.8	0.4	0.3	11.7	0.3	1.5	0.5	0.3	0.4	0.7	2.3	0.1	0.4	0.9	0.5	0.6	1.4	0.7	2.1	0.4	0.3	0.3	1.1	1.1	1.4	20.5	0.3	0.1	0.7	0.4	0.0	0.3	0.4	0.2	0.9	1.8	0.6	4.6	0.9	0.4	0.4	8.8	0.6	0.4	14.0	1.6	0.4	0.1	44.0	1.3	0.7	21.3	2.9	0.8	0.1	1.1	1.0	0.2	9.5	60.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	5.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.1	12.3	0.1	34.1	0.1	38.4	29.0	0.1	0.1	40.5	33.3	1.0	9.5	0.1	1.1	60.1	16.7	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	9.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	18.7	0.0	0.0
SIX1	DFNA23	ENSG00000126778	"SIX homeobox 1"	Q15475	14	60643415-60658259	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 39.1;salivary gland: 55.1;skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in some"	19	"Basal glandular cells: 23.3;Ciliated cells: 65.6;Club cells: 33.0;Glandular cells: 24.0;Urothelial cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"olfactory region: 1.2;pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 14.3;LHCN-M2: 53.4;RH-30: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001893, CAB058690"	Enhanced		Supported	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"CAB058690: AB_2665581, HPA001893: AB_1079991"	"unprognostic (3.62e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.09e-2)"	"prognostic unfavorable (8.92e-6)"	"unprognostic (1.33e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (3.94e-4)"	"unprognostic (1.40e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.06e-8)"	"unprognostic (8.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-1)"	7.1	0.4	0.3	0.1	0.5	0.1	4.7	0.3	0.6	7.4	0.2	0.2	0.0	0.1	0.2	2.1	1.3	0.5	0.4	0.4	0.3	0.3	0.3	0.2	1.8	0.3	0.4	1.2	0.3	0.3	16.8	39.1	0.1	4.5	8.7	0.1	2.0	55.1	0.2	59.0	0.4	0.2	0.7	0.5	0.2	0.5	1.6	0.0	6.5	2.4	22.5	3.0	1.4	9.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	1.9	0.2	11.9	6.9	8.1	0.1	2.0	4.5	2.3	2.0	0.0	3.8	0.0	1.1	0.4	1.1	2.7	3.9	3.6	0.8	0.0	9.5	0.9	0.8	2.7	0.0	0.0	0.1	6.0	1.8	1.6	0.3	14.3	0.1	0.7	2.6	0.0	53.4	1.3	0.0	0.2	0.0	0.0	4.8	0.0	29.2	0.0	2.3	6.5	1.1	0.1	2.3	0.1	2.4	0.2	1.4	0.2	6.8	3.2	3.2	3.7	3.0	0.2	0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.5	0.3	0.3	0.4	1.2	4.5	0.0	3.0	1.0	0.0	23.3	0.1	0.0	0.8	0.0	65.6	33.0	1.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.8	24.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.1	0.0	0.3	0.0	0.2	0.0	2.5	0.1	0.2	0.0	0.0	14.9
SIX4	AREC3	ENSG00000100625	"SIX homeobox 4"	Q9UIU6	14	60709528-60724348	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 20.4;salivary gland: 16.4;skeletal muscle: 19.3"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 9.2;Ciliated cells: 20.1;Cone photoreceptor cells: 19.6;Glandular cells: 15.2;Urothelial cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.7;hTERT-RPE1: 15.9;RH-30: 21.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA031794	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031794: AB_10602928"	"unprognostic (2.23e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.63e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.08e-1)"	2.0	1.5	0.9	0.6	0.9	0.3	4.8	4.3	4.5	3.3	0.7	0.1	3.3	0.4	1.6	1.3	0.5	3.5	1.1	1.5	1.0	1.0	1.4	0.5	2.1	0.2	1.0	2.2	2.9	3.3	20.4	6.3	2.1	3.6	4.0	0.3	0.8	16.4	2.7	19.3	0.5	0.5	0.9	1.8	0.3	2.0	0.7	1.1	0.8	3.9	2.4	1.4	1.7	14.3	0.2	0.1	1.0	0.1	0.3	0.2	0.0	20.7	1.5	1.2	5.6	4.9	6.2	9.8	4.7	7.1	1.4	2.0	1.0	6.6	0.0	3.1	2.3	1.4	7.9	5.6	3.8	3.3	1.6	4.6	0.6	2.1	1.4	1.6	2.1	0.2	2.9	1.8	1.3	6.6	15.9	1.2	0.4	4.1	0.0	7.2	5.2	0.0	0.2	3.6	0.1	8.9	1.3	21.0	0.0	2.5	11.9	3.4	0.3	3.0	4.7	1.2	2.0	6.4	0.1	4.1	4.4	9.7	2.9	4.2	1.4	0.0	0.0	1.5	0.0	0.8	0.3	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.9	0.9	4.3	4.5	1.0	1.0	1.0	2.2	3.6	1.1	3.0	0.3	0.0	9.2	0.3	0.2	1.6	0.0	20.1	6.8	1.8	19.6	4.7	0.0	0.1	0.0	0.3	0.0	0.0	0.9	3.3	1.9	15.2	1.1	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.3	0.1	1.7	0.0	0.0	1.7	2.7	0.0	1.4	0.3	0.4	0.0	0.3	0.1	0.9	0.5	2.6	0.0	0.0	10.5
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362848-110391082	"Predicted membrane proteins"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.4;placenta: 76.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 68.0;Proximal tubular cells: 176.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.0"	"Group enriched"	"Detected in many"	4	"B-cells: 5.0;granulocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	3.8	2.4	1.9	2.1	2.8	0.6	3.4	2.3	1.7	2.7	4.5	2.9	2.7	4.7	2.3	11.9	4.3	2.4	9.6	4.0	2.6	2.1	61.4	7.9	6.1	1.4	2.7	1.4	21.3	0.8	0.5	3.5	76.5	6.9	3.7	0.9	17.3	1.9	3.2	1.1	0.8	14.0	1.8	3.6	2.0	2.5	4.0	1.8	0.0	8.0	1.3	1.3	3.1	3.0	5.0	0.1	1.3	0.6	0.0	0.7	0.3	0.2	5.5	1.2	1.8	4.0	7.8	11.6	3.0	11.7	1.0	2.9	1.7	17.3	0.3	3.3	9.4	0.1	0.3	0.0	1.1	1.1	0.3	1.4	0.3	1.1	1.7	11.6	0.3	0.3	5.7	0.1	1.7	0.1	25.2	2.4	0.4	0.2	0.6	1.9	0.5	0.2	0.3	0.3	0.0	0.2	0.1	0.8	0.1	2.0	0.2	0.7	0.4	0.3	5.6	17.8	5.6	0.3	0.0	0.2	0.7	0.4	0.2	0.8	0.3	0.0	0.9	0.6	0.2	3.2	0.0	0.6	0.3	0.5	0.2	0.2	5.0	0.6	0.1	0.1	1.0	0.6	0.7	1.3	0.0	0.2	0.0	0.2	0.3	1.9	2.8	2.3	1.7	2.6	2.1	2.7	1.4	6.9	1.8	11.9	17.3	3.2	5.2	2.7	11.1	1.1	15.3	0.0	5.7	68.0	5.9	28.5	3.3	2.9	0.4	4.4	1.3	23.3	0.8	29.3	13.9	2.7	4.7	4.5	3.7	3.2	3.4	3.1	1.0	1.1	16.7	0.8	10.1	1.0	0.9	2.3	1.3	0.2	11.0	176.8	17.7	0.0	5.2	3.0	2.0	3.1	29.4	4.6	0.5	5.0
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645857-112663827	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 198.3;Enterocytes: 165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 87.9;U-87 MG: 85.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	23.4	9.9	11.9	38.8	16.0	51.3	18.9	25.6	29.1	9.4	42.7	10.6	4.7	12.3	11.7	8.6	11.0	12.2	22.7	17.0	12.0	12.3	16.3	40.2	23.1	27.6	13.5	16.8	7.7	25.7	7.4	13.3	59.8	20.6	15.3	19.1	17.8	10.4	12.2	25.6	10.2	21.8	13.1	15.5	23.8	13.8	13.3	9.1	19.0	12.8	9.5	22.4	21.6	14.4	3.8	17.9	12.3	25.2	19.9	27.1	13.0	10.9	9.0	11.8	9.5	9.0	22.1	9.1	29.6	35.5	13.2	17.2	13.7	27.1	19.9	16.4	11.0	51.3	11.5	12.9	22.5	19.4	10.9	13.2	16.9	9.2	13.0	13.4	9.6	30.0	11.2	8.9	46.6	32.7	87.9	16.8	8.6	31.3	20.9	57.2	4.3	13.1	37.4	19.8	5.1	24.4	12.4	10.6	5.6	19.1	50.8	10.8	10.2	14.9	9.1	20.4	5.5	9.3	6.9	36.4	24.3	16.0	8.4	22.9	8.7	22.4	16.7	85.5	9.3	29.3	3.8	14.5	12.3	24.2	25.2	27.1	3.8	10.4	17.4	10.9	2.1	8.3	13.1	6.1	19.9	14.7	17.9	6.0	13.0	11.9	16.0	25.6	29.1	12.0	12.3	13.5	16.8	20.6	9.1	11.9	32.9	31.8	53.3	100.2	60.0	31.1	22.9	36.1	31.8	8.7	198.3	36.6	11.6	14.7	0.9	44.4	165.9	23.3	12.2	11.8	33.2	30.0	24.3	49.9	25.2	19.1	34.2	46.1	48.3	2.0	3.4	60.3	25.3	8.2	39.4	21.5	21.0	83.4	4.6	3.8	74.9	0.0	22.1	4.8	17.4	54.1	62.1	52.4	51.1	43.9
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	23.6	14.7	0.8	0.0	0.0	0.5	4.5	2.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	7.5	4.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6	14.9	62.8	0.0	0.3	4.1	0.0	1.6	5.1	1.4	10.3	0.0	0.0	0.4	5.0	9.1	0.4	0.3	0.7	0.0	2.5	0.2	11.0	3.4	2.3	56.3	0.6	0.0	0.0	0.0	0.6	0.9	31.4	1.5	3.3	0.0	0.4	0.0	33.9	0.0	23.0	2.1	0.0	0.0	11.4	0.2	0.1	5.8	0.3	0.0	0.4	0.7
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 3550.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"HEL: 47.7;hTERT-RPE1: 27.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3.0	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3.0	1.0	2.2	47.7	7.0	1.4	4.9	2.7	1.9	6.2	8.0	4.8	4.8	27.9	3.4	5.0	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3.0	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35.0	24.5	60.7	19.4	95.7	12.5	47.1	47.0	15.3	22.7	43.1	139.3
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.7	0.3	0.5	0.0	0.7	1.5	0.4	0.3	0.2	0.3	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.2	0.5	0.2	0.1	3.5	0.9	0.0	0.3	0.2	0.4	0.4	1.1	0.0	0.9	0.4	0.0	8.3	0.1	0.8	0.0	0.4	4.6	0.7	0.0	0.4	0.0	0.0	0.8	0.2	1.3	0.0	0.0	0.1	2.5	0.1	0.0	0.0	1.7	0.2	0.0	0.4	0.7	0.7	0.5	0.2	2.8	0.7	0.7	0.3	0.8	0.4	1.7	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0	3.0	11.4	0.0	0.6	1.4	5.6	0.7	0.0	1.4	4.5	0.0	2.0	0.2	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.1	1.1	8.7	4.7	0.0	0.2	1.6	7.0	0.6	0.3	2.0	0.9	1.4	6.8	1.0	0.0	0.4	0.1	0.0	1.1	0.0	1.1	0.0	0.9	1.7	0.3	1.3	0.0	1.0	0.0	1.2
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 201.0;Horizontal cells: 527.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.2	0.2	2.2	6.5	0.4	0.4	4.4	3.9	4.1	5.3	3.8	4.5	3.6	0.0	1.5	1.4	9.2	3.6	1.1	7.1	1.6	0.0	1.0	0.0	0.0	0.1	1.1	0.1	0.3	3.1	6.7	0.0	2.1	13.4	0.0	0.0	0.2	0.0	1.5	2.1	0.0	0.0	3.6	0.2	5.3	0.0	0.0	0.0	3.6	1.5	1.3	6.4	2.5	6.8	3.3	7.5	0.6	1.6	0.0	3.3	5.8	0.0	3.1	0.0	0.0	0.0	2.7	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5	0.0	0.0	0.0	0.6	0.2	8.9	201.0	0.0	0.0	1.2	1.8	0.0	10.5	1.7	2.8	2.0	0.1	0.0	0.0	1.5	2.5	2.2	0.3	0.0	0.0	1.6	527.6	0.0	0.0	0.0	11.9	14.1	1.1	0.0	1.0	0.0	7.0	1.3	0.0	21.2	0.3	6.7	6.5	1.4	0.5	1.1	0.6	11.6	0.0	0.0	0.0
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA					"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.1	13.9	1.9	2.3	1.8	0.0	0.1	0.0	0.1	6.3	0.6	0.0	0.2	0.0	5.7	0.0	1.8	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.9	0.0	0.6	1.2	0.0	4.7	0.2	0.1	0.2	0.0	0.0	0.0	0.9	14.9	4.2	1.0	0.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	7.9	0.7	5.7	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0	3.0	32.5	1.3	4.2	0.0	0.0	20.1	107.0	14.7	31.8	24.4	0.0	0.2	13.3	81.5	6.6	1.9	173.4	0.0	21.6	0.1	1.1	63.3	1.1	31.7	0.2	0.0	8.2	1.8	0.6	1.0	0.0	1.0	1.7	1.8	66.7	3.3	19.9	56.6	0.0	149.5	1.1	6.5	2.5	0.1	0.4	0.0	0.2	6.9	42.6	7.0
SLITRK5	"bA364G4.2, KIAA0918, LRRC11"	ENSG00000165300	"SLIT and NTRK like family member 5"	O94991	13	87672615-87696272	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.2;fallopian tube: 6.7;salivary gland: 7.4"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 11.5;Horizontal cells: 20.6;Muller glia cells: 6.5"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 11.2;HeLa: 5.5;hTERT-RPE1: 5.1;U-138 MG: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013843	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA013843: AB_1857233"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.11e-4)"	"unprognostic (6.94e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.60e-1)"	0.1	0.3	3.3	0.1	6.8	0.1	0.2	3.1	9.2	0.4	0.2			0.0	0.1	1.0	0.2	6.7	0.1	0.1	4.8	4.2	0.0	0.0	0.2	0.1	2.6		0.6	0.8	0.0	0.0	0.0		1.8	0.3		7.4	3.1	0.2	0.2	0.0	0.0	1.0	0.1	0.5	0.2			2.0		0.3	0.0	0.4	0.7	1.4	1.6	0.3	1.4	0.4	0.1	0.0	1.2	11.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	2.9	0.0	0.0	0.0	2.0	1.3	5.5	0.0	0.8	0.0	0.0	2.5	0.2	0.0	1.0	5.1	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	2.7	0.0	1.4	1.0	0.3	0.2	0.4	0.0	1.7	0.3	0.0	0.3	0.0	0.0	0.8	2.6	0.0	3.9	0.0	0.0	0.6	1.7	0.0	0.0	3.5	0.1	1.1	1.1	0.3	0.4	0.4	0.2	0.4	0.4	0.4	0.3	0.1	0.7	0.4	0.3	1.6	1.4	0.3	1.4	0.2	0.1											0.0	0.6	0.0	1.7	0.1	11.5	1.6	0.0	2.7	0.0	0.0	3.9	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.1	1.1	0.0	0.0	20.6	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	1.5	6.5	0.0	0.0	4.6	0.0	1.6	0.0	0.1	5.0	0.1	0.0	0.0	0.0	0.0	0.9
SPAG4	"CT127, SUN4"	ENSG00000061656	"Sperm associated antigen 4"	Q9NPE6	20	35615892-35621049	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 54.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 155.3;Late spermatids: 107.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 16.9;hTERT-RPE1: 12.4;U-87 MG: 30.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA048393, HPA061789"	Approved					NA	NA					"HPA048393: AB_2680385, HPA061789: AB_2684609"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (1.09e-5)"	"prognostic favorable (9.52e-8)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (6.66e-4)"	1.7	2.9	1.6	4.8	1.4	3.8	3.7	0.4	5.3	2.7	13.9	0.2	3.3	4.0	1.5	4.4	2.8	2.5	3.4	2.6	1.1	2.0	3.1	3.0	3.2	4.9	1.3	1.6	5.2	54.3	3.2	5.0	7.0	2.3	2.6	2.0	2.8	4.5	2.5	0.4	0.4	3.4	1.2	2.9	6.9	4.6	16.9	1.5	0.0	1.3	0.0	7.5	7.2	1.8	0.9	3.9	0.0	0.7	0.0	1.0	0.4	2.3	1.0	0.5	1.4	1.3	0.6	6.7	1.0	1.2	0.9	1.4	2.4	5.1	0.2	16.9	1.3	4.1	0.7	0.3	3.2	1.1	2.5	0.5	1.9	2.3	2.4	6.6	1.3	3.4	3.2	0.6	1.0	0.8	12.4	1.9	0.7	0.5	4.7	2.4	4.9	0.5	3.7	0.0	4.4	4.6	0.3	0.5	6.6	1.7	1.0	0.3	2.4	1.1	0.8	1.8	0.3	3.4	0.6	2.0	4.8	0.7	1.0	1.0	9.1	3.5	1.9	30.6	0.5	0.7	0.0	0.1	0.0	0.0	0.7	0.5	0.9	0.1	0.4	0.4	0.0	0.5	0.0	0.0	0.0	0.0	3.9	1.0	0.4	1.6	1.4	0.4	5.3	1.1	2.0	1.3	1.6	2.3	1.5	0.0	0.3	2.2	0.9	0.3	2.6	1.5	0.0	0.0	1.2	0.0	2.0	1.3	0.0	8.1	155.3	3.6	0.3	0.0	6.5	11.2	1.8	1.0	4.6	4.3	1.3	1.6	4.1	5.5	1.9	107.6	1.7	1.2	25.3	3.6	0.3	14.0	19.0	0.9	2.8	3.1	1.9	0.0	2.5	14.1	0.7	0.1	16.9	2.9	0.4	3.0
SPECC1	"CYTSB, FLJ36955, HCMOGT-1, NSP"	ENSG00000128487	"Sperm antigen with calponin homology and coiled-coil domains 1"	Q5M775	17	20009344-20319026	"Disease related genes, Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 111.1;monocytes: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.6;SuSa: 58.4"	"Low region specificity"	"Detected in all"							"HPA021421, HPA021430, HPA061073"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Vesicles"	"Nucleoli fibrillar center, Cytosol"	"HPA021421: AB_1857431, HPA021430: AB_1857432, HPA061073: "	"unprognostic (1.13e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.10e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.04e-1)"	10.7	8.3	21.3	7.2	38.0	29.9	8.1	16.0	30.8	7.0	14.9	49.9	0.7	9.5	15.4	6.1	11.4	7.3	20.0	4.1	23.1	15.4	4.3	2.0	5.6	5.7	35.8	21.2	17.0	8.3	3.0	6.8	4.8	29.3	7.3	15.5	3.0	5.9	4.9	4.3	4.8	11.4	11.5	28.2	17.3	9.8	25.8	41.5	0.2	6.7	1.4	6.0	7.0	4.2	2.9	14.7	18.9	9.4	8.5	3.4	3.0	14.2	14.8	8.0	2.6	6.1	3.1	17.4	5.8	4.8	5.8	7.2	24.2	12.7	0.8	18.9	5.0	8.7	10.6	6.1	13.8	2.9	4.3	6.5	5.8	16.2	2.6	2.2	0.6	3.4	3.3	14.0	8.2	9.3	35.6	0.0	2.4	0.7	7.2	4.5	12.1	0.1	3.2	6.4	6.3	3.6	3.5	16.2	8.2	14.3	7.1	2.6	2.7	30.4	14.6	6.4	58.4	12.9	3.8	0.4	0.7	8.9	0.8	15.7	2.8	3.5	1.1	8.6	4.9	3.3	18.9	9.4	17.8	3.1	5.3	2.9	2.4	1.9	3.4	14.7	2.9	1.8	2.4	8.1	8.5	4.6	4.4	0.9	3.0	21.3	38.0	16.0	30.8	23.1	15.4	35.8	21.2	29.3	41.5	20.8	14.3	3.2	11.9	4.8	5.9	6.1	7.6	12.0	6.8	17.4	64.8	3.9	8.3	26.9	75.7	5.2	32.8	23.3	31.4	10.8	9.5	14.6	111.1	0.2	18.6	0.0	7.5	3.1	9.7	40.7	4.6	14.0	20.3	103.6	44.0	19.3	54.5	28.3	42.1	2.4	32.8	58.2	31.9	72.4	64.5	2.3	1.8	10.2	18.6	22.1
SPEG	"APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta"	ENSG00000072195	"SPEG complex locus"	Q15772	2	219434846-219498287	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 88.7"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 27.9;U-87 MG: 14.6"	"Low region specificity"	"Detected in all"							HPA018904	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA018904: AB_1844924"	"unprognostic (3.70e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.45e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.29e-2)"	"unprognostic (8.66e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.47e-9)"	"unprognostic (1.14e-1)"	"unprognostic (7.01e-2)"	"unprognostic (5.95e-4)"	"unprognostic (1.28e-3)"	7.7	7.1	10.1	9.1	7.7	1.2	4.2	10.4	9.8	19.2	45.1	4.1	10.5	5.7	31.6	14.1	13.5	19.0	17.4	17.8	8.7	5.3	2.0	1.4	3.0	1.7	4.0	8.0	7.0	2.9	4.7	10.5	4.8	5.5	16.7	4.5	6.7	7.8	23.0	88.7	2.2	9.2	45.2	9.1	1.9	16.1	3.0	3.9	0.0	2.0	16.8	1.6	22.5	12.6	0.0	0.3	0.0	0.0	0.0	0.5	0.7	3.6	0.3	1.8	3.1	0.9	2.9	1.2	7.7	5.2	5.2	3.9	2.8	1.3	0.0	2.8	5.6	2.9	4.5	1.5	1.8	2.0	0.4	1.2	0.4	3.3	0.1	1.3	0.0	0.6	8.2	2.7	4.7	1.1	27.9	0.0	2.0	2.7	0.0	3.7	1.0	0.0	11.0	3.9	0.1	1.4	1.8	4.2	0.6	5.0	0.0	2.1	9.6	0.5	0.0	0.1	9.2	0.3	0.1	0.1	13.0	13.2	1.5	12.1	0.4	0.0	0.1	14.6	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	0.0	0.7	10.1	7.7	10.4	9.8	8.7	5.3	4.0	8.0	5.5	3.9	0.0	2.1	0.0	5.6	2.9	1.1	55.0	5.1	0.0	0.0	1.8	2.0	0.8	0.0	1.2	17.7	1.4	5.9	0.0	1.0	0.7	8.5	2.7	0.0	2.4	1.0	4.8	6.4	3.7	6.6	30.8	9.8	1.7	3.3	1.8	3.3	6.5	0.3	2.9	17.7	2.3	0.8	45.3	36.2	1.1	2.6	1.3	1.1	0.0	2.4	3.5
SPOCK1	"SPOCK, testican-1, TIC1"	ENSG00000152377	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1"	Q08629	5	136975298-137598379	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 92.2"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 83.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.5;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.6;monocytes: 2.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007450, HPA026770"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA007450: AB_10603116, HPA026770: "	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (5.83e-3)"	"prognostic unfavorable (9.08e-4)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (3.77e-5)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.90e-2)"	11.3	31.0	20.6	4.0	30.4	1.5	9.3	68.2	92.2	20.5	7.4	36.0	5.1	2.1	20.5	26.1	5.6	6.8	14.3	38.6	29.9	16.6	18.0	1.4	1.9	1.7	35.5	29.0	3.2	3.7	1.4	3.7	7.6	19.6	48.9	3.6	5.2	2.9	20.7	5.6	3.2	2.6	23.2	21.7	6.8	3.7	15.9	36.0	0.1	3.3	0.0	1.6	8.1	11.5	0.0	1.6	0.4	2.5	0.0	0.0	0.6	0.5	0.1	38.2	0.0	75.8	15.5	0.0	12.4	11.5	27.0	15.2	0.0	0.0	0.0	0.0	25.9	6.8	0.5	0.1	8.9	8.4	2.1	0.0	0.0	2.3	0.0	0.5	0.0	0.0	27.0	3.6	16.6	2.9	144.5	75.8	0.0	0.0	0.0	7.7	0.0	0.0	0.0	2.4	0.0	3.5	0.0	0.0	0.0	18.0	1.2	0.4	1.8	6.1	0.1	0.0	4.8	0.0	0.1	12.1	38.5	1.3	13.1	3.5	0.0	0.0	0.0	20.9	0.5	17.4	0.0	2.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	20.6	30.4	68.2	28.5	29.9	16.6	35.5	29.0	19.6	36.0	0.0	0.0	0.0	1.7	1.5	5.0	54.3	0.0	0.0	0.0	21.0	2.0	0.4	1.7	0.7	8.2	2.1	0.0	0.0	1.2	0.4	9.5	48.4	0.0	0.0	0.8	7.9	33.7	1.3	2.4	8.9	16.1	1.1	6.8	1.0	0.0	252.1	1.5	0.0	141.1	1.7	3.2	12.9	12.8	7.5	5.9	1.3	0.1	0.0	0.1	2.1
SPOCK3	testican-3	ENSG00000196104	"SPARC/osteonectin, cwcv and kazal like domains proteoglycan 3"	Q9BQ16	4	166733384-167234796	"Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.8;parathyroid gland: 184.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 45.8;Ciliated cells: 12.0;Club cells: 18.2;Early spermatids: 12.6;Horizontal cells: 14.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 7.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;intermediate monocyte: 1.8;myeloid DC: 4.5;plasmacytoid DC: 1.4"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.5;monocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.2;hTERT-RPE1: 9.9;PC-3: 3.9;RH-30: 10.4;SCLC-21H: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA						"unprognostic (3.54e-2)"	"unprognostic (8.69e-2)"		"unprognostic (2.90e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.09e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-4)"	"unprognostic (8.92e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.64e-1)"	1.2	10.0	21.7	1.3	30.4	1.1	1.1	5.8	23.2	1.4	1.4	32.2	2.2	1.4	2.2	8.0	1.2	1.5	1.2	1.2	31.3	21.4	1.2	1.2	1.2	1.2	45.4	15.9	7.8	1.3	184.6	0.3	1.1	27.4	28.1	1.3	0.0	1.2	14.1	1.2	1.1	1.6	2.1	46.8	1.2	1.4	1.3	42.9	0.0	1.1	0.9	1.2	1.9	0.3	0.0	4.5	0.0	3.3	0.3	0.0	1.1	0.0	2.4	0.3	0.0	0.0	0.0	0.4	0.0	3.2	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	0.6	0.2	0.3	0.0	1.6	0.2	0.0	0.0	0.3	0.0	0.0	0.4	0.0	9.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	0.0	3.9	0.0	10.4	0.6	0.0	1.5	4.5	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.0	3.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	1.4	0.0	1.1	21.7	30.4	5.8	22.8	31.3	21.4	45.4	15.9	27.4	42.9	0.0	0.0	0.0	1.1	0.0	45.8	0.9	0.0	12.0	18.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	4.0	1.1	0.0	0.1	14.3	0.0	0.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.4	0.0	5.1	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6
SPRED3		ENSG00000188766	"Sprouty related EVH1 domain containing 3"	Q2MJR0	19	38388421-38399587	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 10.7"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 7.3;Intestinal endocrine cells: 10.4"	"Cancer enhanced"	"Detected in many"		"glioma: 3.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.3;TIME: 14.7;U-87 MG: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071521			Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA071521: "	"unprognostic (1.09e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.71e-3)"	"unprognostic (3.35e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.09e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.40e-11)"	"unprognostic (6.21e-4)"	"unprognostic (3.67e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.45e-3)"	2.0	1.2	4.3	2.7	10.1	0.9	1.2	2.8	10.7	0.9	0.6	1.7	0.0	4.7	1.2	1.2	0.9	0.7	2.0	1.1	5.0	4.7	1.2	0.4	0.9	0.5	2.8	4.6	0.5	2.9	4.5	5.8	0.8	4.7	1.2	0.8	0.9	0.8	1.1	0.9	2.3	3.7	2.3	1.7	0.5	1.3	1.7	0.9	0.0	1.8	0.0	0.6	0.9	0.8	0.8	0.7	2.2	0.6	0.9	0.5	0.3	0.2	1.1	3.8	3.1	0.6	1.8	2.1	7.5	5.0	2.5	2.3	0.4	0.8	0.2	2.7	2.5	2.0	0.1	0.6	0.9	2.3	0.7	1.4	0.0	0.2	0.4	1.3	2.0	0.1	1.3	0.9	5.9	1.7	12.3	7.8	0.6	0.6	1.4	7.6	0.4	0.0	0.1	1.7	0.5	3.8	0.9	1.3	0.1	5.4	0.6	0.2	2.9	0.1	0.2	0.3	1.7	0.6	0.1	14.7	2.8	8.6	2.3	4.1	0.6	0.2	0.5	9.4	0.3	4.7	1.6	0.6	0.4	0.4	0.2	0.3	0.3	0.5	0.3	0.1	0.8	0.4	0.3	2.2	0.9	0.5	0.7	0.2	0.3	4.3	10.1	2.8	9.8	5.0	4.7	2.8	4.6	4.7	0.9	0.0	0.0	0.0	1.1	0.0	7.3	1.0	0.0	0.0	0.0	1.8	2.0	0.4	0.0	0.8	0.3	0.1	0.7	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.1	1.6	10.4	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.3	2.5	2.2	0.0	0.0	0.0	0.2	0.0	1.0	0.9	0.6	0.1	0.7	0.0	0.6	0.6
SSC5D	"FLJ35258, S5D-SRCRB"	ENSG00000179954	"Scavenger receptor cysteine rich family member with 5 domains"	A1L4H1	19	55488404-55519098	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 16.7;Peritubular cells: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 18.9;BJ: 17.8;fHDF/TERT166: 18.0;hTERT-RPE1: 17.6;U-87 MG: 19.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA042008, HPA053316"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"	Yes	NA		44000000	"Nucleoplasm, Cytosol"		"HPA042008: AB_10804124, HPA053316: "	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.55e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.20e-3)"	"prognostic unfavorable (4.26e-8)"	"unprognostic (7.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.21e-3)"	10.7	2.1	3.3	4.9	1.8	0.1	8.1	3.5	1.9	33.0	18.4	1.6	6.3	2.1	33.1	15.2	9.8	11.0	30.9	10.6	1.4	0.6	2.5	1.8	5.8	1.2	1.2	1.6	17.0	1.8	0.3	13.4	2.5	3.0	6.8	3.2	4.7	1.9	15.7	4.7	3.8	5.8	23.8	3.2	7.3	6.9	5.7	1.4	0.5	2.4	4.2	1.6	19.3	10.9	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.2	18.9	0.0	17.8	4.0	2.5	3.0	0.2	0.0	0.7	0.2	18.0	0.8	0.0	0.0	0.0	1.3	0.0	0.1	3.1	0.8	0.0	3.7	0.1	5.6	8.9	0.0	3.3	0.0	17.6	0.0	0.4	0.1	0.2	0.3	0.0	0.0	0.4	0.6	0.0	0.1	0.4	0.9	0.1	2.0	0.0	1.9	0.2	0.2	0.0	0.3	0.3	0.2	0.7	7.2	0.8	1.0	0.7	2.8	0.2	0.0	0.1	19.3	0.2	3.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	1.8	3.5	1.9	1.4	0.6	1.2	1.6	3.0	1.4	3.0	1.1	0.0	0.2	1.6	5.4	1.8	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.1	0.4	1.5	1.6	0.0	0.0	0.1	6.0	0.3	0.0	0.0	1.2	3.2	0.0	3.7	0.0	0.4	16.7	1.1	1.7	1.0	0.6	3.2	0.1	0.0	14.9	0.0	1.9	0.0	5.7	0.7	1.1	1.6	0.0	0.0	1.7	0.1
SSPN	"KRAG, SPN1, SPN2"	ENSG00000123096	Sarcospan	Q14714	12	26121991-26299290	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Leydig cells: 172.0;Peritubular cells: 251.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"memory B-cell: 29.7"	"Lineage enriched"	"Detected in many"	21	"B-cells: 29.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 13.0;hTERT-RPE1: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066432			Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nuclear membrane"	Nucleoplasm	"HPA066432: AB_2685669"	"unprognostic (4.82e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.03e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.21e-1)"	12.5	6.8	13.9	6.6	12.6	0.1	11.5	16.5	11.4	24.9	12.7	11.1	4.1	2.7	14.6	10.3	11.4	15.0	14.3	26.2	21.0	6.1	3.8	1.4	5.4	4.5	17.2	8.7	21.5	4.7	2.9	4.8	2.5	20.9	14.5	7.3	7.8	6.8	21.1	38.7	3.6	6.3	20.1	20.4	4.9	6.7	5.8	19.0	3.2	10.0	15.4	6.5	18.2	10.8	29.7	0.0	1.4	0.0	0.0	0.2	0.3	0.3	0.7	2.0	0.0	13.0	7.4	0.1	3.8	5.3	0.5	1.5	0.0	4.7	0.0	0.8	5.2	3.0	1.5	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	4.6	0.4	1.7	0.4	46.8	0.2	0.0	0.0	0.0	4.0	0.8	0.2	1.1	4.4	0.2	1.2	0.1	5.3	1.4	1.2	4.0	0.2	3.8	1.4	0.3	3.7	2.1	0.4	0.1	1.4	1.8	1.0	1.8	0.9	0.1	0.5	0.0	2.8	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.2	29.7	0.0	0.0	0.0	6.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	13.9	12.6	16.5	11.4	21.0	6.1	17.2	8.7	20.9	19.0	3.0	2.7	20.9	16.5	12.0	1.7	79.0	7.6	6.7	19.4	17.4	0.0	63.3	5.0	8.5	3.3	8.3	8.4	0.0	6.5	5.6	56.4	10.8	0.0	0.0	12.1	6.4	4.7	8.6	0.0	3.1	172.0	7.9	18.6	32.5	9.1	35.9	2.4	7.0	251.4	2.2	2.6	38.8	42.9	0.3	0.9	6.1	23.2	1.0	5.8	17.1
SSPO	"FLJ36112, KIAA0543, SCO-spondin"	ENSG00000197558	SCO-spondin		7	149776042-149833979	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"brain: 1.7;salivary gland: 1.7"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 24.9;Cone photoreceptor cells: 7.9;Horizontal cells: 15.9;Muller glia cells: 7.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.2;hTERT-RPE1: 1.4;RPMI-8226: 2.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in some"	13	"midbrain: 44.5"						"Secreted in brain"	NA	NA						"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.95e-4)"	"unprognostic (5.81e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.41e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-10)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.15e-3)"	"unprognostic (2.46e-2)"	0.6	0.0		0.3		0.2	0.1		1.7	0.0	0.0			0.0	0.0	0.0	0.0	0.3	0.1	0.0			0.2	0.0	0.0	0.0			0.1	0.3	0.0		0.0		0.2	0.0		1.7	0.1	0.1	0.3	0.0	0.0		0.4	0.2	0.2			0.2		0.0	0.0		0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.7	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.5	0.7	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	2.7	0.1	0.0	0.4	0.5	0.0	0.1	0.0	0.0	1.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.0	24.9	3.1	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	15.9	0.0	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1
ST6GAL2	"KIAA1877, SIAT2, St6gal2, St6GalII"	ENSG00000144057	"ST6 beta-galactoside alpha-2,6-sialyltransferase 2"	Q96JF0	2	106801600-106887108	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;thyroid gland: 34.0"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 7.7;Ito cells: 2.5;Mucus-secreting cells: 2.3"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 16.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 5.7;hTERT-RPE1: 7.2;NTERA-2: 4.9;PC-3: 6.4;RPMI-8226: 10.2;SCLC-21H: 6.8;U-138 MG: 8.3;U-266/70: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014459	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA014459: AB_1857528"	"unprognostic (2.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-4)"	"unprognostic (4.56e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.01e-4)"	"unprognostic (4.70e-4)"	"unprognostic (4.06e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.07e-2)"	1.2	0.7	14.1	0.7	5.6	1.5	1.3	2.3	16.7	2.1	1.5	4.1	1.7	0.7	3.7	1.9	2.7	1.2	12.7	1.9	5.4	4.0	1.1	3.4	1.2	0.9	3.8	7.1	0.9	0.5	0.5	0.3	2.3	4.2	1.6	3.3	0.0	1.6	1.6	0.7	1.3	0.7	2.8	1.9	0.6	0.9	7.9	1.5	0.0	34.0	1.6	0.8	1.5	1.4	0.7	0.6	1.8	0.5	1.0	0.7	0.5	0.0	5.7	3.1	0.1	0.0	0.0	0.1	0.3	0.0	1.3	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	1.1	0.0	7.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.9	0.0	6.4	0.0	0.0	10.2	0.2	0.0	6.8	4.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	8.3	0.1	0.2	0.0	10.9	0.2	0.1	0.0	0.0	0.0	1.4	0.5	0.4	0.6	0.3	0.5	0.4	0.4	0.5	0.2	0.7	0.5	0.7	1.8	1.0	0.3	0.6	0.5	0.5	14.1	5.6	2.3	14.8	5.4	4.0	3.8	7.1	4.2	1.5	0.0	0.0	0.0	0.1	0.8	7.7	1.2	0.0	0.0	1.2	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.2	0.0	1.2	2.5	0.0	0.0	0.3	0.0	0.0	0.0	2.3	0.8	0.0	0.0	0.7	0.6	0.5	0.0	1.4	0.0	1.3	0.0	0.2	0.0	1.2	0.0
ST8SIA1	"SIAT8, SIAT8A"	ENSG00000111728	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1"	Q92185	12	22063773-22437041	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.2"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 43.2;granulocytes: 32.4;Muller glia cells: 41.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"AF22: 9.1;ASC TERT1: 6.0;hTERT-RPE1: 4.2;RPTEC TERT1: 4.6;SK-MEL-30: 8.3;WM-115: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026775	Approved					NA	NA					"HPA026775: AB_1857534"	"unprognostic (1.98e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.79e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.76e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.16e-2)"	1.7	7.6	7.0	5.3	6.2	2.3	5.9	20.2	13.0	3.5	5.4	2.3	2.3	0.4	4.5	1.4	3.0	2.3	2.4	4.4	7.6	8.5	1.1	0.6	3.8	8.6	7.6	6.5	2.6	1.2	7.2	0.6	0.4	9.4	6.6	3.5	1.5	3.2	4.4	1.0	4.3	2.1	6.3	10.9	2.7	2.1	1.0	4.8	0.2	1.4	0.5	9.2	6.7	3.1	0.3	0.2	1.2	0.2	0.3	3.0	0.6	0.1	0.5	9.1	0.0	1.4	6.0	0.9	0.0	0.0	0.1	0.4	0.3	0.1	1.1	0.0	0.0	0.2	0.4	0.0	0.2	0.6	0.0	0.0	1.1	0.1	0.1	0.0	0.3	0.1	0.5	0.9	0.1	0.9	4.2	0.2	0.1	0.0	0.6	0.2	0.0	1.2	0.3	2.3	3.5	0.0	0.0	0.2	0.2	4.6	0.0	0.1	0.2	0.0	0.1	8.3	0.3	0.7	0.1	0.0	0.7	0.9	0.1	1.4	0.7	0.5	0.7	1.4	0.1	9.0	1.2	0.2	0.2	0.4	0.1	0.9	0.1	2.9	2.3	0.1	0.3	0.4	1.0	0.9	0.3	0.2	0.2	3.0	0.6	7.0	6.2	20.2	13.0	7.6	8.5	7.6	6.5	9.4	4.8	0.0	2.6	0.0	0.4	3.9	7.5	3.1	0.0	8.1	2.3	0.0	43.2	3.0	1.7	0.0	5.3	0.7	0.0	0.0	0.0	10.1	3.0	3.7	32.4	0.0	0.7	4.8	0.0	0.0	0.0	3.0	0.3	0.0	11.8	0.0	0.0	41.7	0.0	0.0	0.0	0.2	2.8	0.0	1.2	3.9	5.5	2.0	3.1	4.3	0.0	0.1
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380344-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	22	"Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 21.3"	"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	3.7	6.4	1.4	1.1	5.4	0.6	5.7	21.3	0.8	9.2	4.6	1.2	4.7	0.3	9.0	2.2	3.3	4.0	5.1	0.7	0.9	3.9	3.3	1.8	15.0	0.7	1.6	0.2	3.2	0.6	18.8	1.8	0.6	5.2	17.2	1.1	1.9	1.8	5.7	4.0	1.6	0.6	12.5	1.2	0.9	1.5	2.4	0.2	0.7	1.0	4.4	0.5	8.4	15.5	0.0	0.6	3.2	0.4	2.8	3.8	0.2	3.5	1.5	0.8	0.0	3.2	1.0	0.0	9.0	0.2	1.9	2.3	0.0	0.0	0.0	3.7	22.0	6.3	16.2	1.1	3.9	2.0	0.0	2.8	0.5	4.9	0.1	0.0	9.0	0.1	1.2	0.1	0.0	0.3	13.5	0.0	0.9	0.0	0.2	0.2	0.0	1.8	0.1	6.7	0.0	1.4	0.0	0.0	0.0	5.1	0.0	3.0	23.2	3.6	2.5	0.0	7.0	0.0	0.9	4.0	0.2	9.4	0.3	14.1	0.0	0.0	0.0	23.9	3.6	4.0	0.0	0.1	3.2	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.1	0.0	3.8	0.2	1.4	5.4	21.3	0.8	0.9	3.9	1.6	0.2	5.2	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.1	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.1	4.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0
STK33		ENSG00000130413	"Serine/threonine kinase 33"	Q9BYT3	11	8391868-8594289	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 34.4"	"Cell type enhanced"	"Detected in many"	12	"Ciliated cells: 245.0;Late spermatids: 113.1;Rod photoreceptor cells: 83.4;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 7.1;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0;hTERT-RPE1: 14.2;Karpas-707: 13.1;SCLC-21H: 14.7;U-251 MG: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA015742, HPA056855"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA015742: AB_1857592, HPA056855: AB_2683257"	"unprognostic (2.57e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.76e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.85e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.46e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (2.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.90e-2)"	0.9	6.1	4.7	1.6	7.5	1.1	0.6	6.1	4.4	5.4	5.3	6.8	7.7	2.6	9.6	15.3	2.3	30.7	4.5	11.4	6.6	6.1	7.7	0.4	5.3	2.3	4.9	2.7	10.3	4.6	20.4	29.9	0.3	17.7	5.3	1.3	14.8	1.6	8.9	2.6	0.3	2.5	7.0	6.7	1.2	4.4	34.4	4.6	4.5	14.6	1.5	1.8	3.7	1.4	7.1	0.7	0.0	0.0	0.2	1.4	0.3	0.0	2.0	9.7	0.0	0.0	0.0	0.0	1.7	1.9	4.2	3.9	1.1	0.0	14.0	7.3	0.3	5.5	0.0	4.3	1.3	3.7	0.0	11.9	0.0	2.6	3.3	1.6	7.8	0.0	0.4	0.0	0.1	0.0	14.2	0.3	6.9	0.0	13.1	0.1	0.0	0.2	0.0	6.9	0.0	0.0	5.2	1.3	8.8	3.8	0.0	14.7	3.9	0.0	0.0	0.1	2.7	0.0	0.8	0.0	0.0	6.6	0.1	14.8	3.1	12.4	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.1	0.0	1.4	0.0	4.4	0.0	1.1	0.0	0.2	0.0	0.7	0.2	0.3	4.7	7.5	6.1	4.4	6.6	6.1	4.9	2.7	17.7	4.6	17.9	12.6	5.4	1.1	0.0	19.2	34.4	10.2	245.0	47.8	19.2	66.8	0.1	3.3	7.5	72.9	1.3	0.0	0.0	4.4	2.7	0.3	0.2	1.1	0.0	0.2	1.6	8.7	0.0	0.0	113.1	4.0	0.4	0.0	0.0	1.3	30.6	4.5	0.0	15.9	11.9	83.4	0.0	0.2	126.9	25.1	0.0	0.0	0.0	2.9	0.0
STON1	"SBLF, stoned-b1"	ENSG00000243244	"Stonin 1"	Q9Y6Q2	2	48529383-48598513	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Muller glia cells: 34.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 11.9;midbrain: 6.8;pons and medulla: 20.7"	"Group enriched"	"Detected in some"	14	"basophil: 4.8;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.0;ASC TERT1: 18.4;HSkMC: 23.0;hTERT-RPE1: 10.6;SuSa: 12.8"									HPA005715	Uncertain					NA	NA					"HPA005715: AB_1080113"	"unprognostic (1.61e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.49e-3)"	16.0	4.4	1.6	10.6	2.1	0.5	12.5	11.9	3.4	26.4	24.0	5.1	8.8	2.9	35.7	8.3	23.3	12.8	13.9	5.6	1.9	2.6	7.8	1.7	8.7	3.3	6.8	0.0	21.8	2.2	2.2	3.1	14.3	20.7	24.5	7.1	9.7	2.6	16.6	3.7	3.6	6.5	52.4	37.3	11.0	11.9	5.6	2.6	2.6	6.9	2.2	1.2	53.5	24.6	0.1	0.1	4.8	0.1	0.1	0.2	0.1	0.0	0.0	5.3	0.1	15.0	18.4	3.1	0.6	5.7	0.5	1.3	0.0	0.0	0.0	0.2	7.3	2.8	5.5	5.1	0.1	1.1	0.0	1.4	0.8	0.4	0.0	8.6	0.0	0.3	23.0	1.1	1.5	0.6	10.6	10.0	0.4	0.1	0.1	3.5	0.3	0.4	0.2	5.0	0.0	0.0	0.8	1.1	0.0	0.5	4.0	0.2	1.2	0.4	0.9	2.4	12.8	0.4	0.2	5.3	1.9	1.5	0.0	0.4	0.3	0.0	0.0	1.0	0.0	1.2	4.8	0.1	0.2	0.1	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.1	3.0	0.1	0.0	0.1	0.2	0.1	1.6	2.1	11.9	1.3	1.9	2.6	6.8	0.0	20.7	2.6	0.0	0.3	0.5	13.7	2.2	1.7	1.6	0.0	0.0	1.2	5.2	2.0	12.1	3.3	0.5	0.2	3.1	0.0	0.0	0.3	0.5	11.7	13.4	0.0	0.0	2.2	12.7	2.4	8.0	2.1	0.2	11.2	1.8	0.0	1.0	0.3	34.8	0.4	0.0	9.6	1.5	1.9	25.8	10.0	0.3	1.5	2.0	10.5	1.3	0.4	13.3
STON1-GTF2A1L	SALF	ENSG00000068781	"STON1-GTF2A1L readthrough"		2	48529925-48776517	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"urinary bladder: 31.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 5.8;Spermatocytes: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.3;midbrain: 3.2;pons and medulla: 12.0"	"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;ASC TERT1: 3.4;HSkMC: 2.4;hTERT-RPE1: 6.0;SuSa: 12.3"									HPA005715	Uncertain					NA	NA					"HPA005715: AB_1080113"	"unprognostic (5.66e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-3)"		"unprognostic (8.26e-2)"	"unprognostic (5.08e-2)"		"unprognostic (3.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	9.4	1.8	1.5	5.7	1.5	0.7	7.3	6.3	1.4	15.1	12.7	2.2	4.4	1.4	20.5	4.6	13.2	5.0	7.9	2.4	1.5	1.5	3.9	1.5	4.7	1.7	3.2	0.0	13.2	1.5	0.8	1.8	7.5	12.0	14.1	3.7	5.5	1.5	5.6	1.6	1.6	3.0	30.3	22.2	7.8	5.3	2.9	0.7	0.8	3.5	0.6	0.8	31.6	15.1	0.0	0.0	0.7	0.0	0.6	1.0	0.0	0.0	0.1	1.3	0.0	3.6	3.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	2.4	0.2	0.0	0.1	6.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	1.5	6.3	1.4	1.5	1.5	3.2	0.0	12.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.1
STX1B	"STX1B1, STX1B2"	ENSG00000099365	"Syntaxin 1B"	P61266	16	30989256-31010661	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 64.9"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 36.5;Late spermatids: 9.9"	"Cancer enriched"	"Detected in some"	7	"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 8.4;hTEC/SVTERT24-B: 10.3;hTERT-RPE1: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069176, CAB079008"	Supported	Approved	Approved	"Nuclear membrane,Vesicles"		NA	NA			Vesicles	"Nuclear membrane"	"CAB079008: , HPA069176: AB_2686098"	"unprognostic (1.43e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.40e-4)"	"unprognostic (3.90e-3)"	"unprognostic (3.98e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.57e-2)"	1.6	1.9	12.7	1.9	31.8	1.3	1.8	45.8	64.9	1.2	1.4	2.9	0.0	1.4	2.7	4.2	1.9	1.4	1.3	2.1	10.5	10.0	1.4	2.5	1.2	2.4	6.8	26.2	1.3	1.3	1.3	2.2	1.2	39.3	1.8	1.4	1.0	1.9	2.8	1.3	4.0	1.8	2.5	3.8	2.2	1.3	3.2	4.5	0.0	1.3	0.0	2.3	1.3	0.7	0.6	0.3	1.3	0.4	0.5	1.7	0.1	0.1	2.7	4.3	0.6	0.4	0.2	0.1	3.8	5.8	4.8	8.4	0.0	3.1	0.7	0.2	5.0	0.1	0.7	1.9	0.5	5.8	2.3	0.4	0.3	2.2	2.1	0.3	0.1	2.7	1.5	0.1	10.3	0.9	19.0	0.0	0.9	0.4	0.2	5.0	1.2	1.7	0.2	2.1	0.0	0.3	6.3	0.2	0.1	0.4	0.0	5.9	3.7	0.4	0.2	0.0	0.7	0.7	0.1	0.7	2.8	2.2	0.3	0.2	0.3	0.2	0.3	3.1	0.2	0.0	0.9	0.4	0.7	0.3	0.2	0.1	0.5	1.7	0.3	0.1	0.6	0.3	0.4	1.3	0.5	0.1	0.3	0.2	0.1	12.7	31.8	45.8	60.5	10.5	10.0	6.8	26.2	39.3	4.5	0.0	0.0	0.0	0.0	0.7	3.6	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	5.7	0.5	0.0	0.0	0.3	0.0	0.3	0.1	0.0	4.9	0.6	36.5	0.0	0.6	0.0	9.9	0.3	0.0	0.0	1.0	0.0	1.7	0.2	0.0	1.8	2.1	2.9	0.0	0.5	5.2	1.0	0.5	0.7	0.0	0.0	0.0
SUMF1	"FGE, UNQ3037"	ENSG00000144455	"Sulfatase modifying factor 1"	Q8NBK3	3	3700814-4467281	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.5;hTERT-RPE1: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038025	Uncertain				"Intracellular and membrane"	NA	NA		350000			"HPA038025: AB_10675624"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.99e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.79e-7)"	"unprognostic (5.12e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.86e-2)"	19.1	19.6	9.0	15.7	10.9	6.1	21.1	7.7	13.4	16.7	16.6	15.7	19.0	9.2	17.4	23.3	25.3	18.6	19.8	11.7	7.7	8.9	27.9	20.6	17.8	21.9	11.5	8.0	15.2	22.4	33.8	14.4	22.7	10.5	16.3	21.3	17.3	20.8	14.9	4.6	17.4	13.5	15.2	10.1	18.3	17.0	7.5	10.3	11.3	20.4	10.7	13.5	17.9	16.6	10.9	32.3	17.6	38.3	14.7	16.1	28.3	7.9	6.7	3.7	2.0	39.5	21.0	7.2	11.2	17.7	5.4	6.1	3.0	25.8	1.1	6.8	20.3	8.1	4.3	1.6	12.7	8.4	3.8	3.3	1.7	6.6	8.3	10.2	1.9	4.7	19.2	14.3	6.0	1.8	39.4	14.7	2.8	2.8	2.7	15.0	12.7	1.0	2.9	3.9	7.3	7.7	2.0	5.6	5.0	28.6	9.0	0.7	4.2	8.0	18.7	6.3	6.7	24.9	5.0	13.4	10.9	1.4	8.3	6.7	3.4	6.9	0.5	21.2	4.3	8.1	17.6	38.3	12.6	15.2	29.9	13.8	10.3	12.5	12.9	32.3	10.9	16.1	13.1	13.7	14.7	26.9	17.1	6.2	28.3	9.0	10.9	7.7	13.4	7.7	8.9	11.5	8.0	10.5	10.3	17.9	16.1	7.3	17.3	11.3	6.0	4.5	17.8	17.4	9.1	36.6	5.9	27.4	10.0	36.6	10.8	12.8	10.7	0.0	16.8	18.4	19.9	20.1	16.2	16.3	26.5	3.2	8.1	16.5	33.9	7.3	15.3	24.3	18.6	49.5	21.4	9.8	14.1	11.5	16.3	21.1	6.6	6.5	15.5	3.1	3.6	10.3	20.4	8.5	25.0	16.6
SYNC	"SYNC1, SYNCOILIN"	ENSG00000162520	"Syncoilin, intermediate filament protein"	Q9H7C4	1	32680360-32703596	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 51.0"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.8;fHDF/TERT166: 38.9;hTERT-RPE1: 23.8;U-138 MG: 34.1;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028311, HPA063549"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA028311: AB_2672554, HPA063549: "	"unprognostic (3.99e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.60e-3)"	"unprognostic (1.99e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.32e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-4)"	4.2	3.2	3.7	5.8	3.9	0.1	6.8	1.1	4.2	5.9	7.2	3.7	1.2	1.5	7.7	7.7	15.6	5.3	4.8	7.9	3.5	3.9	1.4	1.1	4.6	0.6	3.6	2.6	7.9	0.9	2.7	2.8	1.1	3.5	6.1	4.8	4.6	4.1	8.4	51.0	1.6	4.0	28.5	4.5	1.9	6.5	5.4	1.9	0.0	1.9	23.6	2.3	7.8	2.5	0.0	0.3	0.0	1.8	0.0	0.3	0.0	0.0	1.3	0.1	0.0	6.5	10.2	0.0	10.5	26.8	9.1	6.6	0.1	0.1	0.0	0.5	38.9	11.0	0.4	0.3	0.2	5.5	0.0	0.0	0.2	4.4	0.9	5.2	0.0	0.0	15.7	0.9	10.1	0.3	23.8	2.9	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	2.0	0.0	10.6	0.0	0.1	0.1	10.6	2.2	0.0	2.1	0.6	0.0	1.7	34.1	1.5	18.1	2.7	0.0	0.0	0.0	9.5	0.1	22.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.7	3.9	1.1	4.2	3.5	3.9	3.6	2.6	3.5	1.9	8.9	6.0	18.0	11.4	19.6	44.6	0.8	17.8	5.3	13.6	8.7	37.3	7.3	5.0	10.7	8.6	8.7	7.8	23.3	4.7	7.6	12.4	10.4	21.9	16.1	4.8	69.9	7.0	20.3	20.5	12.4	38.6	9.9	32.1	4.6	7.0	16.9	6.8	8.0	60.5	7.8	52.5	19.4	12.0	30.1	26.0	19.4	4.2	21.3	8.9	8.5
SYNDIG1L	"capucin, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405893-74426102	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	27	"brain: 78.1;epididymis: 20.1"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 2.4;Bipolar cells: 8.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 78.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.2;NTERA-2: 1.3;SuSa: 1.8;U-266/70: 1.7;U-266/84: 1.9"	"Region enriched"	"Detected in many"	8	"basal ganglia: 251.1"	"Region enriched"	"Detected in many"	6	"basal ganglia: 71.7"	"HPA042594, HPA048487"	Uncertain					NA	NA					"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.6	0.4	0.3	0.4	78.1	0.2	0.6	0.0	4.0	0.5	0.6	1.1	0.0	0.3	0.6	20.1	0.5	0.4	0.7	0.4	2.4	1.6	0.6	0.3	1.8	0.4	3.5	0.2	0.4	0.5	0.2	0.0	0.3	0.5	0.6	0.6	0.1	0.4	0.6	0.3	0.5	0.9	0.8	0.4	0.4	0.3	0.4	16.6	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	0.5	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.7	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.3	78.1	0.0	4.0	2.4	1.6	3.5	0.2	0.5	16.6	0.0	2.4	0.0	0.0	0.3	8.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 141.7"	"Group enriched"	"Detected in many"	9	"Bipolar cells: 1152.5;Cone photoreceptor cells: 842.3;Muller glia cells: 363.8;Rod photoreceptor cells: 831.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.8;hTERT-RPE1: 20.4;LHCN-M2: 17.5;SH-SY5Y: 16.9;WM-115: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA					"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	1.3	11.5	23.9	2.1	31.8	1.3	1.4	44.3	141.7	1.8	2.3	1.8	0.0	1.8	5.6	1.4	1.4	1.4	1.7	1.1	32.4	22.9	2.0	2.0	1.5	1.2	23.1	38.6	3.6	1.2	1.1	1.4	2.3	28.9	4.3	2.5	2.7	1.2	3.8	1.1	1.2	2.6	12.9	2.5	2.2	1.8	1.4	3.6	0.0	1.2	0.0	1.2	1.3	0.7	3.4	0.9	0.0	2.3	0.0	0.0	0.1	0.0	10.2	7.7	0.0	0.7	2.3	0.0	0.7	0.9	0.5	0.6	0.5	0.3	0.0	1.5	0.1	2.8	0.3	0.1	1.2	0.9	0.1	0.4	0.6	0.2	0.0	2.0	0.0	0.1	0.6	0.7	2.8	21.8	20.4	7.3	0.3	0.4	1.2	17.5	1.6	0.9	0.0	5.6	1.1	2.9	0.0	8.0	0.0	0.0	2.9	10.3	16.9	0.0	1.3	0.2	5.5	3.8	0.0	2.9	1.1	0.4	0.0	3.2	1.9	4.1	0.0	2.5	0.0	15.8	0.0	2.3	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.9	31.8	44.3	74.8	32.4	22.9	23.1	38.6	28.9	3.6	0.0	1.1	3.7	0.0	0.8	1152.5	0.4	0.0	0.0	2.3	0.0	842.3	4.4	0.0	0.0	0.9	2.2	0.0	0.0	0.2	2.0	0.7	14.4	0.0	0.0	10.4	58.8	93.0	3.1	4.7	2.0	64.2	1.1	1.7	0.0	0.0	363.8	0.1	0.2	4.2	0.0	831.5	0.0	1.0	1.1	5.2	0.5	4.9	0.0	0.0	0.1
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199321-117204782	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	19	"Peritubular cells: 2168.1;Sertoli cells: 2819.8;Smooth muscle cells: 4737.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 19.0;non-classical monocyte: 26.6"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ: 136.7;BJ hTERT+ SV40 Large T+: 130.0;CACO-2: 122.7;EFO-21: 163.1;fHDF/TERT166: 139.3;hTERT-RPE1: 106.3;LHCN-M2: 96.2;U-138 MG: 126.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 176.0"	"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol		No	No		8000000	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	73.3	22.6	2.3	67.6	5.9	0.2	60.8	2.1	7.7	278.3	328.7	6.1	156.2	22.3	399.7	156.8	337.9	133.3	227.5	48.7	3.1	3.0	49.5	12.9	44.1	38.6	7.1	11.8	159.2	9.3	1.5	8.0	36.2	14.9	237.5	51.6	39.1	24.1	347.5	36.6	17.9	81.0	481.9	9.1	26.0	114.7	65.1	2.1	1.1	47.3	30.0	11.2	473.0	78.1	2.6	1.4	0.8	26.6	0.0	0.3	0.9	1.2	0.3	21.4	0.5	10.0	9.0	18.0	136.7	59.3	130.0	48.7	122.7	1.9	0.2	163.1	139.3	0.1	3.2	0.3	1.1	37.0	0.4	0.2	0.3	4.6	8.3	55.9	0.1	0.3	23.7	4.6	19.0	2.4	106.3	0.2	0.2	0.2	0.4	96.2	0.2	0.1	1.0	6.5	1.1	0.1	0.1	1.6	0.6	0.2	1.7	0.1	0.5	2.1	0.7	0.1	53.6	0.6	0.3	14.6	126.7	21.3	0.9	5.8	0.6	0.4	1.0	0.7	0.4	0.3	0.8	1.1	0.0	0.1	19.0	0.2	1.6	0.0	0.0	1.4	2.6	0.1	0.0	0.1	0.0	26.6	0.7	0.3	0.9	2.3	5.9	2.1	7.7	3.1	3.0	7.1	11.8	14.9	2.1	35.7	6.7	4.5	353.2	56.7	9.9	1.2	5.1	13.4	5.7	38.4	17.7	30.6	0.0	230.9	2.4	73.9	6.2	0.0	68.1	27.0	232.5	54.7	1.1	9.3	37.9	1.6	2.9	944.1	20.6	8.9	44.8	43.3	91.1	9.0	9.0	3.3	40.6	3.5	2168.1	1.3	10.5	2819.8	4737.3	6.1	4.4	53.2	26.9	10.0	2.6	40.6
TBC1D3L		ENSG00000274512	"TBC1 domain family member 3L"	B9A6J9	17	37977972-37989048	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"skin 1: 10.8"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 1.8;Early spermatids: 2.1"	"Low cancer specificity"	"Detected in single"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.7;hTERT-RPE1: 24.9"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869"	"unprognostic (5.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (8.44e-2)"		"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.50e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.63e-6)"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-3)"	0.5	2.4		1.8		0.6	1.8		1.3	0.2	1.2			2.4	0.0	2.9	2.4	1.2	0.8	0.0			0.0	0.6	1.0	1.8			0.5	0.3	0.1		0.3		1.4	1.1		3.3	1.3	4.1	10.8	1.0	0.2		2.7	1.8	0.9			0.0		0.3	1.2		0.6	0.3	3.8	0.8	1.0	1.0	0.4	7.0	9.3	3.8	5.7	7.2	6.6	22.7	3.2	2.2	2.9	3.4	5.1	0.1	2.4	0.1	4.1	2.6	11.6	3.4	3.1	1.9	7.0	8.8	0.0	15.1	2.2	5.1	0.9	8.9	5.5	7.6	3.8	2.2	24.9	3.9	4.6	1.8	8.4	4.8	3.8	4.2	21.0	3.6	5.4	2.1	2.8	4.4	0.0	9.2	9.7	5.2	7.2	0.0	3.8	4.2	9.3	5.5	1.5	8.9	0.0	5.1	3.9	4.4	5.9	2.6	0.0	5.9	3.0	3.3	0.0	0.8	0.9	0.3	0.6	0.0	0.1	0.3	0.9	0.1	0.6	0.6	1.0	3.8	1.0	0.8	0.3	0.3	0.4											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.4	0.0
TCP11L2	MGC40368	ENSG00000166046	"T-complex 11 like 2"	Q8N4U5	12	106301929-106347015	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 21.6;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 32.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 32.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039483, HPA042188"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA039483: AB_10795291, HPA042188: AB_10794415"	"unprognostic (1.41e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (3.87e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.05e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.67e-1)"	9.1	12.0	8.1	6.2	18.2	22.3	9.0	10.4	13.0	9.7	8.6	31.5	3.3	6.2	10.3	7.1	20.1	11.6	8.1	18.9	8.3	5.8	6.1	5.6	14.4	12.9	22.2	9.4	9.7	8.6	11.1	7.2	12.3	16.2	7.5	7.9	9.5	15.9	5.9	18.0	14.0	10.3	10.2	14.6	10.2	10.2	8.7	18.4	16.4	12.2	6.3	14.0	11.3	11.8	6.2	0.8	32.1	3.2	1.9	6.3	1.7	2.5	6.2	0.9	1.8	8.6	10.0	3.9	1.6	8.0	1.0	2.6	1.0	3.3	0.8	2.5	6.2	2.4	11.7	0.8	3.5	1.9	1.3	2.6	0.5	2.4	3.8	8.4	0.2	1.7	12.5	8.1	1.2	6.1	20.0	5.8	4.6	1.5	1.2	1.4	1.8	1.5	1.3	1.1	3.3	3.9	0.7	0.2	2.8	8.1	11.6	3.9	2.8	4.2	1.3	4.8	6.9	3.6	0.3	4.4	1.5	1.3	2.2	0.4	7.8	0.6	3.0	4.2	0.2	0.7	10.8	3.2	4.9	2.4	1.4	1.8	6.2	4.9	2.7	0.8	5.7	6.3	4.1	32.1	1.9	2.2	0.6	5.6	1.7	8.1	18.2	10.4	13.0	8.3	5.8	22.2	9.4	16.2	18.4	11.9	11.8	9.3	3.0	1.0	7.0	8.5	0.0	16.0	10.3	3.5	21.6	1.2	1.7	2.6	4.2	7.7	3.3	0.0	2.2	0.6	2.9	3.7	2.3	1.3	1.2	20.6	4.1	3.1	1.5	3.3	5.5	3.3	3.3	3.6	3.1	3.1	2.9	3.5	2.5	0.8	13.8	12.9	2.8	1.5	2.1	2.3	12.6	4.3	1.5	2.6
TCTN1	"FLJ21127, JBTS13, TECT1"	ENSG00000204852	"Tectonic family member 1"	Q2MV58	12	110614027-110649430	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 186.0;Spermatocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039687, HPA040036"	Approved		Approved	"Nucleoplasm,Actin filaments"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Actin filaments"		"HPA039687: AB_10795293, HPA040036: AB_10794759"	"unprognostic (2.54e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.28e-1)"	"prognostic favorable (1.13e-5)"	"unprognostic (2.89e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.05e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (9.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.27e-2)"	8.0	12.4	11.2	5.1	13.8	3.0	8.9	5.6	10.1	17.7	5.4	12.3	20.6	4.1	10.3	28.7	5.4	35.4	12.3	14.4	11.0	13.0	16.1	7.2	11.6	5.5	11.0	5.3	15.5	9.1	24.1	32.9	8.4	22.1	14.5	4.0	16.3	10.2	20.6	8.0	5.3	4.1	10.3	8.9	6.0	7.2	24.7	8.0	4.4	25.5	3.9	5.2	8.8	12.2	13.7	5.0	8.4	3.5	1.1	2.9	1.9	6.9	8.8	6.2	16.9	17.7	15.4	3.1	4.9	10.2	4.6	4.0	2.0	2.1	1.4	4.4	12.2	4.5	4.9	3.6	3.7	3.3	3.0	5.7	0.4	3.6	4.2	8.4	0.7	0.7	9.6	5.7	6.0	7.3	29.2	3.3	2.2	4.8	2.9	5.6	10.1	0.5	2.4	3.0	3.7	11.8	1.7	3.3	9.9	14.1	1.6	5.3	7.0	8.5	2.0	4.1	4.8	14.2	8.0	3.6	7.9	2.0	2.8	4.2	2.8	1.3	1.9	7.9	0.7	6.3	0.3	2.4	0.4	1.3	3.5	2.9	6.3	1.9	2.7	3.7	13.7	2.9	2.4	8.4	1.1	2.0	5.0	0.6	1.9	11.2	13.8	5.6	10.1	11.0	13.0	11.0	5.3	22.1	8.0	3.0	13.1	7.7	24.6	12.2	10.1	10.2	22.9	186.0	23.9	15.7	29.5	22.5	8.3	18.4	56.3	9.8	0.4	0.0	4.2	7.8	27.9	22.4	3.5	6.8	10.3	3.2	17.3	8.6	3.2	9.5	15.8	7.6	21.9	1.0	5.6	27.8	5.2	0.0	26.9	32.2	30.2	6.5	15.6	102.1	36.2	9.8	15.3	2.2	3.9	12.4
TDRP	"C8orf42, INM01, TDRP1, TDRP2"	ENSG00000180190	"Testis development related protein"	Q86YL5	8	489792-545781	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 41.9"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8"	"Low region specificity"	"Detected in all"							HPA008462	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA008462: AB_1845777"	"unprognostic (1.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (9.37e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.43e-2)"	"unprognostic (5.46e-4)"	"unprognostic (2.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.50e-1)"	5.7	9.0	7.7	6.1	13.1	0.5	11.0	10.4	9.2	8.5	4.9	3.6	8.4	2.3	9.4	9.8	5.7	12.9	9.9	3.7	7.4	10.3	14.3	9.4	9.6	3.9	6.3	3.6	13.0	13.7	15.2	11.1	41.9	8.4	12.5	2.8	17.7	6.2	12.3	2.3	3.3	2.8	5.0	4.6	2.6	3.6	8.1	3.2	3.0	22.7	3.2	6.3	9.9	12.8	0.4	0.0	0.0	0.1	0.0	0.2	1.1	4.8	4.9	8.6	0.0	0.0	0.0	28.9	2.8	1.7	2.7	2.4	0.0	0.0	0.0	1.2	0.9	2.7	1.0	0.0	13.9	3.4	0.0	0.4	0.0	0.0	7.2	3.3	0.0	2.1	3.4	11.1	0.0	5.2	12.3	0.4	0.0	0.6	0.0	2.9	0.0	0.0	0.0	10.2	0.0	1.0	0.0	0.0	0.0	9.0	7.3	2.6	4.1	0.0	8.7	2.1	14.8	2.9	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	7.7	13.1	10.4	7.5	7.4	10.3	6.3	3.6	8.4	3.2	20.8	9.6	0.9	22.5	20.8	15.6	4.1	10.2	32.1	14.8	17.4	2.0	125.8	36.5	9.2	51.1	18.0	0.0	0.0	4.2	49.4	8.3	25.0	0.0	17.5	11.0	9.5	7.5	7.4	3.8	11.1	6.6	1.9	8.5	0.0	1.5	8.3	4.4	0.0	6.0	15.4	11.0	19.4	16.0	21.2	5.9	6.0	227.6	0.0	0.0	9.2
TENM4	"KIAA1302, ODZ4, Ten-M4"	ENSG00000149256	"Teneurin transmembrane protein 4"	Q6N022	11	78652831-79440948	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 23.0;parathyroid gland: 44.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 74.5;Late spermatids: 45.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HSkMC: 8.2;hTERT-RPE1: 8.5;PC-3: 9.4;REH: 8.9;SH-SY5Y: 15.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019521, HPA065961"	Approved					NA	NA					"HPA019521: AB_2670171, HPA065961: AB_2685588"	"unprognostic (2.81e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.71e-1)"	"unprognostic (6.51e-3)"	"unprognostic (5.40e-3)"	"unprognostic (5.64e-2)"	"unprognostic (7.07e-2)"	"unprognostic (9.81e-3)"	3.2	2.8	14.7	2.2	13.0	1.0	1.6	1.4	16.9	4.4	1.4	3.6	0.0	1.1	2.7	1.2	3.1	3.7	1.5	1.3	11.4	6.3	2.9	1.0	1.4	1.5	3.3	5.7	23.0	1.3	44.4	12.0	1.1	8.3	1.4	1.4	4.8	1.5	1.3	1.4	5.1	1.2	2.2	12.5	1.3	1.5	2.9	5.7	0.6	8.2	2.1	2.5	1.6	2.3	0.3	1.4	0.6	0.6	0.3	0.1	0.0	0.0	0.0	3.0	0.0	3.4	5.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.7	0.0	1.8	4.4	4.6	0.0	3.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.2	2.0	2.2	4.1	8.5	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.0	1.6	0.2	9.4	8.9	0.0	0.0	5.9	1.0	6.4	15.6	0.0	0.0	0.0	5.8	0.0	0.1	0.4	0.1	1.1	0.1	5.1	0.0	0.0	0.1	6.2	0.0	0.0	0.5	0.6	0.0	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.3	0.0	0.0	0.6	0.3	0.3	0.3	0.1	0.0	14.7	13.0	1.4	16.9	11.4	6.3	3.3	5.7	8.3	5.7	0.0	0.0	0.0	0.4	0.8	2.6	1.6	5.1	5.3	0.0	0.0	0.0	0.1	0.0	0.4	74.5	0.0	0.0	0.0	0.0	0.1	0.7	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.3	45.5	4.9	0.2	0.0	0.0	0.0	13.2	0.0	0.0	1.8	0.0	0.3	0.0	0.4	1.7	0.7	1.8	0.1	0.0	0.0	0.5
TGFB1I1	"ARA55, Hic-5, TSC-5"	ENSG00000140682	"Transforming growth factor beta 1 induced transcript 1"	O43294	16	31471585-31477960	"Predicted intracellular proteins"	"Differentiation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Leydig cells: 85.4;Peritubular cells: 168.3;Sertoli cells: 219.9;Smooth muscle cells: 134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			CAB020844	Enhanced		Supported	"Focal adhesion sites,Cytosol"		NA	NA		13000000	"Focal adhesion sites"	Cytosol	"CAB020844: "	"unprognostic (5.80e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.64e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.06e-8)"	"unprognostic (1.06e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.73e-5)"	16.8	4.1	1.0	14.4	1.4	0.3	18.5	1.2	1.6	42.9	51.1	1.8	22.1	5.8	80.7	22.7	34.1	28.9	36.2	11.8	0.9	0.7	8.6	2.8	11.2	10.6	1.1	1.3	40.3	2.2	5.1	1.8	11.5	2.3	37.7	10.4	11.1	7.1	34.7	5.7	5.9	12.8	71.9	1.8	11.5	19.6	10.9	0.9	0.7	5.8	7.8	3.6	69.9	23.5	1.3	0.5	8.8	0.0	0.0	2.5	2.3	4.2	5.3	8.7	0.0	8.6	15.8	0.1	22.8	21.4	14.3	9.7	2.2	1.4	0.0	21.5	19.5	9.6	6.3	1.8	4.2	18.8	0.0	0.0	5.0	9.8	1.1	22.0	0.0	6.5	10.2	6.2	8.9	5.3	33.8	9.4	0.0	0.5	0.0	17.4	0.0	0.0	0.5	0.4	0.4	5.4	0.0	10.4	0.0	4.0	2.1	0.0	6.2	8.8	0.0	4.4	7.4	0.0	0.5	25.4	25.8	6.3	7.1	9.9	0.0	0.0	0.0	11.4	0.2	15.8	8.8	0.0	0.1	0.3	0.0	0.5	1.3	1.4	0.2	0.1	0.5	0.2	1.0	0.2	0.0	0.0	0.5	2.5	2.3	1.0	1.4	1.2	1.6	0.9	0.7	1.1	1.3	2.3	0.9	6.0	3.7	0.0	18.4	11.2	0.4	8.1	2.5	0.0	2.3	7.0	0.0	1.2	6.6	27.3	0.9	35.1	1.6	0.0	20.6	1.5	58.4	4.7	5.8	0.0	11.3	0.0	0.0	30.7	0.8	2.1	85.4	3.2	38.8	7.2	4.2	7.1	19.0	0.0	168.3	12.6	1.3	219.9	134.8	1.1	2.7	9.8	1.5	0.5	5.3	4.4
TGFB2		ENSG00000092969	"Transforming growth factor beta 2"	P61812	1	218346235-218444619	"Cancer-related genes, Disease related genes, Predicted secreted proteins"		"Growth factor, Mitogen"	"Aortic aneurysm, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 71.5;Muller glia cells: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 21.0;hTERT-RPE1: 56.1;U-2 OS: 20.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	4890000					"unprognostic (7.24e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.86e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.04e-2)"	2.9	2.6	13.4	3.2	11.4	0.8	7.0	5.2	13.7	12.3	5.2	10.0	7.0	1.6	10.8	7.5	3.6	6.9	3.9	9.5	13.3	6.7	2.9	1.6	12.4	1.6	5.9	9.9	8.1	3.5	4.3	6.3	20.1	10.2	27.8	2.1	11.6	16.9	18.7	6.9	3.8	1.8	8.5	19.0	4.4	2.8	2.1	8.2	0.0	4.8	2.8	1.9	5.2	7.4	2.6	0.5	0.0	0.0	0.0	0.1	0.0	1.3	7.0	0.6	5.5	1.6	0.8	0.0	1.0	0.1	11.2	8.0	1.8	16.9	0.0	21.0	0.0	9.3	3.6	0.4	0.9	11.6	0.0	0.1	0.0	0.6	0.0	17.4	0.0	0.0	0.7	1.9	1.5	5.9	56.1	3.0	0.0	0.0	0.0	10.6	0.1	0.0	0.0	0.5	0.0	0.6	0.0	3.1	0.0	3.6	0.0	0.1	0.0	11.6	1.4	0.2	15.1	1.0	0.4	13.0	7.9	20.8	6.5	10.6	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	11.4	5.2	13.7	13.3	6.7	5.9	9.9	10.2	8.2	71.5	4.6	0.0	5.8	7.7	6.2	3.0	12.7	12.0	14.8	5.2	0.0	0.3	0.0	30.1	16.2	3.5	0.0	0.0	15.1	10.2	15.5	11.6	1.1	0.0	1.2	1.6	0.0	3.1	0.6	22.2	7.5	1.7	11.8	1.8	0.0	97.9	15.5	0.0	13.1	0.3	2.0	0.0	22.4	0.2	0.4	2.5	0.5	0.0	0.0	2.0
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049741	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Endothelial cells: 100.4;Leydig cells: 121.1;Peritubular cells: 243.6;Suprabasal keratinocytes: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 17.7;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.8;CAPAN-2: 19.9;EFO-21: 17.3;HaCaT: 16.7;hTCEpi: 22.0;hTERT-RPE1: 11.9;OE19: 14.8;THP-1: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	690000	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	27.0	6.3	1.4	10.5	6.7	6.9	11.8	1.2	2.7	13.2	14.4	1.4	4.3	2.9	9.7	11.5	21.7	15.8	18.2	24.3	5.0	1.5	7.0	10.0	61.9	26.8	2.5	0.1	10.2	7.2	10.0	10.9	16.4	6.2	6.1	3.3	8.8	6.0	4.2	55.5	32.4	14.1	8.5	7.7	44.4	14.4	15.8	2.4	2.1	18.3	32.2	10.4	14.2	10.4	0.0	7.8	17.7	6.2	1.5	0.0	1.1	5.6	5.0	0.1	0.0	12.8	0.7	0.1	0.1	0.0	0.0	0.0	0.0	19.9	0.0	17.3	1.7	0.8	16.7	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.1	0.5	22.0	0.3	1.4	11.9	5.6	0.0	2.1	0.0	0.5	0.4	0.0	2.0	0.0	14.8	0.8	0.0	0.0	2.4	0.1	8.1	0.3	0.0	4.7	0.6	8.6	1.6	0.0	12.3	10.9	0.0	0.3	1.6	0.0	0.0	0.0	0.0	1.0	2.9	0.4	0.0	2.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	17.7	1.5	5.8	7.8	0.0	1.1	1.4	6.7	1.2	2.7	5.0	1.5	2.5	0.1	6.2	2.4	20.8	30.8	2.2	6.9	30.5	0.0	9.0	0.0	2.7	18.2	0.0	0.0	2.5	0.0	1.4	0.7	100.4	0.0	0.0	0.2	35.7	22.8	3.0	7.0	0.8	14.1	0.0	0.0	52.2	38.0	4.5	121.1	62.8	15.1	1.0	0.0	0.0	5.3	0.0	243.6	0.2	0.0	6.5	63.8	0.2	0.9	86.2	35.5	0.0	0.0	32.5
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	23	"Early spermatids: 241.6;Late spermatids: 766.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 36.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		4100000	Vesicles		"HPA006293: AB_10602898, HPA073242: AB_2732223"	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavorable (2.43e-4)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	10.5	5.5	6.2	12.2	19.5	5.4	15.4	4.7	10.0	20.7	12.6	8.5	8.2	3.4	34.4	24.7	15.1	13.8	19.2	14.4	5.8	3.3	10.1	8.1	8.5	3.2	9.5	6.1	17.5	11.4	12.8	9.5	8.6	7.0	11.4	7.5	8.1	7.5	11.4	5.7	12.9	8.0	24.5	6.1	6.4	8.1	8.3	4.2	1.1	14.3	23.5	7.4	14.4	11.4	1.7	3.5	2.2	4.1	0.9	4.3	2.0	1.4	3.6	13.3	13.5	7.3	8.5	0.8	6.1	9.1	2.8	5.2	0.4	11.0	1.0	6.9	13.4	0.8	3.6	0.3	2.3	2.1	2.4	0.8	0.8	3.9	0.5	7.8	0.7	1.8	14.6	8.1	4.2	5.8	36.1	5.1	2.2	0.7	2.1	2.5	5.3	0.5	1.3	3.0	3.1	1.8	11.8	0.5	2.3	5.9	3.7	19.7	11.2	1.5	3.0	3.1	20.1	8.9	1.8	3.9	9.5	2.2	1.7	2.1	5.2	0.6	0.2	8.6	0.7	0.8	0.0	4.1	1.6	1.8	2.2	1.1	1.7	2.7	2.2	3.5	0.9	3.0	1.0	2.2	0.9	0.7	0.5	4.3	2.0	6.2	19.5	4.7	10.0	5.8	3.3	9.5	6.1	7.0	4.2	0.0	14.7	0.0	2.1	7.0	2.7	1.2	2.5	2.7	1.2	0.0	0.0	1.1	1.7	3.7	241.6	6.3	2.6	0.0	2.3	1.5	11.7	2.2	0.0	3.9	10.0	7.9	4.6	1.8	4.8	766.9	21.6	4.9	10.1	1.0	4.8	1.7	4.0	2.9	9.6	2.8	2.7	0.0	8.1	21.2	2.5	4.5	1.1	0.7	3.1	1.3
TM4SF1	"L6, M3S1"	ENSG00000169908	"Transmembrane 4 L six family member 1"	P30408	3	149369022-149377865	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Basal glandular cells: 4692.6;Glandular cells: 2223.6;Pancreatic endocrine cells: 1835.5;Urothelial cells: 5293.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 71.8;hTERT-RPE1: 98.5;HUVEC TERT2: 64.8;LHCN-M2: 69.8;OE19: 70.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002760, HPA002823"	Uncertain					NA	NA					"CAB002760: , HPA002823: AB_1079221"	"unprognostic (1.94e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.09e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (4.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.43e-6)"	72.7	16.9	10.2	11.8	15.5	0.3	44.3	6.4	11.6	33.6	16.3	8.2	4.0	8.6	32.0	35.5	89.2	18.2	54.2	37.5	10.2	10.0	26.9	22.8	111.0	10.9	13.2	2.9	26.0	54.3	3.9	5.2	50.8	17.6	26.0	14.0	20.4	45.4	7.8	29.6	14.8	15.9	21.5	13.1	35.8	25.9	14.4	11.8	1.7	17.0	76.0	48.4	32.4	26.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	36.5	39.0	0.0	0.1	12.1	46.4	0.0	11.6	46.6	2.5	0.9	15.6	71.8	0.0	37.4	2.3	57.6	44.2	0.2	8.2	2.4	0.1	0.0	0.6	42.4	51.7	4.4	0.0	0.0	4.5	2.1	17.8	8.8	98.5	64.8	0.0	0.0	0.0	69.8	0.0	0.0	0.0	0.1	70.9	17.7	0.0	0.0	0.0	46.3	5.5	0.0	0.0	4.9	2.6	0.4	0.6	0.0	0.1	40.9	24.2	4.2	0.4	24.5	0.0	0.0	0.0	35.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	10.2	15.5	6.4	11.6	10.2	10.0	13.2	2.9	17.6	11.8	536.0	334.5	11.8	4692.6	246.9	0.0	21.3	221.7	149.9	565.3	54.1	0.0	0.4	0.0	1034.2	4.3	1040.2	30.7	23.3	1399.4	0.7	167.3	2223.6	29.1	22.1	1.6	0.0	37.5	904.2	35.1	4.7	236.8	42.2	285.1	45.9	2.1	0.0	1835.5	0.9	165.5	0.2	0.0	316.9	211.2	1.4	1.2	221.8	1.1	4.8	7.1	5293.1
TMEM130	"DKFZp761L1417, FLJ42643"	ENSG00000166448	"Transmembrane protein 130"	Q8N3G9	7	98846488-98870771	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 49.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 4.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012928	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA012928: AB_1858085"	"unprognostic (1.36e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.97e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.73e-1)"	1.3	28.2	27.3	2.0	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0.0	1.6	1.8	8.0	2.2	1.7	2.2	1.4	29.3	47.0	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24.0	1.3	25.8	2.7	1.9	1.0	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0.0	1.2	1.7	1.2	1.0	0.6	4.8	0.9	1.0	0.7	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.2	3.4	7.6	0.6	0.5	0.1	0.1	0.1	7.4	1.9	8.0	0.1	0.0	0.0	0.1	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	12.8	0.3	0.1	0.1	0.6	0.4	0.6	0.1	0.1	4.4	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.5	9.1	0.1	0.1	0.0	3.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.4	0.2	0.1	0.3	0.4	0.1	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1.0	0.7	0.6	4.8	1.0	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47.0	13.4	35.1	25.8	3.9	0.0	0.0	0.0	0.3	0.3	49.7	0.8	2.5	0.0	3.4	1.8	2.0	0.1	0.0	0.0	1.3	0.3	0.0	0.0	0.2	0.1	1.1	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.9	0.9	0.2	0.0	0.0	0.0	1.3	0.0	0.0	6.3	0.0	3.7	0.0	0.3	0.4	0.7	0.3	0.2	0.0	0.0	0.1
TMEM190	MDAC1	ENSG00000160472	"Transmembrane protein 190"	Q8WZ59	19	55376836-55378244	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 63.6;ovary: 17.7;testis: 21.5"	"Group enriched"	"Detected in some"	9	"Ciliated cells: 338.6;Early spermatids: 390.3;Late spermatids: 112.4"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 11.5;lung cancer: 2.6;ovarian cancer: 2.6"	"Region enhanced"	"Detected in some"		"hypothalamus: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 14.0;hTERT-RPE1: 5.0;SCLC-21H: 7.0"	"Region enriched"	"Detected in single"	7	"cerebellum: 0.9"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"							NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.24e-3)"	"unprognostic (3.97e-2)"		"unprognostic (1.42e-1)"	"unprognostic (5.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.38e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.93e-1)"	0.1	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0.5	5.7	0.1	0.5	0.1	0.1	1.4	1.1	0.1	63.6	0.1	0.1	0.6	2.7	0.1	0.1	11.8	0.1	0.1	0.1	17.7	0.1	0.0	3.0	0.3	1.0	0.1	0.0	0.1	0.1	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.5	21.5	0.3	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.4	2.5	0.0	0.5	0.0	0.0	0.2	0.7	0.3	0.6	0.1	1.8	1.5	2.6	0.2	0.7	0.4	4.5	0.0	0.0	0.0	4.3	0.2	0.0	2.7	14.0	0.9	0.0	0.1	0.2	0.0	0.1	0.0	5.0	0.0	0.2	0.0	3.4	0.0	2.0	0.3	0.0	0.5	1.7	0.8	0.2	1.6	1.4	0.0	1.3	7.0	1.3	1.4	1.8	0.6	1.3	0.8	0.0	0.0	0.2	1.1	0.2	0.7	0.5	3.2	0.8	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.5	0.6	2.7	0.1	0.1	1.0	0.3	0.0	5.8	0.0	0.0	0.0	0.4	0.0	0.0	338.6	33.0	0.0	0.0	0.1	0.0	0.1	390.3	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.1	0.0	0.1	0.0	8.5	0.0	0.0	112.4	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	2.4	1.7	0.0	0.3	0.0	0.0	0.0
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130365734-130443063	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 36.2"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 25.8;Erythroid cells: 23.3;Horizontal cells: 12.7;Intestinal endocrine cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 1.8;NK-cell: 7.1"	"Group enriched"	"Detected in many"	8	"NK-cells: 7.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 20.8;hTEC/SVTERT24-B: 33.6;hTERT-RPE1: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain					NA	NA					"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	6.0	17.0	4.6	7.6	2.7	0.0	5.6	0.6	6.2	12.1	7.1	1.5	0.0	4.7	36.2	8.1	1.9	10.6	4.2	4.3	3.1	2.2	14.4	1.2	7.0	3.9	1.1	2.5	26.0	3.9	0.4	11.6	2.1	1.4	4.3	15.1	6.8	2.0	0.8	2.6	2.3	5.3	13.5	0.9	1.2	3.9	7.8	0.2	7.4	3.6	0.3	2.1	8.7	4.0	0.5	0.0	0.0	0.0	7.1	1.8	0.4	0.0	0.0	0.1	0.0	6.0	7.6	0.0	5.2	6.4	5.6	9.9	8.1	0.0	0.0	0.0	10.9	1.2	1.2	0.5	0.0	20.8	7.4	0.0	0.0	0.0	0.3	2.7	0.1	0.0	8.5	0.0	33.6	6.7	16.9	0.2	0.1	0.0	0.7	2.6	0.0	0.0	0.0	4.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	6.5	6.4	2.0	0.5	0.9	4.1	0.0	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.6	0.0	1.0	0.5	1.8	1.0	0.0	0.1	0.3	0.1	0.0	7.1	0.0	0.0	0.0	0.4	4.6	2.7	0.6	6.2	3.1	2.2	1.1	2.5	1.4	0.2	0.0	0.3	0.0	0.0	1.8	25.8	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.2	6.4	23.3	0.0	1.3	4.1	0.0	0.0	0.0	0.2	12.7	23.6	0.0	0.0	1.3	5.5	0.0	1.7	0.0	1.4	0.5	0.2	7.2	9.9	9.2	1.9	0.0	2.3	0.5	1.5	1.3	0.5	1.5	3.3	0.0
TMEM233	IFITMD2	ENSG00000224982	"Transmembrane protein 233"	B4DJY2	12	119593459-119643066	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 88.0"	"Cell type enriched"	"Detected in some"	4	"granulocytes: 76.3"	"Cancer enriched"	"Detected in many"	6	"thyroid cancer: 12.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.5;hTERT-RPE1: 4.7;RH-30: 6.1;U-2197: 9.2;U-87 MG: 37.0"	"Not detected"	"Not detected"							"HPA047506, HPA075435"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047506: AB_10963068, HPA075435: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.66e-1)"	0.6	0.3	0.8	0.0	0.4	0.0	0.6	0.1	8.8	0.2	0.2	0.0	0.0	0.1	0.9	0.6	0.2	0.2	1.0	0.7	0.2	0.5	0.5	0.3	0.6	0.2	0.1	1.4	0.6	0.1	1.7	0.4	0.0	0.4	0.4	0.1	0.7	0.5	0.3	88.0	0.1	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.1	11.1	5.2	0.3	0.4	1.8	0.3	0.3	0.7	0.1	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	11.5	0.0	4.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.2	0.3	0.3	0.2	0.0	0.3	0.2	0.5	0.7	0.6	0.1	0.3	0.1	0.1	0.8	0.4	0.1	1.5	0.2	0.5	0.1	1.4	0.4	0.0	3.0	1.4	0.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	7.2	6.8	0.0	0.0	7.8	0.0	0.4	0.3	76.3	0.0	0.1	7.9	0.0	18.4	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	2.1	0.0	0.2	2.3	0.2	0.1	0.1	0.0	0.0	0.2
TMEM246	"C9orf125, MGC12992"	ENSG00000165152	"Transmembrane protein 246"	Q9BRR3	9	101473171-101533537	"Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 14.4;hTERT-RPE1: 16.4;OE19: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011318, HPA054041"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA011318: AB_2668482, HPA054041: AB_2682353"	"unprognostic (2.58e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.52e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.72e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.24e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.55e-8)"	"unprognostic (1.62e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.16e-2)"	3.4	10.2	10.8	3.1	19.4	0.8	2.9	23.2	31.1	17.1	12.6	7.6	1.6	8.0	5.9	4.0	11.0	13.5	7.0	27.3	17.6	20.6	4.6	2.6	5.4	0.8	10.8	14.3	19.4	10.9	19.6	9.2	1.0	23.2	7.0	10.8	8.1	4.6	9.7	4.3	11.2	7.1	6.7	8.5	1.8	15.1	2.9	4.0	0.0	4.3	4.4	2.9	4.7	8.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	8.1	6.3	0.0	0.2	0.1	0.0	5.4	7.9	3.9	7.9	0.4	4.3	0.0	1.8	9.8	0.4	12.8	0.0	8.9	2.4	0.0	3.2	4.4	6.1	0.0	0.3	0.0	0.0	3.5	14.4	0.0	2.1	16.4	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	7.8	26.2	0.0	0.0	3.2	0.0	5.9	1.5	10.7	10.1	3.0	0.0	0.0	1.6	0.0	7.5	0.0	6.1	3.8	0.0	0.0	0.5	0.0	0.0	8.7	0.0	2.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	10.8	19.4	23.2	31.1	17.6	20.6	10.8	14.3	23.2	4.0	20.8	0.3	0.0	13.2	4.7	38.3	42.4	33.1	9.4	10.3	15.7	3.9	0.0	0.0	12.9	2.2	5.9	16.1	0.0	15.0	0.1	1.5	11.6	0.0	6.2	0.0	15.9	23.6	1.3	0.3	0.8	4.9	0.0	0.0	1.0	35.3	1.4	12.8	38.6	10.6	4.2	4.4	12.9	5.2	2.3	1.0	8.7	0.0	0.0	26.7	23.0
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 20.3;SK-BR-3: 19.0;T-47d: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		4900000	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	4.8	15.0	15.0	3.7	23.3	1.7	12.0	28.0	36.5	9.4	19.4	9.5	6.7	35.5	10.1	21.2	9.0	9.2	7.1	6.4	11.9	17.0	14.7	10.6	8.0	3.5	10.7	19.5	19.4	14.1	17.3	15.9	4.9	14.0	12.5	3.2	14.4	16.1	15.5	12.7	6.2	26.2	8.7	9.7	4.0	6.7	3.9	5.1	1.5	12.7	4.3	4.6	8.3	6.1	3.8	3.4	0.5	0.2	6.6	11.1	3.8	1.8	0.4	3.3	5.3	3.4	0.5	3.2	2.9	5.5	2.7	5.6	14.7	10.4	0.1	11.4	2.8	6.2	8.2	0.0	10.0	2.4	6.3	6.1	0.2	2.9	3.4	9.0	0.1	0.2	4.2	6.1	3.0	0.5	20.3	3.9	7.5	1.3	6.5	2.7	2.2	3.1	0.2	2.7	0.0	7.1	4.3	2.3	6.5	14.1	0.2	9.8	6.5	2.8	19.0	0.0	5.1	24.7	0.3	1.3	1.2	6.1	0.2	0.8	6.6	4.3	1.6	0.2	0.1	0.1	0.5	0.2	0.2	5.6	0.2	7.5	3.8	7.9	3.1	0.5	3.0	11.1	5.8	0.4	6.6	0.2	3.4	6.1	3.8	15.0	23.3	28.0	36.5	11.9	17.0	10.7	19.5	14.0	5.1	6.0	3.8	3.4	10.2	5.0	24.2	5.0	2.5	10.7	7.9	15.7	27.5	30.1	10.0	14.8	1.7	4.9	1.4	0.0	5.8	13.6	6.0	5.5	9.2	7.7	2.5	11.1	10.9	2.5	0.0	3.8	21.6	0.2	6.8	5.4	3.2	24.3	5.9	1.4	21.9	20.2	34.1	0.0	6.1	4.1	5.1	3.1	13.6	4.1	2.9	2.7
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 148.3"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA					"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	2.6	12.8	36.9	2.5	39.4	1.7	1.9	41.9	148.3	2.2	2.9	7.5	0.0	2.0	2.5	2.0	2.5	2.1	2.9	3.5	39.9	49.6	1.9	1.8	1.9	1.8	17.7	32.8	1.8	2.8	4.9	13.2	2.3	24.1	2.2	2.2	1.9	2.3	2.6	2.5	1.8	3.0	3.1	7.3	1.7	2.0	2.4	5.2	0.0	1.8	0.0	1.7	2.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.2	20.4	24.8	1.2	0.0	2.1	0.4	0.8	0.4	0.0	1.0	0.1	14.6	1.3	2.0	0.3	6.0	0.0	0.7	0.1	0.9	0.0	0.3	14.8	3.8	0.0	0.3	9.1	0.0	0.2	0.7	13.4	0.0	0.8	0.0	0.1	0.5	0.9	0.1	0.0	1.8	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	12.1	1.4	0.0	0.0	0.2	0.2	0.0	0.2	0.4	4.9	0.1	1.3	3.0	1.1	0.1	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	36.9	39.4	41.9	70.3	39.9	49.6	17.7	32.8	24.1	5.2	0.0	0.0	0.0	0.2	0.0	92.0	0.4	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	47.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	72.1	0.3	0.0	0.0	0.0	22.8	0.0	2.7	2.6	0.9	0.1	0.1	0.0	0.0	0.0
TMEM95	"MGC129793, UNQ9390"	ENSG00000182896	"Transmembrane protein 95"	Q3KNT9	17	7355123-7357219	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	21	"testis: 19.3"	"Group enriched"	"Detected in some"	23	"Early spermatids: 20.4;Late spermatids: 25.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;BJ: 1.0;hTERT-RPE1: 1.4"														"Intracellular and membrane"	NA	NA							"unprognostic (1.54e-1)"				"unprognostic (1.03e-1)"		"unprognostic (1.15e-1)"		"unprognostic (5.15e-2)"				"unprognostic (7.42e-2)"			"unprognostic (7.44e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0
TNS2	"C1-TEN, KIAA1075, TENC1"	ENSG00000111077	"Tensin 2"	Q63HR2	12	53046969-53064372	"Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 80.4;Leydig cells: 131.2;Peritubular cells: 107.1;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.2;ASC TERT1: 28.1;HHSteC: 21.7;HSkMC: 30.8;hTERT-RPE1: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034659	Approved					NA	Yes					"HPA034659: AB_10603349"	"unprognostic (1.04e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.97e-3)"	"prognostic favorable (1.72e-4)"	"prognostic favorable (9.32e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-2)"	69.5	26.5	13.2	12.8	17.4	0.8	43.9	8.1	14.7	37.4	22.1	17.5	22.0	9.7	35.3	23.6	20.1	30.4	32.9	34.2	13.3	9.8	21.1	18.7	25.8	16.5	15.8	10.5	48.6	18.0	14.8	13.0	22.0	14.6	23.7	8.4	33.7	21.4	29.6	38.7	11.2	14.8	25.0	13.4	27.9	16.7	16.6	16.0	0.6	23.2	26.5	7.2	24.1	47.6	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.7	7.2	0.9	0.7	41.2	28.1	0.2	4.0	9.5	2.1	1.1	0.5	1.9	0.0	8.9	11.0	0.9	0.5	0.0	2.6	0.8	0.1	0.2	0.1	7.8	3.8	21.7	0.1	0.1	30.8	0.1	2.8	1.6	21.9	12.6	0.1	0.2	0.1	8.7	1.7	0.0	0.0	0.6	0.5	2.0	0.2	2.3	0.1	2.9	0.1	0.4	0.9	1.5	0.8	3.1	0.6	9.1	0.2	17.9	4.5	5.4	1.6	0.7	0.2	0.0	0.0	7.2	0.1	7.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	17.4	8.1	14.7	13.3	9.8	15.8	10.5	14.6	16.0	3.0	18.8	0.0	7.4	0.0	19.6	7.3	7.6	2.7	4.5	5.2	0.0	0.4	3.3	3.6	1.9	56.1	0.0	0.0	3.7	0.3	14.3	3.4	0.0	28.2	1.9	28.6	1.2	80.4	7.1	2.9	131.2	1.3	0.0	0.0	4.2	37.3	2.5	4.2	107.1	2.2	12.0	148.8	8.8	2.3	3.6	0.0	0.7	0.0	2.4	2.2
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.6;hTERT-RPE1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA					"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	18.1	28.6	16.0	15.8	24.8	9.7	17.7	67.8	28.1	19.1	19.1	30.8	23.6	17.0	23.9	19.7	21.8	19.2	25.3	46.5	18.0	11.4	31.2	15.2	18.6	13.6	34.4	17.9	25.6	30.3	28.5	25.0	16.4	28.4	16.3	17.5	26.7	29.9	28.7	28.4	13.2	19.4	16.9	22.1	18.0	11.3	9.7	27.8	5.4	32.5	16.1	24.8	17.4	15.5	5.5	9.3	5.0	13.7	8.6	3.4	3.8	4.8	14.8	1.7	2.1	13.3	15.1	5.0	6.9	49.6	3.7	4.4	10.9	16.9	11.2	10.5	7.1	12.1	6.1	3.9	12.4	5.0	1.3	3.0	4.2	7.5	6.0	17.3	1.4	9.5	14.3	6.3	7.2	12.7	41.5	5.6	3.2	4.7	4.0	4.5	5.9	0.4	22.1	2.8	6.0	7.5	0.8	2.1	21.8	11.9	17.9	2.1	3.3	5.6	14.5	5.8	3.6	4.6	13.5	2.3	5.5	2.7	7.5	4.3	6.7	4.0	9.7	16.2	3.5	4.1	5.0	13.7	1.2	1.7	2.3	2.1	3.5	2.4	2.3	9.3	5.5	3.4	2.1	0.5	8.6	0.3	4.9	1.1	3.8	16.0	24.8	67.8	28.1	18.0	11.4	34.4	17.9	28.4	27.8	8.9	18.7	3.7	4.9	4.0	16.8	28.8	12.7	12.0	9.1	26.2	15.7	5.9	1.7	11.7	10.3	4.4	26.0	0.0	15.9	2.6	8.7	9.8	31.1	17.1	18.6	47.7	27.6	19.6	17.3	8.7	19.8	9.6	6.8	4.6	24.8	20.4	10.4	19.9	20.1	17.5	13.4	0.0	10.3	3.0	2.0	3.4	5.5	6.1	15.8	14.8
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 12627.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 206.7;SuSa: 259.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"		NA	NA		280000000	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavorable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	33.8	22.3	27.0	1.3	9.4	5.9	88.9	95.4	35.1	58.7	43.6	15.7	6.7	0.1	43.8	95.3	39.4	18.8	22.9	15.3	39.1	0.8	3.2	5.0	24.1	7.6	26.5	0.2	1.1	8.3	8.8	48.2	12.8	206.7	15.3	0.8	0.5	1.2	44.8	17.5	1.5	0.4	32.1	8.0	3.8	0.5	9.5	0.9	83.8	18.7	6.4	4.4	11.4	18.1	4.0	259.0	13.2	0.9	70.7	77.6	38.1	11.5	67.6	0.3	0.2	0.4	21.9	1.3	53.7	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3	53.6	87.9	11.7	166.6	63.8	52.3	12627.3	392.4	116.4	116.0	301.8	361.3	128.4	159.2	2265.1	4.5	128.8	537.1	0.0	1464.0	2646.2	335.9	214.6	50.8	122.9	165.5	49.3	257.1	251.7	29.3	13.2	189.8	54.2	77.6	57.7	811.2	43.7	1740.7	585.7	1062.5	207.5	461.5	1021.9	1520.7	21.6	75.4	44.2	86.2	21.9	280.4	186.5
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 1091.5;tongue: 332.2"	"Group enriched"	"Detected in many"	4	"Peritubular cells: 1947.8;Sertoli cells: 2186.0;Smooth muscle cells: 3115.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	727	"plasmacytoid DC: 76.4"	"Lineage enriched"	"Detected in single"	727	"dendritic cells: 76.4"	"Cell line enhanced"	"Detected in many"		"BJ: 196.4;fHDF/TERT166: 107.2;hTERT-RPE1: 123.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA047089, HPA053624"	Approved					NA	NA		290000000			"HPA047089: AB_2679928, HPA053624: AB_2682210"	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavorable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	14.5	8.2	1.8	24.5	1.6	0.7	9.1	3.7	1.7	47.5	101.0	1.4	76.0	8.4	86.6	51.1	166.5	26.8	100.3	34.6	1.9	1.4	9.5	1.1	10.0	5.3	1.5	3.1	29.2	2.2	1.1	2.6	8.6	3.4	72.2	9.6	15.0	21.0	81.0	1091.5	4.2	27.4	231.7	1.6	4.7	48.7	13.4	0.6	0.2	9.3	332.2	22.0	190.7	38.6	0.0	76.4	0.1	0.0	0.0	0.0	0.4	29.7	22.8	16.0	2.6	30.2	80.8	9.8	196.4	80.1	83.2	56.5	0.9	1.9	0.0	17.6	107.2	11.7	0.6	0.2	24.2	38.6	54.9	0.7	0.7	81.3	0.9	48.2	0.1	8.0	94.3	3.8	62.2	0.0	123.3	19.5	1.9	0.3	0.0	83.6	1.1	0.1	2.0	20.2	0.1	1.3	1.3	29.6	0.2	2.5	0.5	0.2	1.0	37.3	0.6	1.3	24.1	0.5	2.1	2.3	1.2	45.4	0.9	56.0	0.0	0.1	0.2	2.8	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.4	0.0	0.4	1.8	1.6	3.7	1.7	1.9	1.4	1.5	3.1	3.4	0.6	3.0	5.5	3.2	76.3	50.7	0.8	590.1	2.5	9.4	22.7	7.0	0.0	10.2	0.0	16.3	3.1	80.7	0.4	0.0	5.0	76.5	194.5	31.7	2.3	1.3	30.2	1.6	2.4	259.7	5.9	15.9	262.1	16.2	64.1	10.8	1.3	9.5	12.0	0.0	1947.8	0.3	0.8	2186.0	3115.2	2.3	25.4	37.4	12.2	3.5	1.6	26.2
TRHDE	"PAP-II, PGPEP2, TRH-DE"	ENSG00000072657	"Thyrotropin releasing hormone degrading enzyme"	Q9UKU6	12	72087266-72670757	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;pancreas: 19.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.7;Late spermatids: 47.8;Leydig cells: 27.3;Peritubular cells: 12.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.9"	"Region enhanced"	"Detected in many"		"cerebellum: 30.3"	"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BJ: 20.8;BJ hTERT+: 20.2;EFO-21: 10.9;HBF TERT88: 7.4;hTERT-RPE1: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		6200000				"unprognostic (3.56e-2)"	"unprognostic (4.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.44e-6)"	"unprognostic (1.77e-1)"	"unprognostic (6.37e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.14e-4)"	"unprognostic (2.40e-1)"	"prognostic favorable (1.53e-7)"	"unprognostic (2.55e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.94e-2)"	6.2	2.2	2.9	1.0	4.7	1.0	7.6	30.3	12.3	10.2	2.4	0.1	2.5	4.8	2.7	1.7	0.9	2.5	2.5	2.2	7.3	2.8	9.9	1.5	3.0	0.6	1.2	5.5	6.5	19.4	0.4	1.6	0.7	1.5	5.5	1.5	1.0	2.4	5.8	0.7	0.8	4.2	1.2	0.9	4.8	1.1	1.7	0.5	0.0	0.5	0.4	1.0	2.8	7.6	0.2	0.0	1.0	0.3	0.3	0.0	0.0	2.4	0.0	0.4	0.0	1.1	0.0	6.7	20.8	20.2	2.0	1.4	0.0	0.0	0.0	10.9	3.0	2.1	0.2	3.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.0	0.0	0.0	0.0	6.9	4.6	2.0	0.0	0.0	0.0	0.0	0.4	0.0	4.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	2.9	4.7	30.3	12.3	7.3	2.8	1.2	5.5	1.5	0.5	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	1.4	0.0	1.8	0.0	0.0	3.3	0.0	30.7	0.0	6.9	0.0	2.2	0.3	0.5	0.2	0.0	1.3	0.2	0.0	0.0	0.0	0.0	47.8	27.3	0.3	0.0	0.0	1.5	0.3	2.1	2.9	12.7	7.4	0.6	0.0	0.4	0.1	0.7	0.0	0.1	0.0	0.7	0.1
TRIM61	RNF35	ENSG00000183439	"Tripartite motif containing 61"	Q5EBN2	4	164954446-164977668	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 16.1;thyroid gland: 15.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 14.4;Late spermatids: 9.0;Spermatocytes: 18.1"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HHSteC: 9.7;HSkMC: 6.5;hTERT-RPE1: 5.2;SuSa: 6.9;U-266/70: 12.9;U-266/84: 6.5"									HPA049109	Uncertain		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA049109: AB_2680636"	"unprognostic (2.05e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.92e-1)"	"unprognostic (9.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.32e-2)"	2.4	5.4	1.8	3.0	2.5	3.3	1.6	1.3	2.1	2.6	1.4	1.1	7.2	2.2	2.8	1.9	0.8	3.5	3.1	5.9	2.4	3.0	1.0	1.1	2.1	2.9	2.7	1.3	5.8	0.9	1.5	6.8	1.8	3.8	2.1	1.1	2.9	0.9	1.9	1.2	1.1	1.7	2.1	4.2	4.7	1.5	16.1	1.6	2.7	15.5	0.7	2.8	3.0	5.2	5.5	5.1	3.6	1.3	7.8	4.1	1.5	0.2	0.4	0.9	0.8	0.6	0.6	0.6	2.4	0.8	0.0	0.0	0.3	0.3	0.7	0.2	3.5	0.2	0.3	0.6	0.6	0.4	0.4	0.5	0.2	0.5	0.7	9.7	0.5	0.6	6.5	0.5	2.1	0.2	5.2	0.2	0.3	0.5	1.4	0.3	0.4	0.3	0.7	3.8	0.0	0.0	0.5	0.2	1.0	0.3	0.9	0.8	0.5	0.1	0.3	0.4	6.9	0.3	0.3	0.7	1.2	0.4	0.1	0.2	12.9	6.5	0.4	0.3	0.2	0.3	3.6	1.3	0.1	3.3	1.1	3.4	3.6	1.6	3.3	1.5	5.5	4.1	4.0	0.5	7.8	0.8	5.1	0.4	1.5	1.8	2.5	1.3	2.1	2.4	3.0	2.7	1.3	3.8	1.6	0.0	3.5	2.2	0.6	0.2	0.7	1.7	0.0	0.0	0.0	3.5	3.9	0.1	0.0	0.3	14.4	0.3	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.4	1.0	1.6	0.0	0.0	0.6	9.0	1.1	0.3	0.0	2.8	0.0	2.8	0.1	0.0	1.4	2.5	0.3	0.0	0.3	18.1	3.4	0.0	0.2	2.9	0.0	0.5
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078024	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 24.2;Basal keratinocytes: 49.6;Club cells: 45.5;Early spermatids: 30.8;Late spermatids: 20.5;Suprabasal keratinocytes: 22.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 10.3;HHSteC: 11.7;hTCEpi: 6.9;hTEC/SVTERT24-B: 14.7;hTERT-HME1: 8.4;hTERT-RPE1: 26.0;U-87 MG: 9.5"									HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	38400		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (6.47e-4)"	"unprognostic (3.26e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.03e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.74e-3)"	5.1	1.7	0.7	2.0	1.1	0.2	19.1	0.5	0.8	5.4	4.6	1.4	6.6	1.5	4.2	0.7	14.1	1.1	14.1	18.7	1.4	0.8	1.6	17.3	4.6	1.8	1.2	1.7	1.1	0.8	0.2	1.5	0.4	2.3	16.4	1.7	1.0	3.5	6.8	2.3	1.7	2.7	12.6	4.6	1.0	2.6	7.9	1.1	0.3	4.1	3.2	2.3	10.0	6.0	0.0	0.0	0.0	0.5	0.0	2.1	0.3	0.0	0.0	0.0	1.2	1.6	10.3	0.0	0.0	1.5	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.3	0.5	0.0	1.6	1.8	0.1	0.0	11.7	0.3	0.0	0.2	6.9	14.7	8.4	26.0	0.0	4.3	0.1	0.0	2.1	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.9	0.0	0.7	0.0	0.0	0.6	0.0	0.0	2.7	0.0	0.0	9.5	0.2	0.4	0.0	0.5	0.0	0.9	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.7	1.1	0.5	0.8	1.4	0.8	1.2	1.7	2.3	1.1	0.0	1.9	0.0	24.2	49.6	0.0	5.2	0.0	2.7	45.5	0.0	0.0	0.0	0.0	0.1	30.8	4.7	0.0	0.0	0.0	0.0	2.1	4.0	0.0	8.3	0.2	0.0	0.0	4.9	0.0	20.5	0.6	0.2	3.3	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	3.1	0.3	0.4	22.0	0.0	0.0	0.0	2.1
TSPAN10	OCSP	ENSG00000182612	"Tetraspanin 10"		17	81637171-81648749	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	29	"retina: 117.4"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 12.2;Horizontal cells: 12.7"	"Cancer enriched"	"Detected in many"	15	"melanoma: 32.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 6.2;SK-MEL-30: 17.9;U-138 MG: 6.5;U-87 MG: 8.2"	"Region enriched"	"Detected in single"	12	"olfactory region: 1.6"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.81e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.74e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.58e-1)"	1.0	0.1	0.1	1.3	0.1	0.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.9	1.1	0.5	0.3	0.7	0.1	0.1		0.1	0.2	0.5	2.2	0.1	0.1	0.2	0.9	0.0	0.1	1.4	0.2	1.1	0.0	117.4	0.3	1.0	0.1	4.0	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.4	0.1	0.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	1.9	0.2	0.2	0.6	0.7	0.2	1.9	6.0	2.9	1.7	0.6	3.2	0.8	0.7	1.8	1.6	0.1	0.1	0.4	0.3	0.6	3.6	0.0	0.4	0.4	0.4	0.0	1.1	0.7	0.8	3.4	0.1	6.2	0.0	0.7	0.0	0.2	2.8	0.2	0.1	0.4	0.2	0.0	2.9	1.3	0.0	0.0	0.2	0.5	0.0	1.3	3.3	0.4	17.9	1.7	3.6	0.4	0.1	6.5	2.0	0.5	1.7	0.0	0.0	0.0	8.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	8.2	0.5	2.3	0.0	1.7	1.4	5.1	6.7	4.5	12.2	3.9	1.6	8.3	2.4	0.6	1.0	1.3	0.0	2.0	4.6	1.4	1.9	7.0	1.0	7.5	12.7	0.0	3.7	1.3	1.8	1.4	0.9	0.0	0.0	0.8	5.2	1.0	0.0	1.1	2.2	4.9	0.0	0.5	2.6	6.4	0.0	1.1	0.0	0.9	0.9
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.5	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.4	2.2	1.7	5.2	0.0	35.1	1.9	1.9	1.2	1.1	0.0	1.5	1.7	0.7	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	9.8	0.0	6.9	0.0	0.5	0.0	0.4	4.6	0.7	8.0	1.7	0.9	0.0	0.5	0.0	0.2	3.2	1.8	2.9	2.1	0.9	0.1	4.9	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.3	0.2	0.0	0.0	15.4	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8	0.0	1.1	0.0	22.5	7.1	0.2	9.2	0.0	10.7	2.3	10.4	0.0	0.1	0.0	16.3	10.8	15.0	0.0	0.0	2.2	3.1	3.1	10.9	0.0	0.0	0.6	0.0	37.7	5.5	0.8	2.7	0.6	0.9	3.3	0.0	0.8	0.0	7.7	0.0	2.8	1.0	0.4	6.5	20.2	0.1	0.9	2.4	0.2	5.0	1.0	9.2
TXNIP	"ARRDC6, EST01027, HHCPA78, THIF, VDUP1"	ENSG00000265972	"Thioredoxin interacting protein"	Q9H3M7	1	145992435-145996600	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Sertoli cells: 1177.1;T-cells: 976.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031085, HPA053694"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA031085: AB_10601706, HPA053694: AB_2682232"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.22e-3)"	127.7	10.6	4.1	17.0	4.6	10.5	73.6	2.5	6.0	45.9	49.8	16.1	25.0	6.3	39.3	22.8	41.0	20.3	20.4	55.3	4.8		34.8	11.7	52.3	82.6	6.5	4.2	34.1	25.8	9.3	20.2	19.1	8.3	47.4	16.1	18.8	18.5	19.5	97.0	15.3	27.7	34.6	9.2	39.0	13.6	23.1	6.0	29.0	85.3	16.0	41.5	52.5	32.3	64.9	35.5	134.9	58.3	65.3	90.0	132.5	5.9	0.0	1.4	0.1	33.1	109.0	3.3	7.1	14.4	6.5	8.9	3.8	8.1	1.6	42.4	1.9	1.0	1.6	1.4	13.5	17.4	7.8	0.7	4.8	2.1	3.4	1.5	19.9	10.2	145.0	73.9	13.2	23.2	87.5	2.5	6.7	19.3	13.4	3.3	8.1	3.3	19.0	4.0	12.0	5.3	3.0	11.9	51.8	16.9	13.3	6.8	11.1	30.7	8.9	24.4	3.0	3.2	28.5	6.1	18.0	1.1	33.6	11.6	18.8	17.9	1.5	4.4	9.2	9.4	94.7	53.3	123.0	90.0	58.3	83.1	58.8	76.5	79.9	35.5	64.9	76.0	80.3	134.9	65.3	49.9	16.7	70.6	132.5											211.4	256.3	523.2	152.7	62.8	5.2	378.6	219.1	167.3	228.6	258.2	27.5	4.8	381.3	68.3	6.0	390.7	127.9	140.2	46.4	5.0	157.0	217.7	358.0	65.3	218.0	6.4	157.7	332.7	859.8	16.4	606.1	469.7	102.9	128.0	291.4	3.4	148.2	357.3	420.4	90.8	3.3	1177.1	168.0	6.4	34.1	63.1	9.2	976.9	145.3	211.3
UBE2Q2L		ENSG00000259511	"Ubiquitin conjugating enzyme E2 Q2 like"	H0YL09	15	84172490-84182234	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ovary: 6.5;testis: 8.1"	"Group enriched"	"Detected in many"	4	"Early spermatids: 15.0;Spermatocytes: 14.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 1.9;K-562: 5.8;Karpas-707: 4.8;RPMI-8226: 1.7;RPTEC TERT1: 1.6;U-266/70: 3.4"															NA	NA							"unprognostic (3.37e-2)"			"unprognostic (1.48e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.66e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.16e-2)"				0.8	1.8	0.3	1.0	0.2	0.7	0.8	0.0	2.3	1.2	1.2			0.0	1.3	0.0	0.3	0.8	1.3	2.4	0.4	0.5	0.1	0.0	0.2	0.0	0.3		6.5	3.0	2.2	0.9	0.0		0.7	0.0		0.1	1.7	0.0	0.5	0.2	0.0	0.5	0.0	0.7	8.1			0.1		0.2	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											3.0	0.3	0.0	2.0	0.5	0.0	0.3	0.0	0.0	2.3	3.5	2.0	0.0	1.7	0.5	15.0	0.3	0.0	0.0	0.3	0.0	1.3	0.5	1.1	0.0	0.1	1.6	0.0	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	0.7	0.0	0.0	1.4	14.9	2.5	1.0	0.1	0.0	0.0	0.6
UBQLNL	"MGC20470, MGC26958"	ENSG00000175518	"Ubiquilin like"	Q8IYU4	11	5514393-5516705	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 31.9"	"Group enriched"	"Detected in some"	69	"Early spermatids: 172.7;Late spermatids: 509.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.4;hTERT-RPE1: 3.4;SK-BR-3: 2.4"															NA	NA						"unprognostic (2.86e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.43e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.52e-8)"	"unprognostic (1.17e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-5)"	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.6	0.6	0.3	0.2	0.2	0.1	0.5	1.2	0.2	0.4	0.2	0.2	0.2	0.0	0.5	0.4	0.3	0.2	0.2	0.2	1.6	0.3	0.1	0.2	0.2	0.2	0.8	0.1	0.2	0.3	0.2	0.2	0.5	0.3	0.3	0.2	0.8	0.1	31.9	0.2	0.2	0.6	0.2	0.2	0.2	0.4	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	1.0	0.7	0.5	0.2	0.4	0.3	0.4	0.0	0.5	0.0	0.2	0.5	0.6	0.2	0.1	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.3	1.6	2.4	0.0	0.1	3.4	0.0	0.7	0.1	0.0	0.4	0.1	0.0	1.0	0.0	0.2	0.6	1.6	0.0	0.0	0.4	0.1	0.0	0.0	0.0	2.4	0.3	0.4	0.0	0.0	0.3	0.1	1.0	0.0	0.0	1.6	0.4	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	172.7	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	1.8	0.0	509.3	4.9	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	3.4	2.5	0.1	0.2	0.0	0.1	0.0
UPP2	"UDRPASE2, UP2, UPASE2"	ENSG00000007001	"Uridine phosphorylase 2"	O95045	2	157876702-158136154	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"kidney: 40.1;liver: 22.1"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 11.6;Proximal tubular cells: 23.3"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;GAMG: 2.0;hTERT-RPE1: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035225, HPA035226"			Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			Nucleoplasm	"Vesicles, Mitochondria"	"HPA035225: AB_10604002, HPA035226: AB_10696503"	"unprognostic (1.87e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-2)"	1.2	0.4	1.8	0.3	4.1	0.3	1.6	6.9	2.0	0.4	0.3	1.5	0.7	0.3	1.2	2.4	1.0	0.4	2.5	0.8	2.9	1.2	40.1	22.1	0.3	0.4	1.2	0.9	0.6	0.4	0.3	3.9	0.4	1.3	2.3	0.3	1.1	1.7	0.7	0.3	0.6	0.4	0.3	2.3	0.3	0.3	0.4	1.0	0.0	0.5	0.0	0.7	0.4	0.2	0.8	0.0	1.0	0.1	0.0	0.2	0.0	0.3	0.2	0.6	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.9	0.0	0.7	0.8	0.9	0.0	0.0	0.0	0.1	1.1	0.6	1.2	1.4	0.3	0.0	0.3	0.6	0.6	0.4	0.4	0.5	0.0	0.4	0.8	0.1	0.0	0.2	0.2	0.0	0.0	1.2	0.1	0.4	0.3	1.2	0.4	1.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.8	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.0	1.8	4.1	6.9	2.0	2.9	1.2	1.2	0.9	1.3	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.6	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471465-83582303	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 557.1;Kupffer cells: 784.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 55.5;myeloid DC: 21.3"	"Group enriched"	"Detected in many"	31	"dendritic cells: 21.3;monocytes: 55.5"	"Cell line enhanced"	"Detected in some"		"AF22: 43.6;HSkMC: 29.6;hTERT-RPE1: 140.3;RPTEC TERT1: 55.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Approved	Vesicles	"Secreted to blood"	NA	NA		5200000	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (5.17e-4)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	33.3	18.3	14.8	53.2	10.3	20.1	12.3	4.8	16.2	25.2	8.4	17.9	1.7	3.6	14.5	23.5	9.0	7.6	23.2	35.7	19.8	8.9	8.5	3.1	25.8	21.2	13.9	9.8	5.3	3.2	3.7	2.0	52.0	14.4	8.9	8.9	3.3	6.5	4.1	9.0	9.3	4.7	33.9	18.2	18.4	6.2	8.7	19.4	1.1	5.7	6.5	2.3	24.4	9.8	0.0	21.3	1.2	55.5	0.1	0.1	17.7	0.0	0.8	43.6	0.0	17.7	12.2	0.0	0.3	0.8	0.3	0.2	0.4	0.0	0.0	6.7	15.7	0.5	0.0	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.3	0.8	0.0	0.0	29.6	0.0	18.5	0.1	140.3	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	7.4	0.0	1.4	0.0	9.1	0.0	55.4	0.0	0.5	2.2	0.0	0.0	0.0	5.0	0.0	0.0	16.8	13.3	0.0	24.4	25.0	0.0	0.0	0.0	6.1	0.0	2.3	1.2	55.5	0.1	0.1	7.7	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.9	0.1	0.8	0.4	0.0	17.7	14.8	10.3	4.8	9.8	19.8	8.9	13.9	9.8	14.4	19.4	17.9	29.9	3.0	4.4	34.3	0.0	6.8	30.6	25.4	30.7	24.4	0.0	7.1	0.0	1.6	0.8	12.1	0.0	0.0	0.6	5.1	557.1	1.5	11.6	2.1	24.5	0.0	0.0	23.4	784.4	0.7	17.3	132.2	42.2	5.4	0.0	0.0	19.5	0.0	110.7	1.2	0.0	0.0	33.9	0.3	0.4	25.1	9.6	4.4	0.0	0.8
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 90.2;hTERT-RPE1: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	22.4	15.4	27.9	19.7	35.0	40.8	15.4	29.7	90.2	20.3	23.1	13.8	19.6	1.0	24.8	51.8	13.9	28.9	18.3	14.9	21.5	1.9	7.8	10.7	15.0	5.7	19.2	2.1	16.4	33.7	4.0	27.5	25.1	88.6	27.1	1.8	7.7	2.2	33.8	3.8	0.3	2.5	13.2	10.8	54.5	3.7	14.6	2.8	29.1	29.1	1.0	4.1	16.5	18.7	8.5	25.7	8.6	3.2	36.2	22.2	9.3	10.7	27.7	0.4	0.9	4.4	25.9	6.0	6.2	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3	92.3	37.8	11.5	94.3	102.0	13.5	304.7	50.9	28.1	77.3	40.1	80.5	44.5	3.3	59.0	2.3	54.3	61.0	0.0	53.1	67.5	69.7	88.5	33.6	30.6	21.4	15.9	36.8	73.1	36.2	4.7	46.3	28.0	25.3	9.0	29.5	12.2	85.6	31.9	72.2	12.4	35.2	103.5	102.7	14.2	10.9	81.3	33.2	19.8	37.5	76.0
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 324.6;Muller glia cells: 340.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;eosinophil: 1.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.9;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 65.7;U-87 MG: 103.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000				"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	35.0	17.5	16.6	11.4	20.1	12.8	39.5	6.5	32.3	11.8	25.9	8.7	15.0	16.0	54.1	9.4	19.4	10.4	27.5	57.0	13.4	5.4	25.8	58.6	30.0	2.9	15.8	3.7	16.4	25.1	20.6	7.3	16.7	19.8	40.5	7.2	24.4	15.1	23.8	52.9	11.9	26.3	19.2	35.1	19.0	20.5	4.5	15.4	0.3	87.9	19.6	13.6	47.5	15.7	0.0	0.1	1.9	1.2	0.0	0.0	0.0	11.8	2.1	2.0	11.6	3.5	5.5	13.7	7.3	13.0	4.8	9.6	6.8	1.6	3.9	5.9	4.4	50.2	4.9	5.4	14.7	8.6	4.2	1.7	2.9	2.8	4.5	36.9	3.2	6.6	9.7	29.3	47.4	47.2	65.7	1.2	3.3	5.5	19.7	17.6	4.9	0.3	4.4	1.2	34.8	3.3	0.3	1.9	9.3	18.7	10.0	3.6	7.6	10.5	7.2	25.2	2.7	2.8	11.9	1.7	20.2	5.4	29.1	11.9	11.2	6.6	7.6	103.7	7.5	7.0	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.6	20.1	6.5	32.3	13.4	5.4	15.8	3.7	19.8	15.4	324.6	89.9	11.2	34.6	62.6	31.5	146.9	81.5	4.0	93.3	21.0	29.5	1.1	1.7	39.1	0.0	22.8	60.6	23.3	35.0	3.1	45.9	128.0	107.6	99.1	13.4	170.0	26.2	18.4	22.8	0.0	1.7	44.4	27.0	11.8	42.9	340.3	70.3	34.8	3.2	15.2	37.5	0.0	52.8	0.9	0.9	68.4	6.6	6.9	40.0	115.1
VEPH1	"FLJ12604, KIAA1692"	ENSG00000197415	"Ventricular zone expressed PH domain containing 1"	Q14D04	3	157259742-157533619	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 38.1;pituitary gland: 70.3"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 247.1;Alveolar cells type 2: 124.4;Early spermatids: 67.1;Late spermatids: 63.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 2.2;pons and medulla: 5.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.5;hTERT-RPE1: 26.3;HUVEC TERT2: 65.1;TIME: 38.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA026645	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Nucleoli, Cytosol"		"HPA026645: AB_1858741"	"unprognostic (4.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.17e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (7.75e-9)"	"unprognostic (2.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-4)"	"unprognostic (7.49e-2)"	0.5	16.0	0.3	0.2	0.3	1.1	1.4	2.2	3.5	1.9	0.4	0.7	2.0	0.2	0.4	12.1	0.2	3.4	1.1	0.4	0.8	0.5	20.7	0.6	38.1	0.1	0.7	0.1	1.1	8.6	0.7	70.3	1.6	5.5	1.2	0.3	17.7	6.9	4.9	0.2	0.7	0.2	0.1	0.3	2.3	0.6	1.7	0.2	0.1	1.1	0.5	0.6	0.5	0.8	0.0	0.0	1.5	0.7	0.0	0.0	5.1	1.8	0.2	4.3	0.0	2.5	9.4	0.0	11.0	24.5	3.3	4.8	0.3	1.7	0.0	4.3	11.8	0.5	0.0	0.1	0.2	18.3	0.0	0.0	1.8	0.2	0.0	0.8	0.0	0.0	2.7	0.1	14.0	2.8	26.3	65.1	0.0	0.6	0.0	8.9	0.2	0.0	0.0	1.7	0.5	1.6	0.0	0.3	0.0	1.6	0.9	0.1	0.0	0.3	0.5	4.3	0.0	18.9	0.0	38.7	13.1	0.4	4.5	15.1	0.0	0.0	0.0	10.5	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.1	0.3	0.3	2.2	0.4	0.8	0.5	0.7	0.1	5.5	0.2	247.1	124.4	0.0	0.2	1.5	0.0	0.3	12.7	14.7	26.1	29.6	2.0	1.6	39.7	5.5	67.1	0.0	0.0	0.0	8.7	0.1	0.4	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	63.8	1.4	0.4	27.0	1.0	0.2	0.8	2.0	2.8	0.4	24.1	0.3	0.0	0.0	0.3	0.6	0.4	0.0	0.0	0.6	0.1
ZNF385D	"FLJ22419, ZNF659"	ENSG00000151789	"Zinc finger protein 385D"	Q9H6B1	3	21412222-22373321	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 17.7;brain: 59.5;testis: 18.5"	"Group enriched"	"Detected in many"	5	"Early spermatids: 137.4;Horizontal cells: 305.1;Late spermatids: 198.0;Muller glia cells: 119.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	7	"cerebellum: 59.5"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.9;hTERT-RPE1: 4.2;RPTEC TERT1: 6.7;U-87 MG: 12.6"					"Low region specificity"	"Detected in all"			HPA036190	Uncertain					NA	NA					"HPA036190: AB_10602355"	"unprognostic (4.07e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-7)"	"unprognostic (8.70e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.76e-3)"	"unprognostic (2.15e-5)"	17.7	1.1	4.0	2.2	5.9	1.1	5.3	59.5	9.1	4.3	2.2	0.1	1.2	1.2	2.3	3.9	4.0	2.3	4.7	3.9	3.9	3.6	3.2	0.9	1.9	2.0	7.4	4.0	1.7	2.5	1.3	0.5	0.7	4.1	3.0	1.8	4.1	1.9	3.2	2.8	2.4	1.3	3.5	1.9	1.3	1.3	18.5	1.7	0.1	1.5	5.2	2.0	4.0	5.7	0.7	0.3	2.0	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.5	4.9	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	4.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.3	0.0	1.4	0.0	0.0	0.0	6.7	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.7	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.2	4.0	5.9	59.5	9.1	3.9	3.6	7.4	4.0	4.1	1.7	11.9	14.9	0.5	0.6	8.7	41.0	2.8	0.0	8.1	35.2	1.8	7.9	0.2	23.2	0.4	137.4	35.0	1.1	0.0	0.6	0.1	13.6	1.3	4.7	5.9	0.4	305.1	0.0	3.7	0.0	198.0	15.5	5.6	11.8	0.0	0.5	119.7	1.1	0.0	12.7	6.2	28.4	12.9	14.4	9.1	1.3	6.8	0.1	0.0	0.4	0.1
ZNF471	"KIAA1396, Z1971"	ENSG00000196263	"Zinc finger protein 471"	Q9BX82	19	56507843-56530221	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 17.3;Ciliated cells: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 9.5;hTERT-RPE1: 13.8;SuSa: 10.4"	"Low region specificity"	"Detected in all"							HPA066695	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066695: AB_2685704"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.47e-4)"	"unprognostic (9.36e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-3)"	5.8	7.2	18.5	4.1	18.5	3.0	7.8	23.1	19.3	7.8	8.2	11.2	5.9	2.1	14.2	17.8	5.4	9.8	7.4	5.8	17.4	7.5	5.5	2.6	6.2	3.2	12.2	13.3	24.7	3.9	16.3	10.9	6.6	15.1	9.3	5.1	4.6	6.5	8.5	4.9	10.1	3.2	10.4	11.5	4.6	4.5	8.7	21.3	1.6	10.6	3.1	2.2	6.7	9.9	3.1	1.6	5.4	1.3	3.0	2.1	0.3	0.5	0.5	5.4	0.8	4.5	5.1	0.6	4.9	1.8	2.2	2.0	0.8	0.8	0.8	3.3	5.2	4.4	0.5	0.7	0.4	2.2	1.1	2.0	3.9	1.3	0.6	4.4	1.1	3.5	9.5	1.8	2.9	0.2	13.8	0.2	0.6	1.2	1.7	2.5	0.6	0.5	0.7	1.4	0.4	2.1	0.6	3.5	0.5	3.9	4.1	0.9	3.2	0.5	0.2	0.2	10.4	0.7	0.8	0.8	8.4	3.7	0.9	3.7	1.3	1.2	0.5	0.7	0.6	0.6	3.9	1.3	0.9	1.9	1.0	1.5	1.2	1.7	1.2	0.7	3.1	1.7	2.1	5.4	3.0	1.0	1.6	1.0	0.3	18.5	18.5	23.1	19.3	17.4	7.5	12.2	13.3	15.1	21.3	17.9	17.3	0.0	2.3	0.6	9.8	9.3	2.5	17.4	12.5	5.2	5.9	1.0	3.3	1.3	5.3	6.7	0.9	0.0	0.8	0.3	2.6	2.8	2.3	0.8	0.4	6.4	1.2	6.2	0.6	2.5	4.6	1.9	1.7	1.0	0.7	11.3	0.7	0.0	6.7	1.1	9.1	6.5	3.1	7.1	7.5	0.5	0.7	0.0	1.0	1.4
ZNF667	FLJ14011	ENSG00000198046	"Zinc finger protein 667"	Q5HYK9	19	56439325-56478065	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 27.9;Cone photoreceptor cells: 23.6;Horizontal cells: 30.2;Rod photoreceptor cells: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 10.1;hTERT-RPE1: 15.1;U-138 MG: 12.7"					"Low region specificity"	"Detected in all"			"HPA030731, HPA046673"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030731: AB_2673584, HPA046673: AB_2679746"	"unprognostic (6.10e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.91e-2)"	"unprognostic (4.81e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.26e-3)"	"unprognostic (8.55e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.77e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.34e-3)"	"unprognostic (3.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.55e-2)"	2.4	7.7	8.0	1.7	18.2	6.2	6.8	12.1	16.1	4.7	2.6	5.3	1.8	1.6	6.4	11.6	2.4	6.3	4.3	4.0	10.2	9.9	4.1	1.3	2.1	2.4	6.5	8.3	11.1	3.5	6.1	18.9	3.0	9.7	5.6	0.9	3.2	4.5	4.5	2.0	2.9	1.1	5.6	6.6	2.4	1.8	5.9	5.3	2.9	12.6	0.6	1.8	3.7	4.2	6.2	2.2	0.4	0.0	4.5	3.7	0.6	0.1	0.2	8.7	0.1	0.0	0.0	0.2	3.7	2.8	3.4	2.7	0.2	0.1	0.4	5.2	1.3	5.2	0.1	0.0	0.1	5.2	0.0	1.9	10.1	0.1	0.2	2.7	5.9	4.6	5.6	0.1	0.7	0.0	15.1	0.0	0.3	0.0	0.3	2.6	0.2	0.1	0.2	6.3	0.1	1.7	0.0	3.3	7.0	3.4	0.5	0.2	5.1	0.2	0.1	0.0	8.1	2.4	0.0	0.0	12.7	3.4	0.2	6.5	0.2	5.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.4	0.3	0.3	6.2	1.5	3.7	0.4	4.5	0.0	2.2	0.0	0.6	8.0	18.2	12.1	14.4	10.2	9.9	6.5	8.3	9.7	5.3	0.0	0.0	0.0	5.6	3.0	27.9	4.5	0.0	5.3	4.5	5.2	23.6	0.1	0.0	2.7	2.1	3.6	0.0	0.0	0.2	0.0	5.3	3.6	9.2	0.0	0.2	30.2	1.2	1.8	0.0	1.6	4.9	0.6	3.3	0.0	0.0	9.3	0.5	0.0	6.7	1.2	28.2	0.0	3.0	7.7	14.4	3.6	0.1	0.0	0.0	2.5